1	Influence	NN	O	influence	_	0	SENT_1	[p1l166t81r500b149],
2	of	IN	O	of	_	0	SENT_1	[p1l532t81r603b149],
3	ITPII	NNP	O	ITPII	nn	4	SENT_1	[p1l638t81r787b148],
4	Polymorphisms	NNPS	O	Polymorphisms	prep_of	1	SENT_1	[p1l820t83r1373b162],
5	on	IN	O	on	dep	1	SENT_1	[p1l1406t101r1491b149],
6	Decreases	NNP	O	Decreases	pobj	5	SENT_1	[p1l1529t83r1899b149],
7	of	IN	O	of	dep	1	SENT_1	[p1l1932t81r2003b149],

1	Hemoglobin	NN	O	hemoglobin	_	0	SENT_2	[p1l245t191r669b270],
2	During	IN	O	during	dep	1	SENT_2	[p1l707t191r947b270],
3	Treatment	NN	O	treatment	pobj	2	SENT_2	[p1l975t191r1351b257],
4	with	IN	O	with	_	0	SENT_2	[p1l1382t191r1531b257],
5	Pegylated	VBN	O	pegylate	prepc_with	3	SENT_2	[p1l1570t191r1917b270],

1	Interferon	NN	O	interferon	_	0	SENT_3	[p1l422t298r803b380],
2	,	,	O	,	_	0	SENT_3	[p1l422t298r803b380],
3	Ribavirin	NNP	O	Ribavirin	conj_and	1	SENT_3	[p1l843t299r1181b380],
4	,	,	O	,	_	0	SENT_3	[p1l843t299r1181b380],
5	and	CC	O	and	_	0	SENT_3	[p1l1217t299r1347b366],
6	Telaprevir	NNP	O	Telaprevir	conj_and	1	SENT_3	[p1l1381t299r1746b379],

1	Fumitaka	NNP	PERSON	Fumitaka	nn	4	SENT_4	[p1l134t446r292b483],
2	Suzuki	NNP	PERSON	Suzuki	nn	4	SENT_4	[p1l307t438r445b490],
3	,1	CD	NUMBER	,1	num	4	SENT_4	[p1l307t438r445b490],
4	Yoshiyuki	NNP	PERSON	Yoshiyuki	dep	11	SENT_4	[p1l462t446r630b493],
5	Suzuki	NNP	PERSON	Suzuki	nn	8	SENT_4	[p1l646t438r784b490],
6	,1	CD	NUMBER	,1	num	8	SENT_4	[p1l646t438r784b490],
7	Norio	NNP	PERSON	Norio	nn	8	SENT_4	[p1l802t450r897b483],
8	Akuta	NNP	PERSON	Akuta	dep	4	SENT_4	[p1l913t438r1036b490],
9	,1	CD	NUMBER	,1	dep	11	SENT_4	[p1l913t438r1036b490],
10	Hiton1i	NNP	O	Hiton1i	nn	11	SENT_4	[p1l1055t450r1170b483],
11	Sezaki	NNP	O	Sezaki	dep	19	SENT_4	[p1l1186t438r1318b490],
12	,1	CD	NUMBER	,1	num	14	SENT_4	[p1l1186t438r1318b490],
13	Miharu	NNP	PERSON	Miharu	nn	14	SENT_4	[p1l1336t446r1460b483],
14	Hirakawa	NNP	PERSON	Hirakawa	dep	11	SENT_4	[p1l1476t438r1663b490],
15	,1	CD	NUMBER	,1	num	14	SENT_4	[p1l1476t438r1663b490],
16	Yusuke	NNP	PERSON	Yusuke	nn	19	SENT_4	[p1l1680t446r1806b483],
17	Kawamuraf	NNP	PERSON	Kawamuraf	nn	19	SENT_4	[p1l1822t438r2026b490],
18	Tetsuya	NNP	PERSON	Tetsuya	nn	19	SENT_4	[p1l174t514r302b559],
19	Hosaka	NNP	PERSON	Hosaka	dep	27	SENT_4	[p1l316t504r468b556],
20	,1	CD	NUMBER	,1	num	19	SENT_4	[p1l316t504r468b556],
21	Masahjro	NNP	O	Masahjro	nn	24	SENT_4	[p1l487t512r645b549],
22	Kobayashjf	NNP	O	Kobayashjf	nn	24	SENT_4	[p1l663t504r859b559],
23	Satoshi	NNP	PERSON	Satoshi	nn	24	SENT_4	[p1l878t512r998b549],
24	Saito	NNP	PERSON	Saito	dep	19	SENT_4	[p1l1015t504r1121b556],
25	,1	CD	NUMBER	,1	num	27	SENT_4	[p1l1015t504r1121b556],
26	Yasuji	NNP	PERSON	Yasuji	nn	27	SENT_4	[p1l1138t516r1241b559],
27	Arase	NNP	PERSON	Arase	dep	36	SENT_4	[p1l1255t504r1375b557],
28	,1	CD	NUMBER	,1	num	27	SENT_4	[p1l1255t504r1375b557],
29	Kenji	NNP	PERSON	Kenji	nn	35	SENT_4	[p1l1394t516r1479b559],
30	Ikedaf	NNP	PERSON	Ikedaf	nn	35	SENT_4	[p1l1495t504r1616b557],
31	Mariko	NNP	PERSON	Mariko	nn	35	SENT_4	[p1l1635t513r1758b549],
32	Kobayashi	NNP	PERSON	Kobayashi	nn	35	SENT_4	[p1l1775t504r1972b559],
33	}	NNP	O	}	nn	35	SENT_4	[p1l1775t504r1972b559],
34	Kazuaki	NNP	PERSON	Kazuaki	nn	35	SENT_4	[p1l180t579r312b615],
35	Chayama	NNP	PERSON	Chayama	dep	27	SENT_4	[p1l328t570r506b625],
36	,5	CD	NUMBER	,5	dep	43	SENT_4	[p1l328t570r506b625],
37	Naoyuki	NNP	PERSON	Naoyuki	nn	43	SENT_4	[p1l522t579r661b625],
38	Kamatanif	NNP	PERSON	Kamatanif	nn	43	SENT_4	[p1l677t568r861b623],
39	‘	NNP	O	‘	nn	43	SENT_4	[p1l677t568r861b623],
40	Yusuke	NNP	PERSON	Yusuke	nn	43	SENT_4	[p1l876t579r1002b615],
41	Nakamuraf	NNP	PERSON	Nakamuraf	nn	43	SENT_4	[p1l1017t570r1220b623],
42	Yuzo	NNP	PERSON	Yuzo	nn	43	SENT_4	[p1l1236t582r1319b615],
43	Miyakawa	NNP	PERSON	Miyakawa	_	0	SENT_4	[p1l1337t567r1532b625],
44	,6	CD	NUMBER	,6	num	43	SENT_4	[p1l1337t567r1532b625],
45	and	CC	O	and	_	0	SENT_4	[p1l1548t579r1611b615],
46	Hiromitsu	NNP	PERSON	Hiromitsu	nn	47	SENT_4	[p1l1627t582r1798b615],
47	Kumadal	NNP	PERSON	Kumadal	conj_and	43	SENT_4	[p1l1814t571r1966b615],

1	Polymorphisms	NNS	O	polymorphism	dep	7	SENT_5	[p1l295t700r587b745],
2	of	IN	O	of	_	0	SENT_5	[p1l603t700r645b734],
3	the	DT	O	the	det	4	SENT_5	[p1l655t700r714b734],
4	inosine	NN	O	inosine	prep_of	1	SENT_5	[p1l729t702r864b734],
5	triphosphatase	NN	O	triphosphatase	dep	7	SENT_5	[p1l879t700r1155b745],
6	(	CD	NUMBER	(	num	5	SENT_5	[p1l1173t701r1208b741],
7	I	PRP	O	I	dep	13	SENT_5	[p1l1173t701r1208b741],
8	TPA	NN	O	tpa	nn	12	SENT_5	[p1l1208t701r1297b741],
9	)	NN	O	)	nn	12	SENT_5	[p1l1208t701r1297b741],
10	gene	NN	O	gene	nn	12	SENT_5	[p1l1316t713r1400b746],
11	inﬂuence	NN	O	inﬂuence	nn	12	SENT_5	[p1l1416t700r1586b734],
12	anemia	NN	O	anemia	dep	7	SENT_5	[p1l1602t702r1737b734],
13	during	IN	O	during	_	0	SENT_5	[p1l1752t700r1878b746],
14	pegylated	VBN	O	pegylate	pcomp	13	SENT_5	[p1l1892t713r1993b746, p1l294t753r386b788],
15	interferon	NN	O	interferon	nn	17	SENT_5	[p1l405t753r593b787],
16	(	NN	O	(	nn	17	SENT_5	[p1l615t754r819b794],
17	PEG	NN	O	peg	dobj	14	SENT_5	[p1l615t754r819b794],
18	.	.	O	.	_	0	SENT_5	[p1l615t754r819b794],

1	—	NN	O	—	_	0	SENT_6	[p1l615t754r819b794],
2	.	.	O	.	_	0	SENT_6	[p1l615t754r819b794],

1	IFN	NN	O	ifn	nn	2	SENT_7	[p1l615t754r819b794],
2	)	NN	O	)	nsubj	5	SENT_7	[p1l615t754r819b794],
3	and	CC	O	and	_	0	SENT_7	[p1l842t753r912b788],
4	ribavirin	NNP	O	ribavirin	nsubj	5	SENT_7	[p1l931t753r1094b787],
5	(	CD	NUMBER	(	_	0	SENT_7	[p1l1116t754r1231b794],
6	RBV	NN	O	rbv	nn	8	SENT_7	[p1l1116t754r1231b794],
7	)	NN	O	)	nn	8	SENT_7	[p1l1116t754r1231b794],
8	therapy	NN	O	therapy	dobj	5	SENT_7	[p1l1253t753r1402b799],
9	,	,	O	,	_	0	SENT_7	[p1l1253t753r1402b799],
10	but	CC	O	but	_	0	SENT_7	[p1l1423t753r1487b788],
11	their	PRP$	O	they	poss	12	SENT_7	[p1l1505t753r1594b787],
12	effects	NNS	O	effect	conj_but	8	SENT_7	[p1l1613t753r1728b787],
13	during	IN	O	during	_	0	SENT_7	[p1l1748t753r1875b799],
14	triple	JJ	O	triple	amod	15	SENT_7	[p1l1893t753r1994b799],
15	therapy	NN	O	therapy	prep_during	5	SENT_7	[p1l295t807r439b852],
16	with	IN	O	with	_	0	SENT_7	[p1l451t807r535b841],
17	PEG	NN	O	peg	prep_with	15	SENT_7	[p1l552t809r741b846],
18	.	.	O	.	_	0	SENT_7	[p1l552t809r741b846],

1	—	NN	O	—	_	0	SENT_8	[p1l552t809r741b846],
2	.	.	O	.	_	0	SENT_8	[p1l552t809r741b846],

1	IFN	NN	ORGANIZATION	ifn	nsubjpass	9	SENT_9	[p1l552t809r741b846],
2	,	,	O	,	_	0	SENT_9	[p1l552t809r741b846],
3	RBV	NN	O	rbv	nsubjpass	9	SENT_9	[p1l759t809r852b846],
4	,	,	O	,	_	0	SENT_9	[p1l759t809r852b846],
5	and	CC	O	and	_	0	SENT_9	[p1l870t807r939b841],
6	telaprevir	NN	O	telaprevir	nsubjpass	9	SENT_9	[p1l955t807r1133b852],
7	are	VBP	O	be	auxpass	9	SENT_9	[p1l1149t820r1205b841],
8	not	RB	O	not	neg	9	SENT_9	[p1l1220t817r1284b841],
9	known	VBN	O	know	_	0	SENT_9	[p1l1299t807r1437b841],
10	.	.	O	.	_	0	SENT_9	[p1l1299t807r1437b841],

1	Triple	JJ	O	triple	amod	2	SENT_10	[p1l1455t807r1566b852],
2	therapy	NN	O	therapy	nsubj	7	SENT_10	[p1l1582t807r1726b852],
3	for	IN	O	for	_	0	SENT_10	[p1l1740t807r1795b841],
4	12	CD	DURATION	12	num	5	SENT_10	[p1l1814t810r1856b840],
5	weeks	NNS	NUMBER	week	prep_for	2	SENT_10	[p1l1872t807r1992b846],
6	,	,	O	,	_	0	SENT_10	[p1l1872t807r1992b846],
7	followed	VBN	O	follow	_	0	SENT_10	[p1l295t861r456b896],
8	by	IN	O	by	_	0	SENT_10	[p1l470t861r517b906],
9	PEG	NN	O	peg	prep_by	7	SENT_10	[p1l529t863r708b895],
10	.	.	O	.	_	0	SENT_10	[p1l529t863r708b895],

1	—	NN	O	—	_	0	SENT_11	[p1l529t863r708b895],
2	.	.	O	.	_	0	SENT_11	[p1l529t863r708b895],

1	IFN	NN	ORGANIZATION	ifn	nsubjpass	9	SENT_12	[p1l529t863r708b895],
2	and	CC	O	and	_	0	SENT_12	[p1l721t861r791b896],
3	RBV	NN	O	rbv	nsubjpass	9	SENT_12	[p1l805t863r896b895],
4	for	IN	O	for	_	0	SENT_12	[p1l907t861r962b895],
5	12	CD	DURATION	12	num	6	SENT_12	[p1l979t864r1021b895],
6	weeks	NNS	NUMBER	week	prep_for	1	SENT_12	[p1l1035t861r1156b901],
7	,	,	O	,	_	0	SENT_12	[p1l1035t861r1156b901],
8	was	VBD	O	be	auxpass	9	SENT_12	[p1l1170t875r1238b895],
9	given	VBN	O	give	_	0	SENT_12	[p1l1252t863r1351b907],
10	to	TO	O	to	_	0	SENT_12	[p1l1365t871r1401b895],
11	49	CD	NUMBER	49	num	12	SENT_12	[p1l1416t861r1462b897],
12	patients	NNS	O	patient	prep_to	9	SENT_12	[p1l1477t863r1624b906],
13	with	IN	O	with	_	0	SENT_12	[p1l1638t861r1722b895],
14	RBV	NN	O	rbv	nn	18	SENT_12	[p1l1737t863r1994b895],
15	—	CD	NUMBER	—	num	18	SENT_12	[p1l1737t863r1994b895],
16	sensitive	JJ	O	sensitive	amod	18	SENT_12	[p1l1737t863r1994b895],
17	(	NN	O	(	nn	18	SENT_12	[p1l298t915r372b955],
18	CC	NN	O	cc	prep_with	12	SENT_12	[p1l298t915r372b955],
19	at	IN	O	at	_	0	SENT_12	[p1l392t924r426b948],
20	rs1127354	NN	O	rs1127354	nn	21	SENT_12	[p1l445t915r656b955],
21	)	NN	O	)	prep_at	12	SENT_12	[p1l445t915r656b955],
22	and	CC	O	and	_	0	SENT_12	[p1l680t915r749b949],
23	12	CD	NUMBER	12	conj_and	12	SENT_12	[p1l772t918r814b948],
24	with	IN	O	with	_	0	SENT_12	[p1l833t915r917b948],
25	RBV-resistant	JJ	O	rbv-resistant	amod	27	SENT_12	[p1l937t917r1194b948],
26	(	NN	O	(	nn	27	SENT_12	[p1l1216t915r1373b955],
27	CA/AA	NN	O	ca/aa	prep_with	23	SENT_12	[p1l1216t915r1373b955],
28	)	CD	NUMBER	)	num	31	SENT_12	[p1l1216t915r1373b955],
29	IT	NNP	O	IT	nn	31	SENT_12	[p1l1395t916r1449b948],
30	PA	NN	O	pa	nn	31	SENT_12	[p1l1442t917r1495b948],
31	genotypes	NNS	O	genotype	dobj	9	SENT_12	[p1l1514t924r1699b960],
32	who	WP	O	who	nsubjpass	35	SENT_12	[p1l1718t915r1797b948],
33	had	VBD	O	have	aux	35	SENT_12	[p1l1818t915r1888b949],
34	been	VBN	O	be	auxpass	35	SENT_12	[p1l1907t915r1993b948],
35	infected	VBN	O	infect	rcmod	31	SENT_12	[p1l295t968r443b1002],
36	with	IN	O	with	_	0	SENT_12	[p1l456t968r540b1001],
37	hepatitis	NN	O	hepatitis	nn	39	SENT_12	[p1l555t968r714b1013],
38	C	NN	O	c	nn	39	SENT_12	[p1l730t970r760b1002],
39	virus	NN	O	virus	prep_with	35	SENT_12	[p1l773t970r865b1002],
40	`	``	O	`	_	0	SENT_12	[p1l883t968r1006b1008],
41	_	NN	O	_	tmod	35	SENT_12	[p1l883t968r1006b1008],
42	of	IN	O	of	_	0	SENT_12	[p1l1024t968r1067b1001],
43	genotype	NN	O	genotype	prep_of	41	SENT_12	[p1l1075t978r1245b1013],
44	1	CD	NUMBER	1	num	43	SENT_12	[p1l1263t971r1292b1001],
45	.	.	O	.	_	0	SENT_12	[p1l1263t971r1292b1001],

1	Decreases	VBZ	O	decrease	csubj	6	SENT_13	[p1l1309t970r1489b1001],
2	in	IN	O	in	_	0	SENT_13	[p1l1504t970r1541b1001],
3	hemoglobin	NN	O	hemoglobin	nn	4	SENT_13	[p1l1555t968r1780b1013],
4	levels	NNS	O	level	prep_in	1	SENT_13	[p1l1795t968r1894b1001],
5	were	VBD	O	be	cop	6	SENT_13	[p1l1907t981r1994b1001],
6	greater	JJR	O	greater	conj_and	6	SENT_13	[p1l295t1031r423b1067],
7	in	IN	O	in	_	0	SENT_13	[p1l437t1023r474b1055],
8	patients	NNS	O	patient	prep_at	6	SENT_13	[p1l488t1023r636b1066],
9	with	IN	O	with	_	0	SENT_13	[p1l649t1021r733b1055],
10	CC	NN	O	cc	prep_with	8	SENT_13	[p1l748t1023r809b1055],
11	than	IN	O	than	_	0	SENT_13	[p1l823t1021r908b1055],
12	CA/AA	NN	O	ca/aa	nn	13	SENT_13	[p1l923t1023r1056b1055],
13	genotypes	NNS	O	genotype	prep_than	10	SENT_13	[p1l1069t1031r1254b1067],
14	at	IN	O	at	_	0	SENT_13	[p1l1269t1031r1303b1055],
15	Week	NN	DURATION	week	prep_at	13	SENT_13	[p1l1315t1021r1411b1055],
16	2	CD	NUMBER	2	num	15	SENT_13	[p1l1424t1025r1445b1055],
17	(	SYM	O	(	dep	13	SENT_13	[p1l1463t1022r1509b1062],
18	-	:	O	-	_	0	SENT_13	[p1l1463t1022r1509b1062],
19	1.63	CD	NUMBER	1.63	dep	13	SENT_13	[p1l1518t1022r1596b1057],
20	i	FW	O	i	dep	37	SENT_13	[p1l1615t1027r1644b1053],
21	0.92	CD	NUMBER	0.92	amod	20	SENT_13	[p1l1663t1025r1744b1057],
22	vs.	CC	O	vs.	prep	20	SENT_13	[p1l1758t1035r1806b1055],
23	-0.48	CD	NUMBER	-0.48	number	24	SENT_13	[p1l1826t1021r1941b1055],
24	1	CD	NUMBER	1	dep	22	SENT_13	[p1l1961t1027r1989b1053],
25	0.75	CD	NUMBER	0.75	num	26	SENT_13	[p1l295t1078r375b1111],
26	g/dL	NN	O	g/dl	dep	24	SENT_13	[p1l391t1075r489b1120],
27	,	,	O	,	_	0	SENT_13	[p1l391t1075r489b1120],
28	P	NN	O	p	conj_and	24	SENT_13	[p1l503t1077r534b1108],
29	=	JJ	O	=	amod	31	SENT_13	[p1l549t1086r577b1101],
30	0.001	CD	NUMBER	0.001	tmod	29	SENT_13	[p1l596t1075r714b1115],
31	)	NN	O	)	dep	28	SENT_13	[p1l596t1075r714b1115],
32	and	CC	O	and	_	0	SENT_13	[p1l731t1075r800b1109],
33	week	NN	DURATION	week	conj_and	24	SENT_13	[p1l812t1075r908b1108],
34	4	CD	NUMBER	4	number	35	SENT_13	[p1l919t1075r942b1108],
35	(	CD	NUMBER	(	dep	33	SENT_13	[p1l959t1075r1066b1115],
36	-3.5	CD	NUMBER	-3.5	dep	37	SENT_13	[p1l959t1075r1066b1115],
37	i	FW	O	i	dep	41	SENT_13	[p1l1086t1081r1114b1107],
38	1.1	CD	NUMBER	1.1	dep	37	SENT_13	[p1l1136t1078r1187b1108],
39	vs.	CC	O	vs.	prep	38	SENT_13	[p1l1203t1088r1251b1108],
40	-2.2	CD	NUMBER	-2.2	dep	39	SENT_13	[p1l1270t1078r1361b1108],
41	i	FW	O	i	dep	10	SENT_13	[p1l1380t1081r1408b1107],
42	0.96	CD	NUMBER	0.96	dep	41	SENT_13	[p1l1427t1076r1519b1114],
43	,	,	O	,	_	0	SENT_13	[p1l1427t1076r1519b1114],
44	P	NN	O	p	appos	10	SENT_13	[p1l1534t1077r1565b1108],
45	=	JJ	O	=	amod	47	SENT_13	[p1l1579t1086r1607b1101],
46	0.001	CD	NUMBER	0.001	tmod	45	SENT_13	[p1l1626t1075r1758b1115],
47	)	NN	O	)	dep	44	SENT_13	[p1l1626t1075r1758b1115],
48	,	,	O	,	_	0	SENT_13	[p1l1626t1075r1758b1115],
49	as	RB	O	as	_	0	SENT_13	[p1l1773t1088r1808b1108],
50	well	RB	O	well	_	0	SENT_13	[p1l1821t1075r1896b1108],
51	as	IN	O	as	_	0	SENT_13	[p1l1911t1088r1945b1108],
52	at	IN	O	at	_	0	SENT_13	[p1l1960t1084r1994b1108],
53	the	DT	O	the	det	54	SENT_13	[p1l295t1128r353b1161],
54	end	NN	O	end	dep	59	SENT_13	[p1l367t1128r435b1162],
55	of	IN	O	of	_	0	SENT_13	[p1l449t1128r491b1161],
56	treatment	NN	O	treatment	prep_of	54	SENT_13	[p1l499t1138r681b1161],
57	(	CD	NUMBER	(	num	56	SENT_13	[p1l696t1128r805b1168],
58	-2.9	CD	NUMBER	-2.9	dep	59	SENT_13	[p1l696t1128r805b1168],
59	i	FW	O	i	dep	63	SENT_13	[p1l824t1134r852b1160],
60	1.1	CD	NUMBER	1.1	dep	59	SENT_13	[p1l874t1131r925b1161],
61	vs.	CC	O	vs.	prep	60	SENT_13	[p1l941t1142r989b1161],
62	-2.0	CD	NUMBER	-2.0	dep	61	SENT_13	[p1l1009t1131r1100b1161],
63	i	FW	O	i	dep	69	SENT_13	[p1l1119t1134r1147b1160],
64	0.86	CD	NUMBER	0.86	dep	63	SENT_13	[p1l1166t1129r1259b1167],
65	,	,	O	,	_	0	SENT_13	[p1l1166t1129r1259b1167],
66	P	NN	O	p	appos	64	SENT_13	[p1l1273t1130r1304b1161],
67	=	JJ	O	=	amod	66	SENT_13	[p1l1319t1139r1347b1154],
68	0.013	CD	NUMBER	0.013	num	69	SENT_13	[p1l1366t1129r1497b1168],
69	)	NN	O	)	dep	6	SENT_13	[p1l1366t1129r1497b1168],
70	.	.	O	.	_	0	SENT_13	[p1l1366t1129r1497b1168],

1	Risk	NN	O	risk	nn	2	SENT_14	[p1l1513t1128r1598b1161],
2	factors	NNS	O	factor	_	0	SENT_14	[p1l1609t1128r1734b1161],
3	for	IN	O	for	_	0	SENT_14	[p1l1748t1128r1803b1161],
4	hemoglobin	NN	O	hemoglobin	prep_for	2	SENT_14	[p1l1816t1128r1993b1173, p1l295t1181r356b1215],
5	<	JJR	O	<	amod	4	SENT_14	[p1l370t1184r479b1215],
6	11.0	CD	NUMBER	11.0	num	7	SENT_14	[p1l370t1184r479b1215],
7	g/dL	NN	O	g/dl	nsubj	13	SENT_14	[p1l494t1181r583b1227],
8	at	IN	O	at	_	0	SENT_14	[p1l596t1191r631b1215],
9	Week	NN	DURATION	week	prep_at	7	SENT_14	[p1l642t1181r738b1215],
10	4	CD	NUMBER	4	num	9	SENT_14	[p1l750t1182r773b1215],
11	were	VBD	O	be	cop	13	SENT_14	[p1l785t1195r872b1215],
12	female	JJ	O	female	amod	13	SENT_14	[p1l885t1181r1007b1215],
13	gender	NN	O	gender	ccomp	5	SENT_14	[p1l1020t1181r1155b1227],
14	,	,	O	,	_	0	SENT_14	[p1l1020t1181r1155b1227],
15	age	NN	O	age	ccomp	5	SENT_14	[p1l1171t1195r1231b1227],
16	>	JJR	O	>	amod	15	SENT_14	[p1l1244t1184r1317b1218],
17	50	CD	DURATION	50	num	18	SENT_14	[p1l1244t1184r1317b1218],
18	years	NNS	NUMBER	year	tmod	16	SENT_14	[p1l1331t1194r1435b1226],
19	,	,	O	,	_	0	SENT_14	[p1l1331t1194r1435b1226],
20	body	NN	O	body	nn	21	SENT_14	[p1l1450t1181r1545b1226],
21	mass	NN	O	mass	npadvmod	26	SENT_14	[p1l1557t1194r1645b1215],
22	index	NN	O	index	nn	25	SENT_14	[p1l1660t1181r1763b1216],
23	(	CD	NUMBER	(	num	25	SENT_14	[p1l1778t1182r1890b1222],
24	BMI	NN	O	bmus	nn	25	SENT_14	[p1l1778t1182r1890b1222],
25	)	NN	O	)	dep	21	SENT_14	[p1l1778t1182r1890b1222],
26	<	JJR	O	<	dep	16	SENT_14	[p1l1907t1185r1992b1221],
27	23	CD	NUMBER	23	dep	16	SENT_14	[p1l1907t1185r1992b1221],
28	,	,	O	,	_	0	SENT_14	[p1l1907t1185r1992b1221],
29	and	CC	O	and	_	0	SENT_14	[p1l295t1235r365b1269],
30	CC	NN	O	cc	ccomp	5	SENT_14	[p1l384t1237r444b1269],
31	at	IN	O	at	_	0	SENT_14	[p1l462t1245r497b1268],
32	rs1127354	NN	O	rs1127354	prep_at	5	SENT_14	[p1l514t1235r713b1271],
33	by	IN	O	by	_	0	SENT_14	[p1l732t1235r779b1279],
34	multivariate	JJ	O	multivariate	amod	35	SENT_14	[p1l795t1235r1022b1269],
35	analysis	NN	O	analysis	prep_by	5	SENT_14	[p1l1041t1235r1195b1279],
36	.	.	O	.	_	0	SENT_14	[p1l1041t1235r1195b1279],

1	RBV	NN	O	rbv	nn	2	SENT_15	[p1l1216t1237r1306b1269],
2	dose	NN	O	dose	nsubj	9	SENT_15	[p1l1323t1235r1405b1269],
3	during	IN	O	during	_	0	SENT_15	[p1l1424t1235r1551b1280],
4	the	DT	O	the	det	5	SENT_15	[p1l1567t1235r1626b1268],
5	ﬁrst	NN	O	ﬁrst	prep_during	2	SENT_15	[p1l1644t1235r1718b1268],
6	12	CD	DURATION	12	num	7	SENT_15	[p1l1739t1238r1781b1268],
7	weeks	NNS	NUMBER	week	tmod	5	SENT_15	[p1l1799t1235r1908b1268],
8	was	VBD	O	be	cop	9	SENT_15	[p1l1925t1249r1993b1268],
9	smaller	JJR	O	smaller	dep	47	SENT_15	[p1l295t1288r430b1321],
10	in	IN	O	in	_	0	SENT_15	[p1l442t1290r479b1321],
11	patients	NNS	O	patient	prep_in	9	SENT_15	[p1l491t1290r638b1333],
12	with	IN	O	with	_	0	SENT_15	[p1l650t1288r734b1321],
13	CC	NN	O	cc	prep_with	11	SENT_15	[p1l748t1290r809b1322],
14	than	IN	O	than	mark	17	SENT_15	[p1l821t1288r906b1321],
15	CA/AA	NN	O	ca/aa	nn	16	SENT_15	[p1l920t1290r1053b1322],
16	genotypes	NNS	O	genotype	nsubj	17	SENT_15	[p1l1064t1298r1249b1333],
17	(	VBP	O	(	advcl	9	SENT_15	[p1l1265t1288r1323b1328],
18	52	CD	NUMBER	52	dobj	17	SENT_15	[p1l1265t1288r1323b1328],
19	i	FW	O	i	dep	18	SENT_15	[p1l1352t1294r1381b1320],
20	14	CD	PERCENT	14	number	21	SENT_15	[p1l1402t1288r1483b1323],
21	%	NN	PERCENT	%	amod	18	SENT_15	[p1l1402t1288r1483b1323],
22	vs.	CC	O	vs.	dep	24	SENT_15	[p1l1496t1302r1543b1321],
23	65	CD	NUMBER	65	dep	22	SENT_15	[p1l1558t1289r1602b1324],
24	i	FW	O	i	dep	17	SENT_15	[p1l1621t1294r1650b1320],
25	21	CD	PERCENT	21	number	26	SENT_15	[p1l1667t1291r1752b1323],
26	%	NN	PERCENT	%	amod	24	SENT_15	[p1l1667t1291r1752b1323],
27	of	IN	O	of	_	0	SENT_15	[p1l1766t1288r1808b1321],
28	the	DT	O	the	det	30	SENT_15	[p1l1815t1288r1874b1321],
29	target	NN	O	target	nn	30	SENT_15	[p1l1886t1298r1994b1333],
30	dose	NN	O	dose	prep_of	24	SENT_15	[p1l295t1341r388b1380],
31	,	,	O	,	_	0	SENT_15	[p1l295t1341r388b1380],
32	P	NN	O	p	appos	30	SENT_15	[p1l404t1343r435b1374],
33	=	JJ	O	=	amod	35	SENT_15	[p1l450t1353r479b1367],
34	0.039	CD	NUMBER	0.039	tmod	33	SENT_15	[p1l498t1341r630b1381],
35	)	NN	O	)	dep	32	SENT_15	[p1l498t1341r630b1381],
36	,	,	O	,	_	0	SENT_15	[p1l498t1341r630b1381],
37	but	CC	O	but	_	0	SENT_15	[p1l647t1341r711b1375],
38	the	DT	O	the	det	41	SENT_15	[p1l724t1341r783b1375],
39	total	JJ	O	total	amod	41	SENT_15	[p1l797t1341r883b1375],
40	RBV	NN	O	rbv	nn	41	SENT_15	[p1l898t1343r989b1375],
41	dose	NN	O	dose	nsubj	44	SENT_15	[p1l1001t1341r1084b1375],
42	was	VBD	O	be	cop	44	SENT_15	[p1l1097t1355r1165b1375],
43	no	RB	O	no	advmod	44	SENT_15	[p1l1180t1354r1227b1375],
44	different	JJ	O	different	dep	47	SENT_15	[p1l1243t1341r1404b1375],
45	between	IN	O	between	_	0	SENT_15	[p1l1418t1341r1569b1375],
46	them	PRP	O	they	prep_between	44	SENT_15	[p1l1584t1341r1679b1375],
47	(	VBP	O	(	_	0	SENT_15	[p1l1697t1341r1755b1381],
48	49	CD	NUMBER	49	dobj	47	SENT_15	[p1l1697t1341r1755b1381],
49	i	FW	O	i	dep	48	SENT_15	[p1l1775t1347r1804b1373],
50	17	CD	PERCENT	17	number	51	SENT_15	[p1l1826t1344r1908b1377],
51	%	NN	PERCENT	%	amod	49	SENT_15	[p1l1826t1344r1908b1377],
52	and	CC	O	and	_	0	SENT_15	[p1l1925t1341r1994b1375],
53	54	CD	NUMBER	54	conj_and	48	SENT_15	[p1l296t1394r341b1430],
54	i	FW	O	i	dep	53	SENT_15	[p1l359t1400r387b1426],
55	18	CD	PERCENT	18	num	56	SENT_15	[p1l409t1397r490b1429],
56	%	NN	PERCENT	%	nsubj	47	SENT_15	[p1l409t1397r490b1429],
57	of	IN	O	of	_	0	SENT_15	[p1l505t1394r547b1427],
58	the	DT	O	the	det	59	SENT_15	[p1l555t1394r613b1427],
59	target	NN	O	target	prep_of	56	SENT_15	[p1l627t1403r744b1439],
60	,	,	O	,	_	0	SENT_15	[p1l627t1403r744b1439],
61	P	NN	O	p	appos	56	SENT_15	[p1l758t1396r790b1427],
62	=	JJ	O	=	amod	64	SENT_15	[p1l804t1405r832b1420],
63	0.531	CD	NUMBER	0.531	tmod	62	SENT_15	[p1l851t1394r982b1434],
64	)	NN	O	)	dep	61	SENT_15	[p1l851t1394r982b1434],
65	.	.	O	.	_	0	SENT_15	[p1l851t1394r982b1434],

1	Sustained	JJ	O	sustained	amod	6	SENT_16	[p1l997t1394r1178b1428],
2	virological	JJ	O	virological	amod	6	SENT_16	[p1l1190t1394r1389b1439],
3	response	NN	O	response	nn	6	SENT_16	[p1l1403t1407r1563b1439],
4	(	CD	NUMBER	(	num	6	SENT_16	[p1l1579t1394r1686b1434],
5	SVR	NN	ORGANIZATION	svr	nn	6	SENT_16	[p1l1579t1394r1686b1434],
6	)	NN	O	)	nsubjpass	8	SENT_16	[p1l1579t1394r1686b1434],
7	was	VBD	O	be	auxpass	8	SENT_16	[p1l1702t1408r1770b1427],
8	achieved	VBN	O	achieve	_	0	SENT_16	[p1l1784t1394r1944b1428],
9	in	IN	O	in	_	0	SENT_16	[p1l1957t1396r1993b1427],
10	70	CD	PERCENT	70	number	14	SENT_16	[p1l294t1450r380b1483],
11	%	NN	PERCENT	%	dep	14	SENT_16	[p1l294t1450r380b1483],
12	and	CC	O	and	_	0	SENT_16	[p1l394t1447r463b1481],
13	64	CD	PERCENT	64	prep_in	8	SENT_16	[p1l475t1447r560b1482],
14	%	NN	PERCENT	%	prep_in	8	SENT_16	[p1l475t1447r560b1482],
15	of	IN	O	of	_	0	SENT_16	[p1l574t1447r616b1481],
16	them	PRP	O	they	prep_of	14	SENT_16	[p1l623t1447r728b1487],
17	,	,	O	,	_	0	SENT_16	[p1l623t1447r728b1487],
18	respectively	RB	O	respectively	advmod	14	SENT_16	[p1l742t1447r958b1492],
19	(	CD	NUMBER	(	num	20	SENT_16	[p1l972t1447r1015b1488],
20	P	NN	O	p	dep	14	SENT_16	[p1l972t1447r1015b1488],
21	=	JJ	O	=	amod	23	SENT_16	[p1l1028t1459r1056b1473],
22	0.724	CD	NUMBER	0.724	tmod	21	SENT_16	[p1l1073t1447r1205b1488],
23	)	NN	O	)	dep	20	SENT_16	[p1l1073t1447r1205b1488],
24	.	.	O	.	_	0	SENT_16	[p1l1073t1447r1205b1488],

1	Conclusion	NN	O	conclusion	_	0	SENT_17	[p1l1223t1447r1437b1481],
2	:	:	O	:	_	0	SENT_17	[p1l1223t1447r1437b1481],
3	I	PRP	O	I	dep	1	SENT_17	[p1l1448t1449r1470b1480],
4	T	NN	O	t	nn	7	SENT_17	[p1l1470t1448r1501b1480],
5	PA	NN	O	pa	nn	7	SENT_17	[p1l1494t1449r1547b1481],
6	polymorphism	NN	O	polymorphism	nn	7	SENT_17	[p1l1558t1447r1835b1492],
7	inﬂuences	NNS	O	inﬂuences	dep	3	SENT_17	[p1l1847t1447r1993b1481, p1l295t1515r348b1535],
8	hemoglobin	NN	O	hemoglobin	nn	9	SENT_17	[p1l366t1501r591b1547],
9	levels	NNS	O	level	dep	3	SENT_17	[p1l609t1501r708b1535],
10	during	IN	O	during	_	0	SENT_17	[p1l727t1501r854b1547],
11	triple	JJ	O	triple	amod	12	SENT_17	[p1l870t1501r971b1546],
12	therapy	NN	O	therapy	prep_during	3	SENT_17	[p1l989t1501r1138b1546],
13	,	,	O	,	_	0	SENT_17	[p1l989t1501r1138b1546],
14	particularly	RB	O	particularly	advmod	12	SENT_17	[p1l1157t1501r1377b1546],
15	during	IN	O	during	_	0	SENT_17	[p1l1392t1501r1519b1547],
16	the	DT	O	the	det	17	SENT_17	[p1l1535t1501r1594b1535],
17	ﬁrst	NN	O	ﬁrst	prep_during	14	SENT_17	[p1l1611t1501r1685b1535],
18	12	CD	DURATION	12	num	19	SENT_17	[p1l1706t1504r1748b1535],
19	Weeks	NNS	DURATION	week	dep	12	SENT_17	[p1l1765t1501r1875b1535],
20	while	IN	O	while	mark	23	SENT_17	[p1l1892t1501r1994b1535],
21	telaprevir	NN	O	telaprevir	nsubjpass	23	SENT_17	[p1l295t1555r473b1600],
22	is	VBZ	O	be	auxpass	23	SENT_17	[p1l492t1557r519b1588],
23	given	VBN	O	give	dep	19	SENT_17	[p1l539t1557r648b1600],
24	.	.	O	.	_	0	SENT_17	[p1l539t1557r648b1600],

1	With	IN	O	with	_	0	SENT_18	[p1l666t1555r764b1589],
2	careful	JJ	O	careful	amod	3	SENT_18	[p1l784t1555r910b1589],
3	monitoring	NN	O	monitoring	prep_with	16	SENT_18	[p1l930t1557r1144b1600],
4	of	IN	O	of	_	0	SENT_18	[p1l1163t1555r1205b1588],
5	anemia	NN	O	anemia	prep_of	3	SENT_18	[p1l1219t1557r1354b1588],
6	and	CC	O	and	_	0	SENT_18	[p1l1372t1555r1442b1589],
7	prompt	JJ	O	prompt	amod	8	SENT_18	[p1l1460t1565r1603b1600],
8	adjustment	NN	O	adjustment	prep_with	16	SENT_18	[p1l1621t1555r1831b1600],
9	of	IN	O	of	_	0	SENT_18	[p1l1850t1555r1892b1588],
10	RBV	NN	O	rbv	nn	11	SENT_18	[p1l1906t1557r1996b1589],
11	dose	NN	O	dose	prep_of	8	SENT_18	[p1l295t1608r388b1648],
12	,	,	O	,	_	0	SENT_18	[p1l295t1608r388b1648],
13	SVR	NN	ORGANIZATION	svr	nsubjpass	16	SENT_18	[p1l406t1610r490b1642],
14	can	MD	O	can	aux	16	SENT_18	[p1l506t1621r569b1642],
15	be	VB	O	be	auxpass	16	SENT_18	[p1l586t1608r628b1642],
16	achieved	VBN	O	achieve	_	0	SENT_18	[p1l645t1608r805b1642],
17	comparably	RB	O	comparably	dep	16	SENT_18	[p1l821t1608r1043b1653],
18	frequently	RB	O	frequently	advmod	17	SENT_18	[p1l1058t1608r1251b1653],
19	between	IN	O	between	_	0	SENT_18	[p1l1266t1608r1418b1642],
20	patients	NNS	O	patient	prep_between	17	SENT_18	[p1l1434t1610r1581b1653],
21	with	IN	O	with	_	0	SENT_18	[p1l1597t1608r1681b1642],
22	CC	NN	O	cc	nn	25	SENT_18	[p1l1699t1610r1759b1642],
23	and	CC	O	and	_	0	SENT_18	[p1l1776t1608r1845b1642],
24	CA/AA	NN	O	ca/aa	nn	25	SENT_18	[p1l1862t1610r1995b1642],
25	genotypes	NNS	O	genotype	prep_with	16	SENT_18	[p1l295t1671r490b1707],
26	.	.	O	.	_	0	SENT_18	[p1l295t1671r490b1707],

1	(	RB	O	(	advmod	2	SENT_19	[p1l508t1662r742b1702],
2	HEPATOLOGY	NN	O	hepatology	_	0	SENT_19	[p1l508t1662r742b1702],
3	201	CD	NUMBER	201	number	4	SENT_19	[p1l753t1665r819b1695],
4	1	CD	NUMBER	1	num	2	SENT_19	[p1l827t1662r1088b1702],
5	;	:	O	;	_	0	SENT_19	[p1l827t1662r1088b1702],
6	53:415	CD	NUMBER	53:415	num	8	SENT_19	[p1l827t1662r1088b1702],
7	-421	CD	NUMBER	-421	num	8	SENT_19	[p1l827t1662r1088b1702],
8	)	NN	O	)	dep	2	SENT_19	[p1l827t1662r1088b1702],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_20	[p1l81t1923r460b1975],
2	:	:	O	:	_	0	SENT_20	[p1l81t1923r460b1975],
3	BM	NN	O	bm	nn	4	SENT_20	[p1l507t1926r644b1981],
4	]	NN	O	]	dep	1	SENT_20	[p1l507t1926r644b1981],
5	,	,	O	,	_	0	SENT_20	[p1l507t1926r644b1981],
6	body	NN	O	body	nn	8	SENT_20	[p1l700t1923r819b1993],
7	mass	NN	O	mass	nn	8	SENT_20	[p1l866t1943r984b1975],
8	index	NN	O	index	appos	4	SENT_20	[p1l1031t1923r1187b1981],
9	;	:	O	;	_	0	SENT_20	[p1l1031t1923r1187b1981],
10	GVWIS	NNP	LOCATION	GVWIS	dep	1	SENT_20	[p1l1240t1926r1425b1981],
11	,	,	O	,	_	0	SENT_20	[p1l1240t1926r1425b1981],
12	genome	NN	O	genome	nn	16	SENT_20	[p1l1472t1923r1817b1993],
13	—	NN	O	—	nn	16	SENT_20	[p1l1472t1923r1817b1993],
14	ivide	NN	O	ivide	nn	16	SENT_20	[p1l1472t1923r1817b1993],
15	association	NN	O	association	nn	16	SENT_20	[p1l1861t1928r2134b1975],
16	study	NN	O	study	appos	10	SENT_20	[p1l14t2007r164b2077],
17	;	:	O	;	_	0	SENT_20	[p1l14t2007r164b2077],
18	H	NN	O	h	nn	20	SENT_20	[p1l210t2011r271b2058],
19	C	NN	O	c	nn	20	SENT_20	[p1l270t2010r316b2059],
20	V	NN	O	v	dep	1	SENT_20	[p1l318t2011r365b2065],
21	bepatitis	NN	O	bepatitis	nn	23	SENT_20	[p1l408t2007r626b2077],
22	C	NN	O	c	nn	23	SENT_20	[p1l675t2010r721b2059],
23	virus	NN	O	virus	dep	20	SENT_20	[p1l762t2012r903b2065],
24	;	:	O	;	_	0	SENT_20	[p1l762t2012r903b2065],
25	IFIV	NN	O	ifiv	dep	1	SENT_20	[p1l948t2011r1073b2065],
26	,	,	O	,	_	0	SENT_20	[p1l948t2011r1073b2065],
27	interferon	NN	O	interferon	appos	25	SENT_20	[p1l1126t2007r1394b2077],
28	;	:	O	;	_	0	SENT_20	[p1l1126t2007r1394b2077],
29	IL28B	NN	O	il28b	dep	1	SENT_20	[p1l1440t2011r1625b2065],
30	,	,	O	,	_	0	SENT_20	[p1l1440t2011r1625b2065],
31	interleukin	NN	O	interleukin	nn	32	SENT_20	[p1l1679t2007r1961b2059],
32	28B	NN	O	28b	appos	29	SENT_20	[p1l2005t2011r2134b2066],
33	;	:	O	;	_	0	SENT_20	[p1l2005t2011r2134b2066],
34	ITPA	NNP	O	ITPA	dep	1	SENT_20	[p1l17t2092r177b2149],
35	,	,	O	,	_	0	SENT_20	[p1l17t2092r177b2149],
36	inosine	NN	O	inosine	nn	37	SENT_20	[p1l215t2095r396b2143],
37	trip/aospbatase	NN	O	trip/aospbatase	appos	34	SENT_20	[p1l426t2091r806b2161],
38	;	:	O	;	_	0	SENT_20	[p1l426t2091r806b2161],
39	PEG	NN	O	peg	dep	34	SENT_20	[p1l837t2093r1112b2149],
40	.	.	O	.	_	0	SENT_20	[p1l837t2093r1112b2149],

1	—	NN	O	—	_	0	SENT_21	[p1l837t2093r1112b2149],
2	.	.	O	.	_	0	SENT_21	[p1l837t2093r1112b2149],

1	IFN	NN	ORGANIZATION	ifn	_	0	SENT_22	[p1l837t2093r1112b2149],
2	,	,	O	,	_	0	SENT_22	[p1l837t2093r1112b2149],
3	pegylated	VBN	O	pegylate	partmod	1	SENT_22	[p1l1139t2091r1393b2161],
4	interferon	NN	O	interferon	dobj	3	SENT_22	[p1l1418t2091r1686b2161],
5	;	:	O	;	_	0	SENT_22	[p1l1418t2091r1686b2161],
6	RB	NN	O	rb	nn	8	SENT_22	[p1l1717t2094r1799b2142],
7	V	NN	O	v	nn	8	SENT_22	[p1l1805t2094r1853b2149],
8	ribavirin	NNP	O	ribavirin	dep	1	SENT_22	[p1l1884t2091r2134b2149],
9	;	:	O	;	_	0	SENT_22	[p1l1884t2091r2134b2149],
10	SN	NNP	O	SN	nn	11	SENT_22	[p1l17t2177r143b2233],
11	]	NNP	O	]	dep	8	SENT_22	[p1l17t2177r143b2233],
12	?	.	O	?	_	0	SENT_22	[p1l17t2177r143b2233],

1	single	JJ	O	single	amod	3	SENT_23	[p1l167t2175r312b2245],
2	nucleotide	NN	O	nucleotide	nn	3	SENT_23	[p1l337t2175r598b2227],
3	polymorpbism	NN	O	polymorpbism	nsubj	8	SENT_23	[p1l611t2175r998b2245],
4	;	:	O	;	_	0	SENT_23	[p1l611t2175r998b2245],
5	S	NN	O	s	nn	6	SENT_23	[p1l1025t2177r1060b2227],
6	VR	NN	O	vr	dep	3	SENT_23	[p1l1065t2178r1152b2233],
7	,	,	O	,	_	0	SENT_23	[p1l1065t2178r1152b2233],
8	sustained	VBD	O	sustain	_	0	SENT_23	[p1l1181t2175r1425b2227],
9	virological	JJ	O	virological	amod	10	SENT_23	[p1l1445t2175r1716b2245],
10	response	NN	O	response	dobj	8	SENT_23	[p1l1737t2192r1948b2245],
11	.	.	O	.	_	0	SENT_23	[p1l1737t2192r1948b2245],

1	From	IN	O	from	dep	4	SENT_24	[p1l85t2262r224b2310],
2	tbe	NN	O	tbe	pobj	1	SENT_24	[p1l262t2258r339b2310],
3	[	NNP	O	[	nn	4	SENT_24	[p1l375t2247r715b2328],
4	Department	NNP	ORGANIZATION	Department	_	0	SENT_24	[p1l375t2247r715b2328],
5	of	IN	ORGANIZATION	of	_	0	SENT_24	[p1l747t2258r810b2328],
6	Hepatology	NNP	ORGANIZATION	Hepatology	nn	8	SENT_24	[p1l825t2258r1121b2328],
7	Toranomon	NNP	ORGANIZATION	Toranomon	nn	8	SENT_24	[p1l1171t2260r1459b2310],
8	Hospital	NNP	ORGANIZATION	Hospital	prep_of	4	SENT_24	[p1l1494t2258r1725b2328],
9	,	,	O	,	_	0	SENT_24	[p1l1494t2258r1725b2328],
10	Tokyo	NNP	LOCATION	Tokyo	appos	8	SENT_24	[p1l1774t2258r1926b2328],
11	,	,	O	,	_	0	SENT_24	[p1l1774t2258r1926b2328],
12	japan	NN	LOCATION	japan	appos	10	SENT_24	[p1l1957t2262r2134b2328],
13	;	:	O	;	_	0	SENT_24	[p1l1957t2262r2134b2328],
14	2Researcb	NNP	O	2Researcb	nn	15	SENT_24	[p1l14t2332r270b2394],
15	Institute	NNP	ORGANIZATION	Institute	dep	10	SENT_24	[p1l319t2346r546b2394],
16	for	IN	ORGANIZATION	for	_	0	SENT_24	[p1l583t2342r671b2412],
17	Hepatology	NNP	ORGANIZATION	Hepatology	prep_for	15	SENT_24	[p1l717t2342r1025b2412],
18	,	,	O	,	_	0	SENT_24	[p1l717t2342r1025b2412],
19	Ybranomon	NNP	LOCATION	Ybranomon	nn	20	SENT_24	[p1l1091t2344r1389b2394],
20	Hospital	NNP	LOCATION	Hospital	appos	17	SENT_24	[p1l1440t2342r1680b2412],
21	,	,	O	,	_	0	SENT_24	[p1l1440t2342r1680b2412],
22	Tokyo	NNP	LOCATION	Tokyo	appos	17	SENT_24	[p1l1746t2342r1904b2412],
23	,	,	O	,	_	0	SENT_24	[p1l1746t2342r1904b2412],
24	fapan	NN	O	fapan	appos	17	SENT_24	[p1l1951t2346r2134b2412],
25	;	:	O	;	_	0	SENT_24	[p1l1951t2346r2134b2412],
26	3Department	NN	O	3department	dep	10	SENT_24	[p1l14t2421r361b2502],
27	of	IN	O	of	_	0	SENT_24	[p1l387t2432r450b2502],
28	Medical	NNP	O	Medical	prep_of	26	SENT_24	[p1l459t2432r678b2484],
29	and	CC	O	and	_	0	SENT_24	[p1l702t2432r808b2484],
30	Molecular	JJ	O	molecular	amod	31	SENT_24	[p1l829t2432r1098b2484],
31	Science	NN	O	science	conj_and	28	SENT_24	[p1l1125t2435r1319b2490],
32	,	,	O	,	_	0	SENT_24	[p1l1125t2435r1319b2490],
33	Division	NN	O	division	appos	28	SENT_24	[p1l1354t2436r1576b2484],
34	of	IN	O	of	_	0	SENT_24	[p1l1609t2432r1672b2502],
35	Frontier	NNP	ORGANIZATION	Frontier	nn	37	SENT_24	[p1l1682t2436r1899b2484],
36	Medical	NNP	ORGANIZATION	Medical	nn	37	SENT_24	[p1l1922t2432r2141b2484],
37	Science	NNP	ORGANIZATION	Science	prep_of	33	SENT_24	[p1l16t2518r210b2574],
38	,	,	O	,	_	0	SENT_24	[p1l16t2518r210b2574],
39	Programs	NNP	O	Programs	appos	28	SENT_24	[p1l257t2519r500b2585],
40	for	IN	O	for	_	0	SENT_24	[p1l529t2515r614b2585],
41	Biomedical	NNP	O	Biomedical	nn	42	SENT_24	[p1l653t2515r949b2567],
42	Researc/7	NNP	O	Researc/7	prep_for	39	SENT_24	[p1l984t2515r1215b2574],
43	,	,	O	,	_	0	SENT_24	[p1l984t2515r1215b2574],
44	Graduate	NNP	O	Graduate	nn	45	SENT_24	[p1l1268t2515r1512b2567],
45	Sc/aool	NNP	O	Sc/aool	appos	28	SENT_24	[p1l1552t2515r1722b2567],
46	of	IN	O	of	_	0	SENT_24	[p1l1759t2515r1822b2585],
47	Biomedical	NNP	O	Biomedical	nn	48	SENT_24	[p1l1845t2515r2141b2567],
48	Science	NNP	O	Science	prep_of	45	SENT_24	[p1l16t2606r210b2662],
49	,	,	O	,	_	0	SENT_24	[p1l16t2606r210b2662],
50	Hirosbima	NNP	ORGANIZATION	Hirosbima	nn	51	SENT_24	[p1l255t2604r534b2655],
51	University	NNP	ORGANIZATION	University	appos	28	SENT_24	[p1l582t2607r847b2673],
52	,	,	O	,	_	0	SENT_24	[p1l582t2607r847b2673],
53	Hirosbima	NNP	PERSON	Hirosbima	appos	28	SENT_24	[p1l892t2604r1183b2662],
54	,	,	O	,	_	0	SENT_24	[p1l892t2604r1183b2662],
55	fapan	NN	O	fapan	appos	53	SENT_24	[p1l1219t2607r1396b2673],
56	;	:	O	;	_	0	SENT_24	[p1l1219t2607r1396b2673],
57	4Laboratory	JJ	O	4laboratory	amod	59	SENT_24	[p1l1437t2589r1749b2673],
58	ﬂ	NN	O	ﬂ	nn	59	SENT_24	[p1l1775t2604r1860b2673],
59	)	NN	O	)	dep	10	SENT_24	[p1l1775t2604r1860b2673],
60	r	NN	O	r	nn	61	SENT_24	[p1l1775t2604r1860b2673],
61	Statistics	NNS	O	statistics	dep	59	SENT_24	[p1l1897t2606r2129b2662],
62	,	,	O	,	_	0	SENT_24	[p1l1897t2606r2129b2662],

1	RIKEN	NNP	ORGANIZATION	RIKEN	nn	2	SENT_25	[p1l15t2722r224b2770],
2	Center	NNP	ORGANIZATION	Center	_	0	SENT_25	[p1l268t2721r438b2770],
3	for	IN	ORGANIZATION	for	_	0	SENT_25	[p1l470t2718r555b2788],
4	Genomic	JJ	ORGANIZATION	genomic	amod	5	SENT_25	[p1l605t2721r832b2770],
5	Medicine	NN	ORGANIZATION	medicine	prep_for	2	SENT_25	[p1l873t2718r1128b2776],
6	,	,	O	,	_	0	SENT_25	[p1l873t2718r1128b2776],
7	Yokobama	NN	PERSON	yokobama	appos	2	SENT_25	[p1l1188t2718r1463b2776],
8	,	,	O	,	_	0	SENT_25	[p1l1188t2718r1463b2776],
9	japan	NN	LOCATION	japan	appos	2	SENT_25	[p1l1506t2722r1683b2788],
10	;	:	O	;	_	0	SENT_25	[p1l1506t2722r1683b2788],
11	5	CD	NUMBER	5	num	12	SENT_25	[p1l1731t2706r1759b2740],
12	Laboratory	NN	ORGANIZATION	laboratory	dep	2	SENT_25	[p1l1757t2718r2043b2788],
13	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l2091t2718r2154b2788],
14	Molecular	JJ	ORGANIZATION	molecular	amod	15	SENT_25	[p1l13t2801r282b2853],
15	Medicine	NN	ORGANIZATION	medicine	prep_of	12	SENT_25	[p1l316t2801r571b2860],
16	,	,	O	,	_	0	SENT_25	[p1l316t2801r571b2860],
17	Human	JJ	ORGANIZATION	human	amod	19	SENT_25	[p1l618t2805r822b2853],
18	Genome	NNP	ORGANIZATION	Genome	nn	19	SENT_25	[p1l869t2804r1076b2853],
19	Center	NNP	ORGANIZATION	Center	appos	2	SENT_25	[p1l1121t2804r1294b2859],
20	,	,	O	,	_	0	SENT_25	[p1l1121t2804r1294b2859],
21	Institute	NNP	ORGANIZATION	Institute	appos	2	SENT_25	[p1l1341t2805r1558b2853],
22	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l1598t2801r1662b2871],
23	Medical	NNP	ORGANIZATION	Medical	nn	24	SENT_25	[p1l1681t2801r1900b2853],
24	Science	NNP	ORGANIZATION	Science	prep_of	21	SENT_25	[p1l1936t2804r2129b2860],
25	,	,	O	,	_	0	SENT_25	[p1l1936t2804r2129b2860],
26	University	NNP	ORGANIZATION	University	appos	2	SENT_25	[p1l24t2893r311b2960],
27	of	IN	ORGANIZATION	of	_	0	SENT_25	[p1l366t2890r432b2960],
28	Tokyo	NNP	ORGANIZATION	Tokyo	prep_of	26	SENT_25	[p1l476t2890r643b2960],
29	,	,	O	,	_	0	SENT_25	[p1l476t2890r643b2960],
30	Tokyo	NNP	LOCATION	Tokyo	appos	2	SENT_25	[p1l713t2890r880b2960],
31	,	,	O	,	_	0	SENT_25	[p1l713t2890r880b2960],
32	japan	NN	LOCATION	japan	appos	2	SENT_25	[p1l931t2893r1124b2960],
33	;	:	O	;	_	0	SENT_25	[p1l931t2893r1124b2960],
34	6Miyakaiva	NNP	O	6Miyakaiva	nn	37	SENT_25	[p1l1181t2876r1508b2960],
35	Memorial	NNP	O	Memorial	nn	37	SENT_25	[p1l1560t2890r1848b2942],
36	Researc/7	NNP	O	Researc/7	nn	37	SENT_25	[p1l1895t2890r2135b2942],
37	Foundation	NNP	O	Foundation	dep	2	SENT_25	[p1l14t2974r330b3032],
38	,	,	O	,	_	0	SENT_25	[p1l14t2974r330b3032],
39	Tokyo	NNP	LOCATION	Tokyo	appos	37	SENT_25	[p1l347t2974r498b3044],
40	,	,	O	,	_	0	SENT_25	[p1l347t2974r498b3044],
41	fapan	NN	O	fapan	appos	2	SENT_25	[p1l519t2978r690b3044],
42	.	.	O	.	_	0	SENT_25	[p1l519t2978r690b3044],

1	Received	VBN	O	receive	_	0	SENT_26	[p1l86t3058r312b3110],
2	August	NNP	DATE	August	dobj	1	SENT_26	[p1l324t3061r511b3128],
3	12	CD	DATE	12	num	2	SENT_26	[p1l535t3063r611b3116],
4	,	,	DATE	,	_	0	SENT_26	[p1l535t3063r611b3116],
5	2010	CD	DATE	2010	num	2	SENT_26	[p1l639t3063r798b3116],
6	;	:	O	;	_	0	SENT_26	[p1l639t3063r798b3116],
7	accepted	VBN	O	accept	partmod	2	SENT_26	[p1l823t3058r1042b3128],
8	October	NNP	DATE	October	tmod	7	SENT_26	[p1l1064t3058r1267b3110],
9	1	CD	DATE	1	num	8	SENT_26	[p1l1292t3063r1333b3116],
10	,	,	DATE	,	_	0	SENT_26	[p1l1292t3063r1333b3116],
11	2010	CD	DATE	2010	num	8	SENT_26	[p1l1362t3063r1515b3110],
12	.	.	O	.	_	0	SENT_26	[p1l1362t3063r1515b3110],

1	Supported	VBN	O	support	_	0	SENT_27	[p1l87t3142r353b3212],
2	in	IN	O	in	_	0	SENT_27	[p1l380t3147r431b3194],
3	part	NN	O	part	prep_in	1	SENT_27	[p1l454t3158r574b3212],
4	by	IN	O	by	_	0	SENT_27	[p1l604t3142r660b3212],
5	grants	NNS	O	grant	prep_by	3	SENT_27	[p1l685t3158r846b3212],
6	from	IN	O	from	_	0	SENT_27	[p1l864t3142r996b3212],
7	tbe	NN	O	tbe	prep_from	5	SENT_27	[p1l1031t3142r1108b3194],
8	fapanese	JJ	O	fapanese	amod	9	SENT_27	[p1l1127t3146r1357b3212],
9	Ministry	NNP	ORGANIZATION	Ministry	dobj	1	SENT_27	[p1l1383t3146r1611b3212],
10	of	IN	ORGANIZATION	of	_	0	SENT_27	[p1l1643t3142r1706b3212],
11	Healt/7	NNP	ORGANIZATION	Healt/7	prep_of	9	SENT_27	[p1l1717t3142r1907b3200],
12	,	,	O	,	_	0	SENT_27	[p1l1717t3142r1907b3200],
13	Labour	NNP	ORGANIZATION	Labour	conj_and	11	SENT_27	[p1l1944t3142r2138b3194],
14	and	CC	O	and	_	0	SENT_27	[p1l15t3231r122b3282],
15	lVelfare	NNP	O	lVelfare	prep_of	9	SENT_27	[p1l147t3231r344b3300],
16	.	.	O	.	_	0	SENT_27	[p1l147t3231r344b3300],

1	Address	NN	O	address	nsubj	2	SENT_28	[p1l81t3315r281b3366],
2	reprint	VB	O	reprint	_	0	SENT_28	[p1l320t3319r500b3384],
3	requests	NNS	O	request	dobj	2	SENT_28	[p1l535t3331r729b3385],
4	to	TO	O	to	_	0	SENT_28	[p1l768t3331r829b3366],
5	:	:	O	:	_	0	SENT_28	[p1l768t3331r829b3366],
6	Fumitaka	NNP	PERSON	Fumitaka	nn	7	SENT_28	[p1l867t3315r1124b3366],
7	Suzuki	NNP	PERSON	Suzuki	prep_to	2	SENT_28	[p1l1163t3315r1355b3373],
8	,	,	O	,	_	0	SENT_28	[p1l1163t3315r1355b3373],
9	Department	NNP	ORGANIZATION	Department	appos	7	SENT_28	[p1l1398t3318r1716b3384],
10	of	IN	ORGANIZATION	of	_	0	SENT_28	[p1l1751t3315r1814b3384],
11	Hepatology	NNP	ORGANIZATION	Hepatology	prep_of	9	SENT_28	[p1l1832t3315r2129b3384],
12	,	,	O	,	_	0	SENT_28	[p1l1832t3315r2129b3384],
13	Toranomon	NNP	LOCATION	Toranomon	nn	14	SENT_28	[p1l24t3400r313b3450],
14	Hospital	NNP	LOCATION	Hospital	appos	7	SENT_28	[p1l343t3398r574b3468],
15	,	,	O	,	_	0	SENT_28	[p1l343t3398r574b3468],
16	15	CD	NUMBER	15	num	18	SENT_28	[p1l615t3404r773b3457],
17	-	:	O	-	_	0	SENT_28	[p1l615t3404r773b3457],
18	]	CD	NUMBER	]	appos	14	SENT_28	[p1l615t3404r773b3457],
19	,	,	O	,	_	0	SENT_28	[p1l615t3404r773b3457],
20	Kajigaya	NNP	LOCATION	Kajigaya	appos	14	SENT_28	[p1l807t3402r1049b3468],
21	,	,	O	,	_	0	SENT_28	[p1l807t3402r1049b3468],
22	Yakatsu-ku	NN	O	yakatsu-ku	appos	14	SENT_28	[p1l1094t3398r1389b3457],
23	,	,	O	,	_	0	SENT_28	[p1l1094t3398r1389b3457],
24	Kawasaki	NNP	LOCATION	Kawasaki	nn	25	SENT_28	[p1l1424t3399r1681b3450],
25	City	NNP	LOCATION	City	appos	14	SENT_28	[p1l1715t3401r1821b3468],
26	213-8587	CD	NUMBER	213-8587	num	25	SENT_28	[p1l1847t3403r2129b3457],
27	,	,	O	,	_	0	SENT_28	[p1l1847t3403r2129b3457],
28	fapan	NN	O	fapan	appos	14	SENT_28	[p1l6t3486r177b3552],
29	.	.	O	.	_	0	SENT_28	[p1l6t3486r177b3552],

1	E-mail	NN	O	e-mail	_	0	SENT_29	[p1l207t3482r408b3534],
2	:	:	O	:	_	0	SENT_29	[p1l207t3482r408b3534],
3	fumitakas@toranomon.gr]p;	NN	O	fumitakas@toranomon.gr]p;	dep	1	SENT_29	[p1l421t3482r1175b3552],
4	fax	NN	O	fax	dep	3	SENT_29	[p1l1189t3482r1295b3552],
5	:	:	O	:	_	0	SENT_29	[p1l1189t3482r1295b3552],
6	+81	CD	NUMBER	+81	number	7	SENT_29	[p1l1323t3483r1842b3539],
7	-44	CD	NUMBER	-44	dep	4	SENT_29	[p1l1323t3483r1842b3539],
8	-860	CD	NUMBER	-860	dep	7	SENT_29	[p1l1323t3483r1842b3539],
9	-	:	O	-	_	0	SENT_29	[p1l1323t3483r1842b3539],
10	I623	NN	O	i623	dep	4	SENT_29	[p1l1323t3483r1842b3539],
11	.	.	O	.	_	0	SENT_29	[p1l1323t3483r1842b3539],

1	Copyrigbt	NN	O	copyrigbt	_	0	SENT_30	[p1l92t3567r346b3636],
2	©	CD	NUMBER	©	num	3	SENT_30	[p1l358t3568r408b3618],
3	2010	CD	DATE	2010	dep	1	SENT_30	[p1l424t3572r569b3618],
4	by	IN	O	by	_	0	SENT_30	[p1l589t3567r645b3636],
5	t/ae	JJ	O	t/ae	amod	7	SENT_30	[p1l665t3567r742b3618],
6	American	NNP	ORGANIZATION	American	nn	7	SENT_30	[p1l753t3569r1007b3618],
7	Association	NNP	ORGANIZATION	Association	prep_by	3	SENT_30	[p1l1023t3569r1311b3618],
8	for	IN	O	for	_	0	SENT_30	[p1l1320t3567r1406b3636],
9	t/7e	CD	NUMBER	t/7e	num	10	SENT_30	[p1l1424t3567r1501b3618],
10	Study	NN	O	study	prep_for	7	SENT_30	[p1l1519t3567r1665b3636],
11	of	IN	O	of	_	0	SENT_30	[p1l1684t3567r1747b3636],
12	Liver	NN	O	liver	nn	13	SENT_30	[p1l1747t3570r1886b3618],
13	Diseases	NNS	O	disease	prep_of	10	SENT_30	[p1l1901t3570r2118b3618],
14	.	.	O	.	_	0	SENT_30	[p1l1901t3570r2118b3618],

1	View	NNP	O	View	nn	4	SENT_31	[p1l94t3655r221b3703],
2	tbis	NN	O	tbi	nn	4	SENT_31	[p1l258t3651r349b3703],
3	article	NN	O	article	nn	4	SENT_31	[p1l382t3651r545b3703],
4	online	NN	O	online	_	0	SENT_31	[p1l580t3651r741b3703],
5	at	IN	O	at	_	0	SENT_31	[p1l775t3667r830b3703],
6	wileyonlinelibrarycom	NNP	O	wileyonlinelibrarycom	prep_at	4	SENT_31	[p1l864t3651r1457b3721],
7	.	.	O	.	_	0	SENT_31	[p1l864t3651r1457b3721],

1	DO	NN	O	do	_	0	SENT_32	[p1l85t3738r220b3787],
2	]	CD	NUMBER	]	dep	1	SENT_32	[p1l85t3738r220b3787],
3	10	CD	NUMBER	10	dep	2	SENT_32	[p1l242t3740r356b3787],
4	.	.	O	.	_	0	SENT_32	[p1l242t3740r356b3787],
5	]	SYM	O	]	dep	1	SENT_32	[p1l242t3740r356b3787],

1	002	CD	NUMBER	002	_	0	SENT_33	[p1l365t3735r735b3805],
2	/	:	O	/	punct	5	SENT_33	[p1l365t3735r735b3805],
3	/	:	O	/	punct	5	SENT_33	[p1l365t3735r735b3805],
4	7ep	JJ	O	7ep	dep	5	SENT_33	[p1l365t3735r735b3805],
5	.2405	CD	NUMBER	.2405	dep	1	SENT_33	[p1l365t3735r735b3805],
6	8	CD	NUMBER	8	dep	5	SENT_33	[p1l736t3741r769b3787],

1	Potential	JJ	O	potential	amod	2	SENT_34	[p2l85t14r324b65],
2	conﬂict	NN	O	conﬂict	_	0	SENT_34	[p2l344t14r532b83],
3	of	IN	O	of	_	0	SENT_34	[p2l553t14r616b83],
4	interest	NN	O	interest	prep_of	2	SENT_34	[p2l624t18r822b65],
5	:	:	O	:	_	0	SENT_34	[p2l624t18r822b65],
6	Notking	VBG	O	notk	dep	4	SENT_34	[p2l846t14r1067b83],
7	to	TO	O	to	aux	8	SENT_34	[p2l1089t30r1133b65],
8	report	VB	O	report	xcomp	6	SENT_34	[p2l1161t30r1320b83],
9	.	.	O	.	_	0	SENT_34	[p2l1161t30r1320b83],

1	orldwide	RB	O	orldwide	advmod	7	SENT_35	[p2l433t243r783b326],
2	,	,	O	,	_	0	SENT_35	[p2l433t243r783b326],
3	123	CD	NUMBER	123	number	4	SENT_35	[p2l843t250r974b319],
4	million	CD	NUMBER	million	num	5	SENT_35	[p2l1025t243r1298b315],
5	people	NNS	O	people	nsubjpass	7	SENT_35	[p2l1344t243r1591b339],
6	are	VBP	O	be	auxpass	7	SENT_35	[p2l1639t272r1746b315],
7	estimated	VBN	O	estimate	_	0	SENT_35	[p2l1794t243r2152b316],
8	to	TO	O	to	aux	11	SENT_35	[p2l440t384r511b432],
9	have	VB	O	have	aux	11	SENT_35	[p2l552t360r719b432],
10	been	VBN	O	be	auxpass	11	SENT_35	[p2l758t360r932b432],
11	infected	VBN	O	infect	xcomp	7	SENT_35	[p2l972t360r1270b433],
12	with	IN	O	with	_	0	SENT_35	[p2l1305t360r1475b432],
13	hepatitis	NN	O	hepatitis	nn	18	SENT_35	[p2l1512t360r1828b455],
14	C	NN	O	c	nn	18	SENT_35	[p2l1871t363r1933b432],
15	virus	NN	O	virus	nn	18	SENT_35	[p2l1970t365r2150b433],
16	(	CD	NUMBER	(	num	18	SENT_35	[p2l444t460r768b562],
17	HCV	NN	O	hcv	nn	18	SENT_35	[p2l444t460r768b562],
18	)	NN	O	)	prep_with	11	SENT_35	[p2l444t460r768b562],
19	,1	CD	NUMBER	,1	dep	18	SENT_35	[p2l444t460r768b562],
20	and	CC	O	and	_	0	SENT_35	[p2l822t476r959b549],
21	@	SYM	O	@	dep	25	SENT_35	[p2l1006t482r1254b552],
22	300/0	CD	NUMBER	300/0	nsubj	25	SENT_35	[p2l1006t482r1254b552],
23	of	IN	O	of	_	0	SENT_35	[p2l1303t476r1388b548],
24	them	PRP	O	they	prep_of	22	SENT_35	[p2l1421t476r1612b548],
25	develop	VBP	O	develop	dep	53	SENT_35	[p2l1659t475r1945b572],
26	fatal	JJ	O	fatal	amod	28	SENT_35	[p2l1993t476r2151b548],
27	liver	NN	O	liver	nn	28	SENT_35	[p2l11t591r172b663],
28	disease	NN	O	disease	dobj	25	SENT_35	[p2l216t591r468b664],
29	such	JJ	O	such	_	0	SENT_35	[p2l513t591r679b664],
30	as	IN	O	as	_	0	SENT_35	[p2l725t621r790b663],
31	cirrhosis	NN	O	cirrhosis	prep_such_as	28	SENT_35	[p2l837t591r1148b663],
32	and	CC	O	and	_	0	SENT_35	[p2l1195t591r1332b664],
33	hepatocellular	JJ	O	hepatocellular	amod	37	SENT_35	[p2l1375t591r1903b687],
34	carci	NN	O	carcus	nn	37	SENT_35	[p2l1948t596r2149b663],
35	—	NN	O	—	nn	37	SENT_35	[p2l1948t596r2149b663],
36	noma	NN	O	noma	nn	37	SENT_35	[p2l12t691r339b779],
37	.2	NN	NUMBER	.2	conj_and	28	SENT_35	[p2l12t691r339b779],
38	’	CD	NUMBER	’	number	39	SENT_35	[p2l12t691r339b779],
39	3	CD	NUMBER	3	num	40	SENT_35	[p2l12t691r339b779],
40	Currently	NNP	DATE	Currently	dep	37	SENT_35	[p2l398t707r776b803],
41	,	,	O	,	_	0	SENT_35	[p2l398t707r776b803],
42	the	DT	O	the	det	43	SENT_35	[p2l836t707r949b779],
43	standard	NN	O	standard	nsubjpass	53	SENT_35	[p2l1005t707r1327b780],
44	of	IN	O	of	_	0	SENT_35	[p2l1381t707r1466b779],
45	care	NN	O	care	nn	46	SENT_35	[p2l1509t736r1655b779],
46	therapy	NN	O	therapy	prep_of	43	SENT_35	[p2l1711t707r1994b804],
47	for	IN	O	for	_	0	SENT_35	[p2l2046t707r2152b779],
48	patients	NNS	O	patient	prep_for	46	SENT_35	[p2l11t827r303b918],
49	infected	VBN	O	infect	partmod	48	SENT_35	[p2l370t822r668b895],
50	with	IN	O	with	_	0	SENT_35	[p2l729t822r899b894],
51	HCV	NN	O	hcv	prep_with	49	SENT_35	[p2l965t826r1178b894],
52	is	VBZ	O	be	auxpass	53	SENT_35	[p2l1240t827r1291b894],
53	pegylated	VBN	O	pegylate	conj_and	7	SENT_35	[p2l1357t822r1713b919],
54	interferon	NN	O	interferon	nn	56	SENT_35	[p2l1779t822r2151b894],
55	(	NN	O	(	nn	56	SENT_35	[p2l17t939r443b1025],
56	PEG	NN	O	peg	dobj	53	SENT_35	[p2l17t939r443b1025],
57	.	.	O	.	_	0	SENT_35	[p2l17t939r443b1025],

1	—	NN	O	—	_	0	SENT_36	[p2l17t939r443b1025],
2	.	.	O	.	_	0	SENT_36	[p2l17t939r443b1025],

1	IFN	NN	O	ifn	nn	2	SENT_37	[p2l17t939r443b1025],
2	)	NN	O	)	dep	7	SENT_37	[p2l17t939r443b1025],
3	and	CC	O	and	_	0	SENT_37	[p2l527t938r664b1011],
4	ribavirin	NNP	O	ribavirin	conj_and	2	SENT_37	[p2l740t938r1060b1010],
5	(	CD	NUMBER	(	num	6	SENT_37	[p2l1141t940r1378b1025],
6	RBV	NN	O	rbv	dep	7	SENT_37	[p2l1141t940r1378b1025],
7	)	NN	O	)	dep	13	SENT_37	[p2l1141t940r1378b1025],
8	for	IN	O	for	_	0	SENT_37	[p2l1460t938r1567b1010],
9	48	CD	NUMBER	48	num	11	SENT_37	[p2l1641t939r1732b1010],
10	vveeks	NNS	O	vveek	nn	11	SENT_37	[p2l1809t918r2150b1010],
11	.4	NN	NUMBER	.4	prep_for	7	SENT_37	[p2l1809t918r2150b1010],
12	'	''	O	'	_	0	SENT_37	[p2l1809t918r2150b1010],
13	6	CD	NUMBER	6	dep	20	SENT_37	[p2l1809t918r2150b1010],
14	However	RB	O	however	advmod	20	SENT_37	[p2l13t1058r365b1136],
15	,	,	O	,	_	0	SENT_37	[p2l13t1058r365b1136],
16	the	DT	O	the	det	18	SENT_37	[p2l423t1053r537b1125],
17	combined	JJ	O	combined	amod	18	SENT_37	[p2l591t1053r966b1126],
18	treatment	NN	O	treatment	nsubj	20	SENT_37	[p2l1020t1078r1385b1125],
19	can	MD	O	can	aux	20	SENT_37	[p2l1438t1082r1563b1125],
20	induce	VB	O	induce	dep	68	SENT_37	[p2l1617t1053r1867b1126],
21	a	DT	O	a	det	27	SENT_37	[p2l1921t1083r1959b1125],
22	sustained	JJ	O	sustained	amod	27	SENT_37	[p2l2010t1083r2149b1126, p2l12t1168r244b1241],
23	Virological	JJ	O	virological	amod	27	SENT_37	[p2l290t1168r682b1266],
24	response	NN	O	response	nn	27	SENT_37	[p2l733t1197r1051b1265],
25	(	CD	NUMBER	(	num	27	SENT_37	[p2l1107t1170r1360b1255],
26	SVR	NN	ORGANIZATION	svr	nn	27	SENT_37	[p2l1107t1170r1360b1255],
27	)	NN	O	)	dobj	20	SENT_37	[p2l1107t1170r1360b1255],
28	,	,	O	,	_	0	SENT_37	[p2l1107t1170r1360b1255],
29	judged	VBN	O	judge	partmod	27	SENT_37	[p2l1409t1168r1668b1266],
30	by	IN	O	by	_	0	SENT_37	[p2l1717t1168r1809b1264],
31	the	DT	O	the	det	32	SENT_37	[p2l1855t1168r1969b1240],
32	loss	NN	O	loss	agent	29	SENT_37	[p2l2019t1168r2150b1240],
33	of	IN	O	of	_	0	SENT_37	[p2l12t1283r97b1355],
34	detectable	JJ	O	detectable	amod	36	SENT_37	[p2l135t1283r508b1355],
35	HCV	NN	O	hcv	nn	36	SENT_37	[p2l560t1286r772b1355],
36	RNA	NN	O	rna	prep_of	32	SENT_37	[p2l819t1286r1019b1355],
37	from	IN	O	from	_	0	SENT_37	[p2l1065t1283r1248b1355],
38	serum	NN	O	serum	prep_from	36	SENT_37	[p2l1298t1311r1524b1355],
39	24	CD	DURATION	24	num	40	SENT_37	[p2l1575t1283r1667b1354],
40	weeks	NNS	NUMBER	week	tmod	36	SENT_37	[p2l1715t1283r1934b1355],
41	after	IN	O	after	_	0	SENT_37	[p2l1986t1283r2152b1355],
42	treatment	NN	O	treatment	nn	43	SENT_37	[p2l12t1422r377b1469],
43	completion	NN	O	completion	prep_after	29	SENT_37	[p2l442t1398r890b1493],
44	,	,	O	,	_	0	SENT_37	[p2l442t1398r890b1493],
45	in	IN	O	in	_	0	SENT_37	[p2l961t1403r1033b1468],
46	at	IN	O	at	quantmod	48	SENT_37	[p2l1099t1422r1165b1469],
47	most	JJS	O	most	mwe	46	SENT_37	[p2l1230t1422r1414b1469],
48	50	CD	PERCENT	50	num	49	SENT_37	[p2l1482t1403r1652b1475],
49	%	NN	PERCENT	%	prep_in	27	SENT_37	[p2l1482t1403r1652b1475],
50	of	IN	O	of	_	0	SENT_37	[p2l1721t1398r1806b1469],
51	patients	NNS	O	patient	prep_of	49	SENT_37	[p2l1858t1403r2150b1493],
52	infected	VBN	O	infect	partmod	51	SENT_37	[p2l12t1512r310b1585],
53	with	IN	O	with	_	0	SENT_37	[p2l370t1512r540b1585],
54	HCV	NN	O	hcv	nn	55	SENT_37	[p2l605t1516r910b1595],
55	—	NN	O	—	prep_with	52	SENT_37	[p2l605t1516r910b1595],
56	1	CD	NUMBER	1	num	55	SENT_37	[p2l605t1516r910b1595],
57	,	,	O	,	_	0	SENT_37	[p2l605t1516r910b1595],
58	the	DT	O	the	det	59	SENT_37	[p2l978t1512r1092b1584],
59	genotype	NN	O	genotype	nsubj	68	SENT_37	[p2l1156t1537r1496b1610],
60	most	RBS	O	most	advmod	61	SENT_37	[p2l1560t1537r1745b1584],
61	prevalent	JJ	O	prevalent	amod	59	SENT_37	[p2l1807t1512r2152b1609],
62	and	CC	O	and	_	0	SENT_37	[p2l12t1627r150b1699],
63	least	JJS	O	least	dep	64	SENT_37	[p2l185t1627r347b1698],
64	responsive	JJ	O	responsive	amod	59	SENT_37	[p2l383t1632r769b1722],
65	to	TO	O	to	_	0	SENT_37	[p2l807t1651r878b1698],
66	IFN	NN	O	ifn	nn	67	SENT_37	[p2l917t1627r1317b1699],
67	—	NN	O	—	prep_to	64	SENT_37	[p2l917t1627r1317b1699],
68	based	VBN	O	base	_	0	SENT_37	[p2l917t1627r1317b1699],
69	therapies	NNS	O	therapy	dobj	68	SENT_37	[p2l1353t1627r1706b1722],
70	.	.	O	.	_	0	SENT_37	[p2l1353t1627r1706b1722],

1	Recently	RB	DATE	recently	advmod	7	SENT_38	[p2l111t1742r446b1836],
2	,	,	O	,	_	0	SENT_38	[p2l111t1742r446b1836],
3	Fellay	NNP	PERSON	Fellay	nsubj	7	SENT_38	[p2l492t1742r712b1836],
4	et	FW	O	et	nn	5	SENT_38	[p2l750t1766r815b1813],
5	al.	FW	O	al.	dep	3	SENT_38	[p2l856t1727r977b1813],
6	7	CD	NUMBER	7	dep	3	SENT_38	[p2l856t1727r977b1813],
7	reported	VBD	O	report	_	0	SENT_38	[p2l1019t1742r1336b1837],
8	that	IN	O	that	complm	28	SENT_38	[p2l1378t1742r1524b1813],
9	polymorphisms	NNS	O	polymorphism	nsubj	28	SENT_38	[p2l1563t1742r2149b1837],
10	of	IN	O	of	_	0	SENT_38	[p2l12t1856r97b1928],
11	the	DT	O	the	det	18	SENT_38	[p2l130t1856r244b1928],
12	inosine	NN	O	inosine	nn	18	SENT_38	[p2l289t1861r556b1928],
13	triphosphatase	NN	O	triphosphatase	nn	18	SENT_38	[p2l602t1856r1145b1953],
14	(	NN	O	(	nn	18	SENT_38	[p2l1195t1858r1263b1943],
15	1	CD	NUMBER	1	num	18	SENT_38	[p2l1195t1858r1263b1943],
16	TPA	NN	O	tpa	nn	18	SENT_38	[p2l1266t1858r1447b1943],
17	)	NN	O	)	nn	18	SENT_38	[p2l1266t1858r1447b1943],
18	gene	NN	O	gene	prep_of	9	SENT_38	[p2l1497t1885r1666b1954],
19	in	IN	O	in	_	0	SENT_38	[p2l1711t1861r1783b1927],
20	chromosome	NN	O	chromosome	nn	21	SENT_38	[p2l1829t1856r2149b1928, p2l12t1999r204b2042],
21	2O	NN	O	2o	prep_in	18	SENT_38	[p2l248t1978r340b2042],
22	(	CD	NUMBER	(	num	21	SENT_38	[p2l393t1972r687b2066],
23	20p13	NN	O	20p13	nn	27	SENT_38	[p2l393t1972r687b2066],
24	)	NN	O	)	nn	27	SENT_38	[p2l393t1972r687b2066],
25	inﬂuence	NN	O	inﬂuence	nn	27	SENT_38	[p2l738t1971r1079b2043],
26	RBV	NN	O	rbv	nn	27	SENT_38	[p2l1125t1971r1640b2043],
27	—	NN	O	—	dep	9	SENT_38	[p2l1125t1971r1640b2043],
28	induced	VBD	O	induce	ccomp	7	SENT_38	[p2l1125t1971r1640b2043],
29	anemia	NN	O	anemia	dobj	28	SENT_38	[p2l1685t1976r1956b2042],
30	in	IN	O	in	_	0	SENT_38	[p2l1999t1976r2071b2041],
31	a	DT	O	a	det	32	SENT_38	[p2l2116t2001r2154b2042],
32	genome	NN	O	genome	prep_in	28	SENT_38	[p2l11t2085r516b2181],
33	.	.	O	.	_	0	SENT_38	[p2l11t2085r516b2181],

1	—	NN	O	—	_	0	SENT_39	[p2l11t2085r516b2181],
2	.	.	O	.	_	0	SENT_39	[p2l11t2085r516b2181],

1	Wide	NN	O	wide	nn	3	SENT_40	[p2l11t2085r516b2181],
2	association	NN	O	association	nn	3	SENT_40	[p2l551t2090r956b2156],
3	study	NN	O	study	_	0	SENT_40	[p2l991t2085r1195b2179],
4	(	CD	NUMBER	(	num	6	SENT_40	[p2l1229t2086r1573b2171],
5	GWAS	NN	O	gwa	nn	6	SENT_40	[p2l1229t2086r1573b2171],
6	)	NN	O	)	dep	3	SENT_40	[p2l1229t2086r1573b2171],
7	.	.	O	.	_	0	SENT_40	[p2l1229t2086r1573b2171],

1	Single	JJ	O	single	amod	6	SENT_41	[p2l1613t2085r1839b2181],
2	nucleotide	NN	O	nucleotide	nn	6	SENT_41	[p2l1872t2085r2149b2157, p2l12t2199r152b2272],
3	polymorphism	NN	O	polymorphism	nn	6	SENT_41	[p2l188t2199r744b2295],
4	(	CD	NUMBER	(	num	6	SENT_41	[p2l787t2201r1014b2285],
5	SNP	NN	O	snp	nn	6	SENT_41	[p2l787t2201r1014b2285],
6	)	NN	O	)	_	0	SENT_41	[p2l787t2201r1014b2285],
7	at	IN	O	at	_	0	SENT_41	[p2l1057t2224r1124b2271],
8	rs1127354	NN	O	rs1127354	prep_at	6	SENT_41	[p2l1160t2200r1562b2276],
9	for	IN	O	for	_	0	SENT_41	[p2l1601t2199r1707b2271],
10	proline	NN	O	proline	prep_for	8	SENT_41	[p2l1742t2199r2149b2295],
11	—	CD	NUMBER	—	number	13	SENT_41	[p2l1742t2199r2149b2295],
12	to	TO	O	to	dep	13	SENT_41	[p2l1742t2199r2149b2295],
13	—	CD	NUMBER	—	num	18	SENT_41	[p2l1742t2199r2149b2295],
14	threonine	NN	O	threonine	nn	18	SENT_41	[p2l12t2313r374b2385],
15	substitution	NN	O	substitution	nn	18	SENT_41	[p2l424t2313r872b2386],
16	(	CD	NUMBER	(	num	18	SENT_41	[p2l928t2314r1194b2399],
17	P32T	NN	O	p32t	nn	18	SENT_41	[p2l928t2314r1194b2399],
18	)	NN	O	)	dep	6	SENT_41	[p2l928t2314r1194b2399],
19	in	IN	O	in	_	0	SENT_41	[p2l1251t2318r1323b2384],
20	the	DT	DATE	the	det	21	SENT_41	[p2l1374t2313r1488b2385],
21	second	NN	DATE	second	prep_in	18	SENT_41	[p2l1539t2313r1794b2386],
22	of	IN	O	of	_	0	SENT_41	[p2l1845t2313r1930b2385],
23	eight	CD	NUMBER	eight	prep_of	21	SENT_41	[p2l1968t2313r2153b2410],

1	416	CD	NUMBER	416	_	0	SENT_42	[p2l12t2607r116b2659],
2	SUZUKI	NNP	O	SUZUKI	nn	4	SENT_42	[p2l228t2609r481b2659],
3	ET	NNP	O	ET	nn	4	SENT_42	[p2l509t2608r595b2658],
4	AL.	NNP	O	AL.	dep	1	SENT_42	[p2l613t2610r711b2659],
5	.	.	O	.	_	0	SENT_42	[p2l613t2610r711b2659],

1	exons	NNS	O	exon	nsubj	19	SENT_43	[p2l14t2848r219b2891],
2	in	IN	O	in	_	0	SENT_43	[p2l255t2824r327b2889],
3	the	DT	O	the	det	6	SENT_43	[p2l362t2819r475b2891],
4	I	PRP	O	I	nn	6	SENT_43	[p2l507t2824r551b2889],
5	TPA	NN	O	tpa	nn	6	SENT_43	[p2l554t2822r708b2889],
6	gene	NN	O	gene	prep_in	1	SENT_43	[p2l742t2848r930b2915],
7	,	,	O	,	_	0	SENT_43	[p2l742t2848r930b2915],
8	as	IN	O	as	_	0	SENT_43	[p2l969t2849r1034b2891],
9	Well	NNP	O	Well	prep_as	19	SENT_43	[p2l1067t2819r1217b2891],
10	as	IN	O	as	_	0	SENT_43	[p2l1252t2849r1318b2891],
11	that	DT	O	that	prep_as	9	SENT_43	[p2l1354t2819r1499b2891],
12	at	IN	O	at	_	0	SENT_43	[p2l1533t2843r1599b2891],
13	rs7270101	NN	O	rs7270101	prep_at	11	SENT_43	[p2l1632t2826r2023b2895],
14	in	IN	O	in	_	0	SENT_43	[p2l2068t2824r2139b2889],
15	the	DT	O	the	det	17	SENT_43	[p2l14t2933r127b3004],
16	second	JJ	ORDINAL	second	amod	17	SENT_43	[p2l176t2933r430b3005],
17	intron	NN	O	intron	prep_in	13	SENT_43	[p2l478t2938r730b3014],
18	,	,	O	,	_	0	SENT_43	[p2l478t2938r730b3014],
19	affects	VBZ	O	affect	_	0	SENT_43	[p2l784t2933r1012b3004],
20	the	DT	O	the	det	21	SENT_43	[p2l1063t2933r1176b3004],
21	expression	NN	O	expression	dobj	19	SENT_43	[p2l1225t2938r1608b3028],
22	of	IN	O	of	_	0	SENT_43	[p2l1658t2933r1742b3004],
23	ITPA	NN	O	itpa	prep_of	21	SENT_43	[p2l1779t2917r2132b3004],
24	.8	CD	NUMBER	.8	number	25	SENT_43	[p2l1779t2917r2132b3004],
25	'11	CD	NUMBER	'11	num	26	SENT_43	[p2l1779t2917r2132b3004],
26	Patients	NNS	O	patient	nsubj	38	SENT_43	[p2l15t3052r303b3119],
27	infected	VBN	O	infect	partmod	26	SENT_43	[p2l334t3047r630b3119],
28	with	IN	O	with	_	0	SENT_43	[p2l655t3047r824b3119],
29	HCV-1	NN	MISC	hcv-1	prep_with	27	SENT_43	[p2l854t3051r1127b3119],
30	carrying	VBG	O	carry	xcomp	27	SENT_43	[p2l1166t3052r1470b3143],
31	the	DT	O	the	det	33	SENT_43	[p2l1498t3047r1612b3119],
32	CC	NN	O	cc	nn	33	SENT_43	[p2l1642t3051r1772b3119],
33	genotype	NN	O	genotype	dobj	30	SENT_43	[p2l1802t3071r2139b3143],
34	at	IN	O	at	_	0	SENT_43	[p2l14t3185r80b3233],
35	rs1127354	NN	O	rs1127354	prep_at	30	SENT_43	[p2l124t3162r523b3238],
36	are	VBP	O	be	cop	38	SENT_43	[p2l569t3190r675b3233],
37	more	RBR	O	more	advmod	38	SENT_43	[p2l719t3190r911b3233],
38	prone	JJ	O	prone	rcmod	21	SENT_43	[p2l954t3189r1170b3256],
39	to	TO	O	to	aux	40	SENT_43	[p2l1215t3185r1286b3233],
40	develop	VB	O	develop	xcomp	38	SENT_43	[p2l1333t3161r1616b3256],
41	anemia	NN	O	anemia	dobj	40	SENT_43	[p2l1663t3166r1932b3233],
42	than	IN	O	than	_	0	SENT_43	[p2l1974t3161r2139b3233],
43	those	DT	O	those	prep_than	40	SENT_43	[p2l14t3275r206b3347],
44	With	IN	O	with	_	0	SENT_43	[p2l250t3275r419b3347],
45	CA/AA	NN	O	ca/aa	nn	46	SENT_43	[p2l467t3278r747b3347],
46	genotypes	NNS	O	genotype	prep_with	43	SENT_43	[p2l791t3300r1158b3371],
47	during	IN	O	during	_	0	SENT_43	[p2l1207t3275r1456b3371],
48	the	DT	O	the	det	50	SENT_43	[p2l1501t3275r1615b3347],
49	combination	NN	O	combination	nn	50	SENT_43	[p2l1663t3275r2139b3347],
50	therapy	NN	O	therapy	prep_during	40	SENT_43	[p2l14t3391r304b3486],
51	,	,	O	,	_	0	SENT_43	[p2l14t3391r304b3486],
52	and	CC	O	and	_	0	SENT_43	[p2l356t3391r493b3463],
53	the	DT	O	the	det	54	SENT_43	[p2l540t3391r653b3463],
54	decrease	NN	O	decrease	nsubj	58	SENT_43	[p2l701t3391r1004b3463],
55	in	IN	O	in	_	0	SENT_43	[p2l1052t3396r1124b3462],
56	hemoglobin	NN	O	hemoglobin	prep_in	54	SENT_43	[p2l1171t3391r1622b3487],
57	is	VBZ	O	be	cop	58	SENT_43	[p2l1670t3396r1721b3463],
58	greater	JJR	O	greater	conj_and	19	SENT_43	[p2l1769t3415r2021b3487],
59	in	IN	O	in	_	0	SENT_43	[p2l2068t3396r2139b3461],
60	patients	NNS	O	patient	prep_in	58	SENT_43	[p2l13t3510r303b3600],
61	with	IN	O	with	_	0	SENT_43	[p2l380t3505r548b3577],
62	the	DT	O	the	det	63	SENT_43	[p2l626t3505r739b3577],
63	AA	NN	O	aa	prep_with	60	SENT_43	[p2l813t3509r939b3576],
64	than	IN	O	than	_	0	SENT_43	[p2l1014t3505r1179b3577],
65	AC/CC	NN	O	ac/cc	nn	66	SENT_43	[p2l1252t3508r1548b3577],
66	genotypes	NNS	O	genotype	prep_than	63	SENT_43	[p2l1627t3530r1995b3601],
67	at	IN	O	at	_	0	SENT_43	[p2l2075t3530r2141b3577],
68	rs72701O1	NN	O	rs72701o1	prep_at	58	SENT_43	[p2l14t3605r476b3696],
69	.7	CD	NUMBER	.7	num	68	SENT_43	[p2l14t3605r476b3696],
70	Their	PRP$	O	they	poss	71	SENT_43	[p2l516t3619r725b3691],
71	observations	NNS	O	observation	nsubjpass	74	SENT_43	[p2l766t3619r1227b3691],
72	have	VBP	O	have	aux	74	SENT_43	[p2l1269t3619r1436b3691],
73	been	VBN	O	be	auxpass	74	SENT_43	[p2l1478t3620r1650b3691],
74	extended	VBN	O	extend	rcmod	68	SENT_43	[p2l1692t3619r2025b3692],
75	to	TO	O	to	_	0	SENT_43	[p2l2067t3644r2137b3691],
76	many	JJ	O	many	amod	77	SENT_43	[p3l14t56r224b121],
77	patients	NNS	O	patient	prep_to	74	SENT_43	[p3l250t32r540b122],
78	in	IN	O	in	_	0	SENT_43	[p3l573t32r644b97],
79	a	DT	O	a	det	81	SENT_43	[p3l676t57r712b99],
80	large-scale	JJ	O	large-scale	amod	81	SENT_43	[p3l741t27r1120b123],
81	trial	NN	O	trial	prep_in	77	SENT_43	[p3l1152t27r1298b99],
82	with	IN	O	with	_	0	SENT_43	[p3l1326t27r1494b99],
83	pegIFN-oc-2a	NN	O	pegifn-oc-2a	prep_with	81	SENT_43	[p3l1524t32r2017b123],
84	on	IN	O	on	_	0	SENT_43	[p3l2045t56r2139b99],
85	Caucasian	JJ	MISC	caucasian	amod	88	SENT_43	[p3l15t145r393b214],
86	and	CC	O	and	_	0	SENT_43	[p3l441t141r578b213],
87	African	JJ	MISC	african	amod	88	SENT_43	[p3l619t141r897b212],
88	Americans	NNPS	MISC	Americans	prep_on	83	SENT_43	[p3l939t126r1432b223],
89	,	,	O	,	_	0	SENT_43	[p3l939t126r1432b223],
90	”	RB	O	”	advmod	74	SENT_43	[p3l939t126r1432b223],
91	as	RB	O	as	_	0	SENT_43	[p3l1482t171r1547b212],
92	well	RB	O	well	_	0	SENT_43	[p3l1593t141r1743b213],
93	as	IN	O	as	_	0	SENT_43	[p3l1792t171r1857b212],
94	in	IN	O	in	_	0	SENT_43	[p3l1907t146r1978b211],
95	the	DT	O	the	det	96	SENT_43	[p3l2026t141r2139b212],
96	Japanese	JJ	MISC	japanese	prep_in	58	SENT_43	[p3l7t260r330b351],
97	receiving	VBG	O	receive	partmod	96	SENT_43	[p3l373t260r705b352],
98	PEG	NN	O	peg	dobj	97	SENT_43	[p3l746t256r1325b327],
99	.	.	O	.	_	0	SENT_43	[p3l746t256r1325b327],

1	—	NN	O	—	_	0	SENT_44	[p3l746t256r1325b327],
2	.	.	O	.	_	0	SENT_44	[p3l746t256r1325b327],

1	IFN	NN	O	ifn	_	0	SENT_45	[p3l746t256r1325b327],
2	.	.	O	.	_	0	SENT_45	[p3l746t256r1325b327],

1	—	NN	O	—	_	0	SENT_46	[p3l746t256r1325b327],
2	.	.	O	.	_	0	SENT_46	[p3l746t256r1325b327],

1	oc	NN	O	oc	_	0	SENT_47	[p3l746t256r1325b327],
2	.	.	O	.	_	0	SENT_47	[p3l746t256r1325b327],

1	—	NN	O	—	_	0	SENT_48	[p3l746t256r1325b327],
2	.	.	O	.	_	0	SENT_48	[p3l746t256r1325b327],

1	2b	NN	O	2b	_	0	SENT_49	[p3l746t256r1325b327],
2	and	CC	O	and	_	0	SENT_49	[p3l1369t255r1506b328],
3	RBV	NN	O	rbv	conj_and	1	SENT_49	[p3l1548t260r1734b327],
4	who	WP	O	who	nsubjpass	6	SENT_49	[p3l1768t256r1927b327],
5	were	VBD	O	be	auxpass	6	SENT_49	[p3l1967t284r2139b327],
6	infected	VBN	O	infect	rcmod	1	SENT_49	[p3l14t371r310b443],
7	with	IN	O	with	_	0	SENT_49	[p3l335t371r503b442],
8	HCV	NN	O	hcv	prep_with	6	SENT_49	[p3l532t355r910b442],
9	—	CD	NUMBER	—	number	10	SENT_49	[p3l532t355r910b442],
10	1.13	CD	NUMBER	1.13	num	8	SENT_49	[p3l532t355r910b442],

1	For	IN	O	for	_	0	SENT_50	[p3l112t490r236b556],
2	improving	VBG	O	improve	prepc_for	14	SENT_50	[p3l304t490r683b581],
3	SVR	NNP	ORGANIZATION	SVR	dobj	2	SENT_50	[p3l750t489r924b557],
4	in	IN	O	in	_	0	SENT_50	[p3l988t490r1058b555],
5	HCV	NNP	O	HCV	nn	8	SENT_50	[p3l1127t489r1395b557],
6	—	CD	NUMBER	—	num	8	SENT_50	[p3l1127t489r1395b557],
7	1	CD	NUMBER	1	num	8	SENT_50	[p3l1127t489r1395b557],
8	patients	NNS	O	patient	prep_in	3	SENT_50	[p3l1471t490r1773b580],
9	,	,	O	,	_	0	SENT_50	[p3l1471t490r1773b580],
10	protease	NN	O	protease	nn	11	SENT_50	[p3l1844t509r2140b580],
11	inhibitors	NNS	O	inhibitor	nsubjpass	14	SENT_50	[p3l14t598r363b669],
12	have	VBP	O	have	aux	14	SENT_50	[p3l419t598r581b669],
13	been	VBN	O	be	auxpass	14	SENT_50	[p3l636t598r805b669],
14	added	VBN	O	add	_	0	SENT_50	[p3l860t598r1079b670],
15	to	TO	O	to	_	0	SENT_50	[p3l1133t623r1202b669],
16	the	DT	O	the	det	18	SENT_50	[p3l1259t598r1370b669],
17	standard	JJ	O	standard	amod	18	SENT_50	[p3l1425t598r1735b670],
18	treatment	NN	O	treatment	prep_to	14	SENT_50	[p3l1789t623r2141b669],
19	with	IN	O	with	_	0	SENT_50	[p3l10t713r175b784],
20	PEG	NN	O	peg	prep_with	18	SENT_50	[p3l255t716r617b784],
21	.	.	O	.	_	0	SENT_50	[p3l255t716r617b784],

1	—	NN	O	—	_	0	SENT_51	[p3l255t716r617b784],
2	.	.	O	.	_	0	SENT_51	[p3l255t716r617b784],

1	IFN	NN	ORGANIZATION	ifn	_	0	SENT_52	[p3l255t716r617b784],
2	and	CC	O	and	_	0	SENT_52	[p3l696t713r830b785],
3	RBV	NN	O	rbv	conj_and	1	SENT_52	[p3l910t717r1097b794],
4	,	,	O	,	_	0	SENT_52	[p3l910t717r1097b794],
5	and	CC	O	and	_	0	SENT_52	[p3l1181t713r1315b785],
6	increased	VBD	O	increase	amod	7	SENT_52	[p3l1394t713r1725b785],
7	SVR	NN	O	svr	conj_and	1	SENT_52	[p3l1806t716r1979b784],
8	by	IN	O	by	prep	7	SENT_52	[p3l2054t713r2144b807],

1	@	SYM	O	@	dep	3	SENT_53	[p3l16t813r314b902],
2	200/0	CD	NUMBER	200/0	number	3	SENT_53	[p3l16t813r314b902],
3	.1	CD	NUMBER	.1	num	4	SENT_53	[p3l16t813r314b902],
4	16	CD	NUMBER	16	nsubj	19	SENT_53	[p3l387t810r448b856],
5	However	RB	O	however	advmod	4	SENT_53	[p3l511t833r851b910],
6	,	,	O	,	_	0	SENT_53	[p3l511t833r851b910],
7	such	PDT	O	such	predet	9	SENT_53	[p3l916t828r1079b901],
8	a	DT	O	a	det	9	SENT_53	[p3l1140t858r1177b900],
9	gain	NN	O	gain	appos	4	SENT_53	[p3l1235t857r1387b924],
10	in	IN	O	in	_	0	SENT_53	[p3l1449t857r1519b899],
11	efﬁcacy	NN	O	efﬁcacy	nn	12	SENT_53	[p3l1580t828r1849b923],
12	1S	NN	O	1	prep_in	9	SENT_53	[p3l1907t857r1956b900],
13	not	RB	O	not	neg	12	SENT_53	[p3l2019t853r2141b900],
14	without	IN	O	without	_	0	SENT_53	[p3l10t984r299b1057],
15	trade	NN	O	trade	nn	17	SENT_53	[p3l333t984r693b1066],
16	—	CD	NUMBER	—	num	17	SENT_53	[p3l333t984r693b1066],
17	offs	NNS	O	off	prep_without	12	SENT_53	[p3l333t984r693b1066],
18	,	,	O	,	_	0	SENT_53	[p3l333t984r693b1066],
19	represented	VBN	O	represent	_	0	SENT_53	[p3l732t984r1147b1080],
20	by	IN	O	by	_	0	SENT_53	[p3l1180t984r1269b1079],
21	aggravation	NN	O	aggravation	prep_by	19	SENT_53	[p3l1300t989r1718b1081],
22	of	IN	O	of	_	0	SENT_53	[p3l1752t984r1834b1056],
23	anemia	NN	O	anemia	prep_of	21	SENT_53	[p3l1857t989r2135b1056],
24	.	.	O	.	_	0	SENT_53	[p3l1857t989r2135b1056],

1	Early	RB	O	early	advmod	2	SENT_54	[p3l14t1099r204b1193],
2	decreases	VBZ	O	decrease	_	0	SENT_54	[p3l255t1099r578b1171],
3	in	IN	O	in	_	0	SENT_54	[p3l633t1104r704b1169],
4	hemoglobin	NN	O	hemoglobin	nn	5	SENT_54	[p3l756t1099r1196b1195],
5	levels	NNS	O	level	prep_in	2	SENT_54	[p3l1249t1099r1437b1170],
6	during	IN	O	during	_	0	SENT_54	[p3l1492t1099r1735b1195],
7	the	DT	O	the	det	10	SENT_54	[p3l1786t1099r1897b1170],
8	triple	JJ	O	triple	amod	10	SENT_54	[p3l1951t1099r2140b1194],
9	therapy	NN	O	therapy	nn	10	SENT_54	[p3l14t1212r288b1307],
10	reach	NN	O	reach	prep_during	2	SENT_54	[p3l321t1212r511b1283],
11	4	CD	NUMBER	4	num	12	SENT_54	[p3l546t1213r590b1282],
12	g/dL	NN	O	g/dl	nsubj	2	SENT_54	[p3l628t1212r818b1308],
13	,	,	O	,	_	0	SENT_54	[p3l628t1212r818b1308],
14	and	CC	O	and	_	0	SENT_54	[p3l859t1212r992b1284],
15	they	PRP	O	they	nsubj	16	SENT_54	[p3l1028t1212r1184b1306],
16	exceed	VBP	O	exceed	conj_and	2	SENT_54	[p3l1217t1212r1452b1284],
17	%	NN	O	%	nn	19	SENT_54	[p3l1490t1219r1676b1288],
18	3.0	CD	NUMBER	3.0	num	19	SENT_54	[p3l1490t1219r1676b1288],
19	g/dL	NN	O	g/dl	dobj	16	SENT_54	[p3l1714t1212r1887b1308],
20	in	IN	O	in	_	0	SENT_54	[p3l1922t1217r1992b1282],
21	the	DT	O	the	det	23	SENT_54	[p3l2029t1212r2140b1283],
22	standard	JJ	O	standard	amod	23	SENT_54	[p3l14t1327r323b1399],
23	treatment	NN	O	treatment	prep_in	19	SENT_54	[p3l389t1308r919b1398],
24	.14	CD	NUMBER	.14	number	25	SENT_54	[p3l389t1308r919b1398],
25	’15	CD	NUMBER	’15	num	23	SENT_54	[p3l389t1308r919b1398],
26	Because	IN	O	because	mark	31	SENT_54	[p3l989t1332r1271b1399],
27	there	EX	O	there	expl	31	SENT_54	[p3l1338t1327r1517b1398],
28	have	VBP	O	have	aux	31	SENT_54	[p3l1582t1327r1745b1398],
29	been	VBN	O	be	cop	31	SENT_54	[p3l1811t1327r1980b1398],
30	no	DT	O	no	det	31	SENT_54	[p3l2047t1356r2137b1398],
31	reports	NNS	O	report	advcl	52	SENT_54	[p3l14t1466r263b1537],
32	focusing	VBG	O	focus	partmod	31	SENT_54	[p3l305t1442r610b1538],
33	on	IN	O	on	_	0	SENT_54	[p3l648t1470r742b1513],
34	the	DT	O	the	det	35	SENT_54	[p3l781t1442r892b1513],
35	influence	NN	O	influence	prep_on	32	SENT_54	[p3l933t1442r1263b1514],
36	of	IN	O	of	_	0	SENT_54	[p3l1303t1442r1387b1513],
37	[	CD	NUMBER	[	num	39	SENT_54	[p3l1411t1444r1608b1512],
38	TPA	NN	O	tpa	nn	39	SENT_54	[p3l1411t1444r1608b1512],
39	genotypes	NNS	O	genotype	prep_of	35	SENT_54	[p3l1648t1466r2005b1538],
40	on	IN	O	on	_	0	SENT_54	[p3l2047t1470r2141b1513],
41	anemia	NN	O	anemia	prep_on	32	SENT_54	[p3l14t1562r277b1629],
42	developing	VBG	O	develop	partmod	41	SENT_54	[p3l316t1557r713b1654],
43	in	IN	O	in	_	0	SENT_54	[p3l753t1562r823b1628],
44	patients	NNS	O	patient	prep_in	42	SENT_54	[p3l863t1562r1144b1653],
45	during	IN	O	during	_	0	SENT_54	[p3l1188t1558r1431b1654],
46	triple	JJ	O	triple	amod	47	SENT_54	[p3l1470t1557r1659b1653],
47	therapy	NN	O	therapy	prep_during	42	SENT_54	[p3l1701t1557r1983b1653],
48	,	,	O	,	_	0	SENT_54	[p3l1701t1557r1983b1653],
49	hemoglobin	NN	O	hemoglobin	nn	50	SENT_54	[p3l2027t1557r2139b1629, p3l14t1671r366b1767],
50	levels	NNS	O	level	nsubjpass	52	SENT_54	[p3l417t1671r605b1742],
51	were	VBD	O	be	auxpass	52	SENT_54	[p3l653t1699r822b1742],
52	followed	VBN	O	follow	rcmod	19	SENT_54	[p3l874t1671r1185b1743],
53	in	IN	O	in	_	0	SENT_54	[p3l1236t1676r1306b1741],
54	61	CD	NUMBER	61	num	56	SENT_54	[p3l1358t1673r1439b1742],
55	Japanese	JJ	MISC	japanese	amod	56	SENT_54	[p3l1494t1675r1807b1766],
56	patients	NNS	O	patient	prep_in	52	SENT_54	[p3l1857t1676r2138b1766],
57	with	IN	O	with	_	0	SENT_54	[p3l10t1784r175b1855],
58	HCV-1	NN	O	hcv-1	prep_with	56	SENT_54	[p3l215t1787r482b1855],
59	who	WP	O	who	nsubj	61	SENT_54	[p3l528t1784r684b1855],
60	had	VBD	O	have	aux	61	SENT_54	[p3l725t1784r859b1856],
61	received	VBN	O	receive	rcmod	56	SENT_54	[p3l899t1784r1190b1856],
62	it	PRP	O	it	dobj	61	SENT_54	[p3l1229t1789r1296b1855],
63	.	.	O	.	_	0	SENT_54	[p3l1229t1789r1296b1855],

1	The	DT	O	the	det	2	SENT_55	[p3l1338t1784r1486b1855],
2	results	NNS	O	result	nsubjpass	4	SENT_55	[p3l1527t1784r1751b1855],
3	were	VBD	O	be	auxpass	4	SENT_55	[p3l1788t1812r1957b1855],
4	correlated	VBN	O	correlate	_	0	SENT_55	[p3l1997t1812r2137b1855, p3l14t1898r256b1971],
5	with	IN	O	with	_	0	SENT_55	[p3l298t1898r463b1970],
6	polymorphisms	NNS	O	polymorphism	prep_with	4	SENT_55	[p3l508t1898r1075b1994],
7	at	IN	O	at	_	0	SENT_55	[p3l1123t1923r1188b1970],
8	rs1127354	NN	O	rs1127354	prep_at	6	SENT_55	[p3l1234t1899r1622b1975],
9	in	IN	O	in	_	0	SENT_55	[p3l1671t1903r1741b1969],
10	the	DT	O	the	det	13	SENT_55	[p3l1788t1899r1899b1970],
11	I	PRP	O	I	nn	13	SENT_55	[p3l1943t1903r1987b1969],
12	TPA	NN	O	tpa	nn	13	SENT_55	[p3l1989t1901r2140b1969],
13	gene	NN	O	gene	prep_in	8	SENT_55	[p3l13t2040r177b2108],
14	because	IN	O	because	mark	18	SENT_55	[p3l219t2012r493b2084],
15	the	DT	O	the	det	16	SENT_55	[p3l535t2012r645b2083],
16	Japanese	NNS	MISC	japanese	nsubj	18	SENT_55	[p3l680t2016r993b2107],
17	are	VBP	O	be	cop	18	SENT_55	[p3l1035t2040r1139b2083],
18	monoallelic	JJ	O	monoallelic	advcl	4	SENT_55	[p3l1181t2012r1604b2083],
19	at	IN	O	at	_	0	SENT_55	[p3l1644t2036r1709b2083],
20	rs7270101	NN	O	rs7270101	prep_at	18	SENT_55	[p3l1749t2019r2129b2088],
21	and	CC	O	and	_	0	SENT_55	[p3l14t2126r148b2198],
22	have	VBP	O	have	conj_and	18	SENT_55	[p3l181t2126r344b2197],
23	the	DT	O	the	det	25	SENT_55	[p3l380t2126r491b2197],
24	AA	NN	O	aa	nn	25	SENT_55	[p3l520t2129r645b2196],
25	genotype	NN	O	genotype	dobj	22	SENT_55	[p3l677t2150r1005b2222],
26	exclusively	RB	O	exclusively	advmod	25	SENT_55	[p3l1041t2111r1498b2220],
27	.	.	O	.	_	0	SENT_55	[p3l1041t2111r1498b2220],

1	“	NN	O	“	_	0	SENT_56	[p3l1041t2111r1498b2220],

1	Patients	NNS	O	patient	_	0	SENT_57	[p3l19t2382r401b2467],
2	and	CC	O	and	_	0	SENT_57	[p3l449t2383r617b2467],
3	Methods	NNS	O	method	conj_and	1	SENT_57	[p3l672t2383r1077b2467],

1	Study	NNP	O	Study	nn	2	SENT_58	[p3l113t2564r340b2660],
2	Cohort	NNP	O	Cohort	_	0	SENT_58	[p3l394t2564r678b2636],
3	.	.	O	.	_	0	SENT_58	[p3l394t2564r678b2636],

1	This	DT	O	this	det	4	SENT_59	[p3l725t2564r892b2635],
2	retrospective	JJ	O	retrospective	amod	4	SENT_59	[p3l945t2569r1414b2659],
3	cohort	NN	O	cohort	nn	4	SENT_59	[p3l1466t2564r1709b2636],
4	study	NN	O	study	nsubjpass	6	SENT_59	[p3l1759t2564r1961b2658],
5	was	VBD	O	be	auxpass	6	SENT_59	[p3l2006t2594r2138b2636],
6	performed	VBN	O	perform	_	0	SENT_59	[p3l13t2678r405b2773],
7	in	IN	O	in	_	0	SENT_59	[p3l443t2683r514b2749],
8	61	CD	NUMBER	61	num	9	SENT_59	[p3l552t2680r635b2750],
9	patients	NNS	O	patient	prep_in	6	SENT_59	[p3l682t2683r972b2773],
10	with	IN	O	with	_	0	SENT_59	[p3l1007t2678r1175b2750],
11	chronic	JJ	O	chronic	amod	13	SENT_59	[p3l1213t2678r1493b2750],
12	hepatitis	NN	O	hepatitis	nn	13	SENT_59	[p3l1528t2678r1842b2773],
13	C	NN	O	c	prep_with	6	SENT_59	[p3l1882t2682r1944b2750],
14	who	WP	O	who	nsubj	15	SENT_59	[p3l1979t2678r2137b2750],
15	met	VBD	O	meet	rcmod	13	SENT_59	[p3l14t2816r156b2864],
16	the	DT	O	the	det	18	SENT_59	[p3l225t2792r338b2864],
17	following	VBG	O	follow	amod	18	SENT_59	[p3l407t2792r761b2888],
18	inclusion	NN	O	inclusion	dobj	15	SENT_59	[p3l829t2792r1169b2865],
19	and	CC	O	and	_	0	SENT_59	[p3l1239t2792r1375b2865],
20	exclusion	NN	O	exclusion	nn	21	SENT_59	[p3l1445t2792r1787b2865],
21	criteria	NNS	O	criterion	conj_and	18	SENT_59	[p3l1858t2797r2134b2864],
22	.	.	O	.	_	0	SENT_59	[p3l1858t2797r2134b2864],

1	Inclusion	NN	O	inclusion	nn	2	SENT_60	[p3l14t2906r360b2979],
2	criteria	NNS	O	criterion	nsubj	3	SENT_60	[p3l428t2911r688b2978],
3	were	VBD	O	be	_	0	SENT_60	[p3l749t2935r942b2978],
4	:	:	O	:	_	0	SENT_60	[p3l749t2935r942b2978],
5	(	CD	NUMBER	(	number	6	SENT_60	[p3l1019t2908r1115b2992],
6	1	CD	NUMBER	1	num	7	SENT_60	[p3l1019t2908r1115b2992],
7	)	NN	O	)	dobj	3	SENT_60	[p3l1019t2908r1115b2992],
8	diagnosed	VBN	O	diagnose	partmod	7	SENT_60	[p3l1189t2906r1562b3003],
9	with	IN	O	with	_	0	SENT_60	[p3l1625t2906r1793b2978],
10	chronic	JJ	O	chronic	amod	12	SENT_60	[p3l1861t2906r2141b2978],
11	hepatitis	NN	O	hepatitis	nn	12	SENT_60	[p3l13t3020r327b3116],
12	C	NN	O	c	prep_with	8	SENT_60	[p3l366t3024r449b3102],
13	;	:	O	;	_	0	SENT_60	[p3l366t3024r449b3102],
14	(	NN	O	(	dep	12	SENT_60	[p3l493t3021r589b3106],
15	2	CD	NUMBER	2	number	16	SENT_60	[p3l493t3021r589b3106],
16	)	CD	NUMBER	)	num	18	SENT_60	[p3l493t3021r589b3106],
17	HCV	NN	O	hcv	nn	18	SENT_60	[p3l632t3024r905b3092],
18	—	NN	O	—	dep	7	SENT_60	[p3l632t3024r905b3092],
19	1	CD	NUMBER	1	dep	7	SENT_60	[p3l632t3024r905b3092],
20	conﬁrmed	VBN	O	conﬁrmed	partmod	19	SENT_60	[p3l951t3020r1333b3093],
21	by	IN	O	by	_	0	SENT_60	[p3l1369t3020r1460b3115],
22	sequence	NN	O	sequence	nn	23	SENT_60	[p3l1491t3049r1822b3115],
23	analysis	NN	O	analysis	agent	20	SENT_60	[p3l1859t3020r2138b3115],
24	in	IN	O	in	_	0	SENT_60	[p3l14t3139r86b3205],
25	the	DT	O	the	det	27	SENT_60	[p3l135t3134r249b3206],
26	NSSB	NN	O	nssb	nn	27	SENT_60	[p3l297t3138r523b3211],
27	region	NN	O	region	prep_in	23	SENT_60	[p3l575t3139r828b3231],
28	;	:	O	;	_	0	SENT_60	[p3l575t3139r828b3231],
29	(	CD	NUMBER	(	number	30	SENT_60	[p3l887t3136r984b3220],
30	3	CD	NUMBER	3	num	34	SENT_60	[p3l887t3136r984b3220],
31	)	NN	O	)	nn	34	SENT_60	[p3l887t3136r984b3220],
32	HCV	NN	O	hcv	nn	34	SENT_60	[p3l1040t3138r1251b3206],
33	RNA	NN	O	rna	nn	34	SENT_60	[p3l1297t3138r1496b3206],
34	levels	NNS	O	level	dobj	3	SENT_60	[p3l1541t3134r1735b3206],
35	25.0	CD	NUMBER	25.0	num	37	SENT_60	[p3l1791t3140r1976b3218],
36	log	NN	O	log	nn	37	SENT_60	[p3l2027t3134r2142b3231],
37	IU/mL	NN	O	iu/ml	dep	34	SENT_60	[p3l14t3251r280b3320],
38	determined	VBN	O	determine	partmod	34	SENT_60	[p3l318t3249r744b3321],
39	by	IN	O	by	_	0	SENT_60	[p3l784t3249r874b3343],
40	the	DT	O	the	det	44	SENT_60	[p3l910t3249r1023b3320],
41	COBAS	NNP	MISC	COBAS	nn	44	SENT_60	[p3l1064t3252r1368b3320],
42	TaqMan	NNP	MISC	TaqMan	nn	44	SENT_60	[p3l1409t3251r1729b3344],
43	HCV	NNP	MISC	HCV	nn	44	SENT_60	[p3l1768t3252r1980b3320],
44	test	NN	O	test	agent	38	SENT_60	[p3l2015t3273r2141b3320],
45	(	CD	NUMBER	(	num	44	SENT_60	[p3l19t3362r279b3448],
46	Roche	NNP	ORGANIZATION	Roche	nn	49	SENT_60	[p3l19t3362r279b3448],
47	Diagnostics	NNPS	ORGANIZATION	Diagnostics	nn	49	SENT_60	[p3l330t3367r762b3458],
48	K.K.	NNP	ORGANIZATION	K.K.	nn	49	SENT_60	[p3l815t3367r986b3434],
49	Tokyo	NNP	LOCATION	Tokyo	dep	44	SENT_60	[p3l1040t3362r1296b3457],
50	,	,	O	,	_	0	SENT_60	[p3l1040t3362r1296b3457],
51	Japan	NNP	LOCATION	Japan	appos	49	SENT_60	[p3l1345t3363r1610b3457],
52	)	CD	NUMBER	)	num	51	SENT_60	[p3l1345t3363r1610b3457],
53	;	:	O	;	_	0	SENT_60	[p3l1345t3363r1610b3457],
54	(	CD	NUMBER	(	num	63	SENT_60	[p3l1670t3363r1766b3448],
55	4	CD	NUMBER	4	number	56	SENT_60	[p3l1670t3363r1766b3448],
56	)	CD	NUMBER	)	num	63	SENT_60	[p3l1670t3363r1766b3448],
57	Japanese	JJ	MISC	japanese	amod	63	SENT_60	[p3l1817t3367r2139b3457],
58	aged	JJ	O	aged	amod	63	SENT_60	[p3l14t3476r182b3573],
59	from	IN	O	from	_	0	SENT_60	[p3l228t3476r409b3548],
60	20	CD	DURATION	20	number	62	SENT_60	[p3l456t3484r547b3548],
61	to	TO	DURATION	to	dep	62	SENT_60	[p3l597t3501r668b3548],
62	65	CD	DURATION	65	prep_from	58	SENT_60	[p3l717t3479r804b3553],
63	years	NNS	NUMBER	year	conj_and	44	SENT_60	[p3l854t3505r1036b3571],
64	at	IN	O	at	_	0	SENT_60	[p3l1085t3501r1150b3548],
65	the	DT	O	the	det	66	SENT_60	[p3l1195t3476r1309b3548],
66	entry	NN	O	entry	prep_at	63	SENT_60	[p3l1356t3501r1567b3571],
67	;	:	O	;	_	0	SENT_60	[p3l1356t3501r1567b3571],
68	and	CC	O	and	_	0	SENT_60	[p3l1618t3476r1755b3549],
69	(	NN	O	(	conj_and	44	SENT_60	[p3l1806t3478r1902b3562],
70	5	CD	NUMBER	5	number	71	SENT_60	[p3l1806t3478r1902b3562],
71	)	CD	NUMBER	)	num	73	SENT_60	[p3l1806t3478r1902b3562],
72	body	NN	O	body	nn	73	SENT_60	[p3l1955t3476r2144b3571],
73	weight	NN	O	weight	dep	69	SENT_60	[p3l10t3590r262b3686],
74	between	IN	O	between	_	0	SENT_60	[p3l307t3590r612b3661],
75	240	CD	NUMBER	240	num	76	SENT_60	[p3l664t3590r824b3673],
76	kg	NN	O	kg	prep_between	38	SENT_60	[p3l873t3590r961b3686],
77	and	CC	O	and	_	0	SENT_60	[p3l1006t3590r1142b3662],
78	$	$	MONEY	$	dep	80	SENT_60	[p3l1193t3597r1403b3673],
79	120	CD	MONEY	120	num	80	SENT_60	[p3l1193t3597r1403b3673],
80	kg	NN	O	kg	dobj	3	SENT_60	[p3l1450t3590r1540b3686],
81	at	IN	O	at	_	0	SENT_60	[p3l1584t3614r1650b3661],
82	the	DT	O	the	det	83	SENT_60	[p3l1695t3590r1808b3661],
83	time	NN	O	time	prep_at	80	SENT_60	[p3l1855t3595r2021b3661],
84	of	IN	O	of	_	0	SENT_60	[p3l2068t3590r2152b3661],
85	registration	NN	O	registration	prep_of	83	SENT_60	[p3l14t3709r455b3800],
86	.	.	O	.	_	0	SENT_60	[p3l14t3709r455b3800],

1	Exclusion	NN	O	exclusion	nn	2	SENT_61	[p3l497t3704r859b3777],
2	criteria	NNS	O	criterion	nsubj	3	SENT_61	[p3l896t3709r1155b3776],
3	were	VBD	O	be	_	0	SENT_61	[p3l1186t3733r1379b3776],
4	:	:	O	:	_	0	SENT_61	[p3l1186t3733r1379b3776],
5	(	CD	NUMBER	(	number	6	SENT_61	[p3l1424t3705r1521b3790],
6	1	CD	NUMBER	1	num	7	SENT_61	[p3l1424t3705r1521b3790],
7	)	NN	O	)	nsubj	89	SENT_61	[p3l1424t3705r1521b3790],
8	decompensated	VBN	O	decompensate	partmod	7	SENT_61	[p3l1564t3704r2140b3799],
9	liver	NN	O	liver	nn	10	SENT_61	[p4l13t15r173b87],
10	cirrhosis	NN	O	cirrhosis	dobj	8	SENT_61	[p4l211t15r542b97],
11	;	:	O	;	_	0	SENT_61	[p4l211t15r542b97],
12	(	CD	NUMBER	(	number	13	SENT_61	[p4l588t17r684b101],
13	2	CD	NUMBER	2	dep	10	SENT_61	[p4l588t17r684b101],
14	)	NN	O	)	nn	15	SENT_61	[p4l588t17r684b101],
15	hepatitis	NN	O	hepatitis	dep	64	SENT_61	[p4l728t15r1043b111],
16	B	NN	O	b	nn	18	SENT_61	[p4l1083t20r1134b86],
17	surface	NN	O	surface	nn	18	SENT_61	[p4l1174t15r1429b88],
18	antigen	NN	O	antigen	dep	15	SENT_61	[p4l1468t20r1741b112],
19	in	IN	O	in	_	0	SENT_61	[p4l1780t20r1852b86],
20	serum	NN	O	serum	prep_in	18	SENT_61	[p4l1890t44r2135b97],
21	;	:	O	;	_	0	SENT_61	[p4l1890t44r2135b97],
22	(	CD	NUMBER	(	number	23	SENT_61	[p4l19t131r115b216],
23	3	CD	NUMBER	3	num	24	SENT_61	[p4l19t131r115b216],
24	)	NN	O	)	npadvmod	25	SENT_61	[p4l19t131r115b216],
25	hepatocellular	JJ	O	hepatocellular	amod	26	SENT_61	[p4l158t130r683b225],
26	carcinoma	NN	O	carcinoma	dep	18	SENT_61	[p4l721t135r1109b201],
27	or	CC	O	or	_	0	SENT_61	[p4l1145t158r1222b201],
28	its	PRP$	O	its	poss	29	SENT_61	[p4l1259t135r1340b201],
29	history	NN	O	history	conj_or	26	SENT_61	[p4l1378t130r1656b224],
30	;	:	O	;	_	0	SENT_61	[p4l1378t130r1656b224],
31	(	CD	NUMBER	(	number	32	SENT_61	[p4l1702t130r1798b216],
32	4	CD	NUMBER	4	dep	29	SENT_61	[p4l1702t130r1798b216],
33	)	NN	O	)	nn	35	SENT_61	[p4l1702t130r1798b216],
34	autoimmune	JJ	O	autoimmune	amod	35	SENT_61	[p4l1843t135r2137b202, p4l14t272r226b315],
35	hepatitis	NN	O	hepatitis	dep	47	SENT_61	[p4l267t243r602b338],
36	,	,	O	,	_	0	SENT_61	[p4l267t243r602b338],
37	alcoholic	JJ	O	alcoholic	amod	39	SENT_61	[p4l648t243r982b314],
38	liver	NN	O	liver	nn	39	SENT_61	[p4l1021t243r1181b315],
39	disease	NN	O	disease	dep	47	SENT_61	[p4l1220t243r1490b324],
40	,	,	O	,	_	0	SENT_61	[p4l1220t243r1490b324],
41	hemochromatosis	NN	O	hemochromatosis	dep	47	SENT_61	[p4l1535t243r2137b314, p4l14t362r118b439],
42	,	,	O	,	_	0	SENT_61	[p4l1535t243r2137b314, p4l14t362r118b439],
43	or	CC	O	or	_	0	SENT_61	[p4l160t386r237b429],
44	chronic	JJ	O	chronic	amod	45	SENT_61	[p4l274t357r554b429],
45	liver	NN	O	liver	dep	47	SENT_61	[p4l590t357r750b429],
46	disease	NN	O	disease	dep	47	SENT_61	[p4l785t357r1036b430],
47	other	JJ	O	other	dep	29	SENT_61	[p4l1074t357r1269b429],
48	than	IN	O	than	_	0	SENT_61	[p4l1305t357r1470b429],
49	chronic	JJ	O	chronic	amod	51	SENT_61	[p4l1508t357r1789b429],
50	hepatitis	NN	O	hepatitis	nn	51	SENT_61	[p4l1824t357r2138b453],
51	C	NN	O	c	prep_than	47	SENT_61	[p4l15t475r98b553],
52	;	:	O	;	_	0	SENT_61	[p4l15t475r98b553],
53	(	CD	NUMBER	(	number	54	SENT_61	[p4l170t473r266b557],
54	5	CD	NUMBER	5	dep	18	SENT_61	[p4l170t473r266b557],
55	)	NN	O	)	nn	58	SENT_61	[p4l170t473r266b557],
56	chronic	JJ	O	chronic	amod	58	SENT_61	[p4l335t472r616b543],
57	renal	JJ	O	renal	amod	58	SENT_61	[p4l678t472r858b543],
58	disease	NN	O	disease	dep	54	SENT_61	[p4l922t472r1172b543],
59	or	CC	O	or	_	0	SENT_61	[p4l1235t500r1312b543],
60	creatinine	NN	O	creatinine	nn	61	SENT_61	[p4l1374t477r1739b543],
61	clearance	NN	O	clearance	conj_or	58	SENT_61	[p4l1803t472r2139b543],
62	£	CD	MONEY	£	dep	64	SENT_61	[p4l19t591r180b668],
63	50	CD	MONEY	50	num	64	SENT_61	[p4l19t591r180b668],
64	mL/min	NN	O	ml/min	dep	75	SENT_61	[p4l227t587r539b657],
65	at	IN	O	at	_	0	SENT_61	[p4l583t609r649b656],
66	the	DT	O	the	det	67	SENT_61	[p4l692t585r805b656],
67	baseline	NN	O	baseline	prep_at	64	SENT_61	[p4l849t585r1162b666],
68	;	:	O	;	_	0	SENT_61	[p4l849t585r1162b666],
69	(	CD	NUMBER	(	number	70	SENT_61	[p4l1216t586r1312b671],
70	6	CD	NUMBER	6	dep	67	SENT_61	[p4l1216t586r1312b671],
71	)	NN	O	)	nn	73	SENT_61	[p4l1216t586r1312b671],
72	hemoglobin	NN	O	hemoglobin	nn	73	SENT_61	[p4l1361t585r1812b681],
73	£	NN	MONEY	£	dep	70	SENT_61	[p4l1862t592r2023b668],
74	12	CD	MONEY	12	num	75	SENT_61	[p4l1862t592r2023b668],
75	g	NN	O	g	dep	10	SENT_61	[p4l2069t587r2138b681],
76	/	:	O	/	punct	87	SENT_61	[p4l2069t587r2138b681],
77	dL	NN	O	dl	dep	87	SENT_61	[p4l14t700r134b781],
78	,	,	O	,	_	0	SENT_61	[p4l14t700r134b781],
79	neutrophil	NN	O	neutrophil	dep	77	SENT_61	[p4l204t699r597b795],
80	$	$	MONEY	$	dep	79	SENT_61	[p4l668t684r1174b783],
81	1,500	CD	MONEY	1,500	num	80	SENT_61	[p4l668t684r1174b783],
82	/	:	O	/	punct	79	SENT_61	[p4l668t684r1174b783],
83	mm3	CD	NUMBER	mm3	dep	79	SENT_61	[p4l668t684r1174b783],
84	or	CC	O	or	_	0	SENT_61	[p4l1243t728r1320b771],
85	platelet	NN	O	platelet	nn	86	SENT_61	[p4l1383t699r1656b795],
86	§	NN	O	§	dep	79	SENT_61	[p4l1725t702r2138b783],
87	100,000	CD	NUMBER	100,000	dep	10	SENT_61	[p4l1725t702r2138b783],
88	/	:	O	/	punct	87	SENT_61	[p4l1725t702r2138b783],
89	mm3	CD	NUMBER	mm3	parataxis	3	SENT_61	[p4l14t798r199b884],
90	at	IN	O	at	_	0	SENT_61	[p4l238t838r303b884],
91	baseline	NN	O	baseline	prep_at	89	SENT_61	[p4l339t814r651b884],
92	.	.	O	.	_	0	SENT_61	[p4l339t814r651b884],

1	Of	IN	O	of	_	0	SENT_62	[p4l113t927r225b999],
2	the	DT	O	the	det	4	SENT_62	[p4l270t927r383b998],
3	61	CD	NUMBER	61	num	4	SENT_62	[p4l440t929r523b998],
4	patients	NNS	O	patient	prep_of	12	SENT_62	[p4l587t932r899b1022],
5	,	,	O	,	_	0	SENT_62	[p4l587t932r899b1022],
6	44	CD	PERCENT	44	number	7	SENT_62	[p4l959t928r1052b997],
7	(	CD	PERCENT	(	nsubj	12	SENT_62	[p4l1114t928r1342b1013],
8	72	CD	PERCENT	72	num	9	SENT_62	[p4l1114t928r1342b1013],
9	%	NN	PERCENT	%	dep	7	SENT_62	[p4l1114t928r1342b1013],
10	)	CD	NUMBER	)	dep	7	SENT_62	[p4l1114t928r1342b1013],
11	had	VBD	O	have	aux	12	SENT_62	[p4l1403t927r1540b999],
12	received	VBN	O	receive	_	0	SENT_62	[p4l1595t927r1895b999],
13	IFN	NN	O	ifn	nn	14	SENT_62	[p4l1952t932r2138b999],
14	—	NN	O	—	dobj	12	SENT_62	[p4l1952t932r2138b999],
15	based	VBN	O	base	partmod	14	SENT_62	[p4l14t1041r219b1113],
16	treatment	NN	O	treatment	dobj	15	SENT_62	[p4l261t1065r623b1112],
17	before	IN	O	before	prep	15	SENT_62	[p4l664t1041r914b1112],
18	.	.	O	.	_	0	SENT_62	[p4l664t1041r914b1112],

1	Relapse	NN	O	relapse	nsubj	2	SENT_63	[p4l962t1041r1242b1136],
2	occurred	VBD	O	occur	_	0	SENT_63	[p4l1285t1041r1609b1113],
3	in	IN	O	in	_	0	SENT_63	[p4l1651t1046r1723b1111],
4	29	CD	PERCENT	29	num	5	SENT_63	[p4l1765t1048r1856b1117],
5	(	CD	PERCENT	(	prep_in	2	SENT_63	[p4l1906t1041r2133b1127],
6	47	CD	PERCENT	47	num	7	SENT_63	[p4l1906t1041r2133b1127],
7	%	NN	PERCENT	%	dobj	2	SENT_63	[p4l1906t1041r2133b1127],
8	)	CD	NUMBER	)	nsubj	19	SENT_63	[p4l1906t1041r2133b1127],
9	and	CC	O	and	_	0	SENT_63	[p4l14t1155r151b1227],
10	the	DT	O	the	det	16	SENT_63	[p4l202t1155r316b1226],
11	remaining	VBG	O	remain	amod	16	SENT_63	[p4l368t1160r749b1251],
12	15	CD	PERCENT	15	number	13	SENT_63	[p4l808t1161r887b1231],
13	(	CD	PERCENT	(	amod	16	SENT_63	[p4l949t1156r1176b1241],
14	25	CD	PERCENT	25	num	15	SENT_63	[p4l949t1156r1176b1241],
15	%	NN	PERCENT	%	dep	13	SENT_63	[p4l949t1156r1176b1241],
16	)	NN	O	)	nsubj	19	SENT_63	[p4l949t1156r1176b1241],
17	did	VBD	O	do	aux	19	SENT_63	[p4l1235t1155r1357b1227],
18	not	RB	O	not	neg	19	SENT_63	[p4l1408t1179r1533b1226],
19	respond	VB	O	respond	rcmod	7	SENT_63	[p4l1584t1155r1880b1250],
20	(	NN	O	(	nn	21	SENT_63	[p4l1936t1155r2138b1241, p4l1234t1278r1703b1336],
21	nullHEPATOLOGY	NN	O	nullhepatology	dobj	19	SENT_63	[p4l1936t1155r2138b1241, p4l1234t1278r1703b1336],
22	,	,	O	,	_	0	SENT_63	[p4l1936t1155r2138b1241, p4l1234t1278r1703b1336],
23	February	NNP	DATE	February	appos	21	SENT_63	[p4l1734t1277r1976b1345],
24	2011	CD	DATE	2011	num	23	SENT_63	[p4l2000t1282r2132b1329],

1	responders	NNS	O	responder	_	0	SENT_64	[p4l10t1505r460b1600],
2	)	CD	NUMBER	)	num	1	SENT_64	[p4l10t1505r460b1600],
3	.	.	O	.	_	0	SENT_64	[p4l10t1505r460b1600],

1	All	DT	O	all	det	2	SENT_65	[p4l514t1505r624b1576],
2	patients	NNS	O	patient	nsubj	3	SENT_65	[p4l677t1510r968b1600],
3	gave	VBD	O	give	_	0	SENT_65	[p4l1023t1535r1183b1601],
4	consent	NN	O	consent	dobj	3	SENT_65	[p4l1236t1529r1521b1577],
5	for	IN	O	for	_	0	SENT_65	[p4l1573t1505r1679b1576],
6	analysis	NN	O	analysis	prep_for	3	SENT_65	[p4l1732t1505r2011b1599],
7	of	IN	O	of	_	0	SENT_65	[p4l2067t1505r2151b1577],
8	SNPS	NN	O	snp	prep_of	6	SENT_65	[p4l11t1622r211b1691],
9	in	IN	O	in	_	0	SENT_65	[p4l256t1624r327b1689],
10	ITP/1	NN	O	itp/1	prep_in	3	SENT_65	[p4l368t1621r569b1689],
11	and	CC	O	and	_	0	SENT_65	[p4l612t1619r749b1691],
12	interleukin	NN	O	interleukin	prep_in	3	SENT_65	[p4l791t1619r1200b1691],
13	28	CD	NUMBER	28	number	14	SENT_65	[p4l1243t1626r1333b1690],
14	(	CD	NUMBER	(	num	17	SENT_65	[p4l1385t1620r1674b1705],
15	IL28B	NN	O	il28b	nn	17	SENT_65	[p4l1385t1620r1674b1705],
16	)	NN	O	)	nn	17	SENT_65	[p4l1385t1620r1674b1705],
17	genes	NNS	O	gene	dep	3	SENT_65	[p4l1723t1647r1942b1715],
18	.	.	O	.	_	0	SENT_65	[p4l1723t1647r1942b1715],

1	The	DT	O	the	det	2	SENT_66	[p4l1988t1619r2138b1690],
2	study	NN	O	study	nsubjpass	18	SENT_66	[p4l9t1733r213b1827],
3	was	VBD	O	be	auxpass	4	SENT_66	[p4l264t1763r397b1805],
4	conducted	VBN	O	conduct	_	0	SENT_66	[p4l457t1733r846b1806],
5	in	IN	O	in	_	0	SENT_66	[p4l905t1738r976b1804],
6	accordance	NN	O	accordance	prep_in	4	SENT_66	[p4l1034t1733r1444b1806],
7	with	IN	O	with	_	0	SENT_66	[p4l1499t1733r1667b1805],
8	the	DT	O	the	det	10	SENT_66	[p4l1725t1733r1839b1805],
9	ethical	JJ	O	ethical	amod	10	SENT_66	[p4l1897t1733r2137b1805],
10	principles	NNS	O	principle	prep_with	4	SENT_66	[p4l9t1847r371b1943],
11	of	IN	O	of	_	0	SENT_66	[p4l443t1847r527b1919],
12	the	DT	O	the	det	13	SENT_66	[p4l584t1847r697b1919],
13	Declaration	NN	O	declaration	prep_of	10	SENT_66	[p4l767t1847r1206b1919],
14	of	IN	O	of	_	0	SENT_66	[p4l1276t1847r1360b1919],
15	Helsinki	NNP	LOCATION	Helsinki	prep_of	13	SENT_66	[p4l1417t1847r1732b1919],
16	and	CC	O	and	_	0	SENT_66	[p4l1802t1847r1939b1920],
17	was	VBD	O	be	auxpass	18	SENT_66	[p4l2004t1877r2137b1919],
18	approved	VBN	O	approve	conj_and	4	SENT_66	[p4l10t1961r356b2056],
19	by	IN	O	by	_	0	SENT_66	[p4l423t1961r514b2056],
20	the	DT	O	the	det	22	SENT_66	[p4l580t1961r693b2033],
21	Ethics	NNPS	ORGANIZATION	Ethics	nn	22	SENT_66	[p4l761t1961r988b2033],
22	Committee	NNP	ORGANIZATION	Committee	agent	18	SENT_66	[p4l1059t1965r1485b2033],
23	of	IN	ORGANIZATION	of	_	0	SENT_66	[p4l1555t1961r1639b2033],
24	Toranomon	NNP	ORGANIZATION	Toranomon	nn	25	SENT_66	[p4l1692t1963r2138b2033],
25	Hospital	NNP	ORGANIZATION	Hospital	prep_of	22	SENT_66	[p4l10t2075r351b2170],
26	.	.	O	.	_	0	SENT_66	[p4l10t2075r351b2170],

1	Written	VBN	O	write	csubjpass	5	SENT_67	[p4l390t2080r682b2147],
2	informed	JJ	O	informed	amod	3	SENT_67	[p4l720t2075r1066b2147],
3	consent	NN	O	consent	dobj	1	SENT_67	[p4l1104t2099r1388b2147],
4	was	VBD	O	be	auxpass	5	SENT_67	[p4l1421t2105r1555b2147],
5	obtained	VBN	O	obtain	_	0	SENT_67	[p4l1593t2075r1920b2148],
6	from	IN	O	from	_	0	SENT_67	[p4l1957t2075r2138b2147],
7	each	DT	O	each	det	8	SENT_67	[p4l10t2190r173b2262],
8	patient	NN	O	patient	prep_from	5	SENT_67	[p4l208t2195r487b2285],
9	.	.	O	.	_	0	SENT_67	[p4l208t2195r487b2285],

1	Triple	JJ	O	triple	amod	8	SENT_68	[p4l117t2332r346b2428],
2	Yiwatment	NN	O	yiwatment	nn	8	SENT_68	[p4l402t2335r805b2404],
3	wit/J	NN	O	wit/j	nn	8	SENT_68	[p4l849t2332r1025b2404],
4	PEG-IFN	NN	O	peg-ifn	nn	8	SENT_68	[p4l1070t2332r1686b2414],
5	—	CD	NUMBER	—	num	8	SENT_68	[p4l1070t2332r1686b2414],
6	oc	NN	O	oc	nn	8	SENT_68	[p4l1070t2332r1686b2414],
7	—	NN	O	—	nn	8	SENT_68	[p4l1070t2332r1686b2414],
8	2b	NN	O	2b	_	0	SENT_68	[p4l1070t2332r1686b2414],
9	,	,	O	,	_	0	SENT_68	[p4l1070t2332r1686b2414],
10	RB	NN	O	rb	nn	11	SENT_68	[p4l1739t2337r1865b2403],
11	K	NN	O	k	appos	8	SENT_68	[p4l1875t2337r1945b2414],
12	and	CC	O	and	_	0	SENT_68	[p4l1988t2332r2150b2404],
13	Yklaprevir	NN	O	yklaprevir	conj_and	11	SENT_68	[p4l20t2446r426b2542],
14	.	.	O	.	_	0	SENT_68	[p4l20t2446r426b2542],

1	Telaprevir	NNP	O	Telaprevir	nn	3	SENT_69	[p4l471t2446r836b2541],
2	(	CD	NUMBER	(	num	3	SENT_69	[p4l936t2447r1291b2532],
3	MP-424	NN	O	mp-424	nsubjpass	18	SENT_69	[p4l936t2447r1291b2532],
4	;	:	O	;	_	0	SENT_69	[p4l936t2447r1291b2532],
5	Mitsubishi	NNP	ORGANIZATION	Mitsubishi	nn	7	SENT_69	[p4l1391t2446r1781b2518],
6	Tanabe	NNP	ORGANIZATION	Tanabe	nn	7	SENT_69	[p4l1876t2446r2139b2518],
7	Pharma	NNP	ORGANIZATION	Pharma	dep	3	SENT_69	[p4l11t2560r312b2642],
8	,	,	O	,	_	0	SENT_69	[p4l11t2560r312b2642],
9	Osaka	NNP	LOCATION	Osaka	appos	3	SENT_69	[p4l373t2560r617b2642],
10	,	,	O	,	_	0	SENT_69	[p4l373t2560r617b2642],
11	Japan	NNP	LOCATION	Japan	appos	3	SENT_69	[p4l670t2561r928b2655],
12	)	CD	NUMBER	)	num	11	SENT_69	[p4l670t2561r928b2655],
13	,	,	O	,	_	0	SENT_69	[p4l670t2561r928b2655],
14	750	CD	NUMBER	750	num	15	SENT_69	[p4l989t2566r1126b2637],
15	mg	NN	O	mg	appos	3	SENT_69	[p4l1186t2589r1321b2656],
16	,	,	O	,	_	0	SENT_69	[p4l1186t2589r1321b2656],
17	was	VBD	O	be	auxpass	18	SENT_69	[p4l1378t2590r1508b2632],
18	administered	VBN	O	administer	_	0	SENT_69	[p4l1567t2560r2039b2633],
19	3	CD	NUMBER	3	number	20	SENT_69	[p4l2095t2567r2135b2636],
20	times	NNS	O	time	dobj	18	SENT_69	[p4l10t2679r201b2746],
21	a	DT	DURATION	a	det	22	SENT_69	[p4l247t2704r284b2746],
22	day	NN	DURATION	day	dep	20	SENT_69	[p4l327t2674r455b2769],
23	at	IN	O	at	_	0	SENT_69	[p4l496t2699r561b2746],
24	an	DT	O	a	det	29	SENT_69	[p4l603t2703r688b2746],
25	8-hour	JJ	DURATION	8-hour	amod	29	SENT_69	[p4l734t2674r983b2747],
26	(	NN	O	(	nn	29	SENT_69	[p4l1030t2676r1172b2770],
27	q8	NN	O	q8	nn	29	SENT_69	[p4l1030t2676r1172b2770],
28	)	CD	NUMBER	)	num	29	SENT_69	[p4l1030t2676r1172b2770],
29	interval	NN	O	interval	prep_at	18	SENT_69	[p4l1223t2675r1493b2746],
30	after	IN	O	after	_	0	SENT_69	[p4l1538t2674r1698b2746],
31	each	DT	O	each	det	32	SENT_69	[p4l1741t2674r1900b2746],
32	meal	NN	O	meal	prep_after	18	SENT_69	[p4l1944t2674r2133b2746],
33	.	.	O	.	_	0	SENT_69	[p4l1944t2674r2133b2746],

1	Pegylated-IFN-oc-2b	JJ	O	pegylated-ifn-oc-2b	amod	2	SENT_70	[p4l11t2788r742b2884],
2	(	NN	O	(	_	0	SENT_70	[p4l850t2789r1335b2874],
3	PEG	NN	O	peg	dep	2	SENT_70	[p4l850t2789r1335b2874],
4	.	.	O	.	_	0	SENT_70	[p4l850t2789r1335b2874],

1	—	NN	O	—	_	0	SENT_71	[p4l850t2789r1335b2874],
2	.	.	O	.	_	0	SENT_71	[p4l850t2789r1335b2874],

1	Intron	NNP	O	Intron	nsubjpass	11	SENT_72	[p4l850t2789r1335b2874],
2	,	,	O	,	_	0	SENT_72	[p4l850t2789r1335b2874],
3	Schering	NNP	ORGANIZATION	Schering	nn	4	SENT_72	[p4l1441t2788r1757b2884],
4	Plough	NNP	ORGANIZATION	Plough	appos	1	SENT_72	[p4l1857t2788r2134b2884],
5	,	,	O	,	_	0	SENT_72	[p4l1857t2788r2134b2884],
6	Kenilworth	NNP	LOCATION	Kenilworth	appos	1	SENT_72	[p4l10t2902r442b2984],
7	,	,	O	,	_	0	SENT_72	[p4l10t2902r442b2984],
8	NJ	NNP	O	NJ	nn	9	SENT_72	[p4l495t2903r625b2992],
9	)	NNP	O	)	appos	1	SENT_72	[p4l495t2903r625b2992],
10	was	VBD	O	be	auxpass	11	SENT_72	[p4l678t2932r809b2974],
11	injected	VBN	O	inject	_	0	SENT_72	[p4l861t2902r1144b2998],
12	subcutaneously	RB	O	subcutaneously	advmod	11	SENT_72	[p4l1194t2902r1751b2997],
13	at	IN	O	at	_	0	SENT_72	[p4l1798t2926r1864b2974],
14	a	DT	O	a	det	16	SENT_72	[p4l1912t2932r1949b2974],
15	median	NN	O	median	nn	16	SENT_72	[p4l1998t2931r2136b2974, p4l10t3016r167b3089],
16	dose	NN	O	dose	prep_at	11	SENT_72	[p4l208t3016r367b3089],
17	of	IN	O	of	_	0	SENT_72	[p4l408t3016r492b3088],
18	1.5	CD	NUMBER	1.5	num	21	SENT_72	[p4l526t3022r628b3093],
19	Mg/kg	NN	O	mg/kg	nn	21	SENT_72	[p4l674t3016r887b3113],
20	(	NN	O	(	nn	21	SENT_72	[p4l930t3018r1170b3113],
21	range	NN	O	range	prep_of	16	SENT_72	[p4l930t3018r1170b3113],
22	:	:	O	:	_	0	SENT_72	[p4l930t3018r1170b3113],
23	1.32-1	CD	NUMBER	1.32-1	num	24	SENT_72	[p4l1223t3024r1564b3093],
24	.71	CD	NUMBER	.71	dep	16	SENT_72	[p4l1223t3024r1564b3093],
25	,	,	O	,	_	0	SENT_72	[p4l1614t3016r1850b3113],
26	LLg/kg	NN	O	llg/kg	nn	27	SENT_72	[p4l1614t3016r1850b3113],
27	)	NN	O	)	appos	24	SENT_72	[p4l1614t3016r1850b3113],
28	once	RB	DATE	once	advmod	30	SENT_72	[p4l1896t3045r2063b3088],
29	a	DT	DURATION	a	det	30	SENT_72	[p4l2104t3046r2141b3088],
30	Week	NN	DURATION	week	tmod	11	SENT_72	[p4l6t3130r209b3201],
31	.	.	O	.	_	0	SENT_72	[p4l6t3130r209b3201],

1	RBV	NN	O	rbv	nn	3	SENT_73	[p4l250t3134r434b3201],
2	(	CD	NUMBER	(	num	3	SENT_73	[p4l471t3130r793b3215],
3	Rebetol	NNP	PERSON	Rebetol	nsubjpass	11	SENT_73	[p4l471t3130r793b3215],
4	,	,	O	,	_	0	SENT_73	[p4l471t3130r793b3215],
5	Schering	NNP	ORGANIZATION	Schering	nn	6	SENT_73	[p4l834t3130r1149b3226],
6	Plough	NNP	ORGANIZATION	Plough	appos	3	SENT_73	[p4l1185t3130r1466b3226],
7	)	CD	NUMBER	)	num	9	SENT_73	[p4l1185t3130r1466b3226],
8	200-600	CD	NUMBER	200-600	num	9	SENT_73	[p4l1509t3132r1819b3201],
9	mg	NN	O	mg	dep	6	SENT_73	[p4l1858t3158r1976b3226],
10	was	VBD	O	be	auxpass	11	SENT_73	[p4l2007t3160r2137b3201],
11	administered	VBN	O	administer	_	0	SENT_73	[p4l10t3244r481b3317],
12	after	IN	O	after	_	0	SENT_73	[p4l524t3244r684b3316],
13	breakfast	NN	O	breakfast	prep_after	11	SENT_73	[p4l727t3244r1049b3316],
14	and	CC	O	and	_	0	SENT_73	[p4l1091t3244r1225b3317],
15	dinner	NN	O	dinner	prep_after	11	SENT_73	[p4l1268t3244r1517b3317],
16	.	.	O	.	_	0	SENT_73	[p4l1268t3244r1517b3317],

1	The	DT	O	the	det	3	SENT_74	[p4l1564t3244r1712b3316],
2	RBV	NN	O	rbv	nn	3	SENT_74	[p4l1756t3249r1939b3316],
3	dose	NN	O	dose	nsubjpass	5	SENT_74	[p4l1979t3244r2138b3317],
4	was	VBD	O	be	auxpass	5	SENT_74	[p4l6t3389r137b3431],
5	adjusted	VBN	O	adjust	_	0	SENT_74	[p4l179t3359r478b3456],
6	by	IN	O	by	_	0	SENT_74	[p4l517t3359r607b3454],
7	body	NN	O	body	agent	5	SENT_74	[p4l643t3359r828b3454],
8	weight	NN	O	weight	dep	7	SENT_74	[p4l860t3359r1123b3456],
9	:	:	O	:	_	0	SENT_74	[p4l860t3359r1123b3456],
10	600	CD	NUMBER	600	num	11	SENT_74	[p4l1168t3362r1305b3431],
11	mg	NN	O	mg	agent	5	SENT_74	[p4l1347t3388r1465b3456],
12	for	IN	O	for	_	0	SENT_74	[p4l1502t3359r1605b3431],
13	$	$	MONEY	$	amod	15	SENT_74	[p4l1649t3362r1809b3443],
14	60	CD	MONEY	60	number	13	SENT_74	[p4l1649t3362r1809b3443],
15	kg	NN	O	kg	prep_for	11	SENT_74	[p4l1850t3359r1955b3456],
16	;	:	O	;	_	0	SENT_74	[p4l1850t3359r1955b3456],
17	800	CD	NUMBER	800	num	18	SENT_74	[p4l2002t3366r2136b3431],
18	mg	NN	O	mg	agent	5	SENT_74	[p4l10t3501r127b3569],
19	for	IN	O	for	_	0	SENT_74	[p4l168t3473r272b3544],
20	>	JJR	O	>	prep_for	18	SENT_74	[p4l318t3475r478b3547],
21	60	CD	PERCENT	60	num	23	SENT_74	[p4l318t3475r478b3547],
22	kg	CD	PERCENT	kg	num	23	SENT_74	[p4l522t3473r611b3569],
23	%	NN	PERCENT	%	dep	20	SENT_74	[p4l653t3480r891b3556],
24	§	CD	NUMBER	§	number	25	SENT_74	[p4l653t3480r891b3556],
25	80	CD	NUMBER	80	num	26	SENT_74	[p4l653t3480r891b3556],
26	kg	NN	O	kg	dep	23	SENT_74	[p4l936t3473r1041b3569],
27	;	:	O	;	_	0	SENT_74	[p4l936t3473r1041b3569],
28	and	CC	O	and	_	0	SENT_74	[p4l1088t3473r1222b3545],
29	1,000	CD	NUMBER	1,000	num	30	SENT_74	[p4l1272t3480r1472b3554],
30	mg	NN	O	mg	agent	5	SENT_74	[p4l1518t3501r1635b3569],
31	for	IN	O	for	_	0	SENT_74	[p4l1675t3473r1779b3544],
32	280	CD	NUMBER	280	num	33	SENT_74	[p4l1825t3480r1985b3556],
33	kg	NN	O	kg	prep_for	30	SENT_74	[p4l2029t3473r2134b3569],
34	.	.	O	.	_	0	SENT_74	[p4l2029t3473r2134b3569],

1	The	DT	O	the	det	3	SENT_75	[p4l7t3587r155b3659],
2	triple	JJ	O	triple	amod	3	SENT_75	[p4l190t3587r379b3682],
3	therapy	NN	O	therapy	_	0	SENT_75	[p4l414t3587r689b3683],
4	with	IN	O	with	_	0	SENT_75	[p4l716t3587r881b3659],
5	PEG	NN	O	peg	prep_with	3	SENT_75	[p4l916t3587r1502b3669],
6	.	.	O	.	_	0	SENT_75	[p4l916t3587r1502b3669],

1	—	NN	O	—	_	0	SENT_76	[p4l916t3587r1502b3669],
2	.	.	O	.	_	0	SENT_76	[p4l916t3587r1502b3669],

1	IFN-oc-2b	NN	O	ifn-oc-2b	_	0	SENT_77	[p4l916t3587r1502b3669],
2	,	,	O	,	_	0	SENT_77	[p4l916t3587r1502b3669],
3	RBV	NN	O	rbv	conj_and	1	SENT_77	[p4l1542t3592r1729b3669],
4	,	,	O	,	_	0	SENT_77	[p4l1542t3592r1729b3669],
5	and	CC	O	and	_	0	SENT_77	[p4l1768t3587r1902b3660],
6	telaprevir	NN	O	telaprevir	conj_and	1	SENT_77	[p4l1936t3587r2136b3682, p4l10t3706r173b3773],
7	was	VBD	O	be	auxpass	8	SENT_77	[p4l209t3731r340b3773],
8	continued	VBN	O	continue	rcmod	1	SENT_77	[p4l382t3701r750b3774],
9	for	IN	O	for	_	0	SENT_77	[p4l788t3701r892b3773],
10	12	CD	DURATION	12	num	11	SENT_77	[p4l939t3709r1021b3772],
11	Weeks	NNS	DURATION	week	prep_for	8	SENT_77	[p4l1060t3701r1293b3783],
12	,	,	O	,	_	0	SENT_77	[p4l1060t3701r1293b3783],
13	and	CC	O	and	_	0	SENT_77	[p4l1338t3701r1471b3774],
14	then	RB	O	then	advmod	15	SENT_77	[p4l1511t3702r1671b3773],
15	switched	VBD	O	switch	rcmod	1	SENT_77	[p4l1712t3701r2027b3774],
16	to	TO	O	to	prep	15	SENT_77	[p4l2067t3726r2136b3773],

1	PEG	NN	O	peg	_	0	SENT_78	[p5l11t23r577b95],
2	.	.	O	.	_	0	SENT_78	[p5l11t23r577b95],

1	—	NN	O	—	_	0	SENT_79	[p5l11t23r577b95],
2	.	.	O	.	_	0	SENT_79	[p5l11t23r577b95],

1	IFN	NN	O	ifn	_	0	SENT_80	[p5l11t23r577b95],
2	.	.	O	.	_	0	SENT_80	[p5l11t23r577b95],

1	—	NN	O	—	_	0	SENT_81	[p5l11t23r577b95],
2	.	.	O	.	_	0	SENT_81	[p5l11t23r577b95],

1	oc	NN	O	oc	_	0	SENT_82	[p5l11t23r577b95],
2	.	.	O	.	_	0	SENT_82	[p5l11t23r577b95],

1	—	NN	O	—	_	0	SENT_83	[p5l11t23r577b95],
2	.	.	O	.	_	0	SENT_83	[p5l11t23r577b95],

1	2b	NN	O	2b	_	0	SENT_84	[p5l11t23r577b95],
2	and	CC	O	and	_	0	SENT_84	[p5l618t23r752b95],
3	RBV	NN	O	rbv	conj_and	1	SENT_84	[p5l791t27r975b95],
4	for	IN	O	for	_	0	SENT_84	[p5l1010t23r1113b94],
5	an	DT	O	a	det	8	SENT_84	[p5l1151t52r1236b95],
6	additional	JJ	O	additional	amod	8	SENT_84	[p5l1275t23r1642b95],
7	12	CD	DURATION	12	num	8	SENT_84	[p5l1689t30r1770b93],
8	weeks	NNS	NUMBER	week	prep_for	1	SENT_84	[p5l1808t23r2040b95],
9	.	.	O	.	_	0	SENT_84	[p5l1808t23r2040b95],

1	It	PRP	O	it	nsubjpass	3	SENT_85	[p5l2085t27r2140b94],
2	was	VBD	O	be	auxpass	3	SENT_85	[p5l6t167r137b209],
3	withdrawn	VBN	O	withdraw	_	0	SENT_85	[p5l177t137r571b210],
4	when	WRB	O	when	advmod	7	SENT_85	[p5l610t138r809b209],
5	hemoglobin	NN	O	hemoglobin	nn	6	SENT_85	[p5l850t137r1290b234],
6	levels	NNS	O	level	nsubj	7	SENT_85	[p5l1331t137r1519b209],
7	decreased	VBD	O	decrease	advcl	3	SENT_85	[p5l1563t137r1907b210],
8	<	JJR	O	<	dobj	7	SENT_85	[p5l1953t143r2133b214],
9	8.5	CD	NUMBER	8.5	num	10	SENT_85	[p5l1953t143r2133b214],
10	g/dL	NN	O	g/dl	dep	8	SENT_85	[p5l9t251r199b348],
11	.	.	O	.	_	0	SENT_85	[p5l9t251r199b348],

1	After	IN	O	after	mark	5	SENT_86	[p5l241t251r428b323],
2	the	DT	O	the	det	3	SENT_86	[p5l470t251r580b323],
3	therapy	NN	O	therapy	nsubjpass	5	SENT_86	[p5l622t251r897b347],
4	was	VBD	O	be	auxpass	5	SENT_86	[p5l933t281r1063b323],
5	completed	VBN	O	complete	advcl	11	SENT_86	[p5l1108t251r1489b347],
6	or	CC	O	or	_	0	SENT_86	[p5l1530t280r1607b323],
7	discontinued	VBN	O	discontinue	conj_or	5	SENT_86	[p5l1646t251r2134b333],
8	,	,	O	,	_	0	SENT_86	[p5l1646t251r2134b333],
9	patients	NNS	O	patient	nsubjpass	11	SENT_86	[p5l9t371r290b461],
10	were	VBD	O	be	auxpass	11	SENT_86	[p5l323t394r492b437],
11	followed	VBN	O	follow	_	0	SENT_86	[p5l527t366r840b438],
12	for	IN	O	for	_	0	SENT_86	[p5l874t366r977b437],
13	24	CD	DURATION	24	num	14	SENT_86	[p5l1011t366r1102b436],
14	weeks	NNS	NUMBER	week	prep_for	11	SENT_86	[p5l1135t366r1347b437],
15	for	IN	O	for	_	0	SENT_86	[p5l1384t366r1489b437],
16	SVR	NNP	ORGANIZATION	SVR	prep_for	14	SENT_86	[p5l1523t369r1709b437],
17	.	.	O	.	_	0	SENT_86	[p5l1523t369r1709b437],

1	The	DT	O	the	det	3	SENT_87	[p5l105t479r253b551],
2	RBV	NN	O	rbv	nn	3	SENT_87	[p5l292t484r475b551],
3	dose	NN	O	dose	nsubjpass	5	SENT_87	[p5l509t480r668b552],
4	was	VBD	O	be	auxpass	5	SENT_87	[p5l703t509r833b551],
5	cut	VBN	O	cut	_	0	SENT_87	[p5l873t504r985b552],
6	by	IN	O	by	_	0	SENT_87	[p5l1021t479r1111b574],
7	200	CD	NUMBER	200	num	8	SENT_87	[p5l1144t486r1282b551],
8	mg	NN	O	mg	agent	5	SENT_87	[p5l1322t508r1440b576],
9	in	IN	O	in	_	0	SENT_87	[p5l1476t484r1546b550],
10	patients	NNS	O	patient	prep_in	8	SENT_87	[p5l1582t484r1864b575],
11	receiving	VBG	O	receive	partmod	10	SENT_87	[p5l1903t484r2136b551, p5l10t598r125b689],
12	600	CD	NUMBER	600	num	16	SENT_87	[p5l183t595r320b664],
13	or	CC	O	or	_	0	SENT_87	[p5l382t621r458b664],
14	800	CD	NUMBER	800	num	16	SENT_87	[p5l518t600r653b664],
15	mg	NN	O	mg	nn	16	SENT_87	[p5l715t621r833b689],
16	(	NN	O	(	dobj	11	SENT_87	[p5l895t593r1010b687],
17	by	IN	O	by	_	0	SENT_87	[p5l895t593r1010b687],
18	400	CD	NUMBER	400	num	19	SENT_87	[p5l1065t593r1203b664],
19	mg	NN	O	mg	agent	11	SENT_87	[p5l1265t621r1383b689],
20	in	IN	O	in	_	0	SENT_87	[p5l1440t598r1510b663],
21	those	DT	O	those	prep_in	19	SENT_87	[p5l1571t593r1758b664],
22	receiving	VBG	O	receive	partmod	21	SENT_87	[p5l1819t598r2141b689],
23	1,000	CD	NUMBER	1,000	num	25	SENT_87	[p5l18t714r217b788],
24	mg	NN	O	mg	nn	25	SENT_87	[p5l263t708r402b803],
25	)	NN	O	)	dobj	22	SENT_87	[p5l263t708r402b803],
26	when	WRB	O	when	advmod	28	SENT_87	[p5l448t707r646b779],
27	hemoglobin	NN	O	hemoglobin	nsubj	28	SENT_87	[p5l689t707r1128b803],
28	decreased	VBD	O	decrease	advcl	22	SENT_87	[p5l1172t707r1515b779],
29	<	JJR	O	<	acomp	28	SENT_87	[p5l1563t714r1723b781],
30	12	CD	NUMBER	12	num	31	SENT_87	[p5l1563t714r1723b781],
31	g/dL	NN	O	g/dl	dobj	28	SENT_87	[p5l1768t707r1958b803],
32	,	,	O	,	_	0	SENT_87	[p5l1768t707r1958b803],
33	and	CC	O	and	dep	34	SENT_87	[p5l2006t707r2139b779],
34	by	IN	O	by	dep	28	SENT_87	[p5l10t821r100b915],
35	another	DT	O	another	det	37	SENT_87	[p5l144t821r422b893],
36	200	CD	NUMBER	200	num	37	SENT_87	[p5l469t828r607b893],
37	mg	NN	O	mg	pobj	34	SENT_87	[p5l658t850r775b917],
38	when	WRB	O	when	advmod	40	SENT_87	[p5l819t821r1017b893],
39	it	PRP	O	it	nsubj	40	SENT_87	[p5l1067t826r1117b892],
40	was	VBD	O	be	advcl	28	SENT_87	[p5l1161t851r1291b893],
41	below	IN	O	below	_	0	SENT_87	[p5l1341t821r1558b893],
42	<	JJR	O	<	prep_below	40	SENT_87	[p5l1608t828r1768b895],
43	10	CD	NUMBER	10	num	44	SENT_87	[p5l1608t828r1768b895],
44	g/dL	NN	O	g/dl	dep	42	SENT_87	[p5l1819t821r2008b917],
45	.	.	O	.	_	0	SENT_87	[p5l1819t821r2008b917],

1	In	IN	O	in	_	0	SENT_88	[p5l2062t826r2138b891],
2	addition	NN	O	addition	prep_in	6	SENT_88	[p5l10t936r334b1017],
3	,	,	O	,	_	0	SENT_88	[p5l10t936r334b1017],
4	RBV	NN	O	rbv	nsubjpass	6	SENT_88	[p5l378t940r561b1007],
5	was	VBD	O	be	auxpass	6	SENT_88	[p5l593t966r724b1007],
6	reduced	VBN	O	reduce	_	0	SENT_88	[p5l765t936r1051b1008],
7	by	IN	O	by	_	0	SENT_88	[p5l1089t936r1179b1030],
8	200	CD	NUMBER	200	num	9	SENT_88	[p5l1213t943r1351b1007],
9	mg	NN	O	mg	agent	6	SENT_88	[p5l1393t964r1510b1032],
10	in	IN	O	in	_	0	SENT_88	[p5l1548t941r1618b1006],
11	patients	NNS	O	patient	prep_in	9	SENT_88	[p5l1656t941r1938b1031],
12	with	IN	O	with	_	0	SENT_88	[p5l1975t936r2139b1007],
13	hemoglobin	NN	O	hemoglobin	prep_with	6	SENT_88	[p5l9t1049r449b1145],
14	<	JJR	O	<	amod	13	SENT_88	[p5l491t1056r649b1124],
15	13	CD	NUMBER	13	num	16	SENT_88	[p5l491t1056r649b1124],
16	g/dL	NN	O	g/dl	npadvmod	17	SENT_88	[p5l690t1049r862b1145],
17	at	IN	O	at	advmod	13	SENT_88	[p5l898t1073r963b1120],
18	baseline	NN	O	baseline	dep	13	SENT_88	[p5l998t1049r1282b1120],
19	and	CC	O	and	_	0	SENT_88	[p5l1319t1049r1453b1121],
20	those	DT	O	those	prep_with	6	SENT_88	[p5l1490t1049r1677b1120],
21	in	IN	O	in	_	0	SENT_88	[p5l1714t1054r1784b1119],
22	whom	WP	O	whom	rel	24	SENT_88	[p5l1818t1049r2052b1121],
23	it	PRP	O	it	nsubj	24	SENT_88	[p5l2089t1054r2140b1120],
24	decreased	VBD	O	decrease	rcmod	20	SENT_88	[p5l10t1163r355b1236],
25	by	IN	O	by	_	0	SENT_88	[p5l393t1163r482b1257],
26	1	CD	NUMBER	1	num	27	SENT_88	[p5l527t1170r553b1233],
27	g/dL	NN	O	g/dl	prep_by	24	SENT_88	[p5l603t1163r775b1259],
28	to	TO	O	to	_	0	SENT_88	[p5l814t1187r883b1235],
29	<	JJR	O	<	prep_to	24	SENT_88	[p5l931t1170r1089b1239],
30	13	CD	NUMBER	13	num	31	SENT_88	[p5l931t1170r1089b1239],
31	g/dL	NN	O	g/dl	npadvmod	32	SENT_88	[p5l1132t1163r1304b1259],
32	within	IN	O	within	advmod	29	SENT_88	[p5l1336t1163r1574b1235],
33	a	DT	DURATION	a	det	34	SENT_88	[p5l1614t1193r1652b1235],
34	week	NN	DURATION	week	tmod	24	SENT_88	[p5l1686t1163r1887b1235],
35	.	.	O	.	_	0	SENT_88	[p5l1686t1163r1887b1235],

1	PEGIFN	NNP	O	PEGIFN	nn	2	SENT_89	[p5l1933t1167r2137b1235, p5l10t1282r164b1349],
2	dose	NN	O	dose	nsubjpass	4	SENT_89	[p5l211t1278r370b1350],
3	was	VBD	O	be	auxpass	4	SENT_89	[p5l413t1308r545b1349],
4	reduced	VBN	O	reduce	_	0	SENT_89	[p5l591t1278r878b1350],
5	by	IN	O	by	_	0	SENT_89	[p5l922t1278r1012b1372],
6	one	CD	NUMBER	one	num	8	SENT_89	[p5l1054t1278r1364b1349],
7	—	CD	NUMBER	—	num	8	SENT_89	[p5l1054t1278r1364b1349],
8	half	NN	O	half	agent	4	SENT_89	[p5l1054t1278r1364b1349],
9	when	WRB	O	when	advmod	13	SENT_89	[p5l1394t1278r1593b1350],
10	the	DT	O	the	det	12	SENT_89	[p5l1639t1278r1750b1349],
11	leukocyte	NN	O	leukocyte	nn	12	SENT_89	[p5l1795t1278r2138b1372],
12	count	NN	O	count	nsubj	13	SENT_89	[p5l10t1415r219b1463],
13	decreased	VBD	O	decrease	dep	8	SENT_89	[p5l261t1391r605b1463],
14	<	JJR	O	<	acomp	13	SENT_89	[p5l652t1376r1170b1472],
15	1,500	CD	NUMBER	1,500	dobj	13	SENT_89	[p5l652t1376r1170b1472],
16	/	:	O	/	punct	17	SENT_89	[p5l652t1376r1170b1472],
17	mm3	CD	NUMBER	mm3	dep	15	SENT_89	[p5l652t1376r1170b1472],
18	,	,	O	,	_	0	SENT_89	[p5l652t1376r1170b1472],
19	neutrophil	NN	O	neutrophil	nn	20	SENT_89	[p5l1217t1391r1599b1486],
20	count	NN	O	count	appos	17	SENT_89	[p5l1643t1415r1851b1463],
21	<	JJR	O	<	dep	20	SENT_89	[p5l1898t1393r2137b1468],
22	750	CD	NUMBER	750	dep	17	SENT_89	[p5l1898t1393r2137b1468],
23	/	:	O	/	punct	17	SENT_89	[p5l1898t1393r2137b1468],
24	mms	NNS	O	mm	dep	15	SENT_89	[p5l10t1491r213b1588],
25	,	,	O	,	_	0	SENT_89	[p5l10t1491r213b1588],
26	or	CC	O	or	_	0	SENT_89	[p5l276t1535r352b1578],
27	platelet	NN	O	platelet	nn	28	SENT_89	[p5l407t1506r671b1601],
28	count	NN	O	count	dep	29	SENT_89	[p5l728t1530r936b1578],
29	<	JJR	O	<	dobj	13	SENT_89	[p5l999t1513r1158b1580],
30	80	CD	NUMBER	80	dep	31	SENT_89	[p5l999t1513r1158b1580],
31	>	JJR	O	>	npadvmod	32	SENT_89	[p5l1229t1528r1276b1575],
32	<	JJR	O	<	amod	29	SENT_89	[p5l1229t1528r1276b1575],
33	103/mm3	CD	NUMBER	103/mm3	tmod	13	SENT_89	[p5l1356t1491r1712b1588],
34	;	:	O	;	_	0	SENT_89	[p5l1356t1491r1712b1588],
35	PEG	NN	O	peg	dep	8	SENT_89	[p5l1775t1510r2137b1578],
36	.	.	O	.	_	0	SENT_89	[p5l1775t1510r2137b1578],

1	—	NN	O	—	_	0	SENT_90	[p5l1775t1510r2137b1578],
2	.	.	O	.	_	0	SENT_90	[p5l1775t1510r2137b1578],

1	IFN	NN	ORGANIZATION	ifn	nsubjpass	3	SENT_91	[p5l1775t1510r2137b1578],
2	was	VBD	O	be	auxpass	3	SENT_91	[p5l6t1651r137b1692],
3	withdrawn	VBN	O	withdraw	_	0	SENT_91	[p5l171t1621r566b1693],
4	when	WRB	O	when	advmod	6	SENT_91	[p5l599t1621r798b1692],
5	they	PRP	O	they	nsubj	6	SENT_91	[p5l835t1621r993b1715],
6	decreased	VBD	O	decrease	advcl	3	SENT_91	[p5l1025t1621r1369b1693],
7	<	JJR	O	<	acomp	6	SENT_91	[p5l1411t1605r1928b1702],
8	1,000	CD	NUMBER	1,000	dep	7	SENT_91	[p5l1411t1605r1928b1702],
9	/	:	O	/	punct	10	SENT_91	[p5l1411t1605r1928b1702],
10	mm5	CD	NUMBER	mm5	dep	8	SENT_91	[p5l1411t1605r1928b1702],
11	,	,	O	,	_	0	SENT_91	[p5l1411t1605r1928b1702],
12	500	CD	NUMBER	500	appos	10	SENT_91	[p5l1972t1623r2137b1697],
13	/	:	O	/	punct	10	SENT_91	[p5l1972t1623r2137b1697],
14	mm3	CD	NUMBER	mm3	dep	8	SENT_91	[p5l10t1721r213b1817],
15	,	,	O	,	_	0	SENT_91	[p5l10t1721r213b1817],
16	or	CC	O	or	_	0	SENT_91	[p5l253t1764r330b1807],
17	50	CD	NUMBER	50	number	18	SENT_91	[p5l366t1742r452b1813],
18	X	NN	O	x	amod	19	SENT_91	[p5l500t1757r548b1805],
19	103/mm3	NN	O	103/mm3	dep	7	SENT_91	[p5l605t1721r961b1817],
20	,	,	O	,	_	0	SENT_91	[p5l605t1721r961b1817],
21	respectively	RB	O	respectively	advmod	6	SENT_91	[p5l1000t1736r1423b1831],
22	.	.	O	.	_	0	SENT_91	[p5l1000t1736r1423b1831],

1	The	DT	O	the	det	3	SENT_92	[p5l105t1890r256b1962],
2	triple	JJ	O	triple	amod	3	SENT_92	[p5l304t1890r500b1985],
3	therapy	NN	O	therapy	nsubjpass	5	SENT_92	[p5l548t1890r830b1985],
4	was	VBD	O	be	auxpass	5	SENT_92	[p5l870t1920r1003b1962],
5	withdrawn	VBN	O	withdraw	_	0	SENT_92	[p5l1049t1890r1454b1963],
6	or	CC	O	or	_	0	SENT_92	[p5l1502t1919r1579b1962],
7	stopped	VBN	O	stop	conj_or	5	SENT_92	[p5l1625t1890r1919b1985],
8	temporarily	RB	O	temporarily	advmod	5	SENT_92	[p5l1966t1914r2137b1962, p5l9t2004r304b2099],
9	when	WRB	O	when	advmod	11	SENT_92	[p5l358t2004r561b2076],
10	hemoglobin	NN	O	hemoglobin	nsubj	11	SENT_92	[p5l620t2004r1071b2100],
11	decreased	VBD	O	decrease	advcl	5	SENT_92	[p5l1133t2004r1487b2077],
12	<	JJR	O	<	dobj	11	SENT_92	[p5l1552t2010r1735b2081],
13	85	CD	NUMBER	85	num	14	SENT_92	[p5l1552t2010r1735b2081],
14	g/dL	NN	O	g/dl	dep	12	SENT_92	[p5l1800t2004r1994b2100],
15	.	.	O	.	_	0	SENT_92	[p5l1800t2004r1994b2100],

1	In	IN	O	in	_	0	SENT_93	[p5l2061t2009r2140b2075],
2	patients	NNS	O	patient	prep_in	18	SENT_93	[p5l9t2123r299b2213],
3	in	IN	O	in	_	0	SENT_93	[p5l363t2123r434b2188],
4	whom	WP	O	whom	rel	6	SENT_93	[p5l492t2118r730b2190],
5	hemoglobin	NN	O	hemoglobin	nsubj	6	SENT_93	[p5l792t2118r1243b2214],
6	increased	VBD	O	increase	rcmod	2	SENT_93	[p5l1306t2118r1647b2190],
7	28.5	CD	NUMBER	28.5	num	8	SENT_93	[p5l1714t2124r1897b2202],
8	g/dL	NN	O	g/dl	dobj	6	SENT_93	[p5l1963t2118r2140b2214],
9	within	IN	O	within	_	0	SENT_93	[p5l6t2232r251b2303],
10	2	CD	DURATION	2	num	11	SENT_93	[p5l310t2239r353b2302],
11	weeks	NNS	NUMBER	week	prep_within	6	SENT_93	[p5l411t2232r628b2303],
12	after	IN	O	after	_	0	SENT_93	[p5l690t2232r855b2303],
13	the	DT	O	the	det	14	SENT_93	[p5l914t2232r1027b2303],
14	withdrawal	NN	O	withdrawal	prep_after	6	SENT_93	[p5l1083t2232r1522b2314],
15	,	,	O	,	_	0	SENT_93	[p5l1083t2232r1522b2314],
16	treatment	NN	O	treatment	nsubjpass	18	SENT_93	[p5l1586t2256r1949b2303],
17	was	VBD	O	be	auxpass	18	SENT_93	[p5l2004t2262r2137b2303],
18	resumed	VBN	O	resume	_	0	SENT_93	[p5l10t2346r324b2419],
19	with	IN	O	with	_	0	SENT_93	[p5l368t2346r537b2418],
20	PEG	NN	O	peg	prep_with	18	SENT_93	[p5l586t2350r956b2418],
21	.	.	O	.	_	0	SENT_93	[p5l586t2350r956b2418],

1	—	NN	O	—	_	0	SENT_94	[p5l586t2350r956b2418],
2	.	.	O	.	_	0	SENT_94	[p5l586t2350r956b2418],

1	IFN	NN	ORGANIZATION	ifn	_	0	SENT_95	[p5l586t2350r956b2418],
2	and	CC	O	and	_	0	SENT_95	[p5l1003t2346r1140b2419],
3	RBV	NN	O	rbv	conj_and	1	SENT_95	[p5l1188t2351r1375b2418],
4	200	CD	NUMBER	200	num	5	SENT_95	[p5l1417t2353r1557b2418],
5	mg	NN	O	mg	dep	1	SENT_95	[p5l1608t2375r1744b2442],
6	.	.	O	.	_	0	SENT_95	[p5l1608t2375r1744b2442],

1	A	DT	O	a	det	4	SENT_96	[p5l1791t2350r1857b2417],
2	reduc	JJ	O	reduc	amod	4	SENT_96	[p5l1902t2346r2137b2419],
3	—	NN	O	—	nn	4	SENT_96	[p5l1902t2346r2137b2419],
4	tion	NN	O	tion	nsubjpass	15	SENT_96	[p5l10t2465r159b2532],
5	of	IN	O	of	_	0	SENT_96	[p5l198t2460r282b2532],
6	telaprevir	NN	O	telaprevir	nn	9	SENT_96	[p5l309t2460r659b2555],
7	(	CD	NUMBER	(	num	9	SENT_96	[p5l702t2461r1071b2546],
8	MP	NN	O	mp	nn	9	SENT_96	[p5l702t2461r1071b2546],
9	—	NN	O	—	prep_of	4	SENT_96	[p5l702t2461r1071b2546],
10	424	CD	NUMBER	424	number	11	SENT_96	[p5l702t2461r1071b2546],
11	)	CD	NUMBER	)	num	12	SENT_96	[p5l702t2461r1071b2546],
12	dose	NN	O	dose	dep	9	SENT_96	[p5l1117t2460r1280b2533],
13	was	VBD	O	be	auxpass	15	SENT_96	[p5l1316t2490r1449b2532],
14	not	RB	O	not	neg	15	SENT_96	[p5l1489t2484r1614b2532],
15	permitted	VBN	O	permit	_	0	SENT_96	[p5l1651t2460r2038b2555],
16	.	.	O	.	_	0	SENT_96	[p5l1651t2460r2038b2555],

1	It	PRP	O	it	nsubjpass	3	SENT_97	[p5l2083t2465r2140b2532],
2	was	VBD	O	be	auxpass	3	SENT_97	[p5l6t2604r139b2646],
3	discontinued	VBN	O	discontinue	_	0	SENT_97	[p5l202t2574r687b2647],
4	when	WRB	O	when	advmod	8	SENT_97	[p5l744t2574r947b2646],
5	severe	JJ	O	severe	amod	7	SENT_97	[p5l1007t2603r1225b2646],
6	side	JJ	O	side	amod	7	SENT_97	[p5l1286t2574r1427b2647],
7	effects	NNS	O	effect	nsubj	8	SENT_97	[p5l1489t2574r1717b2646],
8	appeared	VBD	O	appear	advcl	3	SENT_97	[p5l1780t2574r2134b2669],
9	,	,	O	,	_	0	SENT_97	[p5l1780t2574r2134b2669],
10	whereas	IN	O	whereas	mark	11	SENT_97	[p5l6t2688r299b2760],
11	PEG	NN	O	peg	dep	3	SENT_97	[p5l350t2692r720b2761],
12	.	.	O	.	_	0	SENT_97	[p5l350t2692r720b2761],

1	—	NN	O	—	_	0	SENT_98	[p5l350t2692r720b2761],
2	.	.	O	.	_	0	SENT_98	[p5l350t2692r720b2761],

1	IFN	NN	ORGANIZATION	ifn	nsubjpass	5	SENT_99	[p5l350t2692r720b2761],
2	and	CC	O	and	_	0	SENT_99	[p5l767t2689r903b2761],
3	RBV	NN	O	rbv	nsubjpass	5	SENT_99	[p5l951t2693r1139b2760],
4	were	VBD	O	be	auxpass	5	SENT_99	[p5l1178t2717r1351b2760],
5	continued	VBN	O	continue	_	0	SENT_99	[p5l1399t2688r1795b2761],
6	.	.	O	.	_	0	SENT_99	[p5l1399t2688r1795b2761],

1	Growth	NN	O	growth	nn	2	SENT_100	[p5l1850t2688r2139b2760],
2	factors	NNS	O	factor	nsubjpass	5	SENT_100	[p5l10t2803r252b2875],
3	were	VBD	O	be	auxpass	5	SENT_100	[p5l287t2832r460b2875],
4	not	RB	O	not	neg	5	SENT_100	[p5l497t2827r622b2875],
5	used	VBN	O	use	_	0	SENT_100	[p5l659t2803r824b2875],
6	for	IN	O	for	_	0	SENT_100	[p5l860t2803r965b2874],
7	elevating	VBG	O	elevate	prepc_for	5	SENT_100	[p5l1002t2803r1332b2899],
8	hemoglobin	NN	O	hemoglobin	nn	9	SENT_100	[p5l1366t2803r1817b2899],
9	levels	NNS	O	level	dobj	7	SENT_100	[p5l1853t2803r2068b2875],
10	.	.	O	.	_	0	SENT_100	[p5l1853t2803r2068b2875],

1	Determination	NN	O	determination	_	0	SENT_101	[p5l104t2922r697b2989],
2	of	IN	O	of	_	0	SENT_101	[p5l864t2917r960b3013],
3	I	PRP	O	I	prep_of	1	SENT_101	[p5l1098t2922r1146b2987],
4	T	NN	O	t	dep	1	SENT_101	[p5l1146t2919r1212b2988],
5	PA	NN	O	pa	nn	6	SENT_101	[p5l1197t2921r1310b2988],
6	Genotypes	NNS	O	genotype	dep	4	SENT_101	[p5l1480t2921r1892b3013],
7	.	.	O	.	_	0	SENT_101	[p5l1480t2921r1892b3013],

1	I	PRP	O	I	_	0	SENT_102	[p5l1938t2922r1981b2988],
2	TPA	NN	O	tpa	dep	1	SENT_102	[p5l1984t2920r2139b2988],

1	(	NN	O	(	nn	3	SENT_103	[p5l14t3055r468b3140],
2	rs1127354	NN	O	rs1127354	nn	3	SENT_103	[p5l14t3055r468b3140],
3	)	NN	O	)	_	0	SENT_103	[p5l14t3055r468b3140],
4	and	CC	O	and	_	0	SENT_103	[p5l523t3055r660b3126],
5	[	NN	O	[	nn	6	SENT_103	[p5l704t3059r947b3125],
6	L283	NN	O	l283	conj_and	3	SENT_103	[p5l704t3059r947b3125],
7	(	CD	NUMBER	(	num	8	SENT_103	[p5l996t3056r1424b3140],
8	rs8099917	NN	O	rs8099917	dep	3	SENT_103	[p5l996t3056r1424b3140],
9	and	CC	O	and	_	0	SENT_103	[p5l1473t3054r1609b3126],
10	rs	NNS	O	r	dep	3	SENT_103	[p5l1656t3083r1715b3125],
11	1	CD	NUMBER	1	number	12	SENT_103	[p5l1728t3062r1754b3124],
12	2979860	CD	NUMBER	2979860	num	13	SENT_103	[p5l1768t3056r2132b3140],
13	)	NN	O	)	dep	10	SENT_103	[p5l1768t3056r2132b3140],

1	were	VBD	O	be	auxpass	2	SENT_104	[p5l6t3232r179b3275],
2	genotyped	VBN	O	genotype	_	0	SENT_104	[p5l217t3203r605b3299],
3	by	IN	O	by	_	0	SENT_104	[p5l643t3203r734b3297],
4	the	DT	O	the	det	5	SENT_104	[p5l768t3203r881b3275],
5	Invader	NNP	MISC	Invader	agent	2	SENT_104	[p5l920t3203r1201b3275],
6	assay	NN	O	assay	nsubjpass	2	SENT_104	[p5l1238t3233r1431b3297],
7	,	,	O	,	_	0	SENT_104	[p5l1238t3233r1431b3297],
8	TaqMan	NN	O	taqman	appos	6	SENT_104	[p5l1470t3205r1790b3298],
9	assay	NN	O	assay	npadvmod	15	SENT_104	[p5l1828t3233r2021b3297],
10	,	,	O	,	_	0	SENT_104	[p5l1828t3233r2021b3297],
11	or	CC	O	or	_	0	SENT_104	[p5l2063t3232r2140b3275],
12	direct	JJ	O	direct	amod	13	SENT_104	[p5l10t3346r221b3419],
13	sequencing	NN	O	sequencing	npadvmod	15	SENT_104	[p5l257t3351r690b3442],
14	,	,	O	,	_	0	SENT_104	[p5l257t3351r690b3442],
15	as	IN	O	as	advmod	16	SENT_104	[p5l731t3376r797b3418],
16	described	VBN	O	describe	partmod	8	SENT_104	[p5l835t3331r1372b3419],
17	.17	CD	NUMBER	.17	num	18	SENT_104	[p5l835t3331r1372b3419],
18	’18	CD	NUMBER	’18	dobj	16	SENT_104	[p5l835t3331r1372b3419],

1	Statistical	JJ	O	statistical	amod	2	SENT_105	[p5l109t3460r514b3532],
2	Analyses	NNS	O	analysis	_	0	SENT_105	[p5l549t3460r905b3557],
3	.	.	O	.	_	0	SENT_105	[p5l549t3460r905b3557],

1	Continuous	JJ	O	continuous	amod	2	SENT_106	[p5l955t3464r1400b3533],
2	variables	NNS	O	variable	nsubjpass	6	SENT_106	[p5l1455t3460r1775b3532],
3	between	IN	O	between	_	0	SENT_106	[p5l1833t3460r2138b3532],
4	groups	NNS	O	group	prep_between	2	SENT_106	[p5l9t3602r259b3670],
5	were	VBD	O	be	auxpass	6	SENT_106	[p5l304t3602r477b3645],
6	compared	VBN	O	compare	_	0	SENT_106	[p5l524t3574r894b3669],
7	by	IN	O	by	_	0	SENT_106	[p5l940t3574r1031b3668],
8	the	DT	O	the	det	9	SENT_106	[p5l1074t3574r1188b3645],
9	Mann	NNP	O	Mann	agent	6	SENT_106	[p5l1233t3574r1826b3668],
10	.	.	O	.	_	0	SENT_106	[p5l1233t3574r1826b3668],

1	—	NN	O	—	_	0	SENT_107	[p5l1233t3574r1826b3668],
2	.	.	O	.	_	0	SENT_107	[p5l1233t3574r1826b3668],

1	Whitney	NNP	PERSON	Whitney	nn	2	SENT_108	[p5l1233t3574r1826b3668],
2	test	NN	O	test	_	0	SENT_108	[p5l1869t3598r1995b3645],
3	(	CD	NUMBER	(	num	6	SENT_108	[p5l2044t3575r2153b3659],
4	U	NNP	O	U	nn	6	SENT_108	[p5l2044t3575r2153b3659],
5	test	NN	O	test	nn	6	SENT_108	[p5l10t3689r186b3774],
6	)	NN	O	)	dep	2	SENT_108	[p5l10t3689r186b3774],
7	,	,	O	,	_	0	SENT_108	[p5l10t3689r186b3774],
8	and	CC	O	and	_	0	SENT_108	[p5l228t3688r365b3761],
9	discontinuous	JJ	O	discontinuous	amod	10	SENT_108	[p5l402t3688r924b3761],
10	variables	NNS	O	variable	dep	2	SENT_108	[p5l960t3688r1280b3760],
11	by	IN	O	by	_	0	SENT_108	[p5l1319t3688r1410b3783],
12	the	DT	O	the	det	14	SENT_108	[p5l1444t3688r1557b3760],
13	chi	NN	O	chus	nn	14	SENT_108	[p5l1594t3688r1976b3783],
14	—	NN	O	—	prep_by	10	SENT_108	[p5l1594t3688r1976b3783],
15	square	JJ	O	square	amod	16	SENT_108	[p5l1594t3688r1976b3783],
16	test	NN	O	test	dep	2	SENT_108	[p5l2014t3712r2140b3760],

1	HEPATOLOGY	NNP	O	HEPATOLOGY	_	0	SENT_109	[p6l56t58r276b85],
2	,	,	O	,	_	0	SENT_109	[p6l56t58r276b85],
3	Vol	NNP	O	Vol	appos	1	SENT_109	[p6l289t57r339b81],
4	.	.	O	.	_	0	SENT_109	[p6l289t57r339b81],

1	53	CD	NUMBER	53	_	0	SENT_110	[p6l355t59r393b85],
2	,	,	O	,	_	0	SENT_110	[p6l355t59r393b85],
3	No.	NN	O	no.	appos	1	SENT_110	[p6l406t59r453b81],
4	2	CD	NUMBER	2	num	3	SENT_110	[p6l467t59r489b85],
5	,	,	O	,	_	0	SENT_110	[p6l467t59r489b85],
6	2011	CD	DATE	2011	appos	1	SENT_110	[p6l503t59r565b81],

1	SUZUKI	NNP	O	SUZUKI	nn	3	SENT_111	[p6l1777t58r1896b81],
2	ET	NNP	O	ET	nn	3	SENT_111	[p6l1908t58r1949b81],
3	AL.	NNP	O	AL.	_	0	SENT_111	[p6l1957t58r2003b81],
4	417	CD	NUMBER	417	dep	3	SENT_111	[p6l2056t57r2104b83],

1	Table	NNP	O	Table	_	0	SENT_112	[p6l204t161r287b190],
2	1	CD	NUMBER	1	dep	1	SENT_112	[p6l305t161r331b190],
3	.	.	O	.	_	0	SENT_112	[p6l305t161r331b190],

1	Baseline	NN	O	baseline	nn	2	SENT_113	[p6l352t161r487b190],
2	Characteristics	NNS	O	characteristic	_	0	SENT_113	[p6l504t161r744b190],
3	of	IN	O	of	_	0	SENT_113	[p6l760t160r790b190],
4	the	DT	O	the	det	6	SENT_113	[p6l804t161r855b190],
5	61	CD	NUMBER	61	num	6	SENT_113	[p6l871t161r910b190],
6	Patients	NNS	O	patient	prep_of	2	SENT_113	[p6l928t161r1057b190],
7	Infected	JJ	O	infected	amod	6	SENT_113	[p6l1074t160r1202b190],
8	with	IN	O	with	_	0	SENT_113	[p6l1218t161r1283b190],
9	HCV-1	NN	O	hcv-1	prep_with	7	SENT_113	[p6l1302t161r1395b190],
10	Who	WP	O	who	nsubj	11	SENT_113	[p6l1411t161r1479b190],
11	Received	VBN	O	receive	rcmod	9	SENT_113	[p6l1497t161r1635b190],
12	Triple	JJ	O	triple	amod	13	SENT_113	[p6l1651t161r1737b197],
13	Therapy	NN	O	therapy	dobj	11	SENT_113	[p6l1751t161r1875b197],
14	with	IN	O	with	prep	11	SENT_113	[p6l1888t161r1953b190],

1	Pegylated-Interferon	NNP	O	Pegylated-Interferon	_	0	SENT_114	[p6l713t211r1044b247],
2	,	,	O	,	_	0	SENT_114	[p6l713t211r1044b247],
3	Ribavirin	NNP	O	Ribavirin	conj_and	1	SENT_114	[p6l1063t212r1207b247],
4	,	,	O	,	_	0	SENT_114	[p6l1063t212r1207b247],
5	and	CC	O	and	_	0	SENT_114	[p6l1225t212r1281b240],
6	Telaprevir	NNP	O	Telaprevir	conj_and	1	SENT_114	[p6l1297t212r1450b247],

1	Total	JJ	O	total	_	0	SENT_115	[p6l900t344r952b364],

1	Demographic	JJ	MISC	demographic	amod	2	SENT_116	[p6l7t431r355b494],
2	data	NNS	O	datum	_	0	SENT_116	[p6l383t431r496b481],

1	Number	NNP	O	Number	nn	4	SENT_117	[p6l80t520r289b569],
2	Sex	NN	O	sex	nn	4	SENT_117	[p6l78t609r171b661],
3	(	NN	O	(	nn	4	SENT_117	[p6l199t610r583b672],
4	male/female	NN	O	male/female	dep	14	SENT_117	[p6l199t610r583b672],
5	)	CD	NUMBER	)	num	8	SENT_117	[p6l199t610r583b672],
6	Age	NNP	O	Age	nn	8	SENT_117	[p6l77t702r171b765],
7	(	CD	NUMBER	(	num	8	SENT_117	[p6l201t702r377b764],
8	years	NNS	NUMBER	year	dep	4	SENT_117	[p6l201t702r377b764],
9	)	CD	NUMBER	)	num	10	SENT_117	[p6l201t702r377b764],
10	Body	NN	O	body	dep	14	SENT_117	[p6l80t793r210b855],
11	weight	NN	O	weight	nn	14	SENT_117	[p6l234t793r405b856],
12	(	CD	NUMBER	(	num	14	SENT_117	[p6l432t793r530b856],
13	kg	NN	O	kg	nn	14	SENT_117	[p6l432t793r530b856],
14	)	NN	O	)	dep	19	SENT_117	[p6l432t793r530b856],
15	Body	NN	O	body	nn	17	SENT_117	[p6l80t882r210b945],
16	mass	NN	O	mass	nn	17	SENT_117	[p6l238t894r374b933],
17	index	NN	O	index	dep	14	SENT_117	[p6l404t882r542b933],
18	(	CD	NUMBER	(	num	19	SENT_117	[p6l569t866r778b945],
19	kg/m2	NN	O	kg/m2	dep	21	SENT_117	[p6l569t866r778b945],
20	)	CD	NUMBER	)	num	21	SENT_117	[p6l569t866r778b945],
21	Genotypes	NNS	O	genotype	dep	36	SENT_117	[p6l6t972r284b1035],
22	of	IN	O	of	_	0	SENT_117	[p6l312t971r362b1023],
23	the	DT	O	the	det	27	SENT_117	[p6l385t972r467b1023],
24	lL28B	NN	O	ll28b	nn	27	SENT_117	[p6l495t971r649b1023],
25	gene	NN	O	gene	nn	27	SENT_117	[p6l676t980r801b1036],
26	rs8099917	NN	O	rs8099917	nn	27	SENT_117	[p6l80t1062r380b1112],
27	(	NN	O	(	prep_of	21	SENT_117	[p6l411t1062r501b1123],
28	for	IN	O	for	_	0	SENT_117	[p6l411t1062r501b1123],
29	59	CD	NUMBER	59	num	30	SENT_117	[p6l527t1062r594b1112],
30	patients	NNS	O	patient	prep_for	27	SENT_117	[p6l626t1063r856b1123],
31	)	IN	O	)	_	0	SENT_117	[p6l626t1063r856b1123],
32	(	CD	NUMBER	(	num	33	SENT_117	[p6l79t1151r244b1214],
33	1T/TG	NN	O	1t/tg	prep_)	36	SENT_117	[p6l79t1151r244b1214],
34	+	CC	O	+	_	0	SENT_117	[p6l277t1159r326b1208],
35	GG	NNS	O	gg	prep_)	36	SENT_117	[p6l357t1151r455b1214],
36	)	VBP	O	)	_	0	SENT_117	[p6l357t1151r455b1214],
37	rs1297986O	NN	O	rs1297986o	nn	38	SENT_117	[p6l80t1242r418b1294],
38	(	NN	O	(	dobj	36	SENT_117	[p6l449t1242r538b1305],
39	for	IN	O	for	_	0	SENT_117	[p6l449t1242r538b1305],
40	57	CD	NUMBER	57	num	41	SENT_117	[p6l563t1243r631b1294],
41	patients	NNS	O	patient	prep_for	38	SENT_117	[p6l664t1243r893b1305],
42	)	IN	O	)	_	0	SENT_117	[p6l664t1243r893b1305],
43	(	CD	NUMBER	(	num	44	SENT_117	[p6l79t1333r199b1396],
44	CC	NN	O	cc	prep_)	36	SENT_117	[p6l79t1333r199b1396],
45	/	:	O	/	punct	51	SENT_117	[p6l79t1333r199b1396],
46	CT	NN	O	ct	dep	51	SENT_117	[p6l208t1333r270b1385],
47	+	CC	O	+	_	0	SENT_117	[p6l296t1340r345b1390],
48	Tl	NN	O	tl	dep	51	SENT_117	[p6l371t1334r444b1396],
49	)	CD	NUMBER	)	num	51	SENT_117	[p6l371t1334r444b1396],
50	Laboratory	NNP	O	Laboratory	nn	51	SENT_117	[p6l7t1425r285b1488],
51	data	NNS	O	datum	dep	44	SENT_117	[p6l312t1425r425b1476],

1	Hemoglobin	NN	O	hemoglobin	nn	3	SENT_118	[p6l80t1516r391b1579],
2	(	NN	O	(	nn	3	SENT_118	[p6l423t1516r588b1579],
3	g/dL	NN	O	g/dl	dep	15	SENT_118	[p6l423t1516r588b1579],
4	)	CD	NUMBER	)	num	5	SENT_118	[p6l423t1516r588b1579],
5	Platelets	NNS	O	platelet	dep	3	SENT_118	[p6l80t1608r303b1659],
6	(	CD	NUMBER	(	dep	5	SENT_118	[p6l333t1608r377b1670],
7	x	CC	O	x	_	0	SENT_118	[p6l333t1608r377b1670],
8	104/mm3	CD	NUMBER	104/mm3	num	10	SENT_118	[p6l409t1591r684b1670],
9	)	CD	NUMBER	)	num	10	SENT_118	[p6l409t1591r684b1670],
10	Albumin	NN	O	albumin	conj_x	5	SENT_118	[p6l77t1699r290b1750],
11	(	CD	NUMBER	(	num	12	SENT_118	[p6l322t1699r487b1762],
12	g/dL	NN	O	g/dl	dep	10	SENT_118	[p6l322t1699r487b1762],
13	)	CD	NUMBER	)	num	14	SENT_118	[p6l322t1699r487b1762],
14	Alanine	NN	O	alanine	dep	15	SENT_118	[p6l76t1790r272b1839],
15	aminotransferase	NN	O	aminotransferase	dep	20	SENT_118	[p6l302t1789r757b1839],
16	(	CD	NUMBER	(	num	15	SENT_118	[p6l789t1790r926b1850],
17	U/L	NN	O	u/l	nn	19	SENT_118	[p6l789t1790r926b1850],
18	)	CD	NUMBER	)	num	19	SENT_118	[p6l789t1790r926b1850],
19	Aspartate	NNP	O	Aspartate	dep	15	SENT_118	[p6l77t1879r328b1941],
20	aminotransferase	NN	O	aminotransferase	dep	22	SENT_118	[p6l357t1878r813b1929],
21	(	CD	NUMBER	(	num	20	SENT_118	[p6l844t1879r929b1941],
22	U	NNP	O	U	_	0	SENT_118	[p6l844t1879r929b1941],
23	/	:	O	/	punct	22	SENT_118	[p6l844t1879r929b1941],
24	L	NN	O	l	nn	27	SENT_118	[p6l939t1879r982b1941],
25	)	CD	NUMBER	)	num	27	SENT_118	[p6l939t1879r982b1941],
26	HCV	NN	O	hcv	nn	27	SENT_118	[p6l80t1969r186b2021],
27	RNA	NN	O	rna	dep	32	SENT_118	[p6l215t1970r323b2020],
28	(	NN	O	(	nn	29	SENT_118	[p6l352t1970r451b2033],
29	log	NN	O	log	dep	27	SENT_118	[p6l352t1970r451b2033],
30	lU/mL	NN	O	lu/ml	dep	32	SENT_118	[p6l479t1970r661b2032],
31	)	CD	NUMBER	)	num	30	SENT_118	[p6l479t1970r661b2032],
32	HCV	NN	O	hcv	dep	34	SENT_118	[p6l80t2061r186b2112],
33	genotype	NN	O	genotype	dep	32	SENT_118	[p6l212t2065r450b2125],
34	1a/1b	NN	O	1a/1b	dep	22	SENT_118	[p6l485t2061r649b2123],

1	Previous	JJ	O	previous	amod	3	SENT_119	[p6l7t2151r224b2200],
2	lFN	NN	O	lfn	nn	3	SENT_119	[p6l255t2151r518b2200],
3	—	NN	O	—	_	0	SENT_119	[p6l255t2151r518b2200],
4	based	VBN	O	base	dep	3	SENT_119	[p6l255t2151r518b2200],
5	treatment	NN	O	treatment	dep	4	SENT_119	[p6l547t2154r805b2200],

1	Treatment	NN	O	treatment	nsubj	3	SENT_120	[p6l74t2240r336b2290],
2	naive	JJ	O	naive	amod	1	SENT_120	[p6l363t2240r498b2290],
3	Relapsed	VBD	O	relapse	_	0	SENT_120	[p6l80t2330r321b2390],
4	Null	JJ	O	null	amod	5	SENT_120	[p6l80t2419r176b2468],
5	response	NN	O	response	dobj	3	SENT_120	[p6l210t2430r446b2479],

1	ITPA	NN	O	itpa	nn	2	SENT_121	[p6l1558t283r1604b303],
2	Genotypes	NNS	O	genotype	_	0	SENT_121	[p6l1615t283r1730b308],
3	at	IN	O	at	_	0	SENT_121	[p6l1741t284r1763b303],
4	rs1127354	NN	O	rs1127354	prep_at	2	SENT_121	[p6l1774t283r1897b303],

1	CA+AA	NN	O	ca+aa	_	0	SENT_122	[p6l1943t344r2047b364],

1	Data	NNS	O	datum	nsubj	4	SENT_123	[p7l78t1454r192b1502],
2	are	VBP	O	be	cop	4	SENT_123	[p7l222t1465r299b1502],
3	median	JJ	O	median	amod	4	SENT_123	[p7l330t1454r517b1502],
4	values	NNS	O	value	_	0	SENT_123	[p7l544t1454r707b1502],
5	(	JJ	O	(	amod	7	SENT_123	[p7l735t1454r915b1515],
6	range	NN	O	range	nn	7	SENT_123	[p7l735t1454r915b1515],
7	)	NN	O	)	dep	4	SENT_123	[p7l735t1454r915b1515],
8	or	CC	O	or	_	0	SENT_123	[p7l946t1465r995b1502],
9	n.	NN	O	n.	conj_or	4	SENT_123	[p7l1022t1465r1062b1501],

1	and	CC	O	and	cc	2	SENT_124	[p7l10t1676r147b1748],
2	Fisher	NNP	PERSON	Fisher	_	0	SENT_124	[p7l195t1676r465b1748],
3	’s	POS	O	’s	possessive	2	SENT_124	[p7l195t1676r465b1748],
4	exact	JJ	O	exact	amod	5	SENT_124	[p7l514t1700r700b1748],
5	test	NN	O	test	dep	2	SENT_124	[p7l747t1700r891b1748],
6	.	.	O	.	_	0	SENT_124	[p7l747t1700r891b1748],

1	Kaplan	NNP	PERSON	Kaplan	_	0	SENT_125	[p7l945t1676r1468b1771],
2	.	.	O	.	_	0	SENT_125	[p7l945t1676r1468b1771],

1	—	NN	O	—	_	0	SENT_126	[p7l945t1676r1468b1771],
2	.	.	O	.	_	0	SENT_126	[p7l945t1676r1468b1771],

1	Meier	JJR	PERSON	meier	amod	2	SENT_127	[p7l945t1676r1468b1771],
2	analysis	NN	O	analysis	nsubjpass	11	SENT_127	[p7l1515t1676r1796b1770],
3	and	CC	O	and	_	0	SENT_127	[p7l1847t1676r1983b1749],
4	the	DT	O	the	det	7	SENT_127	[p7l2031t1676r2145b1748],
5	log	NN	O	log	nn	7	SENT_127	[p7l9t1791r327b1887],
6	—	CD	NUMBER	—	num	7	SENT_127	[p7l9t1791r327b1887],
7	ranl	NN	O	ranl	conj_and	2	SENT_127	[p7l9t1791r327b1887],
8	<	JJR	O	<	amod	9	SENT_127	[p7l9t1791r327b1887],
9	test	NN	O	test	dep	7	SENT_127	[p7l383t1815r510b1863],
10	were	VBD	O	be	auxpass	11	SENT_127	[p7l563t1820r737b1863],
11	applied	VBN	O	apply	_	0	SENT_127	[p7l797t1791r1072b1886],
12	to	TO	O	to	aux	13	SENT_127	[p7l1130t1815r1201b1863],
13	estimate	VB	O	estimate	xcomp	11	SENT_127	[p7l1262t1796r1569b1863],
14	and	CC	O	and	_	0	SENT_127	[p7l1629t1791r1765b1864],
15	compare	VB	O	compare	xcomp	11	SENT_127	[p7l1824t1819r2145b1886],
16	decreases	NNS	O	decrease	dobj	13	SENT_127	[p7l10t1905r345b1977],
17	of	IN	O	of	_	0	SENT_127	[p7l398t1905r482b1976],
18	RBV	NN	O	rbv	nn	19	SENT_127	[p7l522t1910r710b1976],
19	dose	NN	O	dose	prep_of	16	SENT_127	[p7l756t1905r920b1977],
20	between	IN	O	between	_	0	SENT_127	[p7l972t1905r1277b1976],
21	groups	NNS	O	group	prep_between	13	SENT_127	[p7l1328t1933r1599b2001],
22	.	.	O	.	_	0	SENT_127	[p7l1328t1933r1599b2001],

1	Factors	NNS	O	factor	nsubj	2	SENT_128	[p7l1657t1910r1920b1976],
2	evaluated	VBD	O	evaluate	_	0	SENT_128	[p7l1973t1905r2143b1977, p7l10t2019r214b2091],
3	for	IN	O	for	mark	11	SENT_128	[p7l250t2019r356b2091],
4	inﬂuence	NN	O	inﬂuence	nsubj	11	SENT_128	[p7l391t2019r731b2091],
5	on	IN	O	on	_	0	SENT_128	[p7l768t2048r862b2090],
6	hemoglobin	NN	O	hemoglobin	nn	7	SENT_128	[p7l897t2019r1350b2115],
7	decrease	NN	O	decrease	prep_on	4	SENT_128	[p7l1387t2019r1691b2092],
8	by	IN	O	by	_	0	SENT_128	[p7l1727t2019r1819b2113],
9	univariate	JJ	O	univariate	amod	10	SENT_128	[p7l1852t2024r2143b2091, p7l10t2158r113b2205],
10	analysis	NN	O	analysis	prep_by	7	SENT_128	[p7l170t2133r451b2228],
11	Were	VBD	O	be	advcl	2	SENT_128	[p7l505t2162r698b2205],
12	:	:	O	:	_	0	SENT_128	[p7l505t2162r698b2205],
13	sex	NN	O	sex	nsubj	54	SENT_128	[p7l759t2163r888b2215],
14	;	:	O	;	_	0	SENT_128	[p7l759t2163r888b2215],
15	age	NN	O	age	dep	13	SENT_128	[p7l948t2163r1086b2229],
16	;	:	O	;	_	0	SENT_128	[p7l948t2163r1086b2229],
17	body	NN	O	body	nn	19	SENT_128	[p7l1146t2133r1336b2228],
18	mass	NN	O	mass	nn	19	SENT_128	[p7l1388t2162r1564b2205],
19	index	NN	O	index	dep	13	SENT_128	[p7l1621t2133r1826b2206],
20	(	CD	NUMBER	(	num	22	SENT_128	[p7l1884t2134r2140b2219],
21	BMI	NN	O	bmus	nn	22	SENT_128	[p7l1884t2134r2140b2219],
22	)	NN	O	)	dep	19	SENT_128	[p7l1884t2134r2140b2219],
23	;	:	O	;	_	0	SENT_128	[p7l1884t2134r2140b2219],
24	body	NN	O	body	dep	13	SENT_128	[p7l10t2247r199b2341],
25	Weight	NNP	O	Weight	dep	24	SENT_128	[p7l239t2247r510b2343],
26	;	:	O	;	_	0	SENT_128	[p7l239t2247r510b2343],
27	hemoglobin	NN	O	hemoglobin	nn	28	SENT_128	[p7l560t2247r1013b2343],
28	levels	NNS	O	level	dep	13	SENT_128	[p7l1059t2247r1276b2329],
29	;	:	O	;	_	0	SENT_128	[p7l1059t2247r1276b2329],
30	initial	JJ	O	initial	amod	31	SENT_128	[p7l1327t2247r1543b2319],
31	PEG-IFN	NN	O	peg-ifn	dep	28	SENT_128	[p7l1591t2251r1963b2319],
32	and	CC	O	and	_	0	SENT_128	[p7l2009t2247r2146b2319],
33	RBV	NN	O	rbv	nn	34	SENT_128	[p7l10t2366r199b2433],
34	doses	NNS	O	dose	dep	28	SENT_128	[p7l234t2361r449b2443],
35	;	:	O	;	_	0	SENT_128	[p7l234t2361r449b2443],
36	amino	NN	O	amino	nn	38	SENT_128	[p7l493t2366r728b2432],
37	acid	NN	O	acid	nn	38	SENT_128	[p7l770t2361r920b2434],
38	substitutions	NNS	O	substitution	dep	13	SENT_128	[p7l959t2361r1436b2433],
39	in	IN	O	in	_	0	SENT_128	[p7l1478t2366r1550b2431],
40	the	DT	O	the	det	43	SENT_128	[p7l1589t2361r1703b2432],
41	HCV	NNP	O	HCV	nn	43	SENT_128	[p7l1743t2365r1956b2433],
42	core	NN	O	core	nn	43	SENT_128	[p7l1991t2390r2145b2432],
43	protein	NN	O	protein	prep_in	38	SENT_128	[p7l9t2480r301b2570],
44	;	:	O	;	_	0	SENT_128	[p7l9t2480r301b2570],
45	number	NN	O	number	dep	13	SENT_128	[p7l366t2475r662b2548],
46	of	IN	O	of	_	0	SENT_128	[p7l721t2475r805b2547],
47	amino	NN	O	amino	nn	49	SENT_128	[p7l853t2480r1088b2547],
48	acid	NN	O	acid	nn	49	SENT_128	[p7l1151t2475r1301b2548],
49	substitutions	NNS	O	substitution	prep_of	45	SENT_128	[p7l1360t2475r1837b2548],
50	in	IN	O	in	_	0	SENT_128	[p7l1899t2480r1971b2546],
51	the	DT	O	the	det	53	SENT_128	[p7l2031t2475r2145b2547],
52	interferon	NN	O	interferon	nn	53	SENT_128	[p7l10t2589r382b2661],
53	sensitivity	NN	O	sensitivity	prep_in	13	SENT_128	[p7l441t2594r815b2684],
54	determining	VBG	O	determine	parataxis	11	SENT_128	[p7l872t2589r1334b2686],
55	region	NN	O	region	dobj	54	SENT_128	[p7l1391t2594r1647b2686],
56	;	:	O	;	_	0	SENT_128	[p7l1391t2594r1647b2686],
57	and	CC	O	and	_	0	SENT_128	[p7l1711t2590r1848b2662],
58	H283	NN	O	h283	nn	59	SENT_128	[p7l1905t2594r2149b2661],
59	polymorphisms	NNS	O	polymorphism	nsubj	60	SENT_128	[p7l9t2703r594b2798],
60	(	VBP	O	(	conj_and	2	SENT_128	[p7l650t2704r743b2789],
61	at	IN	O	at	_	0	SENT_128	[p7l650t2704r743b2789],
62	rs8099917	NN	O	rs8099917	nn	65	SENT_128	[p7l792t2710r1195b2780],
63	and	CC	O	and	_	0	SENT_128	[p7l1246t2703r1383b2776],
64	rs12979860	NN	O	rs12979860	conj_and	62	SENT_128	[p7l1433t2704r1935b2789],
65	)	NN	O	)	prep_at	60	SENT_128	[p7l1433t2704r1935b2789],
66	.	.	O	.	_	0	SENT_128	[p7l1433t2704r1935b2789],

1	Factors	NNS	O	factor	nsubj	9	SENT_129	[p7l1991t2708r2143b2775, p7l10t2842r146b2889],
2	associated	VBN	O	associate	partmod	1	SENT_129	[p7l188t2817r557b2890],
3	with	IN	O	with	_	0	SENT_129	[p7l593t2817r763b2889],
4	a	DT	O	a	det	5	SENT_129	[p7l803t2847r840b2889],
5	decrease	NN	O	decrease	prep_with	2	SENT_129	[p7l878t2817r1183b2890],
6	in	IN	O	in	_	0	SENT_129	[p7l1223t2822r1295b2888],
7	hemoglobin	NN	O	hemoglobin	nn	8	SENT_129	[p7l1334t2817r1787b2914],
8	levels	NNS	O	level	prep_in	5	SENT_129	[p7l1827t2817r2022b2889],
9	(	VBP	O	(	dep	38	SENT_129	[p7l2068t2819r2153b2903],
10	P	NN	O	p	nsubjpass	15	SENT_129	[p7l2068t2819r2153b2903],
11	<	JJR	O	<	dep	15	SENT_129	[p7l15t2932r278b3016],
12	0.10	CD	NUMBER	0.10	num	13	SENT_129	[p7l15t2932r278b3016],
13	)	NN	O	)	nsubjpass	15	SENT_129	[p7l15t2932r278b3016],
14	were	VBD	O	be	auxpass	15	SENT_129	[p7l341t2959r515b3002],
15	assessed	VBN	O	assess	xcomp	9	SENT_129	[p7l576t2931r866b3003],
16	by	IN	O	by	_	0	SENT_129	[p7l926t2931r1017b3025],
17	multiple	JJ	O	multiple	amod	20	SENT_129	[p7l1074t2931r1390b3026],
18	logistic	JJ	O	logistic	amod	20	SENT_129	[p7l1450t2931r1715b3027],
19	regression	NN	O	regression	nn	20	SENT_129	[p7l1775t2936r2145b3027],
20	analysis	NN	O	analysis	agent	15	SENT_129	[p7l10t3045r312b3140],
21	,	,	O	,	_	0	SENT_129	[p7l10t3045r312b3140],
22	and	CC	O	and	_	0	SENT_129	[p7l353t3045r490b3118],
23	the	DT	O	the	det	24	SENT_129	[p7l526t3045r639b3117],
24	odds	NNS	O	odds	xcomp	9	SENT_129	[p7l676t3045r849b3118],
25	ratio	NN	O	ratio	nn	27	SENT_129	[p7l887t3050r1056b3117],
26	(	CD	NUMBER	(	num	27	SENT_129	[p7l1098t3046r1287b3131],
27	OR	NN	O	or	npadvmod	29	SENT_129	[p7l1098t3046r1287b3131],
28	)	CD	NUMBER	)	num	27	SENT_129	[p7l1098t3046r1287b3131],
29	With	IN	O	with	dep	24	SENT_129	[p7l1326t3045r1495b3117],
30	95	CD	PERCENT	95	number	31	SENT_129	[p7l1532t3051r1704b3122],
31	%	NN	PERCENT	%	amod	33	SENT_129	[p7l1532t3051r1704b3122],
32	conﬁdence	NN	O	conﬁdence	nn	33	SENT_129	[p7l1743t3045r2145b3118],
33	interval	NN	O	interval	pobj	29	SENT_129	[p7l10t3159r290b3231],
34	(	CD	NUMBER	(	num	36	SENT_129	[p7l350t3161r499b3245],
35	CI	NN	O	ci	nn	36	SENT_129	[p7l350t3161r499b3245],
36	)	NN	O	)	nsubjpass	38	SENT_129	[p7l350t3161r499b3245],
37	was	VBD	O	be	auxpass	38	SENT_129	[p7l558t3189r692b3231],
38	determined	VBN	O	determine	_	0	SENT_129	[p7l749t3159r1196b3232],
39	.	.	O	.	_	0	SENT_129	[p7l749t3159r1196b3232],

1	All	DT	O	all	det	2	SENT_130	[p7l1252t3159r1363b3230],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_130	[p7l1419t3159r1713b3254],
3	were	VBD	O	be	auxpass	4	SENT_130	[p7l1767t3188r1940b3231],
4	performed	VBN	O	perform	_	0	SENT_130	[p7l1995t3188r2143b3255, p7l10t3273r281b3345],
5	using	VBG	O	use	xcomp	4	SENT_130	[p7l319t3278r518b3369],
6	SPSS	NNP	ORGANIZATION	SPSS	nn	7	SENT_130	[p7l555t3276r744b3344],
7	software	NN	O	software	dobj	5	SENT_130	[p7l784t3273r1093b3344],
8	(	CD	NUMBER	(	num	7	SENT_130	[p7l1135t3274r1352b3358],
9	SPSS	NNP	ORGANIZATION	SPSS	nn	10	SENT_130	[p7l1135t3274r1352b3358],
10	II	NNP	O	II	nsubjpass	27	SENT_130	[p7l1394t3277r1452b3343],
11	v.	CC	O	v.	prep	10	SENT_130	[p7l1486t3304r1539b3344],
12	11.0	CD	NUMBER	11.0	dep	11	SENT_130	[p7l1590t3280r1769b3354],
13	,	,	O	,	_	0	SENT_130	[p7l1590t3280r1769b3354],
14	Chicago	NNP	LOCATION	Chicago	dep	11	SENT_130	[p7l1811t3273r2140b3369],
15	,	,	O	,	_	0	SENT_130	[p7l1811t3273r2140b3369],
16	IL	NN	LOCATION	il	nn	17	SENT_130	[p7l10t3388r144b3473],
17	)	NN	O	)	dep	11	SENT_130	[p7l10t3388r144b3473],
18	,	,	O	,	_	0	SENT_130	[p7l10t3388r144b3473],
19	and	CC	O	and	_	0	SENT_130	[p7l185t3387r322b3460],
20	a	DT	O	a	det	23	SENT_130	[p7l359t3417r396b3459],
21	P	NN	O	p	nn	23	SENT_130	[p7l428t3387r707b3460],
22	—	NN	O	—	nn	23	SENT_130	[p7l428t3387r707b3460],
23	value	NN	O	value	dep	24	SENT_130	[p7l428t3387r707b3460],
24	<	JJR	O	<	conj_and	12	SENT_130	[p7l749t3404r809b3461],
25	0.05	CD	NUMBER	0.05	dep	24	SENT_130	[p7l853t3393r1014b3464],
26	Was	VBD	O	be	auxpass	27	SENT_130	[p7l1052t3417r1186b3459],
27	considered	VBN	O	consider	rcmod	7	SENT_130	[p7l1224t3387r1626b3460],
28	signiﬁcant	NN	O	signiﬁcant	dobj	27	SENT_130	[p7l1662t3387r2064b3483],
29	.	.	O	.	_	0	SENT_130	[p7l1662t3387r2064b3483],

1	Results	NNS	O	result	_	0	SENT_131	[p7l14t3645r358b3730],

1	Triple	JJ	O	triple	amod	2	SENT_132	[p8l117t55r347b151],
2	T	NN	O	t	_	0	SENT_132	[p8l420t58r485b126],
3	/	:	O	/	punct	2	SENT_132	[p8l472t55r741b152],
4	yempy	NN	O	yempy	dep	2	SENT_132	[p8l472t55r741b152],
5	in	IN	O	in	dep	4	SENT_132	[p8l806t60r885b127],
6	Patients	NNS	O	patient	pobj	5	SENT_132	[p8l948t60r1272b127],
7	with	IN	O	with	dep	4	SENT_132	[p8l1337t55r1513b127],
8	H	NN	O	h	nn	11	SENT_132	[p8l1576t60r1664b126],
9	C	NN	O	c	nn	11	SENT_132	[p8l1662t59r1727b127],
10	V-1	NN	O	v-1	nn	11	SENT_132	[p8l1730t60r1856b127],
11	Infection	NN	O	infection	pobj	7	SENT_132	[p8l1922t55r2146b152, p8l12t174r186b241],
12	.	.	O	.	_	0	SENT_132	[p8l1922t55r2146b152, p8l12t174r186b241],

1	Baseline	NN	O	baseline	nn	2	SENT_133	[p8l236t170r539b241],
2	characteristics	NNS	O	characteristic	nsubj	22	SENT_133	[p8l598t170r1115b241],
3	of	IN	O	of	_	0	SENT_133	[p8l1175t170r1260b241],
4	the	DT	O	the	det	6	SENT_133	[p8l1306t170r1419b241],
5	49	CD	NUMBER	49	num	6	SENT_133	[p8l1477t170r1568b245],
6	patients	NNS	O	patient	prep_of	2	SENT_133	[p8l1629t175r1920b265],
7	with	IN	O	with	_	0	SENT_133	[p8l1976t170r2146b241],
8	CC	NN	O	cc	prep_with	6	SENT_133	[p8l11t286r142b355],
9	and	CC	O	and	_	0	SENT_133	[p8l190t283r326b355],
10	the	DT	O	the	det	11	SENT_133	[p8l373t283r486b354],
11	12	CD	NUMBER	12	conj_and	6	SENT_133	[p8l542t290r626b353],
12	with	IN	O	with	_	0	SENT_133	[p8l671t283r840b355],
13	CA/AA	NN	O	ca/aa	nn	14	SENT_133	[p8l887t285r1169b355],
14	genotypes	NNS	O	genotype	prep_with	11	SENT_133	[p8l1212t307r1581b379],
15	at	IN	O	at	_	0	SENT_133	[p8l1630t307r1696b354],
16	rs1127354	NN	O	rs1127354	prep_at	14	SENT_133	[p8l1742t284r2143b359],
17	in	IN	O	in	_	0	SENT_133	[p8l10t402r82b468],
18	the	DT	O	the	det	21	SENT_133	[p8l131t397r245b469],
19	I	PRP	O	I	nn	21	SENT_133	[p8l290t402r334b468],
20	TPA	NN	O	tpa	nn	21	SENT_133	[p8l337t400r492b468],
21	gene	NN	O	gene	prep_in	16	SENT_133	[p8l540t426r708b494],
22	are	VBP	O	be	_	0	SENT_133	[p8l757t426r864b469],
23	compared	VBN	O	compare	prep	22	SENT_133	[p8l913t398r1284b493],
24	in	IN	O	in	pcomp	23	SENT_133	[p8l1332t402r1404b468],
25	Table	NNP	O	Table	pobj	24	SENT_133	[p8l1450t397r1655b469],
26	1	CD	NUMBER	1	num	25	SENT_133	[p8l1711t405r1767b469],
27	.	.	O	.	_	0	SENT_133	[p8l1711t405r1767b469],

1	They	PRP	O	they	nsubjpass	4	SENT_134	[p8l1818t398r2016b492],
2	all	DT	O	all	advmod	4	SENT_134	[p8l2061t397r2145b469],
3	were	VBD	O	be	auxpass	4	SENT_134	[p8l6t541r180b583],
4	infected	VBN	O	infect	_	0	SENT_134	[p8l227t512r524b584],
5	with	IN	O	with	_	0	SENT_134	[p8l566t512r735b583],
6	HCV	NN	O	hcv	nn	7	SENT_134	[p8l782t515r1085b583],
7	—	NN	O	—	prep_with	4	SENT_134	[p8l782t515r1085b583],
8	1	CD	NUMBER	1	num	7	SENT_134	[p8l782t515r1085b583],
9	.	.	O	.	_	0	SENT_134	[p8l782t515r1085b583],

1	There	EX	O	there	expl	2	SENT_135	[p8l1134t512r1357b583],
2	were	VBD	O	be	_	0	SENT_135	[p8l1400t540r1573b583],
3	no	DT	O	no	det	5	SENT_135	[p8l1621t540r1713b583],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_135	[p8l1761t512r2146b608],
5	differences	NNS	O	difference	nsubj	2	SENT_135	[p8l10t625r407b697],
6	between	IN	O	between	_	0	SENT_135	[p8l459t625r765b697],
7	them	PRP	O	they	prep_between	5	SENT_135	[p8l816t625r1028b706],
8	,	,	O	,	_	0	SENT_135	[p8l816t625r1028b706],
9	except	IN	O	except	_	0	SENT_135	[p8l1082t649r1315b720],
10	that	DT	O	that	det	14	SENT_135	[p8l1364t625r1510b696],
11	alanine	NN	O	alanine	nn	14	SENT_135	[p8l1559t625r1825b696],
12	aminotransferase	NN	O	aminotransferase	nn	14	SENT_135	[p8l1876t630r2143b696, p8l10t740r400b811],
13	(	CD	NUMBER	(	num	14	SENT_135	[p8l510t741r729b826],
14	ALT	NN	O	alt	prep_except	2	SENT_135	[p8l510t741r729b826],
15	)	NN	O	)	nn	22	SENT_135	[p8l510t741r729b826],
16	and	CC	O	and	_	0	SENT_135	[p8l840t740r977b812],
17	aspartate	NN	O	aspartate	nn	22	SENT_135	[p8l1081t764r1407b835],
18	aminotransferase	NN	O	aminotransferase	nn	22	SENT_135	[p8l1512t740r2144b811],
19	(	CD	NUMBER	(	num	22	SENT_135	[p8l14t854r237b939],
20	AST	NNP	O	AST	nn	22	SENT_135	[p8l14t854r237b939],
21	)	NN	O	)	nn	22	SENT_135	[p8l14t854r237b939],
22	levels	NNS	O	level	nsubj	24	SENT_135	[p8l301t853r497b924],
23	were	VBD	O	be	cop	24	SENT_135	[p8l554t882r727b925],
24	higher	JJR	O	higher	rcmod	14	SENT_135	[p8l785t853r1024b949],
25	in	IN	O	in	_	0	SENT_135	[p8l1082t858r1154b923],
26	patients	NNS	O	patient	prep_in	24	SENT_135	[p8l1212t858r1503b948],
27	with	IN	O	with	_	0	SENT_135	[p8l1560t853r1729b924],
28	CC	NN	O	cc	prep_with	26	SENT_135	[p8l1788t856r1919b925],
29	than	IN	O	than	mark	32	SENT_135	[p8l1979t853r2145b924],
30	CA/AA	NN	O	ca/aa	nn	31	SENT_135	[p8l22t970r302b1039],
31	genotypes	NNS	O	genotype	nsubj	32	SENT_135	[p8l339t991r707b1063],
32	(	VBP	O	(	advcl	24	SENT_135	[p8l753t968r837b1053],
33	P	NN	O	p	dobj	32	SENT_135	[p8l753t968r837b1053],
34	=	JJ	O	=	amod	33	SENT_135	[p8l872t1001r937b1024],
35	0.041	CD	NUMBER	0.041	tmod	34	SENT_135	[p8l982t968r1186b1039],
36	and	CC	O	and	_	0	SENT_135	[p8l1236t967r1372b1039],
37	P	NN	O	p	dobj	32	SENT_135	[p8l1409t972r1469b1037],
38	=	JJ	O	=	amod	37	SENT_135	[p8l1504t1001r1569b1024],
39	0.008	CD	NUMBER	0.008	tmod	38	SENT_135	[p8l1613t974r1848b1049],
40	,	,	O	,	_	0	SENT_135	[p8l1613t974r1848b1049],
41	respectively	RB	O	respectively	advmod	42	SENT_135	[p8l1892t995r2147b1062, p8l21t1081r269b1176],
42	)	CD	NUMBER	)	rcmod	37	SENT_135	[p8l1892t995r2147b1062, p8l21t1081r269b1176],
43	.	.	O	.	_	0	SENT_135	[p8l1892t995r2147b1062, p8l21t1081r269b1176],

1	Overall	RB	O	overall	advmod	21	SENT_136	[p8l340t1081r633b1163],
2	,	,	O	,	_	0	SENT_136	[p8l340t1081r633b1163],
3	IL28B	NN	O	il28b	nn	4	SENT_136	[p8l698t1086r941b1153],
4	genotypes	NNS	O	genotype	nsubjpass	24	SENT_136	[p8l1001t1105r1368b1177],
5	resistant	JJ	O	resistant	amod	4	SENT_136	[p8l1434t1086r1740b1153],
6	to	TO	O	to	_	0	SENT_136	[p8l1802t1106r1873b1153],
7	PEGIFN	NN	O	pegifn	prep_to	5	SENT_136	[p8l1940t1085r2148b1153, p8l21t1202r177b1268],
8	and	CC	O	and	_	0	SENT_136	[p8l223t1197r359b1269],
9	RBV	NN	O	rbv	prep_to	5	SENT_136	[p8l406t1202r597b1278],
10	,	,	O	,	_	0	SENT_136	[p8l406t1202r597b1278],
11	TT/TC	NN	O	tt/tc	conj_and	4	SENT_136	[p8l645t1199r937b1269],
12	at	IN	O	at	_	0	SENT_136	[p8l986t1221r1052b1268],
13	rs8099917	NN	O	rs8099917	prep_at	11	SENT_136	[p8l1098t1204r1519b1278],
14	,	,	O	,	_	0	SENT_136	[p8l1098t1204r1519b1278],
15	and	CC	O	and	_	0	SENT_136	[p8l1570t1197r1706b1269],
16	CC/CT	NN	O	cc/ct	conj_and	4	SENT_136	[p8l1753t1199r2049b1268],
17	at	IN	O	at	_	0	SENT_136	[p8l2085t1221r2151b1268],
18	rs12979860	NN	O	rs12979860	prep_at	16	SENT_136	[p8l21t1313r469b1387],
19	were	VBD	O	be	auxpass	21	SENT_136	[p8l532t1340r705b1383],
20	rather	RB	O	rather	advmod	21	SENT_136	[p8l769t1311r988b1383],
21	frequent	JJ	O	frequent	_	0	SENT_136	[p8l1050t1311r1384b1406],
22	,	,	O	,	_	0	SENT_136	[p8l1050t1311r1384b1406],
23	and	CC	O	and	_	0	SENT_136	[p8l1452t1311r1589b1384],
24	possessed	VBN	O	possess	conj_and	21	SENT_136	[p8l1650t1311r1998b1406],
25	by	IN	O	by	_	0	SENT_136	[p8l2062t1311r2153b1405],
26	44	CD	PERCENT	44	number	30	SENT_136	[p8l19t1426r194b1499],
27	%	NN	PERCENT	%	dep	30	SENT_136	[p8l19t1426r194b1499],
28	and	CC	O	and	_	0	SENT_136	[p8l244t1425r380b1498],
29	47	CD	PERCENT	47	conj_and	30	SENT_136	[p8l424t1426r622b1507],
30	%	NN	PERCENT	%	prep_by	24	SENT_136	[p8l424t1426r622b1507],
31	,	,	O	,	_	0	SENT_136	[p8l424t1426r622b1507],
32	respectively	RB	O	respectively	advmod	30	SENT_136	[p8l673t1425r1113b1521],
33	,	,	O	,	_	0	SENT_136	[p8l673t1425r1113b1521],
34	of	IN	O	of	_	0	SENT_136	[p8l1164t1425r1248b1497],
35	the	DT	O	the	det	36	SENT_136	[p8l1283t1425r1396b1497],
36	patients	NNS	O	patient	prep_of	30	SENT_136	[p8l1442t1430r1753b1521],
37	.	.	O	.	_	0	SENT_136	[p8l1442t1430r1753b1521],

1	This	DT	O	this	nsubj	3	SENT_137	[p8l1802t1425r1970b1497],
2	was	VBD	O	be	cop	3	SENT_137	[p8l2015t1455r2148b1497],
3	due	JJ	O	due	_	0	SENT_137	[p8l21t1541r154b1614],
4	to	TO	O	to	_	0	SENT_137	[p8l223t1565r294b1613],
5	inclusion	NN	O	inclusion	prep_to	3	SENT_137	[p8l365t1541r705b1614],
6	of	IN	O	of	_	0	SENT_137	[p8l775t1541r859b1613],
7	15	CD	NUMBER	15	num	8	SENT_137	[p8l923t1547r1002b1618],
8	nonresponders	NNS	O	nonresponder	prep_of	5	SENT_137	[p8l1077t1541r1624b1636],
9	to	TO	O	to	_	0	SENT_137	[p8l1694t1565r1765b1613],
10	previous	JJ	O	previous	amod	12	SENT_137	[p8l1835t1546r2148b1636],
11	IFN	NN	O	ifn	nn	12	SENT_137	[p8l21t1655r419b1727],
12	—	NN	O	—	prep_to	3	SENT_137	[p8l21t1655r419b1727],
13	based	VBN	O	base	partmod	12	SENT_137	[p8l21t1655r419b1727],
14	therapies	NNS	O	therapy	dobj	13	SENT_137	[p8l463t1655r814b1750],
15	,	,	O	,	_	0	SENT_137	[p8l463t1655r814b1750],
16	corresponding	VBG	O	correspond	partmod	13	SENT_137	[p8l864t1655r1401b1751],
17	to	TO	O	to	_	0	SENT_137	[p8l1444t1679r1515b1727],
18	25	CD	PERCENT	25	num	19	SENT_137	[p8l1561t1661r1735b1732],
19	%	NN	PERCENT	%	prep_to	16	SENT_137	[p8l1561t1661r1735b1732],
20	of	IN	O	of	_	0	SENT_137	[p8l1782t1655r1866b1727],
21	the	DT	O	the	det	23	SENT_137	[p8l1898t1655r2011b1727],
22	61	CD	NUMBER	61	num	23	SENT_137	[p8l2057t1657r2139b1727],
23	patients	NNS	O	patient	prep_of	19	SENT_137	[p8l20t1774r310b1865],
24	studied	VBN	O	study	partmod	23	SENT_137	[p8l364t1769r655b1851],
25	,	,	O	,	_	0	SENT_137	[p8l364t1769r655b1851],
26	most	JJS	O	most	nsubj	29	SENT_137	[p8l713t1794r896b1841],
27	of	IN	O	of	_	0	SENT_137	[p8l949t1769r1032b1841],
28	whom	WP	O	whom	prep_of	26	SENT_137	[p8l1070t1769r1307b1841],
29	(	VBP	O	(	rcmod	23	SENT_137	[p8l1367t1770r1611b1855],
30	14/15	CD	PERCENT	14/15	number	31	SENT_137	[p8l1367t1770r1611b1855],
31	[	CD	PERCENT	[	dobj	29	SENT_137	[p8l1677t1770r1933b1855],
32	93	CD	PERCENT	93	num	33	SENT_137	[p8l1677t1770r1933b1855],
33	%	NN	PERCENT	%	dobj	16	SENT_137	[p8l1677t1770r1933b1855],
34	]	CD	NUMBER	]	number	35	SENT_137	[p8l1677t1770r1933b1855],
35	)	CD	NUMBER	)	num	36	SENT_137	[p8l1677t1770r1933b1855],
36	pos	NNS	O	po	nsubj	37	SENT_137	[p8l1992t1797r2147b1865],
37	—	VBP	O	—	rcmod	33	SENT_137	[p8l1992t1797r2147b1865],
38	sessed	VBN	O	sess	csubj	43	SENT_137	[p8l20t1884r238b1957],
39	IFN	NN	O	ifn	npadvmod	41	SENT_137	[p8l284t1889r783b1956],
40	—	CD	NUMBER	—	num	39	SENT_137	[p8l284t1889r783b1956],
41	resistant	JJ	O	resistant	amod	42	SENT_137	[p8l284t1889r783b1956],
42	genotypes	NNS	O	genotype	dobj	38	SENT_137	[p8l828t1909r1196b1981],
43	(	VBP	O	(	ccomp	37	SENT_137	[p8l1248t1886r1566b1970],
44	TT/TG	NN	O	tt/tg	nn	47	SENT_137	[p8l1248t1886r1566b1970],
45	and	CC	O	and	_	0	SENT_137	[p8l1614t1884r1751b1957],
46	CC/CT	NN	O	cc/ct	conj_and	44	SENT_137	[p8l1797t1886r2144b1970],
47	)	NN	O	)	dobj	43	SENT_137	[p8l1797t1886r2144b1970],
48	.	.	O	.	_	0	SENT_137	[p8l1797t1886r2144b1970],

1	Six	CD	NUMBER	six	nsubj	4	SENT_138	[p8l21t2002r133b2070],
2	of	IN	O	of	_	0	SENT_138	[p8l172t1998r256b2070],
3	them	PRP	O	they	prep_of	1	SENT_138	[p8l285t1998r475b2070],
4	had	VBD	O	have	_	0	SENT_138	[p8l516t1998r653b2071],
5	low	JJ	O	low	amod	7	SENT_138	[p8l693t1998r828b2070],
6	hemoglobin	NN	O	hemoglobin	nn	7	SENT_138	[p8l865t1998r1317b2094],
7	levels	NNS	O	level	dobj	4	SENT_138	[p8l1357t1998r1552b2070],
8	(	VBP	O	(	rcmod	7	SENT_138	[p8l1600t1999r1792b2084],
9	<	JJR	O	<	acomp	8	SENT_138	[p8l1600t1999r1792b2084],
10	13	CD	NUMBER	13	num	12	SENT_138	[p8l1600t1999r1792b2084],
11	g/dL	NN	O	g/dl	nn	12	SENT_138	[p8l1836t1998r2036b2094],
12	)	NN	O	)	dep	9	SENT_138	[p8l1836t1998r2036b2094],
13	at	IN	O	at	_	0	SENT_138	[p8l2085t2022r2151b2070],
14	baseline	NN	O	baseline	prep_at	12	SENT_138	[p8l20t2112r314b2184],
15	and	CC	O	and	_	0	SENT_138	[p8l356t2112r493b2185],
16	were	VBD	O	be	auxpass	17	SENT_138	[p8l530t2141r703b2184],
17	started	VBN	O	start	conj_and	4	SENT_138	[p8l744t2112r992b2185],
18	with	IN	O	with	_	0	SENT_138	[p8l1029t2112r1198b2184],
19	an	DT	O	a	det	21	SENT_138	[p8l1239t2141r1324b2184],
20	RBV	NN	MISC	rbv	nn	21	SENT_138	[p8l1367t2117r1554b2184],
21	dose	NN	O	dose	prep_with	17	SENT_138	[p8l1590t2112r1753b2185],
22	decreased	VBN	O	decrease	partmod	21	SENT_138	[p8l1795t2112r2150b2185],
23	by	IN	O	by	_	0	SENT_138	[p8l20t2228r111b2322],
24	200	CD	NUMBER	200	num	25	SENT_138	[p8l150t2235r290b2299],
25	mg	NN	O	mg	agent	22	SENT_138	[p8l334t2256r471b2324],
26	;	:	O	;	_	0	SENT_138	[p8l334t2256r471b2324],
27	they	PRP	O	they	nsubj	28	SENT_138	[p8l518t2228r677b2322],
28	included	VBD	O	include	parataxis	4	SENT_138	[p8l716t2228r1040b2300],
29	five	CD	NUMBER	five	dobj	28	SENT_138	[p8l1081t2228r1208b2299],
30	with	IN	O	with	_	0	SENT_138	[p8l1247t2228r1415b2299],
31	CC	NN	O	cc	prep_with	28	SENT_138	[p8l1459t2231r1589b2299],
32	and	CC	O	and	_	0	SENT_138	[p8l1632t2228r1768b2300],
33	one	CD	NUMBER	one	conj_and	31	SENT_138	[p8l1810t2256r1943b2299],
34	with	IN	O	with	_	0	SENT_138	[p8l1981t2228r2150b2299],
35	CA	NNP	O	CA	nn	36	SENT_138	[p8l22t2345r148b2413],
36	genotypes	NNS	O	genotype	prep_with	28	SENT_138	[p8l182t2365r550b2437],
37	of	IN	O	of	_	0	SENT_138	[p8l588t2341r673b2413],
38	the	DT	O	the	det	40	SENT_138	[p8l697t2341r810b2413],
39	ITPA	NN	O	itpa	nn	40	SENT_138	[p8l845t2344r1046b2412],
40	gene	NN	O	gene	prep_of	36	SENT_138	[p8l1082t2370r1269b2437],
41	.	.	O	.	_	0	SENT_138	[p8l1082t2370r1269b2437],

1	Modiﬁcation	NN	O	modiﬁcation	_	0	SENT_139	[p8l112t2456r629b2553],
2	of	IN	O	of	_	0	SENT_139	[p8l679t2456r774b2553],
3	RB	NN	O	rb	nn	5	SENT_139	[p8l794t2461r920b2527],
4	V	NN	O	v	nn	5	SENT_139	[p8l931t2461r1000b2528],
5	Dose	NN	O	dose	prep_of	1	SENT_139	[p8l1026t2461r1221b2528],
6	During	IN	O	during	dep	5	SENT_139	[p8l1262t2461r1561b2553],
7	Yiiple	JJ	O	yiiple	amod	9	SENT_139	[p8l1611t2456r1840b2552],
8	T	NN	O	t	nn	9	SENT_139	[p8l1894t2459r1959b2527],
9	hempy	NN	O	hempy	pobj	6	SENT_139	[p8l1946t2456r2151b2528, p8l7t2593r127b2666],
10	.	.	O	.	_	0	SENT_139	[p8l1946t2456r2151b2528, p8l7t2593r127b2666],

1	RBV	NN	O	rbv	nn	2	SENT_140	[p8l176t2574r360b2641],
2	dose	NN	O	dose	nsubjpass	4	SENT_140	[p8l418t2570r577b2642],
3	Was	VBD	O	be	auxpass	4	SENT_140	[p8l636t2600r766b2641],
4	reduced	VBN	O	reduce	_	0	SENT_140	[p8l830t2570r1116b2642],
5	by	IN	O	by	_	0	SENT_140	[p8l1177t2570r1267b2664],
6	2200	CD	DATE	2200	num	7	SENT_140	[p8l1331t2577r1539b2653],
7	mg	NN	O	mg	agent	4	SENT_140	[p8l1604t2598r1721b2666],
8	in	IN	O	in	_	0	SENT_140	[p8l1781t2575r1851b2640],
9	all	DT	O	all	det	11	SENT_140	[p8l1914t2570r1995b2641],
10	61	CD	NUMBER	61	num	11	SENT_140	[p8l2058t2572r2140b2641],
11	patients	NNS	O	patient	prep_in	7	SENT_140	[p8l20t2690r300b2780],
12	studied	VBN	O	study	partmod	11	SENT_140	[p8l345t2685r609b2758],
13	during	IN	O	during	_	0	SENT_140	[p8l652t2685r895b2781],
14	triple	JJ	O	triple	amod	15	SENT_140	[p8l937t2685r1126b2780],
15	therapy	NN	O	therapy	prep_during	12	SENT_140	[p8l1169t2685r1444b2780],
16	because	IN	O	because	mark	19	SENT_140	[p8l1483t2685r1757b2758],
17	hemoglobin	NN	O	hemoglobin	nsubj	19	SENT_140	[p8l1800t2685r2148b2781, p8l20t2800r138b2871],
18	had	VBD	O	have	aux	19	SENT_140	[p8l174t2799r308b2872],
19	decreased	VBN	O	decrease	advcl	12	SENT_140	[p8l345t2799r689b2872],
20	<	JJR	O	<	acomp	19	SENT_140	[p8l730t2806r961b2873],
21	12.0	CD	NUMBER	12.0	num	22	SENT_140	[p8l730t2806r961b2873],
22	g/dL	NN	O	g/dl	dep	20	SENT_140	[p8l999t2799r1173b2896],
23	in	IN	O	in	_	0	SENT_140	[p8l1208t2804r1278b2870],
24	them	PRP	O	they	prep_in	22	SENT_140	[p8l1315t2799r1520b2871],
25	.	.	O	.	_	0	SENT_140	[p8l1315t2799r1520b2871],

1	During	IN	O	during	_	0	SENT_141	[p8l1563t2804r1831b2896],
2	the	DT	O	the	det	3	SENT_141	[p8l1865t2800r1976b2871],
3	ﬁrst	NN	O	ﬁrst	prep_during	30	SENT_141	[p8l2013t2799r2151b2871],
4	12	CD	DURATION	12	num	5	SENT_141	[p8l29t2922r111b2985],
5	Weeks	NNS	DURATION	week	nsubj	30	SENT_141	[p8l148t2915r360b2986],
6	of	IN	O	of	_	0	SENT_141	[p8l400t2915r484b2986],
7	therapy	NN	O	therapy	prep_of	5	SENT_141	[p8l509t2915r784b3010],
8	While	IN	O	while	mark	11	SENT_141	[p8l815t2915r1012b2986],
9	telaprevir	NN	O	telaprevir	nsubjpass	11	SENT_141	[p8l1050t2915r1388b3010],
10	was	VBD	O	be	auxpass	11	SENT_141	[p8l1423t2945r1555b2986],
11	given	VBN	O	give	advcl	22	SENT_141	[p8l1593t2920r1803b3011],
12	,	,	O	,	_	0	SENT_141	[p8l1593t2920r1803b3011],
13	the	DT	O	the	det	14	SENT_141	[p8l1846t2915r1957b2986],
14	proportion	NN	O	proportion	nsubj	22	SENT_141	[p8l1995t2943r2148b3010, p8l20t3033r292b3123],
15	of	IN	O	of	_	0	SENT_141	[p8l334t3028r418b3099],
16	patients	NNS	O	patient	prep_of	14	SENT_141	[p8l446t3033r727b3123],
17	receiving	VBG	O	receive	partmod	16	SENT_141	[p8l771t3033r1094b3124],
18	the	DT	O	the	det	21	SENT_141	[p8l1134t3028r1244b3099],
19	ﬁlll	NN	O	ﬁlll	nn	21	SENT_141	[p8l1286t3028r1405b3100],
20	RBV	NN	O	rbv	nn	21	SENT_141	[p8l1448t3033r1631b3099],
21	dose	NN	O	dose	dobj	17	SENT_141	[p8l1670t3028r1829b3100],
22	differed	VBD	O	differ	rcmod	5	SENT_141	[p8l1871t3028r2151b3100],
23	between	IN	O	between	_	0	SENT_141	[p8l20t3142r318b3214],
24	those	DT	O	those	prep_between	22	SENT_141	[p8l358t3143r546b3214],
25	with	IN	O	with	_	0	SENT_141	[p8l583t3142r748b3214],
26	CC	NN	O	cc	nn	29	SENT_141	[p8l789t3146r917b3214],
27	and	CC	O	and	_	0	SENT_141	[p8l959t3142r1093b3215],
28	CA/AA	NN	O	ca/aa	nn	29	SENT_141	[p8l1133t3145r1409b3214],
29	genotypes	NNS	O	genotype	prep_with	22	SENT_141	[p8l1446t3167r1804b3239],
30	(	VBP	O	(	_	0	SENT_141	[p8l1850t3144r2007b3239],
31	Fig	NN	O	fig	dobj	30	SENT_141	[p8l1850t3144r2007b3239],
32	.	.	O	.	_	0	SENT_141	[p8l1850t3144r2007b3239],

1	1	CD	NUMBER	1	_	0	SENT_142	[p8l2060t3144r2144b3228],
2	)	NN	O	)	dep	1	SENT_142	[p8l2060t3144r2144b3228],
3	.	.	O	.	_	0	SENT_142	[p8l2060t3144r2144b3228],

1	RBV	NN	O	rbv	nn	3	SENT_143	[p8l21t3261r205b3329],
2	dose	NN	O	dose	nn	3	SENT_143	[p8l274t3257r433b3329],
3	reduction	NN	O	reduction	nsubjpass	5	SENT_143	[p8l506t3257r855b3329],
4	was	VBD	O	be	auxpass	5	SENT_143	[p8l923t3287r1053b3329],
5	started	VBN	O	start	_	0	SENT_143	[p8l1127t3257r1367b3329],
6	earlier	RBR	O	earlier	advmod	5	SENT_143	[p8l1438t3257r1660b3328],
7	in	IN	O	in	_	0	SENT_143	[p8l1731t3262r1801b3327],
8	the	DT	O	the	det	9	SENT_143	[p8l1874t3257r1985b3328],
9	49	CD	NUMBER	49	prep_in	5	SENT_143	[p8l2056t3257r2146b3333],

1	patients	NNS	O	patient	nsubj	10	SENT_144	[p9l19t31r300b121],
2	with	IN	O	with	_	0	SENT_144	[p9l348t26r513b98],
3	CC	NN	O	cc	prep_with	1	SENT_144	[p9l563t29r692b98],
4	than	IN	O	than	_	0	SENT_144	[p9l743t26r905b97],
5	the	DT	O	the	det	6	SENT_144	[p9l954t26r1065b97],
6	12	CD	NUMBER	12	prep_than	3	SENT_144	[p9l1124t33r1205b96],
7	with	IN	O	with	_	0	SENT_144	[p9l1254t26r1418b98],
8	CA/AA	NN	O	ca/aa	nn	9	SENT_144	[p9l1468t28r1744b98],
9	genotypes	NNS	O	genotype	prep_with	6	SENT_144	[p9l1790t50r2148b122],
10	(	VBP	O	(	_	0	SENT_144	[p9l25t142r165b226],
11	2.6	CD	NUMBER	2.6	dobj	10	SENT_144	[p9l25t142r165b226],
12	i	FW	O	i	dep	11	SENT_144	[p9l217t150r276b208],
13	1.3	CD	NUMBER	1.3	num	14	SENT_144	[p9l340t147r443b216],
14	V8	NN	O	v8	dep	12	SENT_144	[p9l488t170r577b212],
15	.	.	O	.	_	0	SENT_144	[p9l488t170r577b212],

1	4.8	CD	NUMBER	4.8	_	0	SENT_145	[p9l625t141r737b212],
2	i	FW	O	i	dep	1	SENT_145	[p9l792t150r851b208],
3	3.1	CD	DURATION	3.1	num	4	SENT_145	[p9l908t147r1012b216],
4	weeks	NNS	NUMBER	week	tmod	2	SENT_145	[p9l1063t140r1275b212],
5	after	IN	O	after	_	0	SENT_145	[p9l1321t140r1481b212],
6	the	DT	O	the	det	7	SENT_145	[p9l1524t140r1635b212],
7	start	NN	O	start	prep_after	1	SENT_145	[p9l1679t165r1851b222],
8	,	,	O	,	_	0	SENT_145	[p9l1679t165r1851b222],
9	respectively	RB	O	respectively	advmod	7	SENT_145	[p9l1900t169r2147b236, p9l21t255r223b349],
10	,	,	O	,	_	0	SENT_145	[p9l1900t169r2147b236, p9l21t255r223b349],
11	P	NN	O	p	appos	7	SENT_145	[p9l262t259r322b325],
12	=	JJ	O	=	amod	14	SENT_145	[p9l354t288r419b312],
13	0.010	CD	NUMBER	0.010	tmod	12	SENT_145	[p9l462t256r720b340],
14	)	NN	O	)	dep	11	SENT_145	[p9l462t256r720b340],
15	.	.	O	.	_	0	SENT_145	[p9l462t256r720b340],

1	Thus	RB	O	thus	advmod	14	SENT_146	[p9l760t255r968b336],
2	,	,	O	,	_	0	SENT_146	[p9l760t255r968b336],
3	during	IN	O	during	_	0	SENT_146	[p9l1010t255r1254b351],
4	the	DT	O	the	det	5	SENT_146	[p9l1289t255r1400b326],
5	ﬁrst	NN	O	ﬁrst	prep_during	14	SENT_146	[p9l1438t255r1576b326],
6	12	CD	DURATION	12	num	7	SENT_146	[p9l1620t262r1702b325],
7	weeks	NNS	NUMBER	week	tmod	5	SENT_146	[p9l1738t255r1952b326],
8	with	IN	O	with	_	0	SENT_146	[p9l1985t255r2151b326],
9	telaprevir	NN	O	telaprevir	prep_with	5	SENT_146	[p9l21t368r359b463],
10	the	DT	O	the	det	12	SENT_146	[p9l413t368r524b439],
11	RBV	NN	O	rbv	nn	12	SENT_146	[p9l580t373r764b440],
12	dose	NN	O	dose	nsubj	14	SENT_146	[p9l815t368r975b440],
13	was	VBD	O	be	cop	14	SENT_146	[p9l1027t398r1159b440],
14	smaller	JJR	O	smaller	_	0	SENT_146	[p9l1214t368r1472b439],
15	in	IN	O	in	_	0	SENT_146	[p9l1526t373r1596b438],
16	patients	NNS	O	patient	prep_in	14	SENT_146	[p9l1650t373r1932b463],
17	with	IN	O	with	_	0	SENT_146	[p9l1985t368r2150b440],
18	CC	NN	O	cc	prep_with	16	SENT_146	[p9l22t486r150b554],
19	than	IN	O	than	mark	22	SENT_146	[p9l191t482r353b554],
20	CA/AA	NN	O	ca/aa	nn	21	SENT_146	[p9l394t485r669b554],
21	genotypes	NNS	O	genotype	nsubj	22	SENT_146	[p9l706t507r1063b579],
22	(	VBP	O	(	advcl	14	SENT_146	[p9l1110t484r1225b568],
23	52	CD	NUMBER	52	dobj	22	SENT_146	[p9l1110t484r1225b568],
24	i	FW	O	i	dep	23	SENT_146	[p9l1274t492r1332b550],
25	14	CD	PERCENT	14	num	26	SENT_146	[p9l1391t483r1554b557],
26	%	NN	PERCENT	%	dep	29	SENT_146	[p9l1391t483r1554b557],
27	VS.	NNP	O	VS.	dep	26	SENT_146	[p9l1594t512r1683b554],
28	65	CD	NUMBER	65	dep	29	SENT_146	[p9l1728t485r1815b559],
29	i	FW	O	i	dep	23	SENT_146	[p9l1866t492r1924b550],
30	21	CD	PERCENT	21	num	31	SENT_146	[p9l1976t488r2147b556],
31	%	NN	PERCENT	%	dep	29	SENT_146	[p9l1976t488r2147b556],
32	of	IN	O	of	_	0	SENT_146	[p9l21t596r105b667],
33	the	DT	O	the	det	35	SENT_146	[p9l147t596r258b667],
34	target	NN	O	target	nn	35	SENT_146	[p9l313t620r517b692],
35	dose	NN	O	dose	prep_of	31	SENT_146	[p9l571t596r750b677],
36	,	,	O	,	_	0	SENT_146	[p9l571t596r750b677],
37	P	NN	O	p	appos	35	SENT_146	[p9l807t600r866b666],
38	=	JJ	O	=	amod	40	SENT_146	[p9l917t629r982b653],
39	0.039	CD	NUMBER	0.039	tmod	38	SENT_146	[p9l1043t597r1300b682],
40	)	NN	O	)	dep	37	SENT_146	[p9l1043t597r1300b682],
41	.	.	O	.	_	0	SENT_146	[p9l1043t597r1300b682],

1	During	IN	O	during	_	0	SENT_147	[p9l1361t600r1630b692],
2	the	DT	O	the	det	5	SENT_147	[p9l1683t596r1794b667],
3	next	JJ	O	next	amod	5	SENT_147	[p9l1849t620r2004b667],
4	12	CD	NUMBER	12	number	5	SENT_147	[p9l2065t603r2147b666],
5	418	CD	NUMBER	418	pobj	1	SENT_147	[p9l11t716r113b768],
6	SUZUKI	NNP	O	SUZUKI	nn	8	SENT_147	[p9l228t718r482b768],
7	ET	NNP	O	ET	nn	8	SENT_147	[p9l510t717r596b767],
8	AL.	NNP	O	AL.	dep	5	SENT_147	[p9l614t719r713b768],
9	.	.	O	.	_	0	SENT_147	[p9l614t719r713b768],

1	D	NN	O	d	_	0	SENT_148	[p9l286t938r306b984],
2	}	CD	NUMBER	}	num	3	SENT_148	[p9l286t938r306b984],
3	}	NN	O	}	dep	1	SENT_148	[p9l286t938r306b984],
4	+	CC	O	+	_	0	SENT_148	[p9l286t938r306b984],
5	oo	NN	O	oo	nn	6	SENT_148	[p9l318t938r389b984],
6	)	NN	O	)	dep	1	SENT_148	[p9l318t938r389b984],

1	T511	NN	O	t511	_	0	SENT_149	[p9l893t1003r970b1051],
2	1.27354	CD	NUMBER	1.27354	num	1	SENT_149	[p9l983t1003r1192b1051],

1	__	NN	O	__	_	0	SENT_150	[p9l633t1141r687b1168],
2	_	CD	NUMBER	_	num	1	SENT_150	[p9l700t1151r710b1160],
3	__	NN	O	__	nn	6	SENT_150	[p9l723t1151r758b1160],
4	—	CD	NUMBER	—	num	6	SENT_150	[p9l909t1118r1034b1128],
5	C-G	NN	O	c-g	nn	6	SENT_150	[p9l1083t1099r1173b1150],
6	Gen-utype	NN	O	gen-utype	dep	1	SENT_150	[p9l1193t1099r1465b1160],
7	(	CD	NUMBER	(	number	9	SENT_150	[p9l1622t1096r1674b1160],
8	n.	NN	O	n.	dep	9	SENT_150	[p9l1622t1096r1674b1160],
9	=	JJ	O	=	amod	6	SENT_150	[p9l1693t1118r1729b1141],
10	49	CD	NUMBER	49	num	11	SENT_150	[p9l1747t1096r1835b1160],
11	)	CD	NUMBER	)	dep	1	SENT_150	[p9l1747t1096r1835b1160],
12	3	CD	NUMBER	3	num	13	SENT_150	[p9l318t1166r386b1214],
13	°	NN	O	°	rcmod	11	SENT_150	[p9l318t1166r386b1214],
14	5	CD	NUMBER	5	dep	13	SENT_150	[p9l751t1194r758b1252],
15	1	LS	NUMBER	1	dep	14	SENT_150	[p9l908t1207r967b1217],
16	-	:	O	-	_	0	SENT_150	[p9l908t1207r967b1217],
17	-	:	O	-	_	0	SENT_150	[p9l979t1207r989b1217],
18	~	SYM	O	~	dep	20	SENT_150	[p9l1002t1207r1034b1217],
19	-	:	O	-	_	0	SENT_150	[p9l1002t1207r1034b1217],
20	C	NN	O	c	dep	11	SENT_150	[p9l1083t1185r1273b1236],
21	=	JJ	O	=	amod	22	SENT_150	[p9l1083t1185r1273b1236],
22	Ar	NN	O	ar	dep	11	SENT_150	[p9l1083t1185r1273b1236],
23	'	''	O	'	_	0	SENT_150	[p9l1083t1185r1273b1236],
24	.	.	O	.	_	0	SENT_150	[p9l1083t1185r1273b1236],

1	A.A	NN	O	a.a	nn	2	SENT_151	[p9l1083t1185r1273b1236],
2	Ge-netypes	NNS	O	ge-netype	dep	3	SENT_151	[p9l1292t1185r1597b1249],
3	(	VBP	O	(	_	0	SENT_151	[p9l1622t1181r1674b1243],
4	I1	NN	O	i1	nsubj	5	SENT_151	[p9l1622t1181r1674b1243],
5	=	JJ	O	=	xcomp	3	SENT_151	[p9l1693t1201r1729b1223],
6	12	CD	NUMBER	12	num	7	SENT_151	[p9l1751t1181r1835b1243],
7	)	NN	O	)	nsubj	3	SENT_151	[p9l1751t1181r1835b1243],

1	P	NN	O	p	_	0	SENT_152	[p9l1138t1544r1186b1596],
2	=	JJ	O	=	amod	1	SENT_152	[p9l1202t1567r1241b1589],
3	0.0026	CD	NUMBER	0.0026	tmod	2	SENT_152	[p9l1263t1544r1478b1599],

1	M.	NNP	O	M.	nn	2	SENT_153	[p9l318t1858r351b1906],
2	G.	NNP	O	G.	_	0	SENT_153	[p9l354t1858r386b1906],
3	'	POS	O	'	_	0	SENT_153	[p9l1295t1909r1480b1925],

1	-	:	O	-	_	0	SENT_154	[p9l1295t1909r1480b1925],
2	'	''	O	'	_	0	SENT_154	[p9l1295t1909r1480b1925],
3	-	:	O	-	_	0	SENT_154	[p9l1295t1909r1480b1925],
4	In-run-In	NN	O	in-run-in	dep	2	SENT_154	[p9l1295t1909r1480b1925],
5	:	:	O	:	_	0	SENT_154	[p9l1295t1909r1480b1925],
6	I	PRP	O	I	dep	4	SENT_154	[p9l1481t1916r1491b1925],
7	n	NN	O	n	nn	12	SENT_154	[p9l1503t1916r1514b1925],
8	U	NN	O	u	nn	12	SENT_154	[p9l1526t1916r1539b1925],
9	n	NN	O	n	nn	12	SENT_154	[p9l1551t1916r1562b1925],
10	u	NN	O	u	nn	12	SENT_154	[p9l1574t1916r1584b1925],
11	o	NN	O	o	nn	12	SENT_154	[p9l1597t1916r1610b1925],
12	I	NN	O	i	dep	6	SENT_154	[p9l1622t1916r1632b1925],
13	II	CD	NUMBER	ii	dep	6	SENT_154	[p9l1645t1915r1670b1935],
14	.	.	O	.	_	0	SENT_154	[p9l1645t1915r1670b1935],

1	lﬁibavirin	NN	O	lﬁibavirin	_	0	SENT_155	[p9l222t1797r273b2035],
2	Given	VBN	O	give	dep	1	SENT_155	[p9l222t1612r273b1774],
3	in	IN	O	in	pcomp	2	SENT_155	[p9l222t1544r270b1589],
4	the	DT	O	the	det	6	SENT_155	[p9l222t1438r273b1525],
5	Full	JJ	O	full	amod	6	SENT_155	[p9l222t1320r273b1416],
6	Dose	NN	O	dose	pobj	3	SENT_155	[p9l222t1154r273b1297],
7	i	FW	O	i	dep	6	SENT_155	[p9l222t1041r283b1134],
8	(	CD	PERCENT	(	num	9	SENT_155	[p9l222t1041r283b1134],
9	%	NN	PERCENT	%	dep	7	SENT_155	[p9l222t1041r283b1134],
10	)	CD	NUMBER	)	dep	7	SENT_155	[p9l222t1041r283b1134],

1	Iriviiil	NNP	O	Iriviiil	_	0	SENT_156	[p9l1667t2012r1790b2028],
2	i	FW	O	i	nn	6	SENT_156	[p9l575t2114r683b2116],
3	i	FW	O	i	nn	6	SENT_156	[p9l706t2114r791b2115],
4	i	FW	O	i	nn	6	SENT_156	[p9l828t2114r931b2116],
5	i	FW	O	i	nn	6	SENT_156	[p9l941t2114r1054b2116],
6	i	FW	O	i	dep	1	SENT_156	[p9l1064t2114r1176b2116],
7	to	TO	O	to	_	0	SENT_156	[p9l431t2162r466b2210],
8	2	CD	NUMBER	2	number	9	SENT_156	[p9l675t2123r707b2210],
9	4	CD	NUMBER	4	num	11	SENT_156	[p9l811t2129r819b2139],
10	4	CD	NUMBER	4	number	11	SENT_156	[p9l918t2162r951b2210],
11	6	CD	NUMBER	6	prep_to	6	SENT_156	[p9l1163t2162r1196b2210],
12	A	DT	O	a	det	13	SENT_156	[p9l1296t2129r1298b2138],
13	:9	NN	O	:9	dep	1	SENT_156	[p9l1404t2118r1437b2210],
14	in	IN	O	in	_	0	SENT_156	[p9l1635t2162r1699b2210],
15	12	CD	NUMBER	12	prep_in	13	SENT_156	[p9l1876t2162r1938b2210],

1	weeks	NNS	DURATION	week	_	0	SENT_157	[p9l771t2242r963b2290],
2	an	DT	O	a	predet	5	SENT_157	[p9l982t2252r1051b2290],
3	the	DT	O	the	det	5	SENT_157	[p9l1070t2242r1157b2290],
4	Triple	JJ	O	triple	amod	5	SENT_157	[p9l1176t2242r1334b2303],
5	Therapy	NN	O	therapy	dep	1	SENT_157	[p9l1352t2242r1584b2303],

1	Fig	NN	O	fig	_	0	SENT_158	[p9l96t2409r190b2478],
2	.	.	O	.	_	0	SENT_158	[p9l96t2409r190b2478],

1	1	LS	NUMBER	1	_	0	SENT_159	[p9l230t2408r276b2463],
2	.	.	O	.	_	0	SENT_159	[p9l230t2408r276b2463],

1	Patients	NNS	O	patient	_	0	SENT_160	[p9l323t2409r551b2464],
2	who	WP	O	who	nsubj	3	SENT_160	[p9l579t2409r692b2464],
3	received	VBD	O	receive	rcmod	1	SENT_160	[p9l726t2409r960b2464],
4	the	DT	O	the	det	7	SENT_160	[p9l992t2409r1082b2464],
5	full	JJ	O	full	amod	7	SENT_160	[p9l1112t2408r1195b2464],
6	ribavirin	NNP	O	ribavirin	nn	7	SENT_160	[p9l1232t2409r1452b2464],
7	dose	NN	O	dose	dobj	3	SENT_160	[p9l1487t2409r1624b2464],
8	during	IN	O	during	_	0	SENT_160	[p9l1656t2409r1837b2478],
9	12	CD	DURATION	12	num	10	SENT_160	[p9l1871t2408r1939b2463],
10	weeks	NNS	NUMBER	week	prep_during	3	SENT_160	[p9l1971t2409r2148b2464],
11	on	IN	O	on	_	0	SENT_160	[p9l13t2510r79b2552],
12	triple	JJ	O	triple	amod	13	SENT_160	[p9l122t2498r268b2564],
13	therapy	NN	O	therapy	prep_on	3	SENT_160	[p9l310t2498r533b2565],
14	.	.	O	.	_	0	SENT_160	[p9l310t2498r533b2565],

1	The	DT	O	the	det	3	SENT_161	[p9l576t2498r676b2552],
2	49	CD	NUMBER	49	num	3	SENT_161	[p9l720t2497r796b2552],
3	patients	NNS	O	patient	nsubjpass	15	SENT_161	[p9l844t2498r1074b2564],
4	with	IN	O	with	_	0	SENT_161	[p9l1115t2498r1228b2552],
5	CC	NN	O	cc	prep_with	3	SENT_161	[p9l1275t2497r1352b2552],
6	and	CC	O	and	_	0	SENT_161	[p9l1396t2498r1500b2552],
7	the	DT	O	the	det	8	SENT_161	[p9l1544t2498r1634b2552],
8	12	CD	NUMBER	12	nsubjpass	15	SENT_161	[p9l1685t2497r1753b2551],
9	with	IN	O	with	_	0	SENT_161	[p9l1798t2498r1911b2552],
10	CA/AA	NN	O	ca/aa	nn	11	SENT_161	[p9l1958t2497r2148b2564],
11	genotypes	NNS	O	genotype	prep_with	8	SENT_161	[p9l12t2589r307b2654],
12	at	IN	O	at	_	0	SENT_161	[p9l338t2589r393b2640],
13	rs1127354	NN	O	rs1127354	prep_at	11	SENT_161	[p9l423t2584r754b2640],
14	are	VBP	O	be	auxpass	15	SENT_161	[p9l786t2598r873b2640],
15	compared	VBN	O	compare	_	0	SENT_161	[p9l905t2585r1211b2652],
16	.	.	O	.	_	0	SENT_161	[p9l905t2585r1211b2652],

1	weeks	NNS	DURATION	week	nsubj	13	SENT_162	[p9l9t2815r223b2886],
2	without	IN	O	without	_	0	SENT_162	[p9l260t2815r550b2887],
3	telaprevir	NN	O	telaprevir	prep_without	1	SENT_162	[p9l589t2815r940b2910],
4	,	,	O	,	_	0	SENT_162	[p9l589t2815r940b2910],
5	in	IN	O	in	_	0	SENT_162	[p9l985t2820r1056b2885],
6	contrast	NN	O	contrast	prep_in	13	SENT_162	[p9l1096t2839r1402b2896],
7	,	,	O	,	_	0	SENT_162	[p9l1096t2839r1402b2896],
8	the	DT	O	the	det	10	SENT_162	[p9l1447t2815r1557b2886],
9	RBV	NN	O	rbv	nn	10	SENT_162	[p9l1599t2819r1783b2886],
10	dose	NN	O	dose	nsubj	13	SENT_162	[p9l1819t2815r1980b2887],
11	was	VBD	O	be	cop	13	SENT_162	[p9l2016t2845r2147b2886],
12	somewhat	RB	O	somewhat	advmod	13	SENT_162	[p9l13t2928r381b3000],
13	larger	JJR	O	larger	_	0	SENT_162	[p9l414t2928r618b3024],
14	in	IN	O	in	_	0	SENT_162	[p9l652t2933r723b2998],
15	patients	NNS	O	patient	prep_in	13	SENT_162	[p9l757t2933r1039b3023],
16	with	IN	O	with	_	0	SENT_162	[p9l1071t2928r1237b3000],
17	CC	NN	O	cc	prep_with	15	SENT_162	[p9l1272t2931r1402b3000],
18	than	IN	O	than	mark	21	SENT_162	[p9l1438t2928r1601b2999],
19	CA/AA	NN	O	ca/aa	nn	20	SENT_162	[p9l1636t2930r1913b3000],
20	genotypes	NNS	O	genotype	nsubj	21	SENT_162	[p9l1944t2957r2147b3024, p9l13t3066r195b3137],
21	(	VBP	O	(	advcl	13	SENT_162	[p9l237t3043r354b3128],
22	47	CD	NUMBER	47	dobj	21	SENT_162	[p9l237t3043r354b3128],
23	i	FW	O	i	dep	22	SENT_162	[p9l397t3051r456b3109],
24	24	CD	PERCENT	24	number	25	SENT_162	[p9l502t3043r674b3116],
25	%	NN	PERCENT	%	amod	23	SENT_162	[p9l502t3043r674b3116],
26	VS.	NNP	O	VS.	dep	22	SENT_162	[p9l709t3072r798b3114],
27	43	CD	NUMBER	43	num	26	SENT_162	[p9l838t3043r927b3118],
28	i	FW	O	i	dep	26	SENT_162	[p9l974t3051r1032b3109],
29	20	CD	PERCENT	20	number	30	SENT_162	[p9l1079t3048r1272b3124],
30	%	NN	PERCENT	%	amod	28	SENT_162	[p9l1079t3048r1272b3124],
31	,	,	O	,	_	0	SENT_162	[p9l1079t3048r1272b3124],
32	P	NN	O	p	appos	22	SENT_162	[p9l1309t3047r1369b3113],
33	=	JJ	O	=	amod	35	SENT_162	[p9l1399t3076r1464b3099],
34	0.649	CD	NUMBER	0.649	tmod	33	SENT_162	[p9l1506t3043r1764b3128],
35	)	NN	O	)	dep	32	SENT_162	[p9l1506t3043r1764b3128],
36	.	.	O	.	_	0	SENT_162	[p9l1506t3043r1764b3128],

1	The	DT	O	the	det	4	SENT_163	[p9l1802t3042r1951b3114],
2	total	JJ	O	total	amod	4	SENT_163	[p9l1986t3042r2147b3114],
3	RBV	NN	O	rbv	nn	4	SENT_163	[p9l14t3161r198b3228],
4	dose	NN	O	dose	nsubj	11	SENT_163	[p9l235t3156r395b3229],
5	during	IN	O	during	_	0	SENT_163	[p9l437t3156r681b3253],
6	24	CD	DURATION	24	num	7	SENT_163	[p9l720t3157r811b3227],
7	weeks	NNS	NUMBER	week	prep_during	4	SENT_163	[p9l851t3156r1064b3228],
8	on	IN	O	on	_	0	SENT_163	[p9l1108t3185r1200b3228],
9	therapy	NN	O	therapy	prep_on	7	SENT_163	[p9l1242t3156r1518b3251],
10	was	VBD	O	be	cop	11	SENT_163	[p9l1552t3186r1682b3228],
11	comparable	JJ	O	comparable	_	0	SENT_163	[p9l1726t3156r2148b3251],
12	between	IN	O	between	_	0	SENT_163	[p9l13t3270r311b3342],
13	the	DT	O	the	det	15	SENT_163	[p9l351t3270r463b3341],
14	49	CD	NUMBER	49	num	15	SENT_163	[p9l502t3271r592b3346],
15	patients	NNS	O	patient	prep_between	11	SENT_163	[p9l635t3275r918b3365],
16	with	IN	O	with	_	0	SENT_163	[p9l956t3270r1122b3342],
17	CC	NN	O	cc	prep_with	11	SENT_163	[p9l1162t3273r1292b3342],
18	and	CC	O	and	_	0	SENT_163	[p9l1333t3270r1468b3342],
19	the	DT	O	the	det	20	SENT_163	[p9l1508t3270r1619b3341],
20	12	CD	NUMBER	12	prep_with	11	SENT_163	[p9l1668t3277r1750b3340],
21	with	IN	O	with	_	0	SENT_163	[p9l1789t3270r1954b3342],
22	CA	NNP	O	CA	prep_with	11	SENT_163	[p9l1995t3272r2147b3342],
23	/	:	O	/	punct	26	SENT_163	[p9l1995t3272r2147b3342],
24	AA	NN	O	aa	nn	25	SENT_163	[p9l7t3388r133b3455],
25	genotypes	NNS	O	genotype	nsubj	26	SENT_163	[p9l169t3408r528b3480],
26	(	VBP	O	(	dep	22	SENT_163	[p9l574t3385r689b3470],
27	49	CD	NUMBER	49	dobj	26	SENT_163	[p9l574t3385r689b3470],
28	i	FW	O	i	dep	27	SENT_163	[p9l740t3393r798b3451],
29	17	CD	PERCENT	17	num	30	SENT_163	[p9l858t3390r1021b3460],
30	%	NN	PERCENT	%	dep	33	SENT_163	[p9l858t3390r1021b3460],
31	Vs.	NN	O	v.	dep	30	SENT_163	[p9l1061t3414r1150b3456],
32	54	CD	NUMBER	54	dep	33	SENT_163	[p9l1198t3385r1286b3461],
33	i	FW	O	i	dep	27	SENT_163	[p9l1334t3393r1393b3451],
34	18	CD	PERCENT	18	num	35	SENT_163	[p9l1453t3390r1637b3466],
35	%	NN	PERCENT	%	dep	33	SENT_163	[p9l1453t3390r1637b3466],
36	,	,	O	,	_	0	SENT_163	[p9l1453t3390r1637b3466],
37	P	NN	O	p	dep	26	SENT_163	[p9l1679t3389r1739b3454],
38	=	JJ	O	=	amod	37	SENT_163	[p9l1774t3418r1839b3441],
39	0.531	CD	NUMBER	0.531	num	40	SENT_163	[p9l1885t3385r2143b3470],
40	)	NN	O	)	dep	37	SENT_163	[p9l1885t3385r2143b3470],
41	.	.	O	.	_	0	SENT_163	[p9l1885t3385r2143b3470],

1	In	IN	O	in	_	0	SENT_164	[p9l13t3503r90b3569],
2	patients	NNS	O	patient	prep_in	13	SENT_164	[p9l138t3503r420b3594],
3	with	IN	O	with	_	0	SENT_164	[p9l467t3498r632b3570],
4	the	DT	O	the	det	6	SENT_164	[p9l680t3498r791b3570],
5	CC	NN	O	cc	nn	6	SENT_164	[p9l840t3502r970b3570],
6	genotype	NN	O	genotype	prep_with	2	SENT_164	[p9l1019t3522r1367b3595],
7	,	,	O	,	_	0	SENT_164	[p9l1019t3522r1367b3595],
8	the	DT	O	the	det	10	SENT_164	[p9l1420t3498r1532b3570],
9	RBV	NN	O	rbv	nn	10	SENT_164	[p9l1581t3503r1766b3570],
10	dose	NN	O	dose	nsubj	13	SENT_164	[p9l1811t3498r1970b3571],
11	was	VBD	O	be	cop	13	SENT_164	[p9l2015t3528r2147b3570],
12	no	RB	O	no	advmod	13	SENT_164	[p9l13t3641r104b3684],
13	different	JJ	O	different	_	0	SENT_164	[p9l142t3612r452b3685],
14	between	IN	O	between	_	0	SENT_164	[p9l486t3612r785b3684],
15	those	DT	O	those	prep_between	13	SENT_164	[p9l821t3612r1009b3684],
16	who	WP	O	who	nsubj	17	SENT_164	[p9l1042t3612r1199b3684],
17	achieved	VBD	O	achieve	rcmod	15	SENT_164	[p9l1237t3612r1548b3685],
18	SVR	NNP	ORGANIZATION	SVR	dobj	17	SENT_164	[p9l1584t3615r1758b3684],
19	and	CC	O	and	_	0	SENT_164	[p9l1790t3612r1924b3685],
20	those	DT	O	those	conj_and	18	SENT_164	[p9l1960t3612r2148b3684],
21	who	WP	O	who	nsubj	22	SENT_164	[p10l9t28r166b100],
22	did	VBD	O	do	rcmod	20	SENT_164	[p10l212t28r331b101],
23	not	RB	O	not	neg	25	SENT_164	[p10l374t53r497b100],
24	(	CD	NUMBER	(	num	25	SENT_164	[p10l544t29r659b114],
25	50	CD	NUMBER	50	iobj	22	SENT_164	[p10l544t29r659b114],
26	i	FW	O	i	dobj	22	SENT_164	[p10l713t37r771b96],
27	18	CD	PERCENT	18	number	28	SENT_164	[p10l835t34r997b102],
28	%	NN	PERCENT	%	amod	26	SENT_164	[p10l835t34r997b102],
29	VS.	NNP	O	VS.	dobj	22	SENT_164	[p10l1040t58r1129b100],
30	47	CD	NUMBER	47	num	29	SENT_164	[p10l1176t29r1269b105],
31	i	FW	O	i	dep	29	SENT_164	[p10l1321t37r1379b96],
32	13	CD	PERCENT	13	number	33	SENT_164	[p10l1442t34r1627b111],
33	%	NN	PERCENT	%	amod	29	SENT_164	[p10l1442t34r1627b111],
34	,	,	O	,	_	0	SENT_164	[p10l1442t34r1627b111],
35	P	NN	O	p	dobj	22	SENT_164	[p10l1672t33r1732b99],
36	=	JJ	O	=	amod	35	SENT_164	[p10l1770t62r1835b86],
37	0.728	CD	NUMBER	0.728	num	38	SENT_164	[p10l1885t29r2143b114],
38	)	NN	O	)	dep	36	SENT_164	[p10l1885t29r2143b114],
39	.	.	O	.	_	0	SENT_164	[p10l1885t29r2143b114],

1	The	DT	O	the	det	3	SENT_165	[p10l11t143r159b215],
2	RBV	NN	O	rbv	nn	3	SENT_165	[p10l215t148r400b215],
3	dose	NN	O	dose	nsubj	6	SENT_165	[p10l450t143r610b216],
4	did	VBD	O	do	aux	6	SENT_165	[p10l666t143r785b216],
5	not	RB	O	not	neg	6	SENT_165	[p10l839t168r962b215],
6	differ	VB	O	differ	conj_and	6	SENT_165	[p10l1016t143r1212b216],
7	either	CC	O	either	dep	6	SENT_165	[p10l1265t143r1470b215],
8	in	IN	O	in	_	0	SENT_165	[p10l1525t148r1595b214],
9	patients	NNS	O	patient	prep_in	6	SENT_165	[p10l1649t148r1931b238],
10	with	IN	O	with	_	0	SENT_165	[p10l1984t143r2149b215],
11	CA/AA	NN	O	ca/aa	nn	12	SENT_165	[p10l14t259r290b329],
12	genotypes	NNS	O	genotype	prep_with	6	SENT_165	[p10l334t281r693b353],
13	with	IN	O	with	_	0	SENT_165	[p10l738t257r903b329],
14	and	CC	O	and	_	0	SENT_165	[p10l949t257r1084b329],
15	without	IN	O	without	_	0	SENT_165	[p10l1126t257r1416b329],
16	SVR	NNP	O	SVR	prep_with	6	SENT_165	[p10l1463t260r1637b328],
17	(	CD	NUMBER	(	num	16	SENT_165	[p10l1684t258r1801b343],
18	57	CD	NUMBER	57	dep	22	SENT_165	[p10l1684t258r1801b343],
19	i	FW	O	i	dep	18	SENT_165	[p10l1857t266r1916b324],
20	17	CD	PERCENT	17	num	21	SENT_165	[p10l1983t263r2146b333],
21	%	NN	PERCENT	%	dep	22	SENT_165	[p10l1983t263r2146b333],
22	VS.	NNP	O	VS.	dep	6	SENT_165	[p10l10t402r99b444],
23	48	CD	NUMBER	48	num	22	SENT_165	[p10l138t373r228b444],
24	i	FW	O	i	dep	22	SENT_165	[p10l275t381r333b440],
25	20	CD	PERCENT	20	number	26	SENT_165	[p10l379t378r573b454],
26	%	NN	PERCENT	%	amod	24	SENT_165	[p10l379t378r573b454],
27	,	,	O	,	_	0	SENT_165	[p10l379t378r573b454],
28	P	NN	O	p	appos	24	SENT_165	[p10l610t377r669b443],
29	=	JJ	O	=	amod	31	SENT_165	[p10l700t406r765b430],
30	0.368	CD	NUMBER	0.368	tmod	29	SENT_165	[p10l806t373r1064b458],
31	)	NN	O	)	dep	28	SENT_165	[p10l806t373r1064b458],
32	.	.	O	.	_	0	SENT_165	[p10l806t373r1064b458],

1	The	DT	O	the	det	3	SENT_166	[p10l109t487r260b559],
2	total	JJ	O	total	amod	3	SENT_166	[p10l301t487r467b559],
3	dose	NN	O	dose	_	0	SENT_166	[p10l510t487r674b560],
4	of	IN	O	of	_	0	SENT_166	[p10l715t487r800b559],
5	PEG	NN	O	peg	prep_of	3	SENT_166	[p10l829t491r1201b559],
6	.	.	O	.	_	0	SENT_166	[p10l829t491r1201b559],

1	—	NN	O	—	_	0	SENT_167	[p10l829t491r1201b559],
2	.	.	O	.	_	0	SENT_167	[p10l829t491r1201b559],

1	IFN	NN	ORGANIZATION	ifn	nsubj	3	SENT_168	[p10l829t491r1201b559],
2	was	VBD	O	be	cop	3	SENT_168	[p10l1240t517r1374b559],
3	comparable	JJ	O	comparable	_	0	SENT_168	[p10l1416t487r1850b582],
4	among	IN	O	among	_	0	SENT_168	[p10l1892t516r2150b583],
5	49	CD	NUMBER	49	num	6	SENT_168	[p10l12t602r103b677],
6	patients	NNS	O	patient	prep_among	3	SENT_168	[p10l157t606r448b696],
7	with	IN	O	with	_	0	SENT_168	[p10l497t601r666b673],
8	CC	NN	O	cc	prep_with	3	SENT_168	[p10l717t605r848b673],
9	and	CC	O	and	_	0	SENT_168	[p10l900t601r1037b673],
10	12	CD	NUMBER	12	nsubj	14	SENT_168	[p10l1095t608r1179b671],
11	with	IN	O	with	_	0	SENT_168	[p10l1228t601r1397b673],
12	CA/AA	NN	O	ca/aa	nn	13	SENT_168	[p10l1449t604r1730b673],
13	genotypes	NNS	O	genotype	prep_with	10	SENT_168	[p10l1777t625r2147b697],
14	(	VBP	O	(	conj_and	3	SENT_168	[p10l18t717r138b802],
15	87	CD	NUMBER	87	dobj	14	SENT_168	[p10l18t717r138b802],
16	i	FW	O	i	dep	21	SENT_168	[p10l189t725r247b783],
17	23	CD	PERCENT	23	num	18	SENT_168	[p10l299t722r472b792],
18	%	NN	PERCENT	%	dep	16	SENT_168	[p10l299t722r472b792],
19	Vs.	NN	O	v.	dep	21	SENT_168	[p10l514t746r606b788],
20	86	CD	NUMBER	86	num	19	SENT_168	[p10l655t718r745b787],
21	i	FW	O	i	dep	14	SENT_168	[p10l797t725r855b783],
22	20	CD	PERCENT	20	num	23	SENT_168	[p10l907t722r1081b790],
23	%	NN	PERCENT	%	dep	21	SENT_168	[p10l907t722r1081b790],
24	of	IN	O	of	_	0	SENT_168	[p10l1126t716r1210b787],
25	the	DT	O	the	det	26	SENT_168	[p10l1239t716r1353b787],
26	target	NN	O	target	prep_of	14	SENT_168	[p10l1395t740r1626b812],
27	,	,	O	,	_	0	SENT_168	[p10l1395t740r1626b812],
28	P	NN	O	p	appos	26	SENT_168	[p10l1669t721r1728b787],
29	=	JJ	O	=	amod	31	SENT_168	[p10l1765t750r1830b773],
30	0.488	CD	NUMBER	0.488	tmod	29	SENT_168	[p10l1877t717r2143b802],
31	)	NN	O	)	dep	28	SENT_168	[p10l1877t717r2143b802],
32	.	.	O	.	_	0	SENT_168	[p10l1877t717r2143b802],

1	The	DT	O	the	det	4	SENT_169	[p10l11t830r161b902],
2	total	JJ	O	total	amod	4	SENT_169	[p10l241t830r407b902],
3	telaprevir	NN	O	telaprevir	nn	4	SENT_169	[p10l486t830r837b925],
4	dose	NN	O	dose	nsubj	7	SENT_169	[p10l914t830r1078b903],
5	was	VBD	O	be	cop	7	SENT_169	[p10l1153t860r1286b902],
6	no	RB	O	no	advmod	7	SENT_169	[p10l1366t859r1458b902],
7	different	JJ	O	different	dep	11	SENT_169	[p10l1540t830r1860b903],
8	either	CC	O	either	dep	7	SENT_169	[p10l1937t830r2149b902],
9	between	IN	O	between	_	0	SENT_169	[p10l13t944r319b1016],
10	them	PRP	O	they	prep_between	7	SENT_169	[p10l355t945r546b1016],
11	(	VBP	O	(	_	0	SENT_169	[p10l588t946r708b1030],
12	87	CD	NUMBER	87	nsubj	13	SENT_169	[p10l588t946r708b1030],
13	i	FW	O	i	xcomp	11	SENT_169	[p10l753t954r811b1012],
14	27	CD	PERCENT	27	number	15	SENT_169	[p10l857t951r1032b1021],
15	%	NN	PERCENT	%	amod	13	SENT_169	[p10l857t951r1032b1021],
16	VS.	NNP	O	VS.	nsubj	11	SENT_169	[p10l1067t974r1159b1016],
17	71	CD	NUMBER	71	num	16	SENT_169	[p10l1200t952r1283b1021],
18	i	FW	O	i	dep	16	SENT_169	[p10l1338t954r1397b1012],
19	36	CD	PERCENT	36	number	20	SENT_169	[p10l1444t947r1616b1020],
20	%	NN	PERCENT	%	amod	18	SENT_169	[p10l1444t947r1616b1020],
21	of	IN	O	of	_	0	SENT_169	[p10l1656t944r1740b1016],
22	the	DT	O	the	det	23	SENT_169	[p10l1764t944r1878b1016],
23	target	NN	O	target	prep_of	18	SENT_169	[p10l1914t969r2144b1041],
24	,	,	O	,	_	0	SENT_169	[p10l1914t969r2144b1041],
25	P	NN	O	p	appos	23	SENT_169	[p10l11t1063r70b1129],
26	=	JJ	O	=	amod	28	SENT_169	[p10l109t1092r175b1116],
27	0.098	CD	NUMBER	0.098	tmod	26	SENT_169	[p10l223t1059r489b1144],
28	)	NN	O	)	dep	25	SENT_169	[p10l223t1059r489b1144],
29	.	.	O	.	_	0	SENT_169	[p10l223t1059r489b1144],

1	Telaprevir	NNP	O	Telaprevir	nsubjpass	3	SENT_170	[p10l537t1058r913b1154],
2	was	VBD	O	be	auxpass	3	SENT_170	[p10l954t1088r1088b1130],
3	discontinued	VBN	O	discontinue	dep	28	SENT_170	[p10l1134t1058r1619b1131],
4	in	IN	O	in	_	0	SENT_170	[p10l1664t1063r1736b1129],
5	10	CD	NUMBER	10	prep_in	3	SENT_170	[p10l1788t1065r1871b1130],
6	of	IN	O	of	_	0	SENT_170	[p10l1918t1058r2002b1130],
7	the	DT	O	the	det	9	SENT_170	[p10l2034t1058r2148b1130],
8	49	CD	PERCENT	49	number	9	SENT_170	[p10l12t1173r103b1248],
9	(	CD	PERCENT	(	prep_of	5	SENT_170	[p10l163t1174r391b1258],
10	20	CD	PERCENT	20	number	11	SENT_170	[p10l163t1174r391b1258],
11	%	NN	PERCENT	%	amod	9	SENT_170	[p10l163t1174r391b1258],
12	)	CD	NUMBER	)	num	13	SENT_170	[p10l163t1174r391b1258],
13	patients	NNS	O	patient	dep	5	SENT_170	[p10l448t1177r739b1268],
14	with	IN	O	with	_	0	SENT_170	[p10l788t1172r957b1244],
15	CC	NN	O	cc	prep_with	13	SENT_170	[p10l1009t1176r1140b1244],
16	and	CC	O	and	_	0	SENT_170	[p10l1192t1172r1329b1245],
17	5	CD	NUMBER	5	conj_and	5	SENT_170	[p10l1383t1178r1419b1249],
18	of	IN	O	of	_	0	SENT_170	[p10l1476t1172r1560b1244],
19	the	DT	O	the	det	21	SENT_170	[p10l1599t1173r1712b1244],
20	12	CD	NUMBER	12	num	21	SENT_170	[p10l1772t1180r1855b1243],
21	(	NN	O	(	prep_of	17	SENT_170	[p10l1913t1173r2141b1258],
22	42	CD	PERCENT	42	num	23	SENT_170	[p10l1913t1173r2141b1258],
23	%	NN	PERCENT	%	dep	21	SENT_170	[p10l1913t1173r2141b1258],
24	)	CD	NUMBER	)	num	21	SENT_170	[p10l1913t1173r2141b1258],
25	with	IN	O	with	_	0	SENT_170	[p10l9t1286r178b1358],
26	CA/AA	NN	O	ca/aa	nn	27	SENT_170	[p10l216t1289r498b1358],
27	genotypes	NNS	O	genotype	prep_with	3	SENT_170	[p10l531t1311r900b1383],
28	(	VBP	O	(	_	0	SENT_170	[p10l943t1288r1028b1372],
29	P	NN	O	p	nsubj	30	SENT_170	[p10l943t1288r1028b1372],
30	=	JJ	O	=	xcomp	28	SENT_170	[p10l1059t1320r1124b1344],
31	0.147	CD	NUMBER	0.147	num	32	SENT_170	[p10l1166t1287r1432b1372],
32	)	NN	O	)	nsubj	28	SENT_170	[p10l1166t1287r1432b1372],
33	.	.	O	.	_	0	SENT_170	[p10l1166t1287r1432b1372],

1	Decreases	VBZ	O	decrease	_	0	SENT_171	[p10l108t1405r491b1472],
2	in	IN	O	in	_	0	SENT_171	[p10l558t1405r636b1472],
3	Hemoglobin	NN	O	hemoglobin	prep_in	1	SENT_171	[p10l702t1400r1184b1496],
4	Levels	NNS	O	level	nsubj	1	SENT_171	[p10l1249t1400r1490b1472],
5	During	IN	O	during	_	0	SENT_171	[p10l1553t1405r1852b1496],
6	Tﬁple	JJ	O	tﬁple	amod	7	SENT_171	[p10l1923t1400r2153b1496],
7	T	NN	O	t	prep_during	1	SENT_171	[p10l23t1517r88b1585],
8	/	:	O	/	punct	9	SENT_171	[p10l75t1514r359b1611],
9	yempy	NN	O	yempy	dep	7	SENT_171	[p10l75t1514r359b1611],
10	.	.	O	.	_	0	SENT_171	[p10l75t1514r359b1611],

1	Figure	NN	O	figure	nsubj	3	SENT_172	[p10l408t1519r644b1611],
2	2	CD	NUMBER	2	num	1	SENT_172	[p10l692t1521r735b1585],
3	compares	VBZ	O	compare	_	0	SENT_172	[p10l787t1543r1138b1610],
4	decreases	NNS	O	decrease	dobj	3	SENT_172	[p10l1189t1515r1523b1587],
5	in	IN	O	in	_	0	SENT_172	[p10l1575t1519r1647b1585],
6	hemoglobin	NN	O	hemoglobin	nn	7	SENT_172	[p10l1695t1514r2148b1611],
7	levels	NNS	O	level	prep_in	4	SENT_172	[p10l12t1629r207b1700],
8	between	IN	O	between	_	0	SENT_172	[p10l253t1629r559b1700],
9	49	CD	NUMBER	49	num	10	SENT_172	[p10l602t1629r694b1704],
10	patients	NNS	O	patient	prep_between	7	SENT_172	[p10l740t1634r1032b1724],
11	with	IN	O	with	_	0	SENT_172	[p10l1074t1629r1243b1700],
12	CC	NN	O	cc	prep_with	10	SENT_172	[p10l1288t1632r1418b1700],
13	and	CC	O	and	_	0	SENT_172	[p10l1464t1629r1601b1701],
14	12	CD	NUMBER	12	prep_between	7	SENT_172	[p10l1652t1636r1736b1699],
15	with	IN	O	with	_	0	SENT_172	[p10l1778t1629r1948b1700],
16	CA	NNP	O	CA	prep_with	14	SENT_172	[p10l1992t1631r2147b1701],
17	/	:	O	/	punct	19	SENT_172	[p10l1992t1631r2147b1701],
18	AA	NN	O	aa	nn	19	SENT_172	[p10l7t1746r134b1813],
19	genotypes	NNS	O	genotype	dep	16	SENT_172	[p10l178t1767r547b1838],
20	of	IN	O	of	_	0	SENT_172	[p10l597t1742r682b1814],
21	the	DT	O	the	det	24	SENT_172	[p10l717t1742r831b1814],
22	I	PRP	O	I	nn	24	SENT_172	[p10l876t1747r920b1813],
23	TP/1	NN	O	tp/1	nn	24	SENT_172	[p10l923t1745r1077b1813],
24	gene	NN	O	gene	prep_of	19	SENT_172	[p10l1125t1771r1312b1838],
25	.	.	O	.	_	0	SENT_172	[p10l1125t1771r1312b1838],

1	Data	NNS	O	datum	nsubjpass	6	SENT_173	[p10l1366t1747r1549b1814],
2	of	IN	O	of	_	0	SENT_173	[p10l1595t1742r1679b1814],
3	six	CD	NUMBER	six	num	4	SENT_173	[p10l1714t1747r1811b1814],
4	patients	NNS	O	patient	prep_of	1	SENT_173	[p10l1855t1747r2147b1837],
5	were	VBD	O	be	auxpass	6	SENT_173	[p10l9t1885r183b1928],
6	omitted	VBN	O	omit	_	0	SENT_173	[p10l221t1856r516b1929],
7	because	IN	O	because	mark	12	SENT_173	[p10l553t1857r835b1929],
8	the	DT	O	the	det	10	SENT_173	[p10l873t1857r987b1928],
9	triple	JJ	O	triple	amod	10	SENT_173	[p10l1025t1856r1221b1952],
10	therapy	NN	O	therapy	nsubjpass	12	SENT_173	[p10l1260t1857r1542b1952],
11	was	VBD	O	be	auxpass	12	SENT_173	[p10l1573t1886r1706b1928],
12	withdrawn	VBN	O	withdraw	advcl	6	SENT_173	[p10l1741t1856r2148b1929],
13	4-10	CD	NUMBER	4-10	num	14	SENT_173	[p10l12t1971r185b2042],
14	weeks	NNS	NUMBER	week	tmod	12	SENT_173	[p10l224t1971r442b2042],
15	after	IN	O	after	_	0	SENT_173	[p10l485t1971r651b2042],
16	the	DT	O	the	det	17	SENT_173	[p10l690t1971r804b2042],
17	start	NN	O	start	prep_after	12	SENT_173	[p10l845t1995r1024b2052],
18	,	,	O	,	_	0	SENT_173	[p10l845t1995r1024b2052],
19	including	VBG	O	include	_	0	SENT_173	[p10l1069t1971r1427b2067],
20	ﬁve	NN	O	ﬁve	prep_including	12	SENT_173	[p10l1465t1971r1593b2042],
21	with	IN	O	with	_	0	SENT_173	[p10l1630t1971r1799b2042],
22	CC	NN	O	cc	prep_with	20	SENT_173	[p10l1839t1974r1970b2042],
23	and	CC	O	and	_	0	SENT_173	[p10l2012t1971r2149b2043],
24	one	CD	NUMBER	one	prep_including	12	SENT_173	[p10l13t2113r146b2155],
25	with	IN	O	with	_	0	SENT_173	[p10l196t2084r366b2156],
26	CA	NNP	O	CA	nn	27	SENT_173	[p10l419t2087r547b2155],
27	genotype	NN	O	genotype	prep_with	24	SENT_173	[p10l597t2108r955b2180],
28	.	.	O	.	_	0	SENT_173	[p10l597t2108r955b2180],

1	Hemoglobin	NN	O	hemoglobin	nsubj	2	SENT_174	[p10l1015t2084r1493b2180],
2	decreased	VBD	O	decrease	_	0	SENT_174	[p10l1547t2084r1902b2156],
3	more	RBR	O	more	dobj	2	SENT_174	[p10l1956t2113r2148b2155],
4	in	IN	O	in	_	0	SENT_174	[p10l13t2203r85b2269],
5	patients	NNS	O	patient	prep_in	2	SENT_174	[p10l125t2203r416b2294],
6	with	IN	O	with	_	0	SENT_174	[p10l454t2198r623b2270],
7	CC	NN	O	cc	prep_with	5	SENT_174	[p10l665t2202r795b2270],
8	than	IN	O	than	_	0	SENT_174	[p10l836t2198r1002b2270],
9	CA/AA	NN	O	ca/aa	nn	10	SENT_174	[p10l1044t2201r1325b2270],
10	genotypes	NNS	O	genotype	prep_than	2	SENT_174	[p10l1362t2223r1731b2295],
11	at	IN	O	at	_	0	SENT_174	[p10l1773t2223r1840b2270],
12	week	NN	DURATION	week	prep_at	10	SENT_174	[p10l1875t2198r2067b2270],
13	2	CD	NUMBER	2	number	14	SENT_174	[p10l2103t2206r2146b2269],
14	(	CD	NUMBER	(	dep	33	SENT_174	[p10l18t2315r284b2399],
15	-1.63	CD	NUMBER	-1.63	dep	14	SENT_174	[p10l18t2315r284b2399],
16	:	:	O	:	_	0	SENT_174	[p10l343t2323r401b2381],
17	0.92	CD	NUMBER	0.92	dep	14	SENT_174	[p10l459t2321r623b2389],
18	Vs.	NNP	O	Vs.	dep	17	SENT_174	[p10l669t2344r760b2385],
19	-0.48	CD	NUMBER	-0.48	num	18	SENT_174	[p10l818t2314r1051b2385],
20	:	:	O	:	_	0	SENT_174	[p10l1110t2323r1169b2381],
21	0.75	CD	NUMBER	0.75	num	22	SENT_174	[p10l1227t2319r1388b2390],
22	g/dL	NN	O	g/dl	dep	14	SENT_174	[p10l1439t2314r1635b2410],
23	,	,	O	,	_	0	SENT_174	[p10l1439t2314r1635b2410],
24	P	NN	O	p	appos	22	SENT_174	[p10l1684t2318r1744b2384],
25	=	JJ	O	=	amod	27	SENT_174	[p10l1785t2347r1850b2371],
26	0.001	CD	NUMBER	0.001	tmod	25	SENT_174	[p10l1901t2315r2141b2399],
27	)	NN	O	)	dep	24	SENT_174	[p10l1901t2315r2141b2399],
28	and	CC	O	and	_	0	SENT_174	[p10l13t2428r150b2501],
29	week	NN	DURATION	week	conj_and	14	SENT_174	[p10l207t2428r399b2500],
30	4	CD	NUMBER	4	number	31	SENT_174	[p10l455t2429r499b2499],
31	(	CD	NUMBER	(	dep	29	SENT_174	[p10l566t2429r782b2514],
32	-3.5	CD	NUMBER	-3.5	dep	33	SENT_174	[p10l566t2429r782b2514],
33	i	FW	O	i	dep	37	SENT_174	[p10l857t2437r915b2496],
34	1.1	CD	NUMBER	1.1	dep	33	SENT_174	[p10l995t2435r1095b2500],
35	vs.	CC	O	vs.	prep	34	SENT_174	[p10l1162t2458r1254b2500],
36	-2.2	CD	NUMBER	-2.2	dep	35	SENT_174	[p10l1326t2435r1512b2500],
37	i	FW	O	i	dep	10	SENT_174	[p10l1584t2437r1642b2496],
38	0.96	CD	NUMBER	0.96	dep	37	SENT_174	[p10l1715t2430r1901b2510],
39	,	,	O	,	_	0	SENT_174	[p10l1715t2430r1901b2510],
40	P	NN	O	p	appos	10	SENT_174	[p10l1964t2433r2024b2499],
41	=	JJ	O	=	amod	43	SENT_174	[p10l2079t2462r2145b2485],
42	0.001	CD	NUMBER	0.001	tmod	41	SENT_174	[p10l14t2545r280b2629],
43	)	NN	O	)	dep	40	SENT_174	[p10l14t2545r280b2629],
44	.	.	O	.	_	0	SENT_174	[p10l14t2545r280b2629],

1	During	IN	O	during	_	0	SENT_175	[p10l367t2548r644b2640],
2	week	NN	DURATION	week	prep_during	8	SENT_175	[p10l719t2543r911b2615],
3	8	CD	NUMBER	8	num	2	SENT_175	[p10l991t2550r1030b2615],
4	through	IN	O	through	_	0	SENT_175	[p10l1115t2543r1415b2640],
5	12	CD	NUMBER	12	prep_through	2	SENT_175	[p10l1505t2550r1610b2625],
6	,	,	O	,	_	0	SENT_175	[p10l1505t2550r1610b2625],
7	hemoglobin	NN	O	hemoglobin	nsubj	8	SENT_175	[p10l1695t2543r2148b2640],
8	reached	VBD	O	reach	_	0	SENT_175	[p10l13t2658r298b2730],
9	the	DT	O	the	det	10	SENT_175	[p10l347t2658r461b2729],
10	nadir	NN	O	nadir	dobj	8	SENT_175	[p10l510t2658r706b2730],
11	of	IN	O	of	_	0	SENT_175	[p10l754t2658r838b2729],
12	approximately	RB	O	approximately	quantmod	13	SENT_175	[p10l876t2658r1415b2753],
13	-4	CD	NUMBER	-4	num	14	SENT_175	[p10l1466t2658r1580b2728],
14	g/dL	NN	O	g/dl	prep_of	10	SENT_175	[p10l1630t2658r1807b2754],
15	both	CC	O	both	dep	8	SENT_175	[p10l1854t2658r2027b2729],
16	in	IN	O	in	_	0	SENT_175	[p10l2076t2663r2148b2728],
17	patients	NNS	O	patient	prep_in	8	SENT_175	[p10l12t2776r303b2866],
18	with	IN	O	with	_	0	SENT_175	[p10l356t2771r525b2843],
19	CC	NN	O	cc	nn	22	SENT_175	[p10l579t2774r710b2843],
20	and	CC	O	and	_	0	SENT_175	[p10l765t2771r902b2843],
21	CA/AA	NN	O	ca/aa	conj_and	19	SENT_175	[p10l957t2773r1239b2843],
22	genotypes	NNS	O	genotype	prep_with	17	SENT_175	[p10l1289t2795r1679b2867],
23	.	.	O	.	_	0	SENT_175	[p10l1289t2795r1679b2867],

1	Thereafter	RB	O	thereafter	advmod	7	SENT_176	[p10l1737t2771r2144b2852],
2	,	,	O	,	_	0	SENT_176	[p10l1737t2771r2144b2852],
3	differences	NNS	O	difference	nsubj	7	SENT_176	[p10l13t2885r410b2958],
4	in	IN	O	in	_	0	SENT_176	[p10l472t2890r544b2956],
5	hemoglobin	NN	O	hemoglobin	nn	6	SENT_176	[p10l604t2885r1057b2982],
6	decrease	NN	O	decrease	prep_in	3	SENT_176	[p10l1117t2885r1422b2958],
7	started	VBD	O	start	_	0	SENT_176	[p10l1482t2885r1731b2958],
8	to	TO	O	to	aux	9	SENT_176	[p10l1791t2910r1861b2957],
9	widen	VB	O	widen	xcomp	7	SENT_176	[p10l1920t2885r2148b2958],
10	between	IN	O	between	_	0	SENT_176	[p10l13t2999r319b3070],
11	patients	NNS	O	patient	prep_between	9	SENT_176	[p10l363t3004r654b3094],
12	with	IN	O	with	_	0	SENT_176	[p10l698t2999r867b3070],
13	CC	NN	O	cc	nn	16	SENT_176	[p10l913t3002r1043b3070],
14	and	CC	O	and	_	0	SENT_176	[p10l1090t2999r1227b3071],
15	CA/AA	NN	O	ca/aa	nn	16	SENT_176	[p10l1273t3001r1554b3070],
16	genotypes	NNS	O	genotype	prep_with	11	SENT_176	[p10l1596t3023r1965b3095],
17	and	CC	O	and	_	0	SENT_176	[p10l2012t2999r2149b3071],
18	HEPATOLOGY	NN	O	hepatology	conj_and	16	SENT_176	[p10l1235t3122r1704b3180],
19	,	,	O	,	_	0	SENT_176	[p10l1235t3122r1704b3180],
20	February	NNP	DATE	February	prep_between	9	SENT_176	[p10l1735t3121r1977b3189],
21	2011	CD	DATE	2011	num	20	SENT_176	[p10l2001t3126r2133b3173],

1	were	VBD	O	be	cop	36	SENT_177	[p11l7t116r180b159],
2	signiﬁcant	NN	O	signiﬁcant	nn	36	SENT_177	[p11l226t87r609b183],
3	at	IN	O	at	_	0	SENT_177	[p11l653t111r720b159],
4	week	NN	DURATION	week	prep_at	2	SENT_177	[p11l760t87r951b159],
5	20	CD	NUMBER	20	num	4	SENT_177	[p11l992t94r1083b159],
6	(	CD	NUMBER	(	num	7	SENT_177	[p11l1136t88r1353b173],
7	-3.0	CD	NUMBER	-3.0	dep	2	SENT_177	[p11l1136t88r1353b173],
8	:	:	O	:	_	0	SENT_177	[p11l1410t96r1468b154],
9	1.2	CD	NUMBER	1.2	dep	2	SENT_177	[p11l1531t94r1639b158],
10	vs.	CC	O	vs.	prep	9	SENT_177	[p11l1683t117r1774b159],
11	-2.4	CD	NUMBER	-2.4	dep	10	SENT_177	[p11l1830t88r2016b158],
12	i	FW	O	i	dep	25	SENT_177	[p11l2071t96r2130b154],
13	0.88	CD	NUMBER	0.88	num	14	SENT_177	[p11l12t208r174b272],
14	g/dL	NN	O	g/dl	dep	12	SENT_177	[p11l220t201r416b297],
15	,	,	O	,	_	0	SENT_177	[p11l220t201r416b297],
16	P	NN	O	p	appos	14	SENT_177	[p11l460t206r519b271],
17	=	JJ	O	=	amod	19	SENT_177	[p11l557t235r622b258],
18	0.048	CD	NUMBER	0.048	tmod	17	SENT_177	[p11l669t202r908b287],
19	)	NN	O	)	dep	16	SENT_177	[p11l669t202r908b287],
20	and	CC	O	and	_	0	SENT_177	[p11l958t201r1094b273],
21	week	NN	DURATION	week	appos	14	SENT_177	[p11l1133t201r1324b272],
22	24	CD	NUMBER	24	number	23	SENT_177	[p11l1362t202r1455b271],
23	(	CD	NUMBER	(	dep	21	SENT_177	[p11l1503t202r1720b287],
24	-2.9	CD	NUMBER	-2.9	dep	25	SENT_177	[p11l1503t202r1720b287],
25	i	FW	O	i	dep	9	SENT_177	[p11l1775t210r1833b268],
26	1.1	CD	NUMBER	1.1	dep	25	SENT_177	[p11l1894t208r1994b272],
27	vs.	CC	O	vs.	prep	9	SENT_177	[p11l2043t231r2134b272],
28	-2.0	CD	NUMBER	-2.0	dep	27	SENT_177	[p11l16t323r201b388],
29	:	:	O	:	_	0	SENT_177	[p11l249t325r307b383],
30	0.85	CD	NUMBER	0.85	num	31	SENT_177	[p11l356t322r516b393],
31	g/dL	NN	O	g/dl	dep	2	SENT_177	[p11l557t316r753b412],
32	,	,	O	,	_	0	SENT_177	[p11l557t316r753b412],
33	P	NN	O	p	appos	31	SENT_177	[p11l792t321r851b386],
34	=	JJ	O	=	amod	36	SENT_177	[p11l883t350r948b373],
35	0.013	CD	NUMBER	0.013	tmod	34	SENT_177	[p11l989t317r1254b402],
36	)	NN	O	)	_	0	SENT_177	[p11l989t317r1254b402],
37	.	.	O	.	_	0	SENT_177	[p11l989t317r1254b402],

1	SVR	NN	ORGANIZATION	svr	nsubjpass	3	SENT_178	[p11l109t434r286b502],
2	was	VBD	O	be	auxpass	3	SENT_178	[p11l325t460r458b502],
3	achieved	VBN	O	achieve	dep	28	SENT_178	[p11l506t430r824b503],
4	by	IN	O	by	_	0	SENT_178	[p11l871t430r962b525],
5	35	CD	PERCENT	35	number	6	SENT_178	[p11l1005t436r1093b507],
6	(	CD	PERCENT	(	agent	3	SENT_178	[p11l1149t431r1377b516],
7	71	CD	PERCENT	71	num	8	SENT_178	[p11l1149t431r1377b516],
8	%	NN	PERCENT	%	dep	6	SENT_178	[p11l1149t431r1377b516],
9	)	CD	NUMBER	)	dep	6	SENT_178	[p11l1149t431r1377b516],
10	of	IN	O	of	_	0	SENT_178	[p11l1430t430r1514b502],
11	the	DT	O	the	det	13	SENT_178	[p11l1549t430r1663b502],
12	49	CD	NUMBER	49	num	13	SENT_178	[p11l1708t431r1799b506],
13	patients	NNS	O	patient	prep_of	9	SENT_178	[p11l1848t435r2138b525],
14	with	IN	O	with	_	0	SENT_178	[p11l7t544r176b616],
15	CC	NN	O	cc	prep_with	13	SENT_178	[p11l225t548r355b616],
16	and	CC	O	and	_	0	SENT_178	[p11l404t544r541b617],
17	8	CD	PERCENT	8	num	18	SENT_178	[p11l591t551r629b616],
18	(	NN	PERCENT	(	conj_and	6	SENT_178	[p11l686t545r914b630],
19	67	CD	PERCENT	67	num	20	SENT_178	[p11l686t545r914b630],
20	%	NN	PERCENT	%	rcmod	18	SENT_178	[p11l686t545r914b630],
21	)	CD	NUMBER	)	dobj	20	SENT_178	[p11l686t545r914b630],
22	of	IN	O	of	_	0	SENT_178	[p11l968t544r1053b616],
23	the	DT	O	the	det	24	SENT_178	[p11l1088t544r1202b616],
24	12	CD	NUMBER	12	prep_of	21	SENT_178	[p11l1258t551r1341b615],
25	with	IN	O	with	_	0	SENT_178	[p11l1388t544r1557b616],
26	CA/AA	NN	O	ca/aa	nn	27	SENT_178	[p11l1605t547r1886b616],
27	genotypes	NNS	O	genotype	prep_with	20	SENT_178	[p11l1931t573r2137b640, p11l11t682r197b753],
28	(	VBP	O	(	_	0	SENT_178	[p11l254t659r338b744],
29	P	NN	O	p	nsubj	30	SENT_178	[p11l254t659r338b744],
30	=	JJ	O	=	xcomp	28	SENT_178	[p11l382t692r448b715],
31	0.736	CD	NUMBER	0.736	num	32	SENT_178	[p11l502t659r768b744],
32	)	NN	O	)	nsubj	28	SENT_178	[p11l502t659r768b744],
33	.	.	O	.	_	0	SENT_178	[p11l502t659r768b744],

1	Hemoglobin	NN	O	hemoglobin	nn	2	SENT_179	[p11l823t658r1300b754],
2	levels	NNS	O	level	nsubj	5	SENT_179	[p11l1350t658r1544b730],
3	did	VBD	O	do	aux	5	SENT_179	[p11l1596t658r1717b731],
4	not	RB	O	not	neg	5	SENT_179	[p11l1767t682r1892b730],
5	differ	VB	O	differ	_	0	SENT_179	[p11l1941t658r2140b730],
6	between	IN	O	between	_	0	SENT_179	[p11l11t772r315b844],
7	them	PRP	O	they	prep_between	5	SENT_179	[p11l360t772r550b844],
8	24	CD	DURATION	24	num	9	SENT_179	[p11l595t773r687b843],
9	weeks	NNS	NUMBER	week	tmod	7	SENT_179	[p11l728t772r946b844],
10	after	IN	O	after	_	0	SENT_179	[p11l992t772r1157b844],
11	the	DT	O	the	det	12	SENT_179	[p11l1200t772r1314b844],
12	completion	NN	O	completion	prep_after	7	SENT_179	[p11l1358t772r1784b867],
13	of	IN	O	of	_	0	SENT_179	[p11l1828t772r1912b844],
14	triple	JJ	O	triple	amod	15	SENT_179	[p11l1944t772r2139b867],
15	therapy	NN	O	therapy	prep_of	12	SENT_179	[p11l11t886r293b982],
16	(	CD	NUMBER	(	number	17	SENT_179	[p11l343t888r611b972],
17	-0.57	CD	NUMBER	-0.57	dep	7	SENT_179	[p11l343t888r611b972],
18	i	FW	O	i	dep	17	SENT_179	[p11l668t896r727b954],
19	1.1	CD	NUMBER	1.1	dobj	5	SENT_179	[p11l793t894r893b958],
20	vs.	CC	O	vs.	prep	19	SENT_179	[p11l948t916r1039b958],
21	-0.17	CD	NUMBER	-0.17	dep	20	SENT_179	[p11l1098t894r1334b963],
22	i	FW	O	i	dep	21	SENT_179	[p11l1391t896r1450b954],
23	0.87	CD	NUMBER	0.87	num	24	SENT_179	[p11l1510t894r1674b963],
24	g/dL	NN	O	g/dl	dep	21	SENT_179	[p11l1723t886r1919b983],
25	,	,	O	,	_	0	SENT_179	[p11l1723t886r1919b983],
26	P	NN	O	p	appos	21	SENT_179	[p11l1969t891r2028b957],
27	=	JJ	O	=	amod	29	SENT_179	[p11l2071t920r2136b944],
28	0.271	CD	NUMBER	0.271	tmod	27	SENT_179	[p11l12t1001r277b1086],
29	)	NN	O	)	dep	26	SENT_179	[p11l12t1001r277b1086],
30	.	.	O	.	_	0	SENT_179	[p11l12t1001r277b1086],

1	Of	IN	O	of	_	0	SENT_180	[p11l333t1000r446b1072],
2	the	DT	O	the	det	4	SENT_180	[p11l483t1000r596b1071],
3	32	CD	NUMBER	32	num	4	SENT_180	[p11l647t1007r738b1076],
4	patients	NNS	O	patient	prep_of	21	SENT_180	[p11l788t1005r1078b1095],
5	with	IN	O	with	_	0	SENT_180	[p11l1125t1000r1294b1072],
6	TT	NN	O	tt	nn	7	SENT_180	[p11l1341t1002r1469b1071],
7	genotype	NN	O	genotype	prep_with	4	SENT_180	[p11l1517t1024r1855b1096],
8	of	IN	O	of	_	0	SENT_180	[p11l1905t1000r1989b1071],
9	the	DT	O	the	det	12	SENT_180	[p11l2026t1000r2139b1072],
10	[	CD	NUMBER	[	num	12	SENT_180	[p11l8t1119r251b1186],
11	L288	NN	O	l288	nn	12	SENT_180	[p11l8t1119r251b1186],
12	gene	NN	O	gene	prep_of	7	SENT_180	[p11l313t1143r481b1210],
13	at	IN	O	at	_	0	SENT_180	[p11l547t1138r613b1186],
14	rs8099917	NN	O	rs8099917	prep_at	12	SENT_180	[p11l678t1121r1099b1196],
15	,	,	O	,	_	0	SENT_180	[p11l678t1121r1099b1196],
16	30	CD	PERCENT	30	number	17	SENT_180	[p11l1170t1121r1260b1190],
17	(	CD	PERCENT	(	nsubj	21	SENT_180	[p11l1333t1115r1560b1200],
18	94	CD	PERCENT	94	num	19	SENT_180	[p11l1333t1115r1560b1200],
19	%	NN	PERCENT	%	dep	17	SENT_180	[p11l1333t1115r1560b1200],
20	)	CD	NUMBER	)	dep	17	SENT_180	[p11l1333t1115r1560b1200],
21	gained	VBD	O	gain	_	0	SENT_180	[p11l1632t1114r1877b1210],
22	SVR	NNP	O	SVR	dobj	21	SENT_180	[p11l1944t1118r2136b1196],
23	,	,	O	,	_	0	SENT_180	[p11l1944t1118r2136b1196],
24	more	RBR	O	more	advmod	25	SENT_180	[p11l11t1257r202b1300],
25	frequently	RB	O	frequently	advmod	21	SENT_180	[p11l253t1228r637b1324],
26	than	IN	O	than	mark	44	SENT_180	[p11l684t1228r850b1300],
27	10	CD	NUMBER	10	dep	34	SENT_180	[p11l908t1236r991b1300],
28	of	IN	O	of	_	0	SENT_180	[p11l1044t1228r1128b1300],
29	the	DT	O	the	det	31	SENT_180	[p11l1166t1228r1279b1300],
30	26	CD	PERCENT	26	num	31	SENT_180	[p11l1329t1231r1421b1300],
31	(	NN	PERCENT	(	prep_of	27	SENT_180	[p11l1478t1230r1705b1314],
32	38	CD	PERCENT	38	num	33	SENT_180	[p11l1478t1230r1705b1314],
33	%	NN	PERCENT	%	dep	34	SENT_180	[p11l1478t1230r1705b1314],
34	)	CD	NUMBER	)	dep	44	SENT_180	[p11l1478t1230r1705b1314],
35	with	IN	O	with	_	0	SENT_180	[p11l1759t1228r1927b1300],
36	TG	NN	O	tg	prep_with	34	SENT_180	[p11l1975t1230r2138b1300],
37	/	:	O	/	punct	42	SENT_180	[p11l1975t1230r2138b1300],
38	GG	NNS	O	gg	nn	39	SENT_180	[p11l12t1346r151b1414],
39	genotypes	NNS	O	genotype	dep	42	SENT_180	[p11l206t1366r574b1438],
40	(	CD	NUMBER	(	num	41	SENT_180	[p11l633t1343r717b1428],
41	P	NN	O	p	npadvmod	42	SENT_180	[p11l633t1343r717b1428],
42	<	JJR	O	<	dep	36	SENT_180	[p11l768t1359r827b1416],
43	0.001	CD	NUMBER	0.001	num	44	SENT_180	[p11l887t1343r1153b1428],
44	)	NN	O	)	dep	25	SENT_180	[p11l887t1343r1153b1428],
45	.	.	O	.	_	0	SENT_180	[p11l887t1343r1153b1428],

1	Likewise	RB	O	likewise	advmod	17	SENT_181	[p11l1211t1342r1551b1424],
2	,	,	O	,	_	0	SENT_181	[p11l1211t1342r1551b1424],
3	29	CD	NUMBER	29	nsubj	17	SENT_181	[p11l1608t1349r1699b1418],
4	of	IN	O	of	_	0	SENT_181	[p11l1755t1342r1839b1413],
5	the	DT	O	the	det	7	SENT_181	[p11l1880t1342r1993b1414],
6	30	CD	NUMBER	30	num	7	SENT_181	[p11l2047t1349r2137b1418],
7	(	NN	O	(	prep_of	3	SENT_181	[p11l15t1457r243b1542],
8	97	CD	PERCENT	97	number	9	SENT_181	[p11l15t1457r243b1542],
9	%	NN	PERCENT	%	amod	7	SENT_181	[p11l15t1457r243b1542],
10	)	CD	NUMBER	)	num	11	SENT_181	[p11l15t1457r243b1542],
11	patients	NNS	O	patient	dep	3	SENT_181	[p11l324t1461r614b1551],
12	with	IN	O	with	_	0	SENT_181	[p11l687t1456r856b1528],
13	CC	NN	O	cc	nn	14	SENT_181	[p11l931t1460r1061b1528],
14	genotype	NN	O	genotype	prep_with	11	SENT_181	[p11l1136t1481r1474b1552],
15	at	IN	O	at	_	0	SENT_181	[p11l1549t1481r1616b1528],
16	rs12979860	NN	O	rs12979860	prep_at	14	SENT_181	[p11l1689t1458r2137b1533],
17	achieved	VBD	O	achieve	dep	34	SENT_181	[p11l11t1570r330b1643],
18	SVR	NNP	ORGANIZATION	SVR	dobj	17	SENT_181	[p11l393t1574r585b1652],
19	,	,	O	,	_	0	SENT_181	[p11l393t1574r585b1652],
20	more	RBR	O	more	advmod	21	SENT_181	[p11l652t1599r844b1642],
21	frequently	RB	O	frequently	advmod	30	SENT_181	[p11l907t1570r1291b1666],
22	than	IN	O	than	_	0	SENT_181	[p11l1351t1571r1516b1642],
23	11	CD	NUMBER	11	prep_than	21	SENT_181	[p11l1587t1578r1663b1641],
24	of	IN	O	of	_	0	SENT_181	[p11l1735t1570r1819b1642],
25	the	DT	O	the	det	27	SENT_181	[p11l1870t1570r1983b1642],
26	27	CD	PERCENT	27	num	27	SENT_181	[p11l2046t1578r2139b1647],
27	(	NN	PERCENT	(	prep_of	23	SENT_181	[p11l15t1686r243b1771],
28	41	CD	PERCENT	41	num	29	SENT_181	[p11l15t1686r243b1771],
29	%	NN	PERCENT	%	dep	21	SENT_181	[p11l15t1686r243b1771],
30	)	CD	NUMBER	)	rcmod	18	SENT_181	[p11l15t1686r243b1771],
31	with	IN	O	with	_	0	SENT_181	[p11l283t1686r452b1757],
32	CT/TT	NN	O	ct/tt	nn	33	SENT_181	[p11l489t1688r778b1757],
33	genotypes	NNS	O	genotype	prep_with	17	SENT_181	[p11l813t1710r1181b1782],
34	(	VBP	O	(	_	0	SENT_181	[p11l1224t1687r1308b1771],
35	P	NN	O	p	dep	36	SENT_181	[p11l1224t1687r1308b1771],
36	<	JJR	O	<	dobj	34	SENT_181	[p11l1342t1703r1402b1760],
37	0.001	CD	NUMBER	0.001	num	38	SENT_181	[p11l1446t1687r1711b1771],
38	)	NN	O	)	nsubj	34	SENT_181	[p11l1446t1687r1711b1771],
39	.	.	O	.	_	0	SENT_181	[p11l1446t1687r1711b1771],

1	Factors	NNS	O	factor	_	0	SENT_182	[p11l106t1805r391b1872],
2	Inﬂuencing	VBG	O	inﬂuencing	partmod	1	SENT_182	[p11l479t1800r934b1896],
3	Decreases	NNS	O	decrease	dobj	2	SENT_182	[p11l1018t1805r1398b1872],
4	in	IN	O	in	_	0	SENT_182	[p11l1491t1805r1570b1872],
5	Hemoglobin	NN	O	hemoglobin	nn	6	SENT_182	[p11l1661t1800r2141b1896],
6	Levels	NNS	O	level	prep_in	3	SENT_182	[p11l8t1914r263b1986],
7	.	.	O	.	_	0	SENT_182	[p11l8t1914r263b1986],

1	Hemoglobin	NN	O	hemoglobin	nsubj	2	SENT_183	[p11l313t1914r790b2011],
2	decreased	VBD	O	decrease	_	0	SENT_183	[p11l850t1914r1204b1987],
3	<	JJR	O	<	amod	5	SENT_183	[p11l1269t1922r1423b1988],
4	11	CD	NUMBER	11	num	5	SENT_183	[p11l1269t1922r1423b1988],
5	g/dL	NN	O	g/dl	dobj	2	SENT_183	[p11l1492t1914r1669b2011],
6	at	IN	O	at	_	0	SENT_183	[p11l1727t1939r1794b1986],
7	week	NN	DURATION	week	prep_at	5	SENT_183	[p11l1848t1914r2039b1986],
8	4	CD	NUMBER	4	num	7	SENT_183	[p11l2094t1915r2138b1985],
9	during	IN	O	during	_	0	SENT_183	[p11l11t2029r261b2125],
10	the	DT	O	the	det	12	SENT_183	[p11l327t2029r440b2100],
11	triple	JJ	O	triple	amod	12	SENT_183	[p11l508t2029r704b2124],
12	therapy	NN	O	therapy	prep_during	2	SENT_183	[p11l772t2029r1054b2124],
13	in	IN	O	in	_	0	SENT_183	[p11l1118t2034r1190b2099],
14	27	CD	NUMBER	27	prep_in	12	SENT_183	[p11l1257t2036r1351b2105],
15	of	IN	O	of	_	0	SENT_183	[p11l1419t2029r1503b2100],
16	the	DT	O	the	det	18	SENT_183	[p11l1559t2029r1672b2100],
17	61	CD	NUMBER	61	num	18	SENT_183	[p11l1740t2031r1823b2100],
18	(	NN	O	(	prep_of	12	SENT_183	[p11l1906t2029r2133b2114],
19	44	CD	PERCENT	44	number	20	SENT_183	[p11l1906t2029r2133b2114],
20	%	NN	PERCENT	%	amod	18	SENT_183	[p11l1906t2029r2133b2114],
21	)	CD	NUMBER	)	num	22	SENT_183	[p11l1906t2029r2133b2114],
22	patients	NNS	O	patient	dep	12	SENT_183	[p11l10t2147r321b2237],
23	.	.	O	.	_	0	SENT_183	[p11l10t2147r321b2237],

1	Factors	NNS	O	factor	_	0	SENT_184	[p11l395t2147r658b2214],
2	for	IN	O	for	_	0	SENT_184	[p11l727t2142r833b2214],
3	hemoglobin	NN	O	hemoglobin	prep_for	1	SENT_184	[p11l899t2142r1350b2238],
4	<	JJR	O	<	amod	1	SENT_184	[p11l1425t2149r1659b2216],
5	11.0	CD	NUMBER	11.0	num	6	SENT_184	[p11l1425t2149r1659b2216],
6	g/dL	NN	O	g/dl	nsubj	9	SENT_184	[p11l1729t2142r1906b2238],
7	were	VBD	O	be	cop	9	SENT_184	[p11l1966t2171r2139b2214],
8	female	JJ	O	female	amod	9	SENT_184	[p11l11t2256r253b2328],
9	gender	NN	O	gender	dep	4	SENT_184	[p11l305t2256r571b2353],
10	,	,	O	,	_	0	SENT_184	[p11l305t2256r571b2353],
11	age	NN	O	age	npadvmod	12	SENT_184	[p11l627t2286r744b2353],
12	>	JJR	O	>	dep	4	SENT_184	[p11l801t2262r962b2333],
13	50	CD	DURATION	50	num	14	SENT_184	[p11l801t2262r962b2333],
14	years	NNS	NUMBER	year	tmod	12	SENT_184	[p11l1014t2285r1218b2351],
15	,	,	O	,	_	0	SENT_184	[p11l1014t2285r1218b2351],
16	body	NN	O	body	nn	17	SENT_184	[p11l1273t2256r1462b2351],
17	weight	NN	O	weight	appos	1	SENT_184	[p11l1506t2256r1758b2353],
18	<	JJR	O	<	dep	17	SENT_184	[p11l1814t2259r1975b2330],
19	60	CD	NUMBER	60	num	20	SENT_184	[p11l1814t2259r1975b2330],
20	kg	NN	O	kg	dep	18	SENT_184	[p11l2028t2256r2135b2353],
21	,	,	O	,	_	0	SENT_184	[p11l2028t2256r2135b2353],
22	BMI	NN	O	bmus	dep	23	SENT_184	[p11l12t2375r186b2441],
23	<	JJR	O	<	conj_and	18	SENT_184	[p11l230t2378r414b2452],
24	23	CD	NUMBER	23	dep	23	SENT_184	[p11l230t2378r414b2452],
25	,	,	O	,	_	0	SENT_184	[p11l230t2378r414b2452],
26	and	CC	O	and	_	0	SENT_184	[p11l455t2371r592b2443],
27	baseline	NN	O	baseline	nn	28	SENT_184	[p11l628t2371r921b2442],
28	hemoglobin	NN	O	hemoglobin	dep	18	SENT_184	[p11l957t2371r1409b2467],
29	<	JJR	O	<	conj_and	18	SENT_184	[p11l1451t2376r1610b2447],
30	15	CD	NUMBER	15	num	31	SENT_184	[p11l1451t2376r1610b2447],
31	g/dL	NN	O	g/dl	dep	29	SENT_184	[p11l1652t2371r1847b2467],
32	,	,	O	,	_	0	SENT_184	[p11l1652t2371r1847b2467],
33	as	RB	O	as	_	0	SENT_184	[p11l1889t2401r1954b2442],
34	well	RB	O	well	_	0	SENT_184	[p11l1989t2371r2139b2442],
35	as	IN	O	as	_	0	SENT_184	[p11l11t2514r76b2556],
36	the	DT	O	the	det	38	SENT_184	[p11l120t2484r233b2556],
37	CC	NN	O	cc	nn	38	SENT_184	[p11l278t2488r407b2556],
38	genotype	NN	O	genotype	conj_and	1	SENT_184	[p11l450t2509r788b2581],
39	of	IN	O	of	_	0	SENT_184	[p11l831t2484r915b2556],
40	the	DT	O	the	det	42	SENT_184	[p11l945t2484r1059b2556],
41	ITPA	NN	O	itpa	nn	42	SENT_184	[p11l1099t2487r1300b2555],
42	gene	NN	O	gene	prep_of	38	SENT_184	[p11l1341t2513r1529b2581],
43	,	,	O	,	_	0	SENT_184	[p11l1341t2513r1529b2581],
44	in	IN	O	in	_	0	SENT_184	[p11l1577t2489r1648b2555],
45	the	DT	O	the	det	47	SENT_184	[p11l1691t2484r1804b2556],
46	univariate	JJ	O	univariate	amod	47	SENT_184	[p11l1847t2489r2137b2557, p11l11t2623r114b2670],
47	analysis	NN	O	analysis	prep_in	42	SENT_184	[p11l172t2598r452b2693],
48	(	CD	NUMBER	(	num	49	SENT_184	[p11l517t2599r745b2684],
49	Table	NNP	O	Table	dep	42	SENT_184	[p11l517t2599r745b2684],
50	2	CD	NUMBER	2	number	51	SENT_184	[p11l803t2600r899b2684],
51	)	CD	NUMBER	)	dep	49	SENT_184	[p11l803t2600r899b2684],
52	.	.	O	.	_	0	SENT_184	[p11l803t2600r899b2684],

1	Of	IN	O	of	_	0	SENT_185	[p11l963t2598r1076b2670],
2	them	PRP	O	they	prep_of	21	SENT_185	[p11l1120t2598r1332b2680],
3	,	,	O	,	_	0	SENT_185	[p11l1120t2598r1332b2680],
4	female	JJ	O	female	amod	5	SENT_185	[p11l1394t2598r1637b2670],
5	gender	NN	O	gender	nsubj	21	SENT_185	[p11l1694t2598r1960b2695],
6	,	,	O	,	_	0	SENT_185	[p11l1694t2598r1960b2695],
7	age	NN	O	age	npadvmod	8	SENT_185	[p11l2022t2628r2139b2695],
8	>	JJR	O	>	amod	5	SENT_185	[p11l16t2717r177b2788],
9	50	CD	DURATION	50	num	10	SENT_185	[p11l16t2717r177b2788],
10	years	NNS	NUMBER	year	tmod	8	SENT_185	[p11l216t2740r420b2806],
11	,	,	O	,	_	0	SENT_185	[p11l216t2740r420b2806],
12	BMI	NN	O	bmus	npadvmod	13	SENT_185	[p11l465t2716r639b2782],
13	<	JJR	O	<	dep	8	SENT_185	[p11l685t2719r869b2793],
14	23	CD	NUMBER	23	dep	8	SENT_185	[p11l685t2719r869b2793],
15	,	,	O	,	_	0	SENT_185	[p11l685t2719r869b2793],
16	and	CC	O	and	_	0	SENT_185	[p11l913t2712r1050b2784],
17	the	DT	O	the	det	19	SENT_185	[p11l1089t2712r1202b2783],
18	CC	NN	O	cc	nn	19	SENT_185	[p11l1243t2715r1373b2783],
19	genotype	NN	O	genotype	conj_and	5	SENT_185	[p11l1413t2736r1751b2808],
20	remained	VBD	O	remain	cop	21	SENT_185	[p11l1791t2712r2140b2784],
21	significant	JJ	O	significant	_	0	SENT_185	[p11l10t2826r394b2923],
22	in	IN	O	in	_	0	SENT_185	[p11l459t2831r531b2897],
23	the	DT	O	the	det	25	SENT_185	[p11l596t2826r709b2898],
24	multivariate	JJ	O	multivariate	amod	25	SENT_185	[p11l775t2826r1224b2899],
25	analysis	NN	O	analysis	prep_in	21	SENT_185	[p11l1290t2826r1590b2921],
26	.	.	O	.	_	0	SENT_185	[p11l1290t2826r1590b2921],

1	Hemoglobin	NN	O	hemoglobin	nn	2	SENT_186	[p11l1662t2826r2139b2923],
2	levels	NNS	O	level	nsubj	3	SENT_186	[p11l10t2940r204b3011],
3	lowered	VBD	O	lower	_	0	SENT_186	[p11l251t2940r544b3012],
4	<	JJR	O	<	amod	6	SENT_186	[p11l594t2945r776b3016],
5	8.5	CD	NUMBER	8.5	num	6	SENT_186	[p11l594t2945r776b3016],
6	g/dL	NN	O	g/dl	dobj	3	SENT_186	[p11l827t2940r1004b3036],
7	during	IN	O	during	_	0	SENT_186	[p11l1048t2940r1298b3036],
8	the	DT	O	the	det	10	SENT_186	[p11l1342t2940r1456b3011],
9	triple	JJ	O	triple	amod	10	SENT_186	[p11l1501t2940r1698b3035],
10	therapy	NN	O	therapy	prep_during	6	SENT_186	[p11l1743t2940r2025b3035],
11	in	IN	O	in	_	0	SENT_186	[p11l2068t2945r2139b3010],
12	13	CD	NUMBER	13	prep_in	10	SENT_186	[p11l19t3061r101b3129],
13	of	IN	O	of	_	0	SENT_186	[p11l152t3054r236b3125],
14	the	DT	O	the	det	16	SENT_186	[p11l272t3054r386b3125],
15	61	CD	NUMBER	61	num	16	SENT_186	[p11l434t3056r517b3125],
16	(	NN	O	(	prep_of	6	SENT_186	[p11l579t3055r807b3140],
17	21	CD	PERCENT	21	num	18	SENT_186	[p11l579t3055r807b3140],
18	%	NN	PERCENT	%	tmod	3	SENT_186	[p11l579t3055r807b3140],
19	)	CD	NUMBER	)	num	20	SENT_186	[p11l579t3055r807b3140],
20	patients	NNS	O	patient	dep	18	SENT_186	[p11l860t3059r1171b3149],
21	.	.	O	.	_	0	SENT_186	[p11l860t3059r1171b3149],

1	Factors	NNS	O	factor	nsubj	23	SENT_187	[p11l1225t3059r1487b3125],
2	for	IN	O	for	_	0	SENT_187	[p11l1536t3054r1642b3125],
3	hemoglobin	NN	O	hemoglobin	prep_for	1	SENT_187	[p11l1688t3054r2139b3150],
4	<	JJR	O	<	amod	1	SENT_187	[p11l16t3174r199b3245],
5	8.5	CD	NUMBER	8.5	num	6	SENT_187	[p11l16t3174r199b3245],
6	g/dL	NN	O	g/dl	nsubj	9	SENT_187	[p11l254t3168r431b3264],
7	were	VBD	O	be	cop	9	SENT_187	[p11l473t3197r646b3240],
8	female	JJ	O	female	amod	9	SENT_187	[p11l697t3168r940b3240],
9	gender	NN	O	gender	dep	4	SENT_187	[p11l990t3168r1256b3264],
10	,	,	O	,	_	0	SENT_187	[p11l990t3168r1256b3264],
11	age	NN	O	age	npadvmod	12	SENT_187	[p11l1311t3198r1428b3264],
12	>	JJR	O	>	dep	4	SENT_187	[p11l1485t3170r1646b3242],
13	60	CD	DURATION	60	num	14	SENT_187	[p11l1485t3170r1646b3242],
14	years	NNS	NUMBER	year	tmod	12	SENT_187	[p11l1696t3197r1900b3262],
15	,	,	O	,	_	0	SENT_187	[p11l1696t3197r1900b3262],
16	body	NN	O	body	nn	17	SENT_187	[p11l1955t3168r2144b3262],
17	weight	NN	O	weight	dep	18	SENT_187	[p11l7t3283r259b3379],
18	<	JJR	O	<	appos	1	SENT_187	[p11l313t3285r474b3357],
19	60	CD	NUMBER	60	num	20	SENT_187	[p11l313t3285r474b3357],
20	kg	NN	O	kg	dep	18	SENT_187	[p11l526t3283r634b3379],
21	,	,	O	,	_	0	SENT_187	[p11l526t3283r634b3379],
22	BMI	NN	O	bmus	dep	23	SENT_187	[p11l689t3287r863b3354],
23	<	JJR	O	<	_	0	SENT_187	[p11l920t3290r1104b3364],
24	23	CD	NUMBER	23	dobj	23	SENT_187	[p11l920t3290r1104b3364],
25	,	,	O	,	_	0	SENT_187	[p11l920t3290r1104b3364],
26	and	CC	O	and	_	0	SENT_187	[p11l1158t3283r1295b3355],
27	baseline	NN	O	baseline	nn	28	SENT_187	[p11l1344t3283r1638b3354],
28	hemoglobin	NN	O	hemoglobin	dep	29	SENT_187	[p11l1688t3283r2139b3379],
29	<	JJR	O	<	dobj	23	SENT_187	[p11l16t3397r178b3470],
30	14	CD	NUMBER	14	num	31	SENT_187	[p11l16t3397r178b3470],
31	g/dL	NN	O	g/dl	dep	29	SENT_187	[p11l243t3396r420b3492],
32	in	IN	O	in	_	0	SENT_187	[p11l483t3401r554b3466],
33	the	DT	O	the	det	35	SENT_187	[p11l619t3396r732b3467],
34	univariate	JJ	O	univariate	amod	35	SENT_187	[p11l797t3401r1165b3468],
35	analysis	NN	O	analysis	prep_in	23	SENT_187	[p11l1230t3396r1510b3490],
36	(	CD	NUMBER	(	num	35	SENT_187	[p11l1580t3396r1810b3482],
37	Table	NNP	O	Table	nn	39	SENT_187	[p11l1580t3396r1810b3482],
38	3	CD	NUMBER	3	num	39	SENT_187	[p11l1875t3397r1969b3481],
39	)	NN	O	)	dep	35	SENT_187	[p11l1875t3397r1969b3481],
40	.	.	O	.	_	0	SENT_187	[p11l1875t3397r1969b3481],

1	Of	IN	O	of	_	0	SENT_188	[p11l2039t3396r2152b3468],

1	PEG	NN	O	peg	_	0	SENT_189	[p12l381t170r577b209],
2	—	CD	NUMBER	—	number	3	SENT_189	[p12l381t170r577b209],
3	|	CD	NUMBER	|	num	5	SENT_189	[p12l381t170r577b209],
4	Ft	NN	O	ft	nn	5	SENT_189	[p12l381t170r577b209],
5	~	NN	O	~	dep	1	SENT_189	[p12l381t170r577b209],
6	l	NN	O	l	tmod	5	SENT_189	[p12l381t170r577b209],
7	+	CC	O	+	_	0	SENT_189	[p12l599t183r621b208],
8	RBV	NN	O	rbv	conj_+	5	SENT_189	[p12l644t171r740b208],
9	+	CC	O	+	_	0	SENT_189	[p12l759t183r781b206],
10	Tel.	NN	O	tel.	nn	12	SENT_189	[p12l801t171r1021b218],
11	apretrir	NN	O	apretrir	nn	12	SENT_189	[p12l801t171r1021b218],
12	PE	NN	O	pe	conj_+	5	SENT_189	[p12l1464t170r1663b209],
13	}	CD	NUMBER	}	num	19	SENT_189	[p12l1464t170r1663b209],
14	Ge	NNP	O	Ge	nn	19	SENT_189	[p12l1464t170r1663b209],
15	|	CD	NUMBER	|	num	19	SENT_189	[p12l1464t170r1663b209],
16	Fl	NN	O	fl	nn	19	SENT_189	[p12l1464t170r1663b209],
17	'	''	O	'	_	0	SENT_189	[p12l1464t170r1663b209],
18	~	NN	O	~	nn	19	SENT_189	[p12l1464t170r1663b209],
19	l	NN	O	l	rcmod	12	SENT_189	[p12l1464t170r1663b209],
20	+	CC	O	+	cc	21	SENT_189	[p12l1679t180r1707b209],
21	HBU	NN	O	hbu	dep	1	SENT_189	[p12l1726t170r1826b209],

1	I	PRP	O	I	_	0	SENT_190	[p12l823t436r945b471],
2	.	.	O	.	_	0	SENT_190	[p12l823t436r945b471],

1	—	NN	O	—	_	0	SENT_191	[p12l823t436r945b471],
2	.	.	O	.	_	0	SENT_191	[p12l823t436r945b471],

1	I	PRP	O	I	_	0	SENT_192	[p12l823t436r945b471],
2	GE	NNP	O	GE	nn	5	SENT_192	[p12l964t436r1028b474],
3	Genotype	NNP	O	Genotype	nn	5	SENT_192	[p12l1042t436r1237b481],
4	(	NN	O	(	nn	5	SENT_192	[p12l1342t436r1381b481],
5	n	NN	O	n	dep	1	SENT_192	[p12l1342t436r1381b481],
6	:	:	O	:	_	0	SENT_192	[p12l1342t436r1381b481],
7	=	JJ	O	=	quantmod	9	SENT_192	[p12l1393t449r1420b468],
8	49	CD	NUMBER	49	number	9	SENT_192	[p12l1432t436r1496b481],
9	}	CD	NUMBER	}	dep	1	SENT_192	[p12l1432t436r1496b481],
10	Cl	NN	O	cl	dep	9	SENT_192	[p12l823t500r945b535],
11	“	CD	NUMBER	“	num	10	SENT_192	[p12l823t500r945b535],
12	--	:	O	--	_	0	SENT_192	[p12l823t500r945b535],
13	O	NN	O	o	dep	1	SENT_192	[p12l823t500r945b535],
14	GNAA	NN	O	gnaa	nn	15	SENT_192	[p12l964t497r1099b535],
15	Genotypes	NNS	O	genotype	dep	13	SENT_192	[p12l1112t497r1329b545],
16	.	.	O	.	_	0	SENT_192	[p12l1112t497r1329b545],

1	{	NN	O	{	nn	2	SENT_193	[p12l1342t496r1381b539],
2	nu	NN	O	nu	_	0	SENT_193	[p12l1342t496r1381b539],
3	=	JJ	O	=	amod	4	SENT_193	[p12l1394t509r1419b526],
4	12	CD	NUMBER	12	dep	2	SENT_193	[p12l1435t496r1496b541],
5	'	''	O	'	_	0	SENT_193	[p12l1435t496r1496b541],
6	}	SYM	O	}	dep	4	SENT_193	[p12l1435t496r1496b541],

1	I	PRP	O	I	nsubj	2	SENT_194	[p12l87t612r116b618],
2	.5	VBP	NUMBER	.5	_	0	SENT_194	[p12l119t596r132b628],
3	.	.	O	.	_	0	SENT_194	[p12l119t596r132b628],

1	oesreeses	NNS	O	oesreese	nsubj	5	SENT_195	[p12l7t1092r42b1303],
2	in	IN	O	in	_	0	SENT_195	[p12l7t1047r42b1079],
3	Hemegrehrin	NNP	O	Hemegrehrin	nn	4	SENT_195	[p12l7t785r52b1028],
4	Levels	NNS	O	level	prep_in	1	SENT_195	[p12l7t641r42b769],
5	{	VBP	O	{	_	0	SENT_195	[p12l7t515r52b628],
6	gl	NN	O	gl	dobj	5	SENT_195	[p12l7t515r52b628],
7	'	''	O	'	_	0	SENT_195	[p12l7t515r52b628],
8	-:1	CD	NUMBER	-:1	number	9	SENT_195	[p12l7t515r52b628],
9	ll	NN	O	ll	amod	6	SENT_195	[p12l7t515r52b628],
10	.	.	O	.	_	0	SENT_195	[p12l7t515r52b628],
11	]	SYM	O	]	dep	5	SENT_195	[p12l7t515r52b628],

1	I	PRP	O	I	_	0	SENT_196	[p12l87t813r116b820],
2	IN	IN	O	in	dep	1	SENT_196	[p12l116t794r138b830],
3	}	CD	NUMBER	}	pobj	2	SENT_196	[p12l116t794r138b830],

1	11	CD	NUMBER	11	number	2	SENT_197	[p12l209t1457r234b1492],
2	1	CD	NUMBER	1	num	3	SENT_197	[p12l292t1457r305b1492],
3	2	CD	NUMBER	2	_	0	SENT_197	[p12l365t1457r391b1492],
4	"	``	O	"	punct	3	SENT_197	[p12l365t1457r391b1492],
5	3	CD	NUMBER	3	number	6	SENT_197	[p12l442t1457r468b1492],
6	4	CD	NUMBER	4	num	10	SENT_197	[p12l522t1457r545b1492],
7	.5	NN	NUMBER	.5	nn	10	SENT_197	[p12l599t1457r625b1492],
8	B	NN	O	b	nn	10	SENT_197	[p12l679t1457r702b1492],
9	T	NN	O	t	nn	10	SENT_197	[p12l756t1457r781b1492],
10	E	NN	O	e	dep	3	SENT_197	[p12l833t1457r858b1492],
11	9	CD	NUMBER	9	num	12	SENT_197	[p12l912t1457r938b1492],
12	)	NN	O	)	dep	10	SENT_197	[p12l912t1457r938b1492],
13	10	CD	NUMBER	10	number	14	SENT_197	[p12l980t1457r1025b1492],
14	12	CD	NUMBER	12	dep	3	SENT_197	[p12l1137t1457r1183b1492],
15	14	CD	NUMBER	14	num	17	SENT_197	[p12l1294t1457r1339b1492],
16	“	NN	O	“	nn	17	SENT_197	[p12l1448t1457r1496b1492],
17	llE	NN	O	lle	dep	14	SENT_197	[p12l1448t1457r1496b1492],
18	-	:	O	-	_	0	SENT_197	[p12l1448t1457r1496b1492],
19	13	CD	DATE	13	number	20	SENT_197	[p12l1605t1457r1650b1492],
20	20	CD	DATE	20	dep	14	SENT_197	[p12l1758t1457r1807b1492],
21	22	CD	DATE	22	num	22	SENT_197	[p12l1915t1457r1963b1492],
22	24	CD	DATE	24	dep	20	SENT_197	[p12l2072t1457r2120b1492],

1	Weeks	NNS	DURATION	week	_	0	SENT_198	[p12l954t1518r1090b1553],
2	on	IN	O	on	_	0	SENT_198	[p12l1102t1527r1151b1553],
3	Trreartment	NN	O	trreartment	prep_on	1	SENT_198	[p12l1163t1518r1368b1553],

1	Number	NN	O	number	dep	34	SENT_199	[p12l16t1585r174b1621],
2	of	IN	O	of	prep	1	SENT_199	[p12l186t1585r222b1621],
3	patients	NNS	O	patient	dep	11	SENT_199	[p12l237t1585r391b1627],
4	[	CD	NUMBER	[	num	6	SENT_199	[p12l407t1585r605b1627],
5	telaprevir	NN	O	telaprevir	nn	6	SENT_199	[p12l407t1585r605b1627],
6	witltdrawnl	NN	O	witltdrawnl	dep	3	SENT_199	[p12l615t1585r830b1627],
7	GB	NN	O	gb	dep	11	SENT_199	[p12l16t1651r78b1690],
8	49	CD	NUMBER	49	num	7	SENT_199	[p12l199t1654r247b1690],
9	49	CD	NUMBER	49	num	11	SENT_199	[p12l353t1654r404b1690],
10	49	CD	NUMBER	49	num	11	SENT_199	[p12l509t1654r560b1690],
11	)	NN	O	)	dep	21	SENT_199	[p12l509t1654r560b1690],
12	43111	CD	NUMBER	43111	number	13	SENT_199	[p12l666t1651r781b1696],
13	}	CD	NUMBER	}	num	14	SENT_199	[p12l666t1651r781b1696],
14	4E	NN	O	4e	dep	11	SENT_199	[p12l823t1651r938b1696],
15	»	CD	NUMBER	»	num	16	SENT_199	[p12l823t1651r938b1696],
16	[	CD	NUMBER	[	dep	14	SENT_199	[p12l823t1651r938b1696],
17	EI	NN	O	eus	nn	21	SENT_199	[p12l823t1651r938b1696],
18	]	NN	O	]	nn	21	SENT_199	[p12l823t1651r938b1696],
19	l	NN	O	l	nn	21	SENT_199	[p12l823t1651r938b1696],
20	44	CD	NUMBER	44	num	21	SENT_199	[p12l979t1651r1093b1696],
21	{	NN	O	{	dep	29	SENT_199	[p12l979t1651r1093b1696],
22	'	''	O	'	_	0	SENT_199	[p12l979t1651r1093b1696],
23	1	CD	NUMBER	1	number	24	SENT_199	[p12l979t1651r1093b1696],
24	}	CD	NUMBER	}	dep	21	SENT_199	[p12l979t1651r1093b1696],
25	3915	CD	NUMBER	3915	num	27	SENT_199	[p12l1134t1651r1250b1696],
26	)	CD	NUMBER	)	num	27	SENT_199	[p12l1134t1651r1250b1696],
27	I14	NN	O	i14	dep	24	SENT_199	[p12l1291t1654r1339b1687],
28	44	CD	NUMBER	44	num	29	SENT_199	[p12l1448t1654r1496b1687],
29	4-1	CD	NUMBER	4-1	dep	2	SENT_199	[p12l1602t1654r1653b1687],
30	»	NN	O	»	dep	34	SENT_199	[p12l1602t1654r1653b1687],
31	44	CD	NUMBER	44	num	30	SENT_199	[p12l1758t1654r1810b1687],
32	44	CD	NUMBER	44	num	34	SENT_199	[p12l1915t1654r1964b1687],
33	44	CD	NUMBER	44	num	34	SENT_199	[p12l2072t1654r2120b1687],
34	GNAA	NN	O	gnaa	dep	39	SENT_199	[p12l16t1720r148b1759],
35	12	CD	NUMBER	12	number	36	SENT_199	[p12l202t1723r247b1758],
36	1.2	CD	NUMBER	1.2	dep	34	SENT_199	[p12l356t1723r404b1758],
37	12	CD	NUMBER	12	num	38	SENT_199	[p12l513t1723r560b1758],
38	11	CD	NUMBER	11	dep	36	SENT_199	[p12l669t1720r781b1765],
39	(	NN	O	(	dep	44	SENT_199	[p12l669t1720r781b1765],
40	0	CD	NUMBER	0	num	39	SENT_199	[p12l669t1720r781b1765],
41	)	NN	O	)	nn	44	SENT_199	[p12l669t1720r781b1765],
42	912	CD	NUMBER	912	num	44	SENT_199	[p12l848t1720r938b1765],
43	]	NN	O	]	nn	44	SENT_199	[p12l848t1720r938b1765],
44	E13	NN	O	e13	dep	51	SENT_199	[p12l1002t1720r1093b1765],
45	]	CD	NUMBER	]	num	46	SENT_199	[p12l1002t1720r1093b1765],
46	T141111	NN	TIME	t141111	dep	44	SENT_199	[p12l1160t1723r1333b1765],
47	11	CD	NUMBER	11	number	48	SENT_199	[p12l1451t1723r1490b1758],
48	11	CD	NUMBER	11	num	49	SENT_199	[p12l1605t1723r1644b1758],
49	11	CD	NUMBER	11	dep	46	SENT_199	[p12l1762t1723r1800b1758],
50	11	CD	NUMBER	11	num	51	SENT_199	[p12l1918t1723r1957b1758],
51	11	CD	NUMBER	11	_	0	SENT_199	[p12l2072t1723r2114b1758],

1	Fig	NN	O	fig	_	0	SENT_200	[p12l93t1870r187b1939],
2	.	.	O	.	_	0	SENT_200	[p12l93t1870r187b1939],

1	2	LS	NUMBER	2	_	0	SENT_201	[p12l236t1869r288b1924],
2	.	.	O	.	_	0	SENT_201	[p12l236t1869r288b1924],

1	Decreases	VBZ	O	decrease	_	0	SENT_202	[p12l334t1870r632b1925],
2	in	IN	O	in	_	0	SENT_202	[p12l678t1871r722b1924],
3	hemoglobin	NN	O	hemoglobin	nn	4	SENT_202	[p12l772t1870r1106b1939],
4	levels	NNS	O	level	prep_in	1	SENT_202	[p12l1156t1870r1315b1925],
5	during	IN	O	during	_	0	SENT_202	[p12l1359t1870r1540b1939],
6	triple	JJ	O	triple	amod	7	SENT_202	[p12l1579t1870r1724b1937],
7	therapy	NN	O	therapy	prep_during	1	SENT_202	[p12l1767t1870r1982b1938],
8	with	IN	O	with	_	0	SENT_202	[p12l2024t1870r2136b1925],
9	telaprevir	NN	O	telaprevir	prep_with	7	SENT_202	[p12l8t1959r289b2025],
10	,	,	O	,	_	0	SENT_202	[p12l8t1959r289b2025],
11	PEG	NN	O	peg	prep_during	1	SENT_202	[p12l326t1958r573b2022],
12	—	CD	NUMBER	—	number	13	SENT_202	[p12l326t1958r573b2022],
13	|	CD	NUMBER	|	num	14	SENT_202	[p12l326t1958r573b2022],
14	FN	NN	O	fn	dep	11	SENT_202	[p12l326t1958r573b2022],
15	,	,	O	,	_	0	SENT_202	[p12l326t1958r573b2022],
16	and	CC	O	and	_	0	SENT_202	[p12l608t1959r711b2013],
17	RBV	NN	O	rbv	conj_and	7	SENT_202	[p12l749t1959r871b2012],
18	.	.	O	.	_	0	SENT_202	[p12l749t1959r871b2012],

1	The	DT	O	the	det	3	SENT_203	[p12l902t1959r1002b2013],
2	49	CD	NUMBER	49	num	3	SENT_203	[p12l1034t1958r1109b2013],
3	patients	NNS	O	patient	nsubjpass	15	SENT_203	[p12l1145t1959r1374b2025],
4	with	IN	O	with	_	0	SENT_203	[p12l1403t1959r1515b2013],
5	CC	NN	O	cc	prep_with	3	SENT_203	[p12l1550t1958r1627b2013],
6	and	CC	O	and	_	0	SENT_203	[p12l1659t1959r1763b2013],
7	the	DT	O	the	det	8	SENT_203	[p12l1795t1959r1884b2013],
8	12	CD	NUMBER	12	nsubjpass	15	SENT_203	[p12l1923t1958r1990b2012],
9	with	IN	O	with	_	0	SENT_203	[p12l2024t1959r2136b2013],
10	CA/AA	NN	O	ca/aa	nn	11	SENT_203	[p12l11t2045r201b2113],
11	genotypes	NNS	O	genotype	prep_with	8	SENT_203	[p12l238t2050r531b2115],
12	at	IN	O	at	_	0	SENT_203	[p12l569t2050r625b2101],
13	rs1127354	NN	O	rs1127354	prep_at	11	SENT_203	[p12l661t2045r991b2101],
14	are	VBP	O	be	auxpass	15	SENT_203	[p12l1030t2059r1117b2101],
15	compared	VBN	O	compare	_	0	SENT_203	[p12l1156t2046r1461b2113],
16	.	.	O	.	_	0	SENT_203	[p12l1156t2046r1461b2113],

1	Patients	NNS	O	patient	nsubj	2	SENT_204	[p12l1505t2046r1732b2101],
2	evaluated	VBD	O	evaluate	dep	7	SENT_204	[p12l1770t2046r2046b2101],
3	at	IN	O	at	_	0	SENT_204	[p12l2087t2050r2143b2101],
4	each	DT	O	each	det	5	SENT_204	[p12l11t2134r145b2189],
5	timepoint	NN	O	timepoint	prep_at	2	SENT_204	[p12l188t2135r466b2201],
6	are	VBP	O	be	auxpass	7	SENT_204	[p12l507t2147r593b2189],
7	indicated	VBN	O	indicate	_	0	SENT_204	[p12l639t2134r901b2189],
8	below	IN	O	below	prep	7	SENT_204	[p12l950t2134r1125b2198],
9	,	,	O	,	_	0	SENT_204	[p12l950t2134r1125b2198],
10	with	IN	O	with	_	0	SENT_204	[p12l1170t2134r1282b2189],
11	the	DT	O	the	det	12	SENT_204	[p12l1325t2134r1415b2189],
12	number	NN	O	number	prep_with	7	SENT_204	[p12l1462t2134r1682b2189],
13	of	IN	O	of	_	0	SENT_204	[p12l1722t2133r1777b2189],
14	patients	NNS	O	patient	prep_of	12	SENT_204	[p12l1818t2135r2048b2201],
15	in	IN	O	in	_	0	SENT_204	[p12l2093t2135r2136b2188],
16	whom	WP	O	whom	rel	19	SENT_204	[p12l9t2223r175b2278],
17	telaprevir	NN	O	telaprevir	nsubjpass	19	SENT_204	[p12l233t2223r504b2290],
18	was	VBD	O	be	auxpass	19	SENT_204	[p12l556t2236r667b2278],
19	withdrawn	VBN	O	withdraw	rcmod	14	SENT_204	[p12l722t2223r1009b2278],
20	(	JJ	O	(	amod	21	SENT_204	[p12l1071t2222r1325b2290],
21	PEG	NN	O	peg	dobj	19	SENT_204	[p12l1071t2222r1325b2290],
22	—	CD	NUMBER	—	number	23	SENT_204	[p12l1071t2222r1325b2290],
23	|	CD	NUMBER	|	nsubjpass	7	SENT_204	[p12l1071t2222r1325b2290],
24	FN	NN	O	fn	nsubj	27	SENT_204	[p12l1071t2222r1325b2290],
25	and	CC	O	and	_	0	SENT_204	[p12l1386t2223r1490b2278],
26	RBV	NN	O	rbv	nsubj	27	SENT_204	[p12l1553t2223r1668b2277],
27	continued	VBD	O	continue	rcmod	23	SENT_204	[p12l1724t2223r2031b2290],
28	)	CD	NUMBER	)	dobj	27	SENT_204	[p12l1724t2223r2031b2290],
29	in	IN	O	in	_	0	SENT_204	[p12l2093t2223r2136b2277],
30	parentheses	NNS	O	parenthesis	prep_in	27	SENT_204	[p12l13t2310r380b2377],
31	.	.	O	.	_	0	SENT_204	[p12l13t2310r380b2377],

1	HEPATOLOGY	NNP	O	HEPATOLOGY	_	0	SENT_205	[p12l56t2453r276b2480],
2	,	,	O	,	_	0	SENT_205	[p12l56t2453r276b2480],
3	Vol	NNP	O	Vol	appos	1	SENT_205	[p12l289t2452r339b2476],
4	.	.	O	.	_	0	SENT_205	[p12l289t2452r339b2476],

1	53	CD	NUMBER	53	_	0	SENT_206	[p12l355t2454r393b2480],
2	,	,	O	,	_	0	SENT_206	[p12l355t2454r393b2480],
3	No.	NN	O	no.	appos	1	SENT_206	[p12l406t2453r453b2476],
4	2	CD	NUMBER	2	num	3	SENT_206	[p12l467t2454r489b2480],
5	,	,	O	,	_	0	SENT_206	[p12l467t2454r489b2480],
6	2011	CD	DATE	2011	num	9	SENT_206	[p12l503t2454r565b2476],
7	SUZUKI	NNP	O	SUZUKI	nn	9	SENT_206	[p12l1777t2453r1896b2476],
8	ET	NNP	O	ET	nn	9	SENT_206	[p12l1908t2453r1949b2476],
9	AL.	NNP	O	AL.	appos	1	SENT_206	[p12l1957t2453r2003b2476],
10	419	CD	NUMBER	419	dep	9	SENT_206	[p12l2056t2452r2104b2478],

1	Table	NNP	O	Table	_	0	SENT_207	[p12l70t2556r152b2585],
2	2	CD	NUMBER	2	dep	1	SENT_207	[p12l168t2556r197b2585],
3	.	.	O	.	_	0	SENT_207	[p12l168t2556r197b2585],

1	Univariate	NNP	O	Univariate	nn	4	SENT_208	[p12l218t2556r377b2585],
2	and	CC	O	and	_	0	SENT_208	[p12l393t2556r450b2585],
3	Multivariate	NNP	O	Multivariate	conj_and	1	SENT_208	[p12l468t2556r657b2585],
4	Analyses	NNS	O	analysis	nsubj	15	SENT_208	[p12l671t2556r810b2592],
5	of	IN	O	of	_	0	SENT_208	[p12l826t2555r856b2585],
6	Host	NNP	ORGANIZATION	Host	prep_of	4	SENT_208	[p12l872t2556r943b2585],
7	and	CC	O	and	_	0	SENT_208	[p12l958t2556r1014b2585],
8	Viral	JJ	O	viral	amod	9	SENT_208	[p12l1030t2556r1100b2585],
9	Factors	NNS	O	factor	conj_and	4	SENT_208	[p12l1118t2556r1232b2585],
10	Associated	VBN	O	associate	partmod	9	SENT_208	[p12l1246t2556r1419b2585],
11	with	IN	O	with	_	0	SENT_208	[p12l1435t2556r1500b2585],
12	Low	JJ	O	low	amod	14	SENT_208	[p12l1518t2556r1578b2585],
13	Hemoglobin	NN	O	hemoglobin	nn	14	SENT_208	[p12l1593t2556r1779b2592],
14	Levels	NNS	O	level	prep_with	10	SENT_208	[p12l1797t2556r1892b2585],
15	(	VBP	O	(	_	0	SENT_208	[p12l1908t2556r1945b2592],
16	<	JJR	O	<	dobj	15	SENT_208	[p12l1908t2556r1945b2592],
17	11.0	CD	NUMBER	11.0	dep	16	SENT_208	[p12l1963t2556r2033b2585],
18	g	NN	O	g	dep	15	SENT_208	[p12l2049t2556r2087b2592],
19	/	:	O	/	punct	18	SENT_208	[p12l2049t2556r2087b2592],

1	dL	NN	O	dl	_	0	SENT_209	[p12l824t2607r873b2642],
2	)	CD	NUMBER	)	dep	1	SENT_209	[p12l824t2607r873b2642],
3	at	IN	O	at	_	0	SENT_209	[p12l890t2608r922b2635],
4	Week	NN	DURATION	week	prep_at	2	SENT_209	[p12l935t2607r1021b2635],
5	4	CD	NUMBER	4	num	4	SENT_209	[p12l1035t2606r1055b2635],
6	of	IN	O	of	_	0	SENT_209	[p12l1071t2606r1101b2635],
7	Triple	JJ	O	triple	amod	11	SENT_209	[p12l1114t2607r1200b2642],
8	Therapy	NN	O	therapy	nn	11	SENT_209	[p12l1214t2607r1338b2642],
9	Univariate	NNP	O	Univariate	nn	11	SENT_209	[p12l836t2678r948b2698],
10	Analysis	NNP	O	Analysis	nn	11	SENT_209	[p12l958t2678r1049b2703],
11	Multivariate	NNP	O	Multivariate	prep_of	4	SENT_209	[p12l1694t2678r1826b2698],
12	Analysis	NN	O	analysis	dep	1	SENT_209	[p12l1836t2678r1927b2703],

1	Parameter	NN	O	parameter	dep	118	SENT_210	[p12l57t2740r171b2761],
2	OR	NN	O	or	dep	118	SENT_210	[p12l676t2740r707b2761],
3	(	CD	PERCENT	(	dep	118	SENT_210	[p12l718t2740r776b2765],
4	95	CD	PERCENT	95	dep	118	SENT_210	[p12l718t2740r776b2765],
5	%	NN	PERCENT	%	dep	118	SENT_210	[p12l718t2740r776b2765],
6	cl	NN	O	cl	dep	118	SENT_210	[p12l787t2740r818b2765],
7	)	CD	NUMBER	)	dep	118	SENT_210	[p12l787t2740r818b2765],
8	F	NN	O	f	dep	118	SENT_210	[p12l1175t2740r1190b2760],
9	OR	NN	O	or	dep	118	SENT_210	[p12l1562t2740r1593b2761],
10	(	CD	PERCENT	(	dep	118	SENT_210	[p12l1605t2740r1662b2765],
11	95	CD	PERCENT	95	dep	118	SENT_210	[p12l1605t2740r1662b2765],
12	%	NN	PERCENT	%	dep	118	SENT_210	[p12l1605t2740r1662b2765],
13	cl	NN	O	cl	dep	118	SENT_210	[p12l1673t2740r1705b2765],
14	)	CD	NUMBER	)	dep	118	SENT_210	[p12l1673t2740r1705b2765],
15	P	NN	O	p	dep	118	SENT_210	[p12l2060t2740r2075b2760],
16	Sex	NN	O	sex	dep	118	SENT_210	[p12l56t2804r98b2827],
17	(	CD	NUMBER	(	dep	118	SENT_210	[p12l111t2804r211b2832],
18	female	JJ	O	female	dep	118	SENT_210	[p12l111t2804r211b2832],
19	)	JJ	O	)	dep	118	SENT_210	[p12l111t2804r211b2832],
20	14.3	CD	NUMBER	14.3	dep	118	SENT_210	[p12l649t2804r703b2827],
21	(	NN	O	(	dep	118	SENT_210	[p12l717t2804r848b2832],
22	4.1	CD	NUMBER	4.1	dep	118	SENT_210	[p12l717t2804r848b2832],
23	—	CD	NUMBER	—	dep	118	SENT_210	[p12l717t2804r848b2832],
24	50.0	CD	NUMBER	50.0	dep	118	SENT_210	[p12l717t2804r848b2832],
25	)	NN	O	)	dep	118	SENT_210	[p12l717t2804r848b2832],
26	<	JJR	O	<	dep	118	SENT_210	[p12l1129t2809r1149b2828],
27	0.001	CD	NUMBER	0.001	dep	118	SENT_210	[p12l1164t2804r1236b2827],
28	29.41	CD	NUMBER	29.41	dep	118	SENT_210	[p12l1516t2804r1588b2827],
29	(	NN	O	(	dep	118	SENT_210	[p12l1603t2804r1751b2832],
30	3.8	CD	NUMBER	3.8	dep	118	SENT_210	[p12l1603t2804r1751b2832],
31	—	CD	NUMBER	—	dep	118	SENT_210	[p12l1603t2804r1751b2832],
32	250.0	CD	NUMBER	250.0	dep	118	SENT_210	[p12l1603t2804r1751b2832],
33	)	NN	O	)	dep	118	SENT_210	[p12l1603t2804r1751b2832],
34	0.001	CD	NUMBER	0.001	dep	118	SENT_210	[p12l2030t2804r2102b2827],
35	Age	NNP	O	Age	dep	118	SENT_210	[p12l55t2845r98b2874],
36	(	CD	NUMBER	(	dep	118	SENT_210	[p12l112t2845r144b2873],
37	>	JJR	O	>	dep	118	SENT_210	[p12l112t2845r144b2873],
38	50	CD	DURATION	50	dep	118	SENT_210	[p12l159t2845r190b2868],
39	years	NNS	NUMBER	year	dep	118	SENT_210	[p12l203t2845r274b2874],
40	)	CD	NUMBER	)	dep	118	SENT_210	[p12l203t2845r274b2874],
41	4.3	CD	NUMBER	4.3	dep	118	SENT_210	[p12l663t2845r703b2868],
42	(	NN	O	(	dep	118	SENT_210	[p12l717t2845r848b2873],
43	1.0	CD	NUMBER	1.0	dep	118	SENT_210	[p12l717t2845r848b2873],
44	—	CD	NUMBER	—	dep	118	SENT_210	[p12l717t2845r848b2873],
45	17.5	CD	NUMBER	17.5	dep	118	SENT_210	[p12l717t2845r848b2873],
46	)	NN	O	)	dep	118	SENT_210	[p12l717t2845r848b2873],
47	0.030	CD	NUMBER	0.030	dep	118	SENT_210	[p12l1164t2845r1237b2868],
48	7.3	CD	NUMBER	7.3	dep	118	SENT_210	[p12l1551t2845r1589b2868],
49	(	NN	O	(	dep	118	SENT_210	[p12l1603t2845r1734b2873],
50	1.1	CD	NUMBER	1.1	dep	118	SENT_210	[p12l1603t2845r1734b2873],
51	—	CD	NUMBER	—	dep	118	SENT_210	[p12l1603t2845r1734b2873],
52	47.6	CD	NUMBER	47.6	dep	118	SENT_210	[p12l1603t2845r1734b2873],
53	)	NN	O	)	dep	118	SENT_210	[p12l1603t2845r1734b2873],
54	0.039	CD	NUMBER	0.039	dep	118	SENT_210	[p12l2030t2845r2103b2868],
55	Body	NN	O	body	dep	118	SENT_210	[p12l57t2887r116b2916],
56	weight	NN	O	weight	dep	118	SENT_210	[p12l127t2887r205b2916],
57	(	NN	O	(	dep	118	SENT_210	[p12l217t2887r249b2915],
58	<	JJR	O	<	dep	118	SENT_210	[p12l217t2887r249b2915],
59	60	CD	NUMBER	60	dep	118	SENT_210	[p12l264t2886r295b2910],
60	kg	NN	O	kg	dep	118	SENT_210	[p12l309t2887r344b2916],
61	)	NN	O	)	dep	118	SENT_210	[p12l309t2887r344b2916],
62	11.5	CD	NUMBER	11.5	dep	118	SENT_210	[p12l649t2886r703b2910],
63	(	NN	O	(	dep	118	SENT_210	[p12l717t2886r848b2915],
64	3.4	CD	NUMBER	3.4	dep	118	SENT_210	[p12l717t2886r848b2915],
65	—	CD	NUMBER	—	dep	118	SENT_210	[p12l717t2886r848b2915],
66	3s	NNS	O	3	dep	118	SENT_210	[p12l717t2886r848b2915],
67	.2	NN	NUMBER	.2	dep	118	SENT_210	[p12l717t2886r848b2915],
68	)	NN	O	)	dep	118	SENT_210	[p12l717t2886r848b2915],
69	<	JJR	O	<	dep	118	SENT_210	[p12l1129t2891r1149b2911],
70	0.001	CD	NUMBER	0.001	dep	118	SENT_210	[p12l1164t2886r1236b2910],
71	Body	NN	O	body	dep	118	SENT_210	[p12l57t2928r116b2957],
72	mass	NN	O	mass	dep	118	SENT_210	[p12l129t2934r191b2952],
73	index	NN	O	index	dep	118	SENT_210	[p12l205t2928r268b2952],
74	(	NN	O	(	dep	118	SENT_210	[p12l280t2928r311b2957],
75	<	JJR	O	<	dep	118	SENT_210	[p12l280t2928r311b2957],
76	23	CD	NUMBER	23	dep	118	SENT_210	[p12l326t2928r368b2957],
77	)	NN	O	)	dep	118	SENT_210	[p12l326t2928r368b2957],
78	8.4	CD	NUMBER	8.4	dep	118	SENT_210	[p12l663t2928r704b2952],
79	(	CD	NUMBER	(	dep	118	SENT_210	[p12l717t2928r848b2957],
80	2.6-27	CD	NUMBER	2.6-27	dep	118	SENT_210	[p12l717t2928r848b2957],
81	.1	CD	NUMBER	.1	dep	118	SENT_210	[p12l717t2928r848b2957],
82	)	NN	O	)	dep	118	SENT_210	[p12l717t2928r848b2957],
83	<	JJR	O	<	dep	118	SENT_210	[p12l1129t2933r1149b2952],
84	0.001	CD	NUMBER	0.001	dep	118	SENT_210	[p12l1164t2928r1236b2952],
85	17.2	CD	NUMBER	17.2	dep	118	SENT_210	[p12l1535t2928r1589b2951],
86	(	NN	O	(	dep	118	SENT_210	[p12l1603t2928r1751b2957],
87	2.6	CD	NUMBER	2.6	dep	118	SENT_210	[p12l1603t2928r1751b2957],
88	—	CD	NUMBER	—	dep	118	SENT_210	[p12l1603t2928r1751b2957],
89	112.0	CD	NUMBER	112.0	dep	118	SENT_210	[p12l1603t2928r1751b2957],
90	)	NN	O	)	dep	118	SENT_210	[p12l1603t2928r1751b2957],
91	0.003	CD	NUMBER	0.003	dep	118	SENT_210	[p12l2030t2928r2103b2952],
92	Hemoglobin	NN	O	hemoglobin	dep	118	SENT_210	[p12l57t2969r199b2998],
93	(	NN	O	(	dep	118	SENT_210	[p12l213t2969r245b2997],
94	<	JJR	O	<	dep	118	SENT_210	[p12l213t2969r245b2997],
95	15g/dL	CD	NUMBER	15g/dl	dep	118	SENT_210	[p12l262t2969r359b2998],
96	)	NN	O	)	dep	118	SENT_210	[p12l262t2969r359b2998],
97	14.2	CD	NUMBER	14.2	dep	118	SENT_210	[p12l649t2969r702b2992],
98	(	NN	O	(	dep	118	SENT_210	[p12l717t2969r848b2997],
99	3.5	CD	NUMBER	3.5	dep	118	SENT_210	[p12l717t2969r848b2997],
100	—	CD	NUMBER	—	dep	118	SENT_210	[p12l717t2969r848b2997],
101	57.4	CD	NUMBER	57.4	dep	118	SENT_210	[p12l717t2969r848b2997],
102	)	NN	O	)	dep	118	SENT_210	[p12l717t2969r848b2997],
103	<	JJR	O	<	dep	118	SENT_210	[p12l1129t2973r1149b2993],
104	0.001	CD	NUMBER	0.001	dep	118	SENT_210	[p12l1164t2969r1236b2992],
105	ITPA	NN	O	itpa	dep	118	SENT_210	[p12l56t3010r104b3033],
106	gene	NN	O	gene	dep	118	SENT_210	[p12l117t3014r174b3039],
107	(	CD	NUMBER	(	dep	118	SENT_210	[p12l187t3010r229b3039],
108	CC	NN	O	cc	dep	118	SENT_210	[p12l187t3010r229b3039],
109	genotype	NN	O	genotype	dep	118	SENT_210	[p12l242t3010r360b3039],
110	)	CD	NUMBER	)	dep	118	SENT_210	[p12l242t3010r360b3039],
111	0.062	CD	NUMBER	0.062	dep	118	SENT_210	[p12l1164t3010r1236b3033],
112	36.8	CD	NUMBER	36.8	dep	118	SENT_210	[p12l1532t3010r1590b3033],
113	(	NN	O	(	dep	118	SENT_210	[p12l1603t3010r1751b3039],
114	2.5	CD	NUMBER	2.5	dep	118	SENT_210	[p12l1603t3010r1751b3039],
115	—	CD	NUMBER	—	dep	118	SENT_210	[p12l1603t3010r1751b3039],
116	550.2	CD	NUMBER	550.2	dep	118	SENT_210	[p12l1603t3010r1751b3039],
117	)	NN	O	)	dep	118	SENT_210	[p12l1603t3010r1751b3039],
118	0.009	CD	NUMBER	0.009	_	0	SENT_210	[p12l2030t3010r2103b3033],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_211	[p12l74t3116r438b3166],
2	:	:	O	:	_	0	SENT_211	[p12l74t3116r438b3166],
3	OR	NN	O	or	dep	1	SENT_211	[p12l470t3115r556b3173],
4	,	,	O	,	_	0	SENT_211	[p12l470t3115r556b3173],
5	odds	NNS	O	odds	nn	6	SENT_211	[p12l586t3116r712b3166],
6	ratio	NN	O	ratio	appos	3	SENT_211	[p12l741t3116r865b3173],
7	;	:	O	;	_	0	SENT_211	[p12l741t3116r865b3173],
8	CI	NN	O	ci	dep	1	SENT_211	[p12l896t3115r958b3173],
9	,	,	O	,	_	0	SENT_211	[p12l896t3115r958b3173],
10	confidence	NN	O	confidence	nn	11	SENT_211	[p12l989t3115r1270b3165],
11	level	NN	O	level	appos	8	SENT_211	[p12l1300t3116r1426b3165],
12	.	.	O	.	_	0	SENT_211	[p12l1300t3116r1426b3165],

1	them	PRP	O	they	nsubj	9	SENT_212	[p12l10t3334r222b3415],
2	,	,	O	,	_	0	SENT_212	[p12l10t3334r222b3415],
3	only	RB	O	only	advmod	9	SENT_212	[p12l275t3334r440b3428],
4	age	NN	O	age	nn	7	SENT_212	[p12l485t3364r603b3430],
5	and	CC	O	and	_	0	SENT_212	[p12l652t3334r789b3406],
6	body	NN	O	body	conj_and	4	SENT_212	[p12l835t3334r1026b3428],
7	weight	NN	O	weight	nsubj	9	SENT_212	[p12l1066t3334r1319b3430],
8	remained	VBD	O	remain	cop	9	SENT_212	[p12l1366t3334r1717b3406],
9	signiﬁcant	JJ	O	signiﬁcant	_	0	SENT_212	[p12l1764t3334r2150b3430],
10	in	IN	O	in	_	0	SENT_212	[p12l10t3453r82b3519],
11	the	DT	O	the	det	13	SENT_212	[p12l119t3448r233b3519],
12	multivariate	JJ	O	multivariate	amod	13	SENT_212	[p12l270t3448r722b3520],
13	analysis	NN	O	analysis	prep_in	9	SENT_212	[p12l759t3448r1061b3542],
14	.	.	O	.	_	0	SENT_212	[p12l759t3448r1061b3542],

1	Discussion	NN	O	discussion	_	0	SENT_213	[p12l14t3703r517b3788],

1	Anemia	NN	O	anemia	nsubj	5	SENT_214	[p13l102t86r394b154],
2	is	VBZ	O	be	cop	5	SENT_214	[p13l442t87r492b154],
3	a	DT	O	a	det	5	SENT_214	[p13l544t112r581b154],
4	substantial	JJ	O	substantial	amod	5	SENT_214	[p13l629t82r1014b155],
5	risk	NN	O	risk	_	0	SENT_214	[p13l1065t82r1197b154],
6	in	IN	O	in	_	0	SENT_214	[p13l1243t87r1314b153],
7	the	DT	O	the	det	8	SENT_214	[p13l1364t82r1476b154],
8	standard	NN	O	standard	prep_in	5	SENT_214	[p13l1525t82r1836b155],
9	of	IN	O	of	_	0	SENT_214	[p13l1886t82r1970b154],
10	care	NN	O	care	nn	11	SENT_214	[p13l2007t111r2149b154],
11	therapy	NN	O	therapy	prep_of	8	SENT_214	[p13l10t198r286b294],
12	with	IN	O	with	_	0	SENT_214	[p13l328t198r493b271],
13	PEG	NN	O	peg	prep_with	11	SENT_214	[p13l543t202r907b270],
14	.	.	O	.	_	0	SENT_214	[p13l543t202r907b270],

1	—	NN	O	—	_	0	SENT_215	[p13l543t202r907b270],
2	.	.	O	.	_	0	SENT_215	[p13l543t202r907b270],

1	IFN	NN	ORGANIZATION	ifn	dep	112	SENT_216	[p13l543t202r907b270],
2	and	CC	O	and	dep	112	SENT_216	[p13l956t198r1091b271],
3	RBV	NN	O	rbv	dep	112	SENT_216	[p13l1140t179r1427b270],
4	.4	CD	NUMBER	.4	dep	112	SENT_216	[p13l1140t179r1427b270],
5	’	CD	NUMBER	’	dep	112	SENT_216	[p13l1140t179r1427b270],
6	6	CD	NUMBER	6	dep	112	SENT_216	[p13l1140t179r1427b270],
7	Triphosphorylated	VBN	O	triphosphorylate	dep	112	SENT_216	[p13l1473t198r2150b294],
8	RBV	NN	O	rbv	dep	112	SENT_216	[p13l10t318r195b385],
9	accumulates	VBZ	O	accumulate	dep	112	SENT_216	[p13l220t313r662b386],
10	in	IN	O	in	dep	112	SENT_216	[p13l700t318r771b384],
11	erythrocytes	NNS	O	erythrocyte	dep	112	SENT_216	[p13l809t313r1246b408],
12	of	IN	O	of	dep	112	SENT_216	[p13l1286t313r1369b385],
13	patients	NNS	O	patient	dep	112	SENT_216	[p13l1392t318r1675b409],
14	who	WP	O	who	dep	112	SENT_216	[p13l1710t313r1867b385],
15	receive	VBP	O	receive	dep	112	SENT_216	[p13l1906t318r2149b385],
16	RBV	NN	MISC	rbv	dep	112	SENT_216	[p13l10t433r199b509],
17	,	,	O	,	_	0	SENT_216	[p13l10t433r199b509],
18	increasingly	RB	O	increasingly	dep	112	SENT_216	[p13l262t428r693b524],
19	with	IN	O	with	dep	112	SENT_216	[p13l744t428r910b500],
20	RBV	NN	O	rbv	dep	112	SENT_216	[p13l968t433r1153b499],
21	dose	NN	O	dose	dep	112	SENT_216	[p13l1208t428r1368b500],
22	and	CC	O	and	dep	112	SENT_216	[p13l1427t428r1561b500],
23	duration	NN	O	duration	dep	112	SENT_216	[p13l1620t428r1952b509],
24	,	,	O	,	_	0	SENT_216	[p13l1620t428r1952b509],
25	and	CC	O	and	dep	112	SENT_216	[p13l2015t428r2149b500],
26	causes	VBZ	O	cause	dep	112	SENT_216	[p13l10t573r229b615],
27	oxidative	JJ	O	oxidative	dep	112	SENT_216	[p13l281t543r607b615],
28	damage	NN	O	damage	dep	112	SENT_216	[p13l659t543r938b639],
29	to	TO	O	to	dep	112	SENT_216	[p13l990t567r1059b615],
30	erythrocyte	NN	O	erythrocyte	dep	112	SENT_216	[p13l1113t543r1521b637],
31	membranes	NNS	O	membrane	dep	112	SENT_216	[p13l1572t543r1994b615],
32	toward	IN	O	toward	dep	112	SENT_216	[p13l2047t567r2148b615, p13l6t657r188b730],
33	extravascular	JJ	O	extravascular	dep	112	SENT_216	[p13l240t657r704b730],
34	hemolysis	NN	O	hemolysis	dep	112	SENT_216	[p13l754t657r1110b752],
35	by	IN	O	by	dep	112	SENT_216	[p13l1164t657r1254b752],
36	the	DT	O	the	dep	112	SENT_216	[p13l1303t657r1414b729],
37	reticuloendothelial	JJ	O	reticuloendothelial	dep	112	SENT_216	[p13l1468t657r2148b730],
38	system	NN	O	system	dep	112	SENT_216	[p13l10t756r434b866],
39	.19	CD	NUMBER	.19	dep	112	SENT_216	[p13l10t756r434b866],
40	’20	CD	NUMBER	’20	dep	112	SENT_216	[p13l10t756r434b866],
41	Inosine	NN	O	inosine	dep	112	SENT_216	[p13l503t777r768b843],
42	triphosphate	NN	O	triphosphate	dep	112	SENT_216	[p13l837t772r1294b867],
43	accumulates	VBZ	O	accumulate	dep	112	SENT_216	[p13l1363t772r1804b844],
44	also	RB	O	also	dep	112	SENT_216	[p13l1873t772r2007b843],
45	in	IN	O	in	dep	112	SENT_216	[p13l2078t777r2149b842],
46	erythrocytes	NNS	O	erythrocyte	dep	112	SENT_216	[p13l10t886r448b980],
47	of	IN	O	of	dep	112	SENT_216	[p13l501t886r585b958],
48	individuals	NNS	O	individual	dep	112	SENT_216	[p13l624t886r1021b959],
49	who	WP	O	who	dep	112	SENT_216	[p13l1070t886r1227b958],
50	have	VBP	O	have	dep	112	SENT_216	[p13l1280t886r1444b958],
51	mutations	NNS	O	mutation	dep	112	SENT_216	[p13l1496t891r1863b959],
52	in	IN	O	in	dep	112	SENT_216	[p13l1916t891r1986b957],
53	the	DT	O	the	dep	112	SENT_216	[p13l2038t886r2149b958],
54	I	PRP	O	I	dep	112	SENT_216	[p13l7t1006r51b1072],
55	TPA	NN	O	tpa	dep	112	SENT_216	[p13l53t1004r206b1072],
56	gene	NN	O	gene	dep	112	SENT_216	[p13l243t1030r427b1098],
57	,	,	O	,	_	0	SENT_216	[p13l243t1030r427b1098],
58	and	CC	O	and	dep	112	SENT_216	[p13l469t1001r604b1074],
59	results	VBZ	O	result	dep	112	SENT_216	[p13l642t1001r867b1074],
60	in	IN	O	in	dep	112	SENT_216	[p13l907t1006r978b1072],
61	benign	JJ	O	benign	dep	112	SENT_216	[p13l1016t1001r1265b1098],
62	red	JJ	O	red	dep	112	SENT_216	[p13l1304t1001r1569b1074],
63	—	NN	O	—	dep	112	SENT_216	[p13l1304t1001r1569b1074],
64	cell	NN	O	cell	dep	112	SENT_216	[p13l1304t1001r1569b1074],
65	enzymopathy	NN	O	enzymopathy	dep	112	SENT_216	[p13l1608t986r2147b1097],
66	.8	CD	NUMBER	.8	dep	112	SENT_216	[p13l1608t986r2147b1097],
67	The	DT	O	the	dep	112	SENT_216	[p13l7t1117r156b1188],
68	expression	NN	O	expression	dep	112	SENT_216	[p13l216t1122r590b1212],
69	of	IN	O	of	dep	112	SENT_216	[p13l650t1117r733b1188],
70	ITPA	NN	O	itpa	dep	112	SENT_216	[p13l778t1120r976b1187],
71	is	VBZ	O	be	dep	112	SENT_216	[p13l1035t1122r1085b1188],
72	genetically	RB	O	genetically	dep	112	SENT_216	[p13l1145t1117r1531b1213],
73	controlled	VBN	O	control	dep	112	SENT_216	[p13l1586t1117r1957b1189],
74	and	CC	O	and	dep	112	SENT_216	[p13l2016t1117r2150b1189],
75	reduced	VBN	O	reduce	dep	112	SENT_216	[p13l10t1231r299b1304],
76	in	IN	O	in	dep	112	SENT_216	[p13l337t1236r408b1302],
77	individuals	NNS	O	individual	dep	112	SENT_216	[p13l448t1231r845b1304],
78	who	WP	O	who	dep	112	SENT_216	[p13l883t1231r1040b1303],
79	have	VBP	O	have	dep	112	SENT_216	[p13l1081t1231r1244b1303],
80	point	NN	O	point	dep	112	SENT_216	[p13l1283t1236r1481b1326],
81	mutations	NNS	O	mutation	dep	112	SENT_216	[p13l1519t1236r1886b1304],
82	in	IN	O	in	dep	112	SENT_216	[p13l1928t1236r1998b1302],
83	the	DT	O	the	dep	112	SENT_216	[p13l2038t1231r2149b1303],
84	I	PRP	O	I	dep	112	SENT_216	[p13l7t1350r51b1416],
85	TPA	NN	O	tpa	dep	112	SENT_216	[p13l53t1348r206b1416],
86	gene	NN	O	gene	dep	112	SENT_216	[p13l242t1330r551b1442],
87	.8	CD	NUMBER	.8	dep	112	SENT_216	[p13l242t1330r551b1442],
88	'11	CD	NUMBER	'11	dep	112	SENT_216	[p13l242t1330r551b1442],
89	As	IN	O	as	dep	112	SENT_216	[p13l589t1349r681b1417],
90	another	DT	O	another	dep	112	SENT_216	[p13l719t1345r998b1417],
91	achievement	NN	O	achievement	dep	112	SENT_216	[p13l1034t1345r1489b1417],
92	of	IN	O	of	dep	112	SENT_216	[p13l1524t1345r1608b1417],
93	GWAS	NNP	O	GWAS	dep	112	SENT_216	[p13l1632t1349r1889b1417],
94	in	IN	O	in	dep	112	SENT_216	[p13l1928t1350r1999b1416],
95	hepatology	NN	O	hepatology	dep	112	SENT_216	[p13l2034t1345r2148b1417, p13l9t1446r403b1559],
96	,21	CD	NUMBER	,21	dep	112	SENT_216	[p13l2034t1345r2148b1417, p13l9t1446r403b1559],
97	in	IN	O	in	dep	112	SENT_216	[p13l450t1467r521b1533],
98	the	DT	O	the	dep	112	SENT_216	[p13l560t1462r672b1534],
99	wake	NN	O	wake	dep	112	SENT_216	[p13l708t1462r894b1534],
100	of	IN	O	of	dep	112	SENT_216	[p13l933t1462r1016b1534],
101	polymorphisms	NNS	O	polymorphism	dep	112	SENT_216	[p13l1043t1462r1613b1558],
102	of	IN	O	of	dep	112	SENT_216	[p13l1655t1462r1738b1534],
103	the	DT	O	the	dep	112	SENT_216	[p13l1766t1462r1877b1534],
104	[	CD	NUMBER	[	dep	112	SENT_216	[p13l1914t1467r2153b1534],
105	L288	NN	O	l288	dep	112	SENT_216	[p13l1914t1467r2153b1534],
106	gene	NN	O	gene	dep	112	SENT_216	[p13l9t1607r174b1675],
107	that	WDT	O	that	dep	112	SENT_216	[p13l247t1578r391b1650],
108	inﬂuence	VBP	O	inﬂuence	dep	112	SENT_216	[p13l462t1578r793b1651],
109	the	DT	O	the	dep	112	SENT_216	[p13l867t1578r978b1650],
110	response	NN	O	response	dep	112	SENT_216	[p13l1051t1607r1360b1674],
111	to	TO	O	to	dep	112	SENT_216	[p13l1433t1603r1503b1650],
112	PEG	NN	O	peg	_	0	SENT_216	[p13l1579t1582r1943b1650],
113	.	.	O	.	_	0	SENT_216	[p13l1579t1582r1943b1650],

1	—	NN	O	—	_	0	SENT_217	[p13l1579t1582r1943b1650],
2	.	.	O	.	_	0	SENT_217	[p13l1579t1582r1943b1650],

1	IFN	NN	ORGANIZATION	ifn	nsubj	32	SENT_218	[p13l1579t1582r1943b1650],
2	and	CC	O	and	_	0	SENT_218	[p13l2015t1578r2150b1651],
3	RBV	NN	O	rbv	conj_and	1	SENT_218	[p13l10t1674r368b1776],
4	,22	CD	NUMBER	,22	number	5	SENT_218	[p13l10t1674r368b1776],
5	’24	CD	NUMBER	’24	num	6	SENT_218	[p13l10t1674r368b1776],
6	polymorphisms	NNS	O	polymorphism	nsubjpass	14	SENT_218	[p13l422t1694r992b1790],
7	in	IN	O	in	_	0	SENT_218	[p13l1049t1699r1120b1765],
8	the	DT	O	the	det	11	SENT_218	[p13l1174t1694r1286b1766],
9	I	PRP	O	I	nn	11	SENT_218	[p13l1338t1699r1382b1765],
10	TPA	NN	O	tpa	nn	11	SENT_218	[p13l1384t1697r1536b1765],
11	gene	NN	O	gene	prep_in	6	SENT_218	[p13l1590t1723r1755b1791],
12	has	VBZ	O	have	aux	14	SENT_218	[p13l1809t1694r1925b1766],
13	been	VBN	O	be	auxpass	14	SENT_218	[p13l1979t1694r2149b1766],
14	reported	VBN	O	report	rcmod	1	SENT_218	[p13l10t1809r318b1905],
15	to	TO	O	to	_	0	SENT_218	[p13l353t1834r423b1881],
16	inﬂuence	NN	O	inﬂuence	nn	17	SENT_218	[p13l460t1809r792b1882],
17	anemia	NN	O	anemia	prep_to	14	SENT_218	[p13l827t1814r1091b1881],
18	caused	VBN	O	cause	partmod	17	SENT_218	[p13l1124t1810r1363b1882],
19	by	IN	O	by	_	0	SENT_218	[p13l1398t1809r1488b1904],
20	RBV	NN	O	rbv	agent	18	SENT_218	[p13l1521t1795r1749b1881],
21	.7	CD	NUMBER	.7	num	20	SENT_218	[p13l1521t1795r1749b1881],
22	How	WRB	O	how	advmod	25	SENT_218	[p13l1784t1814r1970b1881],
23	inosine	JJ	O	inosine	amod	24	SENT_218	[p13l2001t1814r2148b1881, p13l9t1930r149b1997],
24	triphosphate	NN	O	triphosphate	nsubj	25	SENT_218	[p13l205t1925r662b2020],
25	protects	VBZ	O	protect	ccomp	18	SENT_218	[p13l718t1949r1003b2020],
26	erythrocytes	NNS	O	erythrocyte	dobj	25	SENT_218	[p13l1062t1925r1499b2020],
27	from	IN	O	from	_	0	SENT_218	[p13l1557t1925r1736b1997],
28	hemolysis	NN	O	hemolysis	prep_from	25	SENT_218	[p13l1792t1925r2148b2020],
29	caused	VBN	O	cause	partmod	28	SENT_218	[p13l10t2040r249b2112],
30	by	IN	O	by	_	0	SENT_218	[p13l284t2040r374b2134],
31	RBV	NN	O	rbv	agent	29	SENT_218	[p13l407t2044r592b2111],
32	needs	VBZ	O	need	_	0	SENT_218	[p13l624t2040r823b2112],
33	to	TO	O	to	aux	35	SENT_218	[p13l861t2064r930b2111],
34	be	VB	O	be	auxpass	35	SENT_218	[p13l968t2039r1051b2111],
35	sorted	VBN	O	sort	xcomp	32	SENT_218	[p13l1086t2039r1308b2112],
36	out	RP	O	out	prt	35	SENT_218	[p13l1343t2064r1465b2112],
37	by	IN	O	by	_	0	SENT_218	[p13l1500t2039r1589b2134],
38	in	FW	O	in	dep	43	SENT_218	[p13l1624t2046r1693b2111],
39	vivo	FW	O	vivo	pobj	38	SENT_218	[p13l1732t2046r1873b2111],
40	and	CC	O	and	_	0	SENT_218	[p13l1909t2039r2043b2112],
41	in	FW	O	in	nn	42	SENT_218	[p13l2080t2046r2149b2111],
42	vitro	FW	O	vitro	dep	43	SENT_218	[p13l13t2161r171b2226],
43	experiments	NNS	O	experiment	agent	35	SENT_218	[p13l210t2160r667b2250],
44	.	.	O	.	_	0	SENT_218	[p13l210t2160r667b2250],

1	Inosine	JJ	O	inosine	amod	2	SENT_219	[p13l711t2159r976b2226],
2	triphosphate	NN	O	triphosphate	nsubj	4	SENT_219	[p13l1015t2155r1472b2250],
3	may	MD	O	may	aux	4	SENT_219	[p13l1510t2183r1667b2249],
4	prohibit	VB	O	prohibit	_	0	SENT_219	[p13l1701t2155r2001b2250],
5	the	DT	O	the	det	6	SENT_219	[p13l2037t2155r2149b2226],
6	accumulation	NN	O	accumulation	dobj	4	SENT_219	[p13l10t2269r507b2342],
7	of	IN	O	of	_	0	SENT_219	[p13l541t2269r626b2341],
8	RBV	NN	O	rbv	prep_of	6	SENT_219	[p13l649t2274r833b2341],
9	in	IN	O	in	_	0	SENT_219	[p13l865t2274r936b2340],
10	erythrocytes	NNS	O	erythrocyte	prep_in	4	SENT_219	[p13l971t2269r1430b2365],
11	,	,	O	,	_	0	SENT_219	[p13l971t2269r1430b2365],
12	or	CC	O	or	_	0	SENT_219	[p13l1469t2298r1547b2341],
13	rather	RB	O	rather	advmod	17	SENT_219	[p13l1581t2269r1807b2352],
14	,	,	O	,	_	0	SENT_219	[p13l1581t2269r1807b2352],
15	it	PRP	O	it	nsubj	17	SENT_219	[p13l1846t2274r1898b2341],
16	might	MD	O	might	aux	17	SENT_219	[p13l1932t2269r2151b2366],
17	act	VB	O	act	conj_or	4	SENT_219	[p13l10t2409r113b2456],
18	directly	RB	O	directly	advmod	17	SENT_219	[p13l147t2384r420b2479],
19	toward	IN	O	toward	_	0	SENT_219	[p13l452t2385r705b2457],
20	prohibition	NN	O	prohibition	prep_toward	17	SENT_219	[p13l739t2385r1158b2480],
21	of	IN	O	of	_	0	SENT_219	[p13l1194t2384r1277b2456],
22	hemolysis	NN	O	hemolysis	prep_of	20	SENT_219	[p13l1299t2384r1674b2479],
23	.	.	O	.	_	0	SENT_219	[p13l1299t2384r1674b2479],

1	In	IN	O	in	_	0	SENT_220	[p13l109t2503r187b2569],
2	the	DT	O	the	det	4	SENT_220	[p13l260t2499r374b2570],
3	present	JJ	DATE	present	amod	4	SENT_220	[p13l447t2523r718b2594],
4	study	NN	O	study	prep_in	13	SENT_220	[p13l790t2499r1003b2593],
5	,	,	O	,	_	0	SENT_220	[p13l790t2499r1003b2593],
6	61	CD	NUMBER	61	num	7	SENT_220	[p13l1081t2501r1164b2570],
7	patients	NNS	O	patient	nsubj	13	SENT_220	[p13l1246t2504r1538b2594],
8	infected	VBN	O	infect	partmod	7	SENT_220	[p13l1613t2499r1911b2571],
9	with	IN	O	with	_	0	SENT_220	[p13l1980t2499r2150b2570],
10	HCV	NN	O	hcv	nn	11	SENT_220	[p13l10t2617r285b2685],
11	—	NN	O	—	prep_with	8	SENT_220	[p13l10t2617r285b2685],
12	1	CD	NUMBER	1	num	11	SENT_220	[p13l10t2617r285b2685],
13	received	VBD	O	receive	_	0	SENT_220	[p13l348t2613r649b2686],
14	triple	JJ	O	triple	amod	15	SENT_220	[p13l702t2613r899b2708],
15	therapy	NN	O	therapy	dobj	13	SENT_220	[p13l951t2613r1234b2708],
16	with	IN	O	with	_	0	SENT_220	[p13l1280t2613r1449b2685],
17	PEG	NN	O	peg	prep_with	13	SENT_220	[p13l1502t2617r1896b2695],
18	.	.	O	.	_	0	SENT_220	[p13l1502t2617r1896b2695],

1	—	NN	O	—	_	0	SENT_221	[p13l1502t2617r1896b2695],
2	.	.	O	.	_	0	SENT_221	[p13l1502t2617r1896b2695],

1	IFN	NN	ORGANIZATION	ifn	nsubj	12	SENT_222	[p13l1502t2617r1896b2695],
2	,	,	O	,	_	0	SENT_222	[p13l1502t2617r1896b2695],
3	RBV	NN	O	rbv	conj_and	1	SENT_222	[p13l1953t2618r2145b2695],
4	,	,	O	,	_	0	SENT_222	[p13l1953t2618r2145b2695],
5	and	CC	O	and	_	0	SENT_222	[p13l10t2727r147b2800],
6	telaprevir	NN	O	telaprevir	conj_and	1	SENT_222	[p13l191t2727r542b2823],
7	in	IN	O	in	_	0	SENT_222	[p13l585t2732r657b2798],
8	the	DT	DURATION	the	det	11	SENT_222	[p13l701t2727r815b2799],
9	first	JJ	DURATION	first	amod	11	SENT_222	[p13l858t2727r1001b2799],
10	12	CD	DURATION	12	num	11	SENT_222	[p13l1051t2735r1135b2798],
11	weeks	NNS	NUMBER	week	prep_in	1	SENT_222	[p13l1177t2727r1395b2799],
12	followed	VBN	O	follow	_	0	SENT_222	[p13l1441t2727r1763b2800],
13	by	IN	O	by	_	0	SENT_222	[p13l1807t2728r1898b2822],
14	PEGIFN	NN	ORGANIZATION	pegifn	prep_by	12	SENT_222	[p13l1939t2731r2148b2799, p13l10t2846r167b2914],
15	and	CC	O	and	_	0	SENT_222	[p13l205t2842r342b2914],
16	RBV	NN	O	rbv	prep_by	12	SENT_222	[p13l381t2846r569b2914],
17	in	IN	O	in	_	0	SENT_222	[p13l604t2847r675b2913],
18	the	DT	O	the	det	21	SENT_222	[p13l714t2842r828b2913],
19	second	JJ	ORDINAL	second	amod	21	SENT_222	[p13l867t2842r1122b2914],
20	12	CD	DURATION	12	num	21	SENT_222	[p13l1169t2849r1253b2912],
21	weeks	NNS	NUMBER	week	prep_in	12	SENT_222	[p13l1290t2842r1529b2914],
22	.	.	O	.	_	0	SENT_222	[p13l1290t2842r1529b2914],

1	Then	RB	O	then	dep	3	SENT_223	[p13l1571t2842r1773b2914],
2	the	DT	O	the	det	3	SENT_223	[p13l1813t2842r1927b2913],
3	RBV	NN	O	rbv	_	0	SENT_223	[p13l1966t2846r2153b2914],

1	dose	NN	O	dose	nsubjpass	5	SENT_224	[p13l10t2958r174b3030],
2	and	CC	O	and	_	0	SENT_224	[p13l215t2958r352b3030],
3	hemoglobin	NN	O	hemoglobin	nsubjpass	5	SENT_224	[p13l391t2958r845b3054],
4	were	VBD	O	be	auxpass	5	SENT_224	[p13l882t2987r1056b3030],
5	compared	VBN	O	compare	_	0	SENT_224	[p13l1097t2958r1470b3053],
6	between	IN	O	between	_	0	SENT_224	[p13l1510t2958r1816b3030],
7	patients	NNS	O	patient	prep_between	5	SENT_224	[p13l1856t2963r2148b3053],
8	with	IN	O	with	_	0	SENT_224	[p13l6t3072r176b3145],
9	CC	NN	O	cc	nn	12	SENT_224	[p13l235t3076r366b3145],
10	and	CC	O	and	_	0	SENT_224	[p13l427t3072r564b3145],
11	CA/AA	NN	O	ca/aa	nn	12	SENT_224	[p13l624t3075r906b3145],
12	genotypes	NNS	O	genotype	prep_with	7	SENT_224	[p13l961t3097r1331b3170],
13	in	IN	O	in	_	0	SENT_224	[p13l1393t3077r1465b3143],
14	the	DT	O	the	det	17	SENT_224	[p13l1524t3073r1638b3144],
15	[	CD	NUMBER	[	num	17	SENT_224	[p13l1695t3075r1897b3143],
16	TPA	NN	O	tpa	nn	17	SENT_224	[p13l1695t3075r1897b3143],
17	gene	NN	O	gene	prep_in	5	SENT_224	[p13l1956t3101r2143b3170],
18	.	.	O	.	_	0	SENT_224	[p13l1956t3101r2143b3170],

1	Two	CD	NUMBER	two	num	2	SENT_225	[p13l7t3191r168b3260],
2	polymorphisms	NNS	O	polymorphism	nsubj	24	SENT_225	[p13l206t3189r793b3284],
3	in	IN	O	in	_	0	SENT_225	[p13l832t3194r904b3259],
4	the	DT	O	the	det	7	SENT_225	[p13l941t3189r1055b3260],
5	[	CD	NUMBER	[	num	7	SENT_225	[p13l1090t3191r1291b3259],
6	TPA	NN	O	tpa	nn	7	SENT_225	[p13l1090t3191r1291b3259],
7	gene	NN	O	gene	prep_in	2	SENT_225	[p13l1328t3217r1517b3285],
8	,	,	O	,	_	0	SENT_225	[p13l1328t3217r1517b3285],
9	in	IN	O	in	mark	21	SENT_225	[p13l1559t3194r1631b3259],
10	close	JJ	O	close	amod	12	SENT_225	[p13l1668t3189r1845b3260],
11	linkage	NN	O	linkage	nn	12	SENT_225	[p13l1882t3189r2149b3285],
12	disequilibrium	NN	O	disequilibrium	nsubjpass	21	SENT_225	[p13l10t3303r561b3398],
13	with	IN	O	with	_	0	SENT_225	[p13l614t3303r783b3375],
14	an	DT	O	a	det	16	SENT_225	[p13l838t3332r924b3374],
15	r2	NN	O	r2	nn	16	SENT_225	[p13l979t3288r1042b3373],
16	value	NN	O	value	prep_with	12	SENT_225	[p13l1095t3303r1289b3375],
17	of	IN	O	of	_	0	SENT_225	[p13l1344t3303r1429b3374],
18	0.65,7	CD	NUMBER	0.65,7	prep_of	16	SENT_225	[p13l1472t3288r1700b3384],
19	have	VBP	O	have	aux	21	SENT_225	[p13l1753t3303r1921b3375],
20	been	VBN	O	be	auxpass	21	SENT_225	[p13l1976t3303r2149b3374],
21	recognized	VBN	O	recognize	dep	7	SENT_225	[p13l10t3417r411b3515],
22	in	IN	O	in	_	0	SENT_225	[p13l455t3422r527b3488],
23	Caucasians	NNPS	MISC	Caucasians	prep_in	21	SENT_225	[p13l573t3421r983b3490],
24	(	VBP	O	(	_	0	SENT_225	[p13l1033t3418r1462b3504],
25	rs1127354	NN	O	rs1127354	nn	28	SENT_225	[p13l1033t3418r1462b3504],
26	and	CC	O	and	_	0	SENT_225	[p13l1509t3418r1646b3490],
27	rs7270107	NN	O	rs7270107	nn	28	SENT_225	[p13l1690t3419r2145b3504],
28	)	NN	O	)	dobj	24	SENT_225	[p13l1690t3419r2145b3504],
29	;	:	O	;	_	0	SENT_225	[p13l1690t3419r2145b3504],
30	the	DT	O	the	det	32	SENT_225	[p13l10t3533r124b3604],
31	respective	JJ	O	respective	amod	32	SENT_225	[p13l170t3538r532b3628],
32	CA/AA	NN	O	ca/aa	nsubj	36	SENT_225	[p13l580t3535r862b3604],
33	and	CC	O	and	_	0	SENT_225	[p13l905t3533r1042b3605],
34	AC/CC	NN	O	ac/cc	nn	35	SENT_225	[p13l1082t3535r1380b3604],
35	genotypes	NNS	O	genotype	conj_and	32	SENT_225	[p13l1426t3557r1796b3629],
36	decrease	VBP	O	decrease	parataxis	24	SENT_225	[p13l1844t3533r2149b3605],
37	the	DT	O	the	det	38	SENT_225	[p13l10t3648r124b3719],
38	activi	NN	O	activus	dobj	36	SENT_225	[p13l203t3653r399b3720],
39	of	IN	O	of	_	0	SENT_225	[p13l551t3648r636b3719],
40	inosine	NN	O	inosine	nn	43	SENT_225	[p13l702t3653r969b3719],
41	tri	NN	O	trus	nn	43	SENT_225	[p13l1048t3653r1131b3719],
42	hos	NNS	O	ho	nn	43	SENT_225	[p13l1185t3648r1310b3719],
43	hatase	NN	O	hatase	prep_of	38	SENT_225	[p13l1365t3648r1591b3719],
44	and	CC	O	and	_	0	SENT_225	[p13l1671t3648r1808b3720],
45	rotect	NN	O	rotect	conj_and	43	SENT_225	[p13l1936t3672r2150b3719],

1	P	NN	O	p	_	0	SENT_226	[p13l1135t3676r1179b3743],
2	P	NN	O	p	nn	3	SENT_226	[p13l1315t3676r1359b3743],
3	P	NN	O	p	dep	1	SENT_226	[p13l1884t3676r1929b3743],

1	against	IN	O	against	_	0	SENT_227	[p14l10t30r269b122],
2	anemia	NN	O	anemia	prep_against	31	SENT_227	[p14l311t30r581b97],
3	induced	VBN	O	induce	dep	2	SENT_227	[p14l623t25r924b98],
4	by	IN	O	by	_	0	SENT_227	[p14l966t25r1058b120],
5	RBV	NN	O	rbv	prep_by	3	SENT_227	[p14l1098t9r1422b97],
6	.7	CD	NUMBER	.7	number	7	SENT_227	[p14l1098t9r1422b97],
7	’12	CD	NUMBER	’12	num	5	SENT_227	[p14l1098t9r1422b97],
8	Because	IN	O	because	mark	12	SENT_227	[p14l1467t30r1759b98],
9	the	DT	O	the	det	10	SENT_227	[p14l1803t25r1917b97],
10	Japanese	NNS	MISC	japanese	nsubj	12	SENT_227	[p14l1953t30r2147b121, p14l10t169r166b211],
11	are	VBP	O	be	cop	12	SENT_227	[p14l209t169r316b211],
12	monoallelic	JJ	O	monoallelic	advcl	3	SENT_227	[p14l358t140r797b211],
13	at	IN	O	at	_	0	SENT_227	[p14l839t164r905b211],
14	rs7270107	CD	NUMBER	rs7270107	prep_at	12	SENT_227	[p14l947t147r1349b216],
15	and	CC	O	and	_	0	SENT_227	[p14l1393t140r1530b212],
16	possess	VB	O	possess	conj_and	3	SENT_227	[p14l1571t168r1830b235],
17	the	DT	O	the	det	18	SENT_227	[p14l1874t140r1988b211],
18	AA	NN	O	aa	iobj	16	SENT_227	[p14l2025t143r2153b211],
19	25	CD	NUMBER	25	num	18	SENT_227	[p14l955t267r1021b314],
20	only	RB	O	only	advmod	21	SENT_227	[p14l1126t283r1291b377],
21	polymorphisms	NNS	O	polymorphism	dobj	16	SENT_227	[p14l1388t283r1971b378],
22	at	IN	O	at	_	0	SENT_227	[p14l2075t307r2141b354],
23	genotype	NN	O	genotype	prep_at	21	SENT_227	[p14l10t307r348b379],
24	exclusively	RB	O	exclusively	advmod	23	SENT_227	[p14l451t283r855b377],
25	,	,	O	,	_	0	SENT_227	[p14l451t283r855b377],
26	1	CD	NUMBER	1	number	27	SENT_227	[p14l870t267r889b310],
27	1	CD	NUMBER	1	num	29	SENT_227	[p14l906t267r949b317],
28	’	NN	O	’	nn	29	SENT_227	[p14l906t267r949b317],
29	rs1127354	NN	O	rs1127354	nsubjpass	31	SENT_227	[p14l11t398r411b474],
30	were	VBD	O	be	auxpass	31	SENT_227	[p14l446t426r619b469],
31	examined	VBN	O	examine	_	0	SENT_227	[p14l656t397r1033b469],
32	.	.	O	.	_	0	SENT_227	[p14l656t397r1033b469],

1	Of	IN	O	of	_	0	SENT_228	[p14l110t512r221b584],
2	the	DT	O	the	det	4	SENT_228	[p14l263t513r374b584],
3	61	CD	NUMBER	61	num	4	SENT_228	[p14l428t515r510b584],
4	patients	NNS	O	patient	prep_of	7	SENT_228	[p14l572t517r874b608],
5	,	,	O	,	_	0	SENT_228	[p14l572t517r874b608],
6	49	CD	NUMBER	49	nsubj	7	SENT_228	[p14l931t513r1021b588],
7	possessed	VBD	O	possess	_	0	SENT_228	[p14l1077t512r1415b608],
8	the	DT	O	the	det	13	SENT_228	[p14l1468t512r1579b584],
9	RBV	NN	O	rbv	nn	13	SENT_228	[p14l1633t517r2139b584],
10	—	NN	O	—	nn	13	SENT_228	[p14l1633t517r2139b584],
11	sensitive	JJ	O	sensitive	amod	13	SENT_228	[p14l1633t517r2139b584],
12	CC	NN	O	cc	nn	13	SENT_228	[p14l12t630r141b698],
13	genotype	NN	O	genotype	nsubj	18	SENT_228	[p14l188t651r517b723],
14	and	CC	O	and	_	0	SENT_228	[p14l564t627r698b699],
15	the	DT	O	the	det	17	SENT_228	[p14l744t627r855b698],
16	remaining	VBG	O	remain	amod	17	SENT_228	[p14l902t632r1274b723],
17	12	CD	NUMBER	12	conj_and	13	SENT_228	[p14l1327t634r1409b697],
18	had	VBD	O	have	ccomp	7	SENT_228	[p14l1456t627r1590b699],
19	RBV	NN	O	rbv	npadvmod	21	SENT_228	[p14l1637t631r2141b698],
20	—	CD	NUMBER	—	num	19	SENT_228	[p14l1637t631r2141b698],
21	resistant	JJ	O	resistant	amod	23	SENT_228	[p14l1637t631r2141b698],
22	CA/AA	NN	O	ca/aa	nn	23	SENT_228	[p14l12t743r287b813],
23	genotypes	NNS	O	genotype	dobj	18	SENT_228	[p14l323t765r700b837],
24	.	.	O	.	_	0	SENT_228	[p14l323t765r700b837],

1	Hemoglobin	NN	O	hemoglobin	nn	2	SENT_229	[p14l746t741r1211b837],
2	levels	NNS	O	level	nsubj	3	SENT_229	[p14l1250t741r1438b812],
3	decreased	VBD	O	decrease	_	0	SENT_229	[p14l1479t741r1824b813],
4	both	CC	O	both	dep	3	SENT_229	[p14l1861t741r2029b812],
5	in	IN	O	in	_	0	SENT_229	[p14l2069t746r2139b811],
6	patients	NNS	O	patient	prep_in	3	SENT_229	[p14l10t860r291b951],
7	with	IN	O	with	_	0	SENT_229	[p14l331t855r496b927],
8	CC	NN	O	cc	nn	11	SENT_229	[p14l539t859r668b927],
9	and	CC	O	and	_	0	SENT_229	[p14l711t855r845b928],
10	CA/AA	NN	O	ca/aa	nn	11	SENT_229	[p14l888t858r1163b927],
11	genotypes	NNS	O	genotype	prep_with	6	SENT_229	[p14l1203t880r1579b952],
12	.	.	O	.	_	0	SENT_229	[p14l1203t880r1579b952],

1	They	PRP	O	they	nsubj	2	SENT_230	[p14l1625t855r1818b950],
2	lowered	VBD	O	lower	_	0	SENT_230	[p14l1855t855r2140b928],
3	m4	NN	O	m4	nn	4	SENT_230	[p14l13t970r129b1040],
4	g/dL	NN	O	g/dl	dobj	2	SENT_230	[p14l173t970r346b1066],
5	during	IN	O	during	_	0	SENT_230	[p14l389t970r632b1066],
6	Weeks	NNP	DURATION	Weeks	prep_during	2	SENT_230	[p14l670t970r884b1041],
7	8-12	CD	NUMBER	8-12	num	6	SENT_230	[p14l930t977r1095b1041],
8	on	IN	O	on	_	0	SENT_230	[p14l1141t998r1235b1041],
9	the	DT	O	the	det	11	SENT_230	[p14l1277t970r1388b1041],
10	triple	JJ	O	triple	amod	11	SENT_230	[p14l1431t970r1621b1065],
11	therapy	NN	O	therapy	prep_on	2	SENT_230	[p14l1664t970r1939b1065],
12	with	IN	O	with	_	0	SENT_230	[p14l1976t970r2140b1041],
13	telaprevir	NN	O	telaprevir	prep_with	11	SENT_230	[p14l11t1084r362b1179],
14	,	,	O	,	_	0	SENT_230	[p14l11t1084r362b1179],
15	and	CC	O	and	_	0	SENT_230	[p14l407t1084r541b1156],
16	increased	VBD	O	increase	conj_and	2	SENT_230	[p14l581t1084r913b1156],
17	thereafter	RB	O	thereafter	advmod	18	SENT_230	[p14l954t1084r1297b1155],
18	(	RB	O	(	advmod	16	SENT_230	[p14l1341t1085r1497b1180],
19	Fig	NN	O	fig	dobj	16	SENT_230	[p14l1341t1085r1497b1180],
20	.	.	O	.	_	0	SENT_230	[p14l1341t1085r1497b1180],

1	2	CD	NUMBER	2	num	2	SENT_231	[p14l1542t1085r1636b1170],
2	)	CD	NUMBER	)	_	0	SENT_231	[p14l1542t1085r1636b1170],
3	.	.	O	.	_	0	SENT_231	[p14l1542t1085r1636b1170],

1	Between	IN	O	between	_	0	SENT_232	[p14l1682t1089r1989b1156],
2	the	DT	O	the	det	4	SENT_232	[p14l2029t1084r2140b1155],
3	two	CD	NUMBER	two	num	4	SENT_232	[p14l11t1224r143b1271],
4	groups	NNS	O	group	prep_between	20	SENT_232	[p14l225t1228r469b1296],
5	of	IN	O	of	_	0	SENT_232	[p14l550t1200r634b1271],
6	patients	NNS	O	patient	prep_of	4	SENT_232	[p14l699t1205r1001b1295],
7	,	,	O	,	_	0	SENT_232	[p14l699t1205r1001b1295],
8	differences	NNS	O	difference	nsubj	20	SENT_232	[p14l1086t1200r1469b1272],
9	in	IN	O	in	_	0	SENT_232	[p14l1550t1205r1621b1270],
10	hemoglobin	NN	O	hemoglobin	nn	11	SENT_232	[p14l1700t1200r2140b1296],
11	decrease	NN	O	decrease	prep_in	8	SENT_232	[p14l11t1315r306b1387],
12	were	VBD	O	be	cop	20	SENT_232	[p14l351t1344r521b1387],
13	greatest	JJS	O	greatest	amod	20	SENT_232	[p14l570t1339r842b1411],
14	at	IN	O	at	_	0	SENT_232	[p14l890t1339r956b1386],
15	week	NN	DURATION	week	nn	17	SENT_232	[p14l1000t1315r1187b1387],
16	4	CD	NUMBER	4	num	17	SENT_232	[p14l1231t1316r1275b1385],
17	(	NN	O	(	prep_at	13	SENT_232	[p14l1331t1316r1468b1401],
18	1.3	CD	NUMBER	1.3	num	17	SENT_232	[p14l1331t1316r1468b1401],
19	g/dL	NN	O	g/dl	nn	20	SENT_232	[p14l1520t1315r1741b1411],
20	)	NN	O	)	_	0	SENT_232	[p14l1520t1315r1741b1411],
21	,	,	O	,	_	0	SENT_232	[p14l1520t1315r1741b1411],
22	as	IN	O	as	dep	20	SENT_232	[p14l1794t1345r1860b1386],
23	in	IN	O	in	_	0	SENT_232	[p14l1909t1320r1979b1385],
24	the	DT	O	the	det	26	SENT_232	[p14l2029t1315r2140b1386],
25	standard	JJ	O	standard	amod	26	SENT_232	[p14l10t1430r321b1503],
26	treatment	NN	O	treatment	prep_in	20	SENT_232	[p14l356t1455r709b1502],
27	with	IN	O	with	_	0	SENT_232	[p14l739t1430r904b1502],
28	PEG	NN	O	peg	prep_with	26	SENT_232	[p14l940t1434r1302b1502],
29	.	.	O	.	_	0	SENT_232	[p14l940t1434r1302b1502],

1	—	NN	O	—	_	0	SENT_233	[p14l940t1434r1302b1502],
2	.	.	O	.	_	0	SENT_233	[p14l940t1434r1302b1502],

1	IFN	NN	ORGANIZATION	ifn	_	0	SENT_234	[p14l940t1434r1302b1502],
2	and	CC	O	and	_	0	SENT_234	[p14l1337t1430r1471b1503],
3	RBV	NN	O	rbv	conj_and	1	SENT_234	[p14l1506t1415r1905b1502],
4	.7	CD	NUMBER	.7	number	5	SENT_234	[p14l1506t1415r1905b1502],
5	’	CD	NUMBER	’	dep	1	SENT_234	[p14l1506t1415r1905b1502],
6	12	CD	NUMBER	12	num	7	SENT_234	[p14l1506t1415r1905b1502],
7	’13	CD	NUMBER	’13	dep	5	SENT_234	[p14l1506t1415r1905b1502],

1	When	WRB	O	when	advmod	7	SENT_235	[p14l105t1546r337b1618],
2	anemia	NN	O	anemia	nsubj	7	SENT_235	[p14l379t1551r648b1617],
3	and	CC	O	and	_	0	SENT_235	[p14l688t1546r824b1618],
4	other	JJ	O	other	amod	6	SENT_235	[p14l865t1546r1060b1617],
5	side	JJ	O	side	amod	6	SENT_235	[p14l1100t1546r1242b1619],
6	effects	NNS	O	effect	conj_and	2	SENT_235	[p14l1283t1546r1511b1617],
7	occurred	VBD	O	occur	advcl	18	SENT_235	[p14l1555t1546r1899b1628],
8	,	,	O	,	_	0	SENT_235	[p14l1555t1546r1899b1628],
9	doses	NNS	O	dose	nsubj	18	SENT_235	[p14l1945t1546r2138b1619],
10	of	IN	O	of	_	0	SENT_235	[p14l11t1661r95b1732],
11	RBV	NN	O	rbv	prep_of	9	SENT_235	[p14l133t1666r325b1743],
12	,	,	O	,	_	0	SENT_235	[p14l133t1666r325b1743],
13	PEG-IFN	NN	O	peg-ifn	conj_and	11	SENT_235	[p14l379t1664r771b1742],
14	,	,	O	,	_	0	SENT_235	[p14l379t1664r771b1742],
15	and	CC	O	and	_	0	SENT_235	[p14l824t1661r961b1733],
16	telaprevir	NN	O	telaprevir	conj_and	11	SENT_235	[p14l1010t1661r1360b1756],
17	Were	VBD	O	be	cop	18	SENT_235	[p14l1406t1690r1578b1733],
18	modiﬁed	JJ	O	modiﬁed	_	0	SENT_235	[p14l1628t1661r1983b1733],
19	.	.	O	.	_	0	SENT_235	[p14l1628t1661r1983b1733],

1	Of	IN	O	of	_	0	SENT_236	[p14l2039t1661r2152b1733],
2	the	DT	O	the	det	4	SENT_236	[p14l11t1775r124b1847],
3	61	CD	NUMBER	61	num	4	SENT_236	[p14l178t1777r261b1847],
4	patients	NNS	O	patient	prep_of	13	SENT_236	[p14l323t1780r613b1870],
5	studied	VBN	O	study	partmod	4	SENT_236	[p14l667t1775r958b1857],
6	,	,	O	,	_	0	SENT_236	[p14l667t1775r958b1857],
7	27	CD	PERCENT	27	number	8	SENT_236	[p14l1015t1782r1108b1851],
8	(	CD	PERCENT	(	nsubj	13	SENT_236	[p14l1166t1776r1394b1861],
9	44	CD	PERCENT	44	num	10	SENT_236	[p14l1166t1776r1394b1861],
10	%	NN	PERCENT	%	dep	8	SENT_236	[p14l1166t1776r1394b1861],
11	)	CD	NUMBER	)	dep	8	SENT_236	[p14l1166t1776r1394b1861],
12	were	VBD	O	be	cop	13	SENT_236	[p14l1450t1804r1623b1847],
13	women	NNS	O	woman	_	0	SENT_236	[p14l1673t1804r1951b1847],
14	and	CC	O	and	_	0	SENT_236	[p14l2004t1775r2140b1847],
15	most	JJS	O	most	nsubj	18	SENT_236	[p14l11t1914r194b1961],
16	of	IN	O	of	_	0	SENT_236	[p14l230t1889r314b1961],
17	them	PRP	O	they	prep_of	15	SENT_236	[p14l340t1889r530b1961],
18	were	VBD	O	be	conj_and	13	SENT_236	[p14l564t1918r737b1961],
19	in	IN	O	in	_	0	SENT_236	[p14l775t1894r846b1960],
20	old	JJ	O	old	amod	21	SENT_236	[p14l884t1889r1002b1962],
21	age	NN	O	age	prep_in	18	SENT_236	[p14l1038t1919r1175b1985],
22	.	.	O	.	_	0	SENT_236	[p14l1038t1919r1175b1985],

1	Beyond	IN	O	beyond	_	0	SENT_237	[p14l1219t1889r1503b1984],
2	50	CD	DURATION	50	num	3	SENT_237	[p14l1543t1895r1631b1966],
3	years	NNS	NUMBER	year	prep_beyond	10	SENT_237	[p14l1667t1918r1849b1984],
4	of	IN	O	of	_	0	SENT_237	[p14l1889t1889r1973b1961],
5	age	NN	O	age	prep_of	3	SENT_237	[p14l1998t1919r2136b1985],
6	,	,	O	,	_	0	SENT_237	[p14l1998t1919r2136b1985],
7	women	NNS	O	woman	nsubj	10	SENT_237	[p14l7t2033r285b2076],
8	are	VBP	O	be	cop	10	SENT_237	[p14l337t2033r442b2075],
9	less	RBR	O	less	advmod	10	SENT_237	[p14l493t2004r614b2075],
10	responsive	JJ	O	responsive	_	0	SENT_237	[p14l667t2009r1051b2099],
11	than	IN	O	than	_	0	SENT_237	[p14l1102t2004r1268b2075],
12	men	NNS	O	man	prep_than	10	SENT_237	[p14l1319t2033r1481b2075],
13	to	TO	O	to	_	0	SENT_237	[p14l1533t2028r1604b2075],
14	the	DT	O	the	det	16	SENT_237	[p14l1657t2004r1770b2075],
15	standard	JJ	O	standard	amod	16	SENT_237	[p14l1821t2004r2140b2076],
16	treatment	NN	O	treatment	prep_to	10	SENT_237	[p14l11t2142r374b2190],
17	with	IN	O	with	_	0	SENT_237	[p14l418t2118r586b2190],
18	PEG	NN	O	peg	prep_with	16	SENT_237	[p14l634t2122r1005b2190],
19	.	.	O	.	_	0	SENT_237	[p14l634t2122r1005b2190],

1	—	NN	O	—	_	0	SENT_238	[p14l634t2122r1005b2190],
2	.	.	O	.	_	0	SENT_238	[p14l634t2122r1005b2190],

1	IFN	NN	ORGANIZATION	ifn	nsubj	18	SENT_239	[p14l634t2122r1005b2190],
2	and	CC	O	and	_	0	SENT_239	[p14l1052t2118r1188b2191],
3	RBV	NN	O	rbv	conj_and	1	SENT_239	[p14l1236t2123r1428b2200],
4	,	,	O	,	_	0	SENT_239	[p14l1236t2123r1428b2200],
5	probably	RB	O	probably	advmod	1	SENT_239	[p14l1479t2118r1814b2213],
6	because	IN	O	because	_	0	SENT_239	[p14l1858t2118r2139b2191],
7	estrogens	NNS	O	estrogen	prep_because	5	SENT_239	[p14l11t2257r350b2329],
8	with	IN	O	with	_	0	SENT_239	[p14l402t2233r570b2332],
9	an	DT	O	a	det	12	SENT_239	[p14l624t2262r710b2304],
10	antiflbrotic	JJ	O	antiflbrotic	amod	12	SENT_239	[p14l763t2233r1180b2304],
11	potential	JJ	O	potential	amod	12	SENT_239	[p14l1231t2233r1563b2328],
12	decrease	NN	O	decrease	prep_with	7	SENT_239	[p14l1617t2233r1921b2305],
13	after	IN	O	after	_	0	SENT_239	[p14l1976t2233r2141b2304],
14	menopause	NN	O	menopause	prep_after	12	SENT_239	[p14l11t2373r529b2485],
15	.26	CD	NUMBER	.26	num	17	SENT_239	[p14l11t2373r529b2485],
16	Stringent	JJ	O	stringent	amod	17	SENT_239	[p14l583t2393r926b2486],
17	precautions	NNS	O	precaution	dep	1	SENT_239	[p14l978t2395r1408b2485],
18	had	VBD	O	have	_	0	SENT_239	[p14l1462t2390r1598b2462],
19	to	TO	O	to	aux	21	SENT_239	[p14l1651t2414r1722b2461],
20	be	VB	O	be	auxpass	21	SENT_239	[p14l1777t2390r1861b2461],
21	taken	VBN	O	take	xcomp	18	SENT_239	[p14l1914t2390r2135b2471],
22	,	,	O	,	_	0	SENT_239	[p14l1914t2390r2135b2471],
23	therefore	RB	O	therefore	advmod	21	SENT_239	[p14l11t2504r363b2586],
24	,	,	O	,	_	0	SENT_239	[p14l11t2504r363b2586],
25	by	IN	O	by	_	0	SENT_239	[p14l407t2504r498b2598],
26	reducing	VBG	O	reduce	agent	21	SENT_239	[p14l533t2504r860b2600],
27	the	DT	O	the	det	29	SENT_239	[p14l898t2504r1011b2575],
28	RBV	NN	O	rbv	nn	29	SENT_239	[p14l1051t2509r1238b2576],
29	dose	NN	O	dose	dobj	26	SENT_239	[p14l1272t2504r1435b2577],
30	in	IN	O	in	_	0	SENT_239	[p14l1475t2509r1546b2574],
31	the	DT	O	the	det	32	SENT_239	[p14l1586t2504r1699b2575],
32	patients	NNS	O	patient	prep_in	26	SENT_239	[p14l1737t2509r2027b2599],
33	in	IN	O	in	_	0	SENT_239	[p14l2068t2509r2139b2574],
34	Whom	WP	O	whom	rel	37	SENT_239	[p14l7t2618r245b2690],
35	hemoglobin	NN	O	hemoglobin	nn	36	SENT_239	[p14l296t2618r747b2714],
36	levels	NNS	O	level	nsubj	37	SENT_239	[p14l798t2618r993b2690],
37	decreased	VBD	O	decrease	rcmod	32	SENT_239	[p14l1046t2618r1400b2691],
38	<	JJR	O	<	dobj	37	SENT_239	[p14l1455t2625r1617b2692],
39	12	CD	NUMBER	12	num	40	SENT_239	[p14l1455t2625r1617b2692],
40	g/dL	NN	O	g/dl	dep	38	SENT_239	[p14l1670t2618r1866b2714],
41	,	,	O	,	_	0	SENT_239	[p14l1670t2618r1866b2714],
42	rather	RB	O	rather	_	0	SENT_239	[p14l1922t2618r2141b2690],
43	than	IN	O	than	_	0	SENT_239	[p14l11t2733r176b2804],
44	the	DT	O	the	det	46	SENT_239	[p14l214t2733r327b2804],
45	conventional	JJ	O	conventional	amod	46	SENT_239	[p14l364t2733r845b2805],
46	threshold	NN	O	threshold	dobj	37	SENT_239	[p14l883t2733r1233b2805],
47	of	IN	O	of	_	0	SENT_239	[p14l1270t2733r1354b2804],
48	<	JJR	O	<	prep_of	46	SENT_239	[p14l1383t2740r1544b2807],
49	10	CD	NUMBER	10	num	50	SENT_239	[p14l1383t2740r1544b2807],
50	g/dL	NN	O	g/dl	dep	48	SENT_239	[p14l1583t2733r1778b2829],
51	.	.	O	.	_	0	SENT_239	[p14l1583t2733r1778b2829],

1	Reductions	NNS	O	reduction	_	0	SENT_240	[p14l109t2847r515b2920],
2	of	IN	O	of	_	0	SENT_240	[p14l566t2847r649b2919],
3	RBV	NN	O	rbv	nn	4	SENT_240	[p14l687t2852r870b2919],
4	dose	NN	O	dose	prep_of	1	SENT_240	[p14l916t2847r1075b2920],
5	due	JJ	O	due	_	0	SENT_240	[p14l1125t2847r1256b2920],
6	to	TO	O	to	_	0	SENT_240	[p14l1306t2871r1375b2919],
7	anemia	NN	O	anemia	prep_due_to	4	SENT_240	[p14l1427t2852r1690b2919],
8	in	IN	O	in	_	0	SENT_240	[p14l1738t2852r1808b2918],
9	patients	NNS	O	patient	prep_in	7	SENT_240	[p14l1856t2852r2138b2942],
10	who	WP	O	who	nsubj	11	SENT_240	[p14l7t2962r164b3034],
11	receive	VBP	O	receive	rcmod	9	SENT_240	[p14l204t2967r446b3034],
12	PEG	NN	O	peg	dobj	11	SENT_240	[p14l484t2966r846b3034],
13	.	.	O	.	_	0	SENT_240	[p14l484t2966r846b3034],

1	—	NN	O	—	_	0	SENT_241	[p14l484t2966r846b3034],
2	.	.	O	.	_	0	SENT_241	[p14l484t2966r846b3034],

1	IFN	NN	O	ifn	nsubjpass	5	SENT_242	[p14l484t2966r846b3034],
2	and	CC	O	and	_	0	SENT_242	[p14l883t2962r1017b3035],
3	RBV	NN	O	rbv	nsubjpass	5	SENT_242	[p14l1054t2967r1239b3034],
4	are	VBP	O	be	auxpass	5	SENT_242	[p14l1264t2991r1367b3034],
5	inﬂuenced	VBN	O	inﬂuenced	_	0	SENT_242	[p14l1405t2962r1786b3035],
6	by	IN	O	by	_	0	SENT_242	[p14l1821t2962r1911b3057],
7	I	PRP	O	I	prep_by	8	SENT_242	[p14l1943t2967r1987b3033],
8	TPA	NN	O	tpa	amod	9	SENT_242	[p14l1989t2965r2140b3033],
9	polymorphisms	NNS	O	polymorphism	dobj	5	SENT_242	[p14l10t3062r672b3173],
10	.12	CD	NUMBER	.12	tmod	5	SENT_242	[p14l10t3062r672b3173],
11	Also	RB	O	also	advmod	10	SENT_242	[p14l703t3078r885b3159],
12	,	,	O	,	_	0	SENT_242	[p14l703t3078r885b3159],
13	in	IN	O	in	_	0	SENT_242	[p14l923t3082r994b3148],
14	patients	NNS	O	patient	prep_in	5	SENT_242	[p14l1028t3082r1309b3173],
15	who	WP	O	who	nsubj	17	SENT_242	[p14l1342t3077r1498b3149],
16	had	VBD	O	have	aux	17	SENT_242	[p14l1534t3077r1669b3150],
17	received	VBN	O	receive	rcmod	14	SENT_242	[p14l1703t3077r1994b3150],
18	the	DT	O	the	det	20	SENT_242	[p14l2029t3077r2140b3149],
19	triple	JJ	O	triple	amod	20	SENT_242	[p14l11t3192r200b3287],
20	therapy	NN	O	therapy	dobj	17	SENT_242	[p14l239t3192r514b3287],
21	the	DT	O	the	det	23	SENT_242	[p14l549t3192r660b3264],
22	RBV	NN	O	rbv	nn	23	SENT_242	[p14l699t3197r883b3264],
23	dose	NN	O	dose	nsubj	24	SENT_242	[p14l917t3192r1077b3265],
24	had	VBD	O	have	rcmod	20	SENT_242	[p14l1114t3192r1248b3265],
25	to	TO	O	to	aux	27	SENT_242	[p14l1287t3217r1356b3264],
26	be	VB	O	be	auxpass	27	SENT_242	[p14l1397t3192r1478b3264],
27	reduced	VBN	O	reduce	xcomp	24	SENT_242	[p14l1518t3192r1804b3265],
28	more	RBR	O	more	advmod	29	SENT_242	[p14l1842t3221r2030b3264],
29	in	IN	O	in	advmod	27	SENT_242	[p14l2069t3197r2139b3263],

1	Table	NNP	O	Table	_	0	SENT_243	[p14l64t3450r240b3510],
2	3	CD	NUMBER	3	dep	1	SENT_243	[p14l272t3449r334b3510],
3	.	.	O	.	_	0	SENT_243	[p14l272t3449r334b3510],

1	Univariate	NNP	O	Univariate	nn	4	SENT_244	[p14l380t3450r719b3510],
2	and	CC	O	and	_	0	SENT_244	[p14l754t3450r874b3510],
3	Multivariate	NNP	O	Multivariate	nn	4	SENT_244	[p14l914t3450r1316b3510],
4	Analyses	NNS	O	analysis	_	0	SENT_244	[p14l1346t3450r1643b3525],
5	of	IN	O	of	_	0	SENT_244	[p14l1676t3448r1741b3510],
6	Host	NNP	ORGANIZATION	Host	prep_of	4	SENT_244	[p14l1775t3450r1926b3510],
7	and	CC	O	and	_	0	SENT_244	[p14l1959t3450r2079b3510],
8	Viral	JJ	O	viral	amod	9	SENT_244	[p14l69t3549r218b3609],
9	Factors	NNS	O	factor	prep_of	4	SENT_244	[p14l257t3549r500b3609],
10	Associated	VBN	O	associate	partmod	9	SENT_244	[p14l530t3549r899b3609],
11	with	IN	O	with	_	0	SENT_244	[p14l933t3549r1072b3609],
12	Very	RB	O	very	advmod	13	SENT_244	[p14l1104t3549r1249b3624],
13	Low	JJ	O	low	amod	15	SENT_244	[p14l1281t3549r1408b3609],
14	Hemoglobin	NN	O	hemoglobin	nn	15	SENT_244	[p14l1442t3549r1837b3624],
15	Levels	NNS	O	level	prep_with	10	SENT_244	[p14l1876t3549r2078b3609],

1	(	NN	O	(	_	0	SENT_245	[p14l487t3666r677b3741],
2	<	JJR	O	<	dep	1	SENT_245	[p14l487t3666r677b3741],
3	8.5	CD	NUMBER	8.5	num	4	SENT_245	[p14l487t3666r677b3741],
4	g/dL	NN	O	g/dl	rcmod	2	SENT_245	[p14l711t3667r904b3742],
5	)	CD	NUMBER	)	dep	4	SENT_245	[p14l711t3667r904b3742],
6	During	IN	O	during	dep	4	SENT_245	[p14l944t3666r1164b3742],
7	Triple	JJ	O	triple	amod	8	SENT_245	[p14l1191t3666r1374b3741],
8	Therapy	NN	O	therapy	pobj	6	SENT_245	[p14l1405t3667r1668b3742],

1	Univariate	NNP	O	Univariate	nn	3	SENT_246	[p15l714t25r951b68],
2	Analysis	NNP	O	Analysis	nn	3	SENT_246	[p15l973t26r1167b78],
3	Multivariate	NNP	O	Multivariate	_	0	SENT_246	[p15l1532t25r1814b68],
4	Analysis	NN	O	analysis	dep	3	SENT_246	[p15l1835t25r2029b78],

1	Parameter	NN	O	parameter	nn	2	SENT_247	[p15l115t181r358b223],
2	OR	NN	O	or	_	0	SENT_247	[p15l634t180r699b223],
3	(	CD	PERCENT	(	number	4	SENT_247	[p15l725t180r846b232],
4	95	CD	PERCENT	95	num	5	SENT_247	[p15l725t180r846b232],
5	%	NN	PERCENT	%	dep	2	SENT_247	[p15l725t180r846b232],
6	cl	NN	O	cl	nn	9	SENT_247	[p15l871t180r937b232],
7	)	CD	NUMBER	)	num	9	SENT_247	[p15l871t180r937b232],
8	F	NN	O	f	nn	9	SENT_247	[p15l1205t181r1238b222],
9	OR	NN	O	or	dep	5	SENT_247	[p15l1502t180r1567b223],
10	(	CD	PERCENT	(	num	13	SENT_247	[p15l1592t180r1714b232],
11	95	CD	PERCENT	95	number	12	SENT_247	[p15l1592t180r1714b232],
12	%	NN	PERCENT	%	amod	13	SENT_247	[p15l1592t180r1714b232],
13	cl	NN	O	cl	dep	9	SENT_247	[p15l1738t180r1805b232],
14	)	CD	NUMBER	)	num	15	SENT_247	[p15l1738t180r1805b232],
15	P	NN	O	p	dep	2	SENT_247	[p15l2046t181r2078b222],

1	Sex	NN	O	sex	dep	11	SENT_248	[p15l10t346r101b396],
2	(	CD	NUMBER	(	num	1	SENT_248	[p15l127t347r341b407],
3	female	JJ	O	female	amod	4	SENT_248	[p15l127t347r341b407],
4	)	JJ	O	)	amod	6	SENT_248	[p15l127t347r341b407],
5	6.1	CD	NUMBER	6.1	number	6	SENT_248	[p15l590t347r671b396],
6	(	CD	NUMBER	(	dep	1	SENT_248	[p15l704t346r982b407],
7	1.5	CD	NUMBER	1.5	dep	6	SENT_248	[p15l704t346r982b407],
8	—	NN	O	—	dep	11	SENT_248	[p15l704t346r982b407],
9	25.1	CD	NUMBER	25.1	num	8	SENT_248	[p15l704t346r982b407],
10	)	CD	NUMBER	)	number	11	SENT_248	[p15l704t346r982b407],
11	0.007	CD	NUMBER	0.007	dep	19	SENT_248	[p15l1115t346r1271b396],
12	Age	NNP	O	Age	prep	11	SENT_248	[p15l9t436r101b497],
13	(	CD	NUMBER	(	num	16	SENT_248	[p15l130t435r273b496],
14	>	JJR	O	>	amod	16	SENT_248	[p15l130t435r273b496],
15	60	CD	DURATION	60	num	16	SENT_248	[p15l130t435r273b496],
16	years	NNS	NUMBER	year	dep	12	SENT_248	[p15l300t436r452b496],
17	)	CD	NUMBER	)	num	19	SENT_248	[p15l300t436r452b496],
18	6.8	CD	NUMBER	6.8	num	19	SENT_248	[p15l590t435r674b485],
19	(	NN	O	(	dep	27	SENT_248	[p15l704t435r982b496],
20	1.8	CD	NUMBER	1.8	number	21	SENT_248	[p15l704t435r982b496],
21	—	CD	NUMBER	—	dep	19	SENT_248	[p15l704t435r982b496],
22	26.0	CD	NUMBER	26.0	num	23	SENT_248	[p15l704t435r982b496],
23	)	NN	O	)	dep	21	SENT_248	[p15l704t435r982b496],
24	0.004	CD	NUMBER	0.004	number	25	SENT_248	[p15l1115t435r1272b485],
25	10.1	CD	NUMBER	10.1	num	26	SENT_248	[p15l1426t435r1538b485],
26	(	NN	O	(	dep	21	SENT_248	[p15l1571t435r1850b496],
27	1.9	CD	NUMBER	1.9	dep	35	SENT_248	[p15l1571t435r1850b496],
28	—	CD	NUMBER	—	number	29	SENT_248	[p15l1571t435r1850b496],
29	53.9	CD	NUMBER	53.9	dep	27	SENT_248	[p15l1571t435r1850b496],
30	)	NN	O	)	nn	33	SENT_248	[p15l1571t435r1850b496],
31	0.007	CD	NUMBER	0.007	num	33	SENT_248	[p15l1982t435r2139b485],
32	Body	NN	O	body	nn	33	SENT_248	[p15l12t524r137b584],
33	weight	NN	O	weight	dep	29	SENT_248	[p15l162t524r328b585],
34	23.8	CD	NUMBER	23.8	num	35	SENT_248	[p15l553t523r674b573],
35	(	NN	O	(	dep	42	SENT_248	[p15l704t523r1019b584],
36	2.9	CD	NUMBER	2.9	dep	35	SENT_248	[p15l704t523r1019b584],
37	—	CD	NUMBER	—	number	38	SENT_248	[p15l704t523r1019b584],
38	200.0	CD	NUMBER	200.0	num	39	SENT_248	[p15l704t523r1019b584],
39	)	NN	O	)	npadvmod	40	SENT_248	[p15l704t523r1019b584],
40	<	JJR	O	<	amod	36	SENT_248	[p15l1117t523r1323b575],
41	0.001	CD	NUMBER	0.001	num	42	SENT_248	[p15l1117t523r1323b575],
42	33.3	CD	NUMBER	33.3	dep	47	SENT_248	[p15l1420t523r1540b573],
43	(	NN	O	(	dep	42	SENT_248	[p15l1571t523r1887b584],
44	3.4	CD	NUMBER	3.4	num	43	SENT_248	[p15l1571t523r1887b584],
45	—	CD	NUMBER	—	number	46	SENT_248	[p15l1571t523r1887b584],
46	333.3	CD	NUMBER	333.3	dep	43	SENT_248	[p15l1571t523r1887b584],
47	)	NN	O	)	_	0	SENT_248	[p15l1571t523r1887b584],
48	0.003	CD	NUMBER	0.003	num	47	SENT_248	[p15l1982t523r2138b573],

1	(	NN	O	(	_	0	SENT_249	[p15l85t611r227b672],
2	<	JJR	O	<	dep	1	SENT_249	[p15l85t611r227b672],
3	60	CD	NUMBER	60	num	5	SENT_249	[p15l85t611r227b672],
4	kg	NN	O	kg	nn	5	SENT_249	[p15l257t612r330b673],
5	)	NN	O	)	dep	1	SENT_249	[p15l257t612r330b673],

1	Body	NN	O	body	nn	3	SENT_250	[p15l12t701r137b761],
2	mass	NN	O	mass	nn	3	SENT_250	[p15l166t712r298b750],
3	index	NN	O	index	_	0	SENT_250	[p15l327t701r461b750],
4	14.1	CD	NUMBER	14.1	number	5	SENT_250	[p15l558t700r670b749],
5	(	CD	NUMBER	(	dep	3	SENT_250	[p15l704t700r1019b761],
6	1.7	CD	NUMBER	1.7	num	7	SENT_250	[p15l704t700r1019b761],
7	—	NN	O	—	dep	3	SENT_250	[p15l704t700r1019b761],
8	125.0	CD	NUMBER	125.0	number	9	SENT_250	[p15l704t700r1019b761],
9	)	CD	NUMBER	)	num	10	SENT_250	[p15l704t700r1019b761],
10	0.001	CD	NUMBER	0.001	dep	7	SENT_250	[p15l1115t700r1268b750],

1	Hemoglobin	NN	O	hemoglobin	_	0	SENT_251	[p15l12t878r315b939],
2	4.3	CD	NUMBER	4.3	num	1	SENT_251	[p15l589t877r673b926],
3	(	CD	NUMBER	(	number	4	SENT_251	[p15l704t877r982b937],
4	1.2	CD	NUMBER	1.2	num	5	SENT_251	[p15l704t877r982b937],
5	—	NN	O	—	dep	1	SENT_251	[p15l704t877r982b937],
6	15.6	CD	NUMBER	15.6	number	7	SENT_251	[p15l704t877r982b937],
7	)	CD	NUMBER	)	dep	1	SENT_251	[p15l704t877r982b937],
8	0.023	CD	NUMBER	0.023	dep	7	SENT_251	[p15l1115t877r1270b926],

1	(	NN	O	(	_	0	SENT_252	[p15l84t965r227b1026],
2	<	JJR	O	<	dep	1	SENT_252	[p15l84t965r227b1026],
3	14	CD	NUMBER	14	num	5	SENT_252	[p15l84t965r227b1026],
4	g/dL	NN	O	g/dl	nn	5	SENT_252	[p15l255t966r395b1027],
5	)	NN	O	)	dep	1	SENT_252	[p15l255t966r395b1027],

1	Abbreviations	NNS	O	abbreviation	_	0	SENT_253	[p15l75t1142r437b1191],
2	:	:	O	:	_	0	SENT_253	[p15l75t1142r437b1191],
3	OR	NN	O	or	dep	1	SENT_253	[p15l469t1141r554b1199],
4	,	,	O	,	_	0	SENT_253	[p15l469t1141r554b1199],
5	odds	NNS	O	odds	nn	6	SENT_253	[p15l584t1142r709b1191],
6	ratio	NN	O	ratio	appos	3	SENT_253	[p15l739t1142r862b1199],
7	;	:	O	;	_	0	SENT_253	[p15l739t1142r862b1199],
8	CI	NN	O	ci	dep	1	SENT_253	[p15l893t1141r954b1199],
9	,	,	O	,	_	0	SENT_253	[p15l893t1141r954b1199],
10	confidence	NN	O	confidence	nn	11	SENT_253	[p15l985t1141r1265b1191],
11	level	NN	O	level	appos	8	SENT_253	[p15l1295t1142r1420b1191],
12	.	.	O	.	_	0	SENT_253	[p15l1295t1142r1420b1191],

1	420	CD	NUMBER	420	_	0	SENT_254	[p15l9t1240r112b1292],
2	SUZUKI	NNP	O	SUZUKI	nn	4	SENT_254	[p15l226t1242r479b1292],
3	ET	NNP	O	ET	nn	4	SENT_254	[p15l507t1241r593b1291],
4	AL.	NNP	O	AL.	dep	1	SENT_254	[p15l610t1243r709b1292],
5	.	.	O	.	_	0	SENT_254	[p15l610t1243r709b1292],

1	patients	NNS	O	patient	_	0	SENT_255	[p15l10t1457r291b1547],
2	with	IN	O	with	_	0	SENT_255	[p15l323t1452r487b1524],
3	CC	NN	O	cc	prep_with	1	SENT_255	[p15l523t1456r652b1524],
4	than	IN	O	than	_	0	SENT_255	[p15l687t1452r848b1524],
5	CA/AA	NN	O	ca/aa	nn	6	SENT_255	[p15l884t1455r1159b1524],
6	genotypes	NNS	O	genotype	prep_than	3	SENT_255	[p15l1190t1476r1549b1548],
7	during	IN	O	during	_	0	SENT_255	[p15l1583t1452r1827b1548],
8	the	DT	O	the	det	9	SENT_255	[p15l1859t1452r1970b1524],
9	ﬁrst	NN	O	ﬁrst	prep_during	6	SENT_255	[p15l2003t1452r2141b1523],
10	12	CD	DURATION	12	num	11	SENT_255	[p15l19t1573r101b1636],
11	weeks	NNS	NUMBER	week	dep	14	SENT_255	[p15l129t1566r342b1638],
12	While	IN	O	while	dep	14	SENT_255	[p15l369t1566r566b1638],
13	they	PRP	O	they	nsubj	14	SENT_255	[p15l596t1566r752b1660],
14	received	VBD	O	receive	dep	1	SENT_255	[p15l778t1566r1069b1638],
15	telaprevir	NN	O	telaprevir	dobj	14	SENT_255	[p15l1099t1566r1437b1661],
16	(	CD	NUMBER	(	number	17	SENT_255	[p15l1470t1567r1586b1652],
17	52	CD	NUMBER	52	dep	15	SENT_255	[p15l1470t1567r1586b1652],
18	i	FW	O	i	dep	17	SENT_255	[p15l1624t1575r1683b1633],
19	14	CD	PERCENT	14	num	20	SENT_255	[p15l1733t1567r1895b1640],
20	%	NN	PERCENT	%	dep	14	SENT_255	[p15l1733t1567r1895b1640],
21	vs.	CC	O	vs.	prep	20	SENT_255	[p15l1924t1596r2012b1638],
22	65	CD	NUMBER	65	dep	21	SENT_255	[p15l2048t1568r2134b1643],
23	:	:	O	:	_	0	SENT_255	[p15l18t1689r77b1747],
24	21	CD	PERCENT	21	num	25	SENT_255	[p15l115t1686r286b1754],
25	%	NN	PERCENT	%	dep	1	SENT_255	[p15l115t1686r286b1754],
26	of	IN	O	of	_	0	SENT_255	[p15l317t1680r400b1751],
27	the	DT	O	the	det	29	SENT_255	[p15l414t1680r525b1751],
28	target	NN	O	target	nn	29	SENT_255	[p15l553t1704r758b1776],
29	dose	NN	O	dose	prep_of	25	SENT_255	[p15l783t1680r962b1762],
30	,	,	O	,	_	0	SENT_255	[p15l783t1680r962b1762],
31	P	NN	O	p	appos	29	SENT_255	[p15l991t1685r1050b1750],
32	=	JJ	O	=	amod	34	SENT_255	[p15l1072t1714r1138b1737],
33	0.039	CD	NUMBER	0.039	tmod	32	SENT_255	[p15l1170t1681r1428b1766],
34	)	NN	O	)	dep	31	SENT_255	[p15l1170t1681r1428b1766],
35	.	.	O	.	_	0	SENT_255	[p15l1170t1681r1428b1766],

1	During	IN	O	during	_	0	SENT_256	[p15l1461t1685r1729b1776],
2	the	DT	O	the	det	5	SENT_256	[p15l1755t1680r1865b1752],
3	second	JJ	ORDINAL	second	amod	5	SENT_256	[p15l1893t1680r2140b1752],
4	12	CD	DURATION	12	num	5	SENT_256	[p15l19t1801r101b1865],
5	weeks	NNS	NUMBER	week	prep_during	14	SENT_256	[p15l153t1794r366b1866],
6	off	IN	O	off	_	0	SENT_256	[p15l420t1794r530b1866],
7	telaprevir	NN	O	telaprevir	prep_off	5	SENT_256	[p15l572t1794r922b1889],
8	,	,	O	,	_	0	SENT_256	[p15l572t1794r922b1889],
9	the	DT	O	the	det	11	SENT_256	[p15l981t1794r1091b1866],
10	RBV	NN	O	rbv	nn	11	SENT_256	[p15l1146t1799r1330b1866],
11	dose	NN	O	dose	nsubj	14	SENT_256	[p15l1379t1794r1539b1867],
12	was	VBD	O	be	cop	14	SENT_256	[p15l1589t1824r1719b1866],
13	somewhat	RB	O	somewhat	advmod	14	SENT_256	[p15l1774t1794r2141b1866],
14	greater	JJR	O	greater	dep	22	SENT_256	[p15l10t1933r256b2004],
15	in	IN	O	in	_	0	SENT_256	[p15l282t1913r353b1979],
16	patients	NNS	O	patient	prep_in	14	SENT_256	[p15l379t1913r660b2003],
17	with	IN	O	with	_	0	SENT_256	[p15l685t1908r850b1980],
18	CC	NN	O	cc	prep_with	16	SENT_256	[p15l878t1912r1007b1980],
19	than	IN	O	than	_	0	SENT_256	[p15l1036t1908r1199b1980],
20	CNAA	NN	ORGANIZATION	cnaa	nn	21	SENT_256	[p15l1227t1911r1502b1980],
21	genotypes	NNS	O	genotype	prep_than	14	SENT_256	[p15l1526t1932r1885b2004],
22	(	VBP	O	(	_	0	SENT_256	[p15l1918t1909r2035b1994],
23	47	CD	NUMBER	47	nsubj	24	SENT_256	[p15l1918t1909r2035b1994],
24	i	FW	O	i	xcomp	22	SENT_256	[p15l2072t1917r2130b1976],
25	24	CD	PERCENT	24	num	26	SENT_256	[p15l10t2023r181b2096],
26	%	NN	PERCENT	%	dep	24	SENT_256	[p15l10t2023r181b2096],
27	Vs.	NN	O	v.	dep	24	SENT_256	[p15l222t2052r311b2093],
28	43	CD	NUMBER	43	num	27	SENT_256	[p15l356t2023r445b2097],
29	i	FW	O	i	dep	27	SENT_256	[p15l497t2031r555b2089],
30	20	CD	PERCENT	20	num	31	SENT_256	[p15l607t2028r800b2104],
31	%	NN	PERCENT	%	nsubj	22	SENT_256	[p15l607t2028r800b2104],
32	,	,	O	,	_	0	SENT_256	[p15l607t2028r800b2104],
33	P	NN	O	p	appos	31	SENT_256	[p15l843t2027r902b2092],
34	=	JJ	O	=	amod	36	SENT_256	[p15l938t2056r1004b2079],
35	0.649	CD	NUMBER	0.649	tmod	34	SENT_256	[p15l1050t2023r1307b2107],
36	)	NN	O	)	dep	33	SENT_256	[p15l1050t2023r1307b2107],
37	.	.	O	.	_	0	SENT_256	[p15l1050t2023r1307b2107],

1	Thus	RB	O	thus	advmod	13	SENT_257	[p15l1351t2022r1560b2103],
2	,	,	O	,	_	0	SENT_257	[p15l1351t2022r1560b2103],
3	the	DT	O	the	det	6	SENT_257	[p15l1606t2022r1716b2093],
4	total	JJ	O	total	amod	6	SENT_257	[p15l1757t2022r1918b2093],
5	RBV	NN	O	rbv	nn	6	SENT_257	[p15l1960t2027r2144b2093],
6	dose	NN	O	dose	nsubj	13	SENT_257	[p15l11t2136r170b2209],
7	during	IN	O	during	_	0	SENT_257	[p15l200t2136r443b2232],
8	24	CD	DURATION	24	num	9	SENT_257	[p15l471t2137r562b2207],
9	weeks	NNS	NUMBER	week	prep_during	6	SENT_257	[p15l589t2136r803b2208],
10	of	IN	O	of	_	0	SENT_257	[p15l833t2136r917b2208],
11	therapy	NN	O	therapy	prep_of	9	SENT_257	[p15l933t2136r1207b2231],
12	was	VBD	O	be	cop	13	SENT_257	[p15l1229t2166r1360b2208],
13	comparable	JJ	O	comparable	dep	21	SENT_257	[p15l1391t2136r1812b2231],
14	between	IN	O	between	_	0	SENT_257	[p15l1842t2136r2140b2208],
15	patients	NNS	O	patient	prep_between	13	SENT_257	[p15l10t2255r291b2346],
16	with	IN	O	with	_	0	SENT_257	[p15l320t2250r485b2322],
17	CC	NN	O	cc	nn	20	SENT_257	[p15l518t2254r646b2322],
18	and	CC	O	and	_	0	SENT_257	[p15l679t2250r813b2323],
19	CA/AA	NN	O	ca/aa	nn	20	SENT_257	[p15l845t2253r1121b2322],
20	genotypes	NNS	O	genotype	prep_with	15	SENT_257	[p15l1148t2275r1506b2347],
21	(	VBP	O	(	_	0	SENT_257	[p15l1544t2252r1651b2336],
22	51	CD	NUMBER	51	dobj	21	SENT_257	[p15l1544t2252r1651b2336],
23	i	FW	O	i	dep	22	SENT_257	[p15l1700t2260r1758b2318],
24	15	CD	PERCENT	15	number	25	SENT_257	[p15l1809t2256r1972b2327],
25	%	NN	PERCENT	%	amod	23	SENT_257	[p15l1809t2256r1972b2327],
26	and	CC	O	and	_	0	SENT_257	[p15l2007t2251r2140b2323],
27	57	CD	NUMBER	57	dobj	21	SENT_257	[p15l14t2370r102b2441],
28	i	FW	O	i	dep	27	SENT_257	[p15l141t2373r199b2431],
29	18	CD	PERCENT	18	num	30	SENT_257	[p15l249t2370r433b2446],
30	%	NN	PERCENT	%	nsubj	21	SENT_257	[p15l249t2370r433b2446],
31	,	,	O	,	_	0	SENT_257	[p15l249t2370r433b2446],
32	P	NN	O	p	appos	30	SENT_257	[p15l465t2369r524b2434],
33	=	JJ	O	=	amod	35	SENT_257	[p15l550t2398r615b2421],
34	0.724	CD	NUMBER	0.724	tmod	33	SENT_257	[p15l651t2365r909b2449],
35	)	NN	O	)	dep	32	SENT_257	[p15l651t2365r909b2449],
36	.	.	O	.	_	0	SENT_257	[p15l651t2365r909b2449],

1	Likewise	RB	O	likewise	advmod	54	SENT_258	[p15l944t2364r1274b2445],
2	,	,	O	,	_	0	SENT_258	[p15l944t2364r1274b2445],
3	the	DT	O	the	det	5	SENT_258	[p15l1309t2364r1419b2435],
4	total	JJ	O	total	amod	5	SENT_258	[p15l1450t2364r1611b2435],
5	dose	NN	O	dose	nsubj	54	SENT_258	[p15l1642t2364r1801b2436],
6	of	IN	O	of	_	0	SENT_258	[p15l1832t2364r1915b2435],
7	PEGIFN	NNP	O	PEGIFN	prep_of	5	SENT_258	[p15l1934t2368r2138b2435, p15l11t2483r165b2550],
8	(	CD	NUMBER	(	number	9	SENT_258	[p15l199t2479r316b2564],
9	87	CD	NUMBER	87	dep	5	SENT_258	[p15l199t2479r316b2564],
10	i	FW	O	i	dep	9	SENT_258	[p15l353t2487r411b2546],
11	23	CD	PERCENT	23	num	12	SENT_258	[p15l451t2484r622b2554],
12	%	NN	PERCENT	%	dep	9	SENT_258	[p15l451t2484r622b2554],
13	vs.	CC	O	vs.	prep	12	SENT_258	[p15l650t2508r739b2550],
14	86	CD	NUMBER	86	dep	13	SENT_258	[p15l776t2481r864b2550],
15	i	FW	O	i	dep	35	SENT_258	[p15l902t2487r960b2546],
16	20	CD	PERCENT	20	number	17	SENT_258	[p15l1000t2484r1171b2552],
17	%	NN	PERCENT	%	amod	15	SENT_258	[p15l1000t2484r1171b2552],
18	of	IN	O	of	_	0	SENT_258	[p15l1203t2478r1287b2550],
19	the	DT	O	the	det	20	SENT_258	[p15l1302t2478r1413b2550],
20	target	NN	O	target	prep_of	15	SENT_258	[p15l1443t2503r1664b2574],
21	,	,	O	,	_	0	SENT_258	[p15l1443t2503r1664b2574],
22	P	NN	O	p	appos	20	SENT_258	[p15l1694t2483r1753b2549],
23	=	JJ	O	=	amod	25	SENT_258	[p15l1777t2512r1843b2536],
24	0.806	CD	NUMBER	0.806	tmod	23	SENT_258	[p15l1878t2479r2136b2564],
25	)	NN	O	)	dep	22	SENT_258	[p15l1878t2479r2136b2564],
26	,	,	O	,	_	0	SENT_258	[p15l1878t2479r2136b2564],
27	as	RB	O	as	_	0	SENT_258	[p15l11t2622r76b2664],
28	well	RB	O	well	_	0	SENT_258	[p15l106t2592r253b2664],
29	as	IN	O	as	_	0	SENT_258	[p15l286t2622r350b2664],
30	that	DT	O	that	conj_and	20	SENT_258	[p15l385t2592r528b2664],
31	of	IN	O	of	_	0	SENT_258	[p15l558t2592r641b2664],
32	telaprevir	NN	O	telaprevir	prep_of	30	SENT_258	[p15l662t2592r1000b2688],
33	(	CD	NUMBER	(	num	32	SENT_258	[p15l1036t2594r1154b2678],
34	87	CD	NUMBER	87	dep	35	SENT_258	[p15l1036t2594r1154b2678],
35	i	FW	O	i	dep	40	SENT_258	[p15l1194t2602r1253b2660],
36	27	CD	PERCENT	27	num	37	SENT_258	[p15l1297t2598r1468b2669],
37	%	NN	PERCENT	%	dep	35	SENT_258	[p15l1297t2598r1468b2669],
38	vs.	CC	O	vs.	prep	37	SENT_258	[p15l1501t2622r1590b2664],
39	71	CD	NUMBER	71	dep	38	SENT_258	[p15l1627t2600r1710b2669],
40	i	FW	O	i	dep	12	SENT_258	[p15l1760t2602r1818b2660],
41	36	CD	PERCENT	36	number	42	SENT_258	[p15l1864t2595r2033b2668],
42	%	NN	PERCENT	%	amod	40	SENT_258	[p15l1864t2595r2033b2668],
43	of	IN	O	of	_	0	SENT_258	[p15l2070t2592r2152b2664],
44	the	DT	O	the	det	45	SENT_258	[p15l11t2706r122b2778],
45	target	NN	O	target	prep_of	40	SENT_258	[p15l155t2730r377b2802],
46	,	,	O	,	_	0	SENT_258	[p15l155t2730r377b2802],
47	P	NN	O	p	appos	5	SENT_258	[p15l412t2711r471b2776],
48	=	JJ	O	=	amod	50	SENT_258	[p15l500t2740r565b2763],
49	0.098	CD	NUMBER	0.098	tmod	48	SENT_258	[p15l603t2707r862b2792],
50	)	NN	O	)	dep	47	SENT_258	[p15l603t2707r862b2792],
51	,	,	O	,	_	0	SENT_258	[p15l603t2707r862b2792],
52	was	VBD	O	be	cop	54	SENT_258	[p15l896t2736r1027b2778],
53	no	RB	O	no	advmod	54	SENT_258	[p15l1061t2735r1152b2778],
54	different	JJ	O	different	_	0	SENT_258	[p15l1187t2706r1496b2779],
55	between	IN	O	between	_	0	SENT_258	[p15l1527t2706r1825b2778],
56	patients	NNS	O	patient	prep_between	54	SENT_258	[p15l1857t2711r2138b2801],
57	with	IN	O	with	_	0	SENT_258	[p15l7t2820r172b2892],
58	CC	NN	O	cc	nn	61	SENT_258	[p15l204t2824r333b2892],
59	and	CC	O	and	_	0	SENT_258	[p15l366t2820r500b2893],
60	CA/AA	NN	O	ca/aa	nn	61	SENT_258	[p15l532t2823r807b2892],
61	genotypes	NNS	O	genotype	prep_with	56	SENT_258	[p15l836t2845r1212b2916],
62	.	.	O	.	_	0	SENT_258	[p15l836t2845r1212b2916],

1	SVR	NN	ORGANIZATION	svr	nsubjpass	3	SENT_259	[p15l1251t2824r1425b2892],
2	was	VBD	O	be	auxpass	3	SENT_259	[p15l1448t2850r1578b2892],
3	achieved	VBN	O	achieve	dep	8	SENT_259	[p15l1612t2820r1921b2893],
4	comparably	RB	O	comparably	dep	3	SENT_259	[p15l1952t2849r2138b2892, p15l10t2934r280b3030],
5	frequently	RB	O	frequently	advmod	4	SENT_259	[p15l304t2934r676b3030],
6	in	IN	O	in	_	0	SENT_259	[p15l700t2939r771b3005],
7	them	PRP	O	they	prep_in	4	SENT_259	[p15l798t2934r984b3006],
8	(	VBP	O	(	_	0	SENT_259	[p15l1018t2936r1214b3020],
9	71	CD	PERCENT	71	num	10	SENT_259	[p15l1018t2936r1214b3020],
10	%	NN	PERCENT	%	nsubj	16	SENT_259	[p15l1018t2936r1214b3020],
11	vs.	CC	O	vs.	prep	10	SENT_259	[p15l1240t2964r1329b3006],
12	67	CD	PERCENT	67	num	13	SENT_259	[p15l1363t2937r1556b3016],
13	%	NN	PERCENT	%	dep	11	SENT_259	[p15l1363t2937r1556b3016],
14	,	,	O	,	_	0	SENT_259	[p15l1363t2937r1556b3016],
15	P	NN	O	p	appos	13	SENT_259	[p15l1584t2939r1643b3005],
16	=	JJ	O	=	xcomp	8	SENT_259	[p15l1665t2968r1731b2992],
17	0.736	CD	NUMBER	0.736	num	18	SENT_259	[p15l1764t2936r2021b3020],
18	)	NN	O	)	nsubj	8	SENT_259	[p15l1764t2936r2021b3020],
19	.	.	O	.	_	0	SENT_259	[p15l1764t2936r2021b3020],

1	Decreases	VBZ	O	decrease	csubj	11	SENT_260	[p15l109t3053r469b3120],
2	in	IN	O	in	_	0	SENT_260	[p15l522t3054r594b3119],
3	hemoglobin	NN	O	hemoglobin	nn	4	SENT_260	[p15l643t3049r1094b3145],
4	levels	NNS	O	level	prep_in	1	SENT_260	[p15l1145t3049r1340b3120],
5	during	IN	O	during	_	0	SENT_260	[p15l1392t3049r1642b3145],
6	the	DT	O	the	det	7	SENT_260	[p15l1691t3049r1804b3120],
7	ﬁrst	NN	O	ﬁrst	prep_during	1	SENT_260	[p15l1855t3049r1997b3120],
8	12	CD	DURATION	12	num	9	SENT_260	[p15l2055t3056r2138b3119],
9	week	NN	NUMBER	week	tmod	7	SENT_260	[p15l7t3164r198b3236],
10	were	VBD	O	be	cop	11	SENT_260	[p15l243t3193r416b3236],
11	similar	JJ	O	similar	_	0	SENT_260	[p15l468t3164r721b3236],
12	between	IN	O	between	_	0	SENT_260	[p15l771t3164r1076b3236],
13	the	DT	O	the	det	17	SENT_260	[p15l1128t3164r1241b3236],
14	current	JJ	DATE	current	amod	17	SENT_260	[p15l1294t3189r1563b3237],
15	triple	JJ	O	triple	amod	17	SENT_260	[p15l1613t3164r1809b3259],
16	therapy	NN	O	therapy	nn	17	SENT_260	[p15l1861t3164r2143b3259],
17	cohort	NN	O	cohort	prep_between	11	SENT_260	[p15l11t3278r254b3350],
18	and	CC	O	and	_	0	SENT_260	[p15l305t3278r441b3351],
19	previous	JJ	O	previous	amod	20	SENT_260	[p15l491t3283r804b3374],
20	patients	NNS	O	patient	prep_between	11	SENT_260	[p15l855t3283r1146b3374],
21	receiving	VBG	O	receive	xcomp	11	SENT_260	[p15l1199t3283r1532b3375],
22	PEG	NN	O	peg	dobj	21	SENT_260	[p15l1583t3282r1953b3350],
23	.	.	O	.	_	0	SENT_260	[p15l1583t3282r1953b3350],

1	—	NN	O	—	_	0	SENT_261	[p15l1583t3282r1953b3350],
2	.	.	O	.	_	0	SENT_261	[p15l1583t3282r1953b3350],

1	IFN	NN	ORGANIZATION	ifn	nsubj	20	SENT_262	[p15l1583t3282r1953b3350],
2	and	CC	O	and	_	0	SENT_262	[p15l2004t3278r2140b3351],
3	RBV	NN	O	rbv	nsubj	20	SENT_262	[p15l11t3378r370b3465],
4	.12	CD	NUMBER	.12	number	5	SENT_262	[p15l11t3378r370b3465],
5	’13	CD	NUMBER	’13	dep	1	SENT_262	[p15l11t3378r370b3465],
6	The	DT	O	the	det	9	SENT_262	[p15l423t3394r574b3465],
7	conservative	JJ	O	conservative	amod	9	SENT_262	[p15l628t3399r1081b3465],
8	hemoglobin	NN	O	hemoglobin	nn	9	SENT_262	[p15l1133t3394r1584b3490],
9	levels	NNS	O	level	dep	5	SENT_262	[p15l1637t3394r1832b3465],
10	chosen	VBN	O	choose	partmod	1	SENT_262	[p15l1887t3394r2139b3465],
11	for	IN	O	for	_	0	SENT_262	[p15l11t3507r116b3579],
12	RBV	NN	O	rbv	nn	14	SENT_262	[p15l150t3512r336b3579],
13	dose	NN	O	dose	nn	14	SENT_262	[p15l366t3507r530b3580],
14	reduction	NN	O	reduction	prep_for	10	SENT_262	[p15l564t3507r922b3580],
15	may	MD	O	may	aux	20	SENT_262	[p15l956t3536r1115b3602],
16	be	VB	O	be	cop	20	SENT_262	[p15l1145t3507r1229b3579],
17	a	DT	O	a	det	20	SENT_262	[p15l1263t3537r1300b3579],
18	possible	JJ	O	possible	amod	20	SENT_262	[p15l1331t3507r1625b3602],
19	confounding	JJ	O	confounding	amod	20	SENT_262	[p15l1660t3507r2141b3603],
20	factor	NN	O	factor	_	0	SENT_262	[p15l11t3621r225b3693],
21	on	IN	O	on	_	0	SENT_262	[p15l259t3650r353b3693],
22	the	DT	O	the	det	23	SENT_262	[p15l387t3621r501b3693],
23	impact	NN	O	impact	prep_on	20	SENT_262	[p15l536t3626r793b3717],
24	of	IN	O	of	_	0	SENT_262	[p15l826t3621r911b3693],
25	[	CD	NUMBER	[	num	27	SENT_262	[p15l931t3624r1132b3692],
26	TPA	NN	O	tpa	nn	27	SENT_262	[p15l931t3624r1132b3692],
27	variants	NNS	O	variant	prep_of	23	SENT_262	[p15l1159t3626r1447b3693],
28	in	IN	O	in	_	0	SENT_262	[p15l1483t3626r1555b3692],
29	anemia	NN	O	anemia	prep_in	27	SENT_262	[p15l1590t3626r1877b3703],
30	,	,	O	,	_	0	SENT_262	[p15l1590t3626r1877b3703],
31	which	WDT	O	which	nsubj	35	SENT_262	[p15l1913t3621r2140b3693],
32	would	MD	O	would	aux	35	SENT_262	[p15l7t3735r243b3807],
33	have	VB	O	have	aux	35	SENT_262	[p15l285t3735r452b3806],
34	been	VBN	O	be	cop	35	SENT_262	[p15l495t3735r668b3806],
35	greater	JJR	O	greater	rcmod	29	SENT_262	[p15l711t3759r964b3831],
36	should	MD	O	should	aux	42	SENT_262	[p15l1006t3735r1256b3807],
37	the	DT	O	the	det	39	SENT_262	[p15l1299t3735r1412b3806],
38	RBV	NNP	O	RBV	nn	39	SENT_262	[p15l1457t3739r1643b3806],
39	dose	NN	O	dose	nsubjpass	42	SENT_262	[p15l1683t3735r1846b3807],
40	not	RB	O	not	neg	42	SENT_262	[p15l1890t3759r2015b3806],
41	be	VB	O	be	auxpass	42	SENT_262	[p15l2056t3735r2139b3806],
42	reduced	VBN	O	reduce	dep	35	SENT_262	[p16l11t23r305b96],
43	in	IN	O	in	_	0	SENT_262	[p16l334t28r406b94],
44	patients	NNS	O	patient	prep_in	42	SENT_262	[p16l434t28r724b119],
45	with	IN	O	with	_	0	SENT_262	[p16l751t23r920b95],
46	RBV	NN	O	rbv	npadvmod	48	SENT_262	[p16l949t28r1470b95],
47	—	CD	NUMBER	—	num	46	SENT_262	[p16l949t28r1470b95],
48	sensitive	JJ	O	sensitive	amod	50	SENT_262	[p16l949t28r1470b95],
49	CC	NN	O	cc	nn	50	SENT_262	[p16l1501t27r1631b95],
50	genotypes	NNS	O	genotype	prep_with	35	SENT_262	[p16l1660t48r2049b120],
51	.	.	O	.	_	0	SENT_262	[p16l1660t48r2049b120],

1	I	PRP	O	I	nsubj	2	SENT_263	[p16l106t142r150b208],
2	TP/1	VBP	O	tp/1	_	0	SENT_263	[p16l153t140r307b208],
3	polymorphisms	NNS	O	polymorphism	nsubjpass	7	SENT_263	[p16l354t138r937b233],
4	at	IN	O	at	_	0	SENT_263	[p16l988t162r1054b209],
5	rs1127354	NN	O	rs1127354	prep_at	3	SENT_263	[p16l1102t138r1502b214],
6	were	VBD	O	be	auxpass	7	SENT_263	[p16l1549t166r1722b209],
7	associated	VBN	O	associate	ccomp	2	SENT_263	[p16l1772t138r2140b210],
8	with	IN	O	with	_	0	SENT_263	[p16l7t251r176b323],
9	RBV-induced	JJ	MISC	rbv-induced	amod	10	SENT_263	[p16l208t251r720b323],
10	anemia	NN	O	anemia	prep_with	7	SENT_263	[p16l751t256r1020b322],
11	in	IN	O	in	_	0	SENT_263	[p16l1050t256r1122b321],
12	Japanese	JJ	MISC	japanese	amod	13	SENT_263	[p16l1146t256r1469b346],
13	patients	NNS	O	patient	prep_in	7	SENT_263	[p16l1500t256r1812b346],
14	,	,	O	,	_	0	SENT_263	[p16l1500t256r1812b346],
15	Without	IN	O	without	_	0	SENT_263	[p16l1844t251r2141b323],
16	involvement	NN	O	involvement	prep_without	7	SENT_263	[p16l11t365r475b437],
17	of	IN	O	of	_	0	SENT_263	[p16l514t365r599b437],
18	those	DT	O	those	prep_of	16	SENT_263	[p16l627t365r820b437],
19	at	IN	O	at	_	0	SENT_263	[p16l860t390r927b437],
20	rs7270107	CD	NUMBER	rs7270107	prep_at	18	SENT_263	[p16l966t372r1367b442],
21	reported	VBN	O	report	partmod	16	SENT_263	[p16l1408t365r1724b461],
22	in	IN	O	in	_	0	SENT_263	[p16l1764t370r1836b436],
23	Caucasian	JJ	LOCATION	caucasian	prep_in	21	SENT_263	[p16l1878t369r2138b438, p16l11t486r154b552],
24	and	CC	O	and	_	0	SENT_263	[p16l185t481r322b553],
25	African	JJ	MISC	african	prep_in	21	SENT_263	[p16l347t481r1020b552],
26	.	.	O	.	_	0	SENT_263	[p16l347t481r1020b552],

1	—	NN	O	—	_	0	SENT_264	[p16l347t481r1020b552],
2	.	.	O	.	_	0	SENT_264	[p16l347t481r1020b552],

1	American	JJ	MISC	american	amod	2	SENT_265	[p16l347t481r1020b552],
2	patients	NNS	O	patient	_	0	SENT_265	[p16l1051t465r1439b576],
3	.	.	O	.	_	0	SENT_265	[p16l1051t465r1439b576],

1	”	NN	O	”	ccomp	9	SENT_266	[p16l1051t465r1439b576],
2	Thus	RB	O	thus	advmod	1	SENT_266	[p16l1470t481r1684b562],
3	,	,	O	,	_	0	SENT_266	[p16l1470t481r1684b562],
4	ITPA	NN	O	itpa	nn	5	SENT_266	[p16l1717t483r1918b551],
5	polymorphisms	NNS	O	polymorphism	nsubj	9	SENT_266	[p16l1947t481r2138b576, p16l11t594r428b689],
6	at	IN	O	at	_	0	SENT_266	[p16l480t618r546b665],
7	rs1127354	NN	O	rs1127354	prep_at	5	SENT_266	[p16l594t595r994b671],
8	would	MD	O	would	aux	9	SENT_266	[p16l1041t594r1277b666],
9	play	VB	O	play	_	0	SENT_266	[p16l1325t594r1482b689],
10	a	DT	O	a	det	12	SENT_266	[p16l1528t624r1565b665],
11	major	JJ	O	major	amod	12	SENT_266	[p16l1612t600r1831b690],
12	role	NN	O	role	dobj	9	SENT_266	[p16l1880t594r2018b665],
13	in	IN	O	in	_	0	SENT_266	[p16l2068t599r2139b664],
14	protecting	VBG	O	protect	prepc_in	9	SENT_266	[p16l10t713r395b804],
15	patients	NNS	O	patient	dobj	14	SENT_266	[p16l427t713r718b803],
16	from	IN	O	from	_	0	SENT_266	[p16l754t708r936b779],
17	RBV-induced	JJ	O	rbv-induced	amod	18	SENT_266	[p16l972t708r1485b780],
18	anemia	NN	O	anemia	prep_from	14	SENT_266	[p16l1520t713r1806b780],
19	.	.	O	.	_	0	SENT_266	[p16l1520t713r1806b780],

1	CC	NN	O	cc	_	0	SENT_267	[p16l1848t711r2009b780],
2	/	:	O	/	punct	1	SENT_267	[p16l1848t711r2009b780],
3	CA	NNP	O	CA	nn	4	SENT_267	[p16l2015t712r2142b780],
4	genotypes	NNS	O	genotype	nsubj	7	SENT_267	[p16l10t846r378b918],
5	at	IN	O	at	_	0	SENT_267	[p16l417t846r483b893],
6	rs1127354	NN	O	rs1127354	prep_at	4	SENT_267	[p16l519t822r919b898],
7	occurs	VBZ	O	occur	dep	1	SENT_267	[p16l957t850r1191b894],
8	in	IN	O	in	_	0	SENT_267	[p16l1229t827r1301b892],
9	6	CD	PERCENT	6	num	10	SENT_267	[p16l1338t824r1462b896],
10	%	NN	PERCENT	%	prep_in	7	SENT_267	[p16l1338t824r1462b896],
11	of	IN	O	of	_	0	SENT_267	[p16l1501t822r1585b893],
12	the	DT	O	the	det	14	SENT_267	[p16l1610t822r1723b893],
13	Caucasian	JJ	MISC	caucasian	amod	14	SENT_267	[p16l1761t825r2139b894],
14	population	NN	O	population	prep_of	10	SENT_267	[p16l10t937r442b1032],
15	,	,	O	,	_	0	SENT_267	[p16l10t937r442b1032],
16	much	RB	O	much	advmod	18	SENT_267	[p16l480t937r692b1009],
17	less	RBR	O	less	advmod	18	SENT_267	[p16l724t937r845b1008],
18	often	RB	O	often	advmod	7	SENT_267	[p16l880t937r1070b1008],
19	in	IN	O	in	_	0	SENT_267	[p16l1105t942r1176b1007],
20	the	DT	O	the	det	22	SENT_267	[p16l1210t937r1323b1008],
21	Oriental	JJ	MISC	oriental	amod	22	SENT_267	[p16l1358t937r1670b1009],
22	population	NN	O	population	prep_in	18	SENT_267	[p16l1703t937r2135b1032],
23	,	,	O	,	_	0	SENT_267	[p16l1703t937r2135b1032],
24	at	IN	O	at	_	0	SENT_267	[p16l11t1105r77b1153],
25	16	CD	PERCENT	16	num	26	SENT_267	[p16l120t1065r478b1155],
26	%	NN	PERCENT	%	prep_at	7	SENT_267	[p16l120t1065r478b1155],
27	.25	CD	NUMBER	.25	number	28	SENT_267	[p16l120t1065r478b1155],
28	’27	CD	NUMBER	’27	num	26	SENT_267	[p16l120t1065r478b1155],
29	Although	IN	O	although	mark	36	SENT_267	[p16l508t1081r866b1177],
30	AC	NN	O	ac	nsubj	36	SENT_267	[p16l897t1084r1058b1153],
31	/	:	O	/	punct	33	SENT_267	[p16l897t1084r1058b1153],
32	CC	NN	O	cc	nn	33	SENT_267	[p16l1064t1085r1194b1153],
33	genotypes	NNS	O	genotype	dep	30	SENT_267	[p16l1230t1105r1598b1177],
34	at	IN	O	at	_	0	SENT_267	[p16l1637t1105r1703b1153],
35	rs7270107	NN	O	rs7270107	prep_at	33	SENT_267	[p16l1738t1088r2139b1157],
36	occurs	VBZ	O	occur	advcl	46	SENT_267	[p16l11t1224r244b1268],
37	in	IN	O	in	_	0	SENT_267	[p16l283t1201r354b1266],
38	13	CD	PERCENT	13	num	39	SENT_267	[p16l399t1202r564b1271],
39	%	NN	PERCENT	%	prep_in	36	SENT_267	[p16l399t1202r564b1271],
40	of	IN	O	of	_	0	SENT_267	[p16l604t1196r688b1267],
41	Caucasians	NNPS	MISC	Caucasians	prep_of	39	SENT_267	[p16l714t1199r1143b1277],
42	,	,	O	,	_	0	SENT_267	[p16l714t1199r1143b1277],
43	they	PRP	O	they	nsubj	46	SENT_267	[p16l1185t1196r1345b1290],
44	do	VBP	O	do	aux	46	SENT_267	[p16l1379t1196r1469b1268],
45	not	RB	O	not	neg	46	SENT_267	[p16l1509t1220r1634b1267],
46	exist	VB	O	exist	rcmod	26	SENT_267	[p16l1670t1201r1833b1267],
47	in	IN	O	in	_	0	SENT_267	[p16l1868t1201r1940b1266],
48	Orientals	NNP	O	Orientals	prep_in	46	SENT_267	[p16l1978t1199r2138b1267, p16l11t1295r407b1382],
49	.11	CD	NUMBER	.11	num	48	SENT_267	[p16l1978t1199r2138b1267, p16l11t1295r407b1382],
50	’25	CD	NUMBER	’25	dobj	46	SENT_267	[p16l1978t1199r2138b1267, p16l11t1295r407b1382],
51	Obviously	RB	O	obviously	advmod	55	SENT_267	[p16l447t1311r844b1405],
52	,	,	O	,	_	0	SENT_267	[p16l447t1311r844b1405],
53	different	JJ	O	different	amod	54	SENT_267	[p16l884t1311r1203b1383],
54	polymorphisms	NNS	O	polymorphism	nsubj	55	SENT_267	[p16l1237t1311r1820b1406],
55	need	VBP	O	need	rcmod	50	SENT_267	[p16l1858t1311r2032b1383],
56	to	TO	O	to	aux	58	SENT_267	[p16l2067t1335r2137b1382],
57	be	VB	O	be	auxpass	58	SENT_267	[p16l11t1425r94b1497],
58	examined	VBN	O	examine	xcomp	55	SENT_267	[p16l130t1425r488b1498],
59	in	IN	O	in	_	0	SENT_267	[p16l523t1430r595b1496],
60	patients	NNS	O	patient	prep_in	58	SENT_267	[p16l630t1430r920b1520],
61	of	IN	O	of	_	0	SENT_267	[p16l957t1425r1041b1497],
62	distinct	JJ	O	distinct	amod	63	SENT_267	[p16l1065t1425r1342b1498],
63	ethnicities	NNS	O	ethnicity	prep_of	60	SENT_267	[p16l1377t1425r1754b1497],
64	when	WRB	O	when	advmod	70	SENT_267	[p16l1787t1425r1990b1497],
65	the	DT	O	the	det	66	SENT_267	[p16l2026t1425r2139b1497],
66	inﬂuence	NN	O	inﬂuence	nsubj	70	SENT_267	[p16l11t1540r350b1612],
67	on	IN	O	on	_	0	SENT_267	[p16l380t1568r474b1611],
68	RBV	NN	O	rbv	nn	69	SENT_267	[p16l503t1540r1016b1612],
69	—	NN	O	—	prep_on	66	SENT_267	[p16l503t1540r1016b1612],
70	induced	VBD	O	induce	advcl	58	SENT_267	[p16l503t1540r1016b1612],
71	anemia	NN	O	anemia	nsubj	72	SENT_267	[p16l1045t1545r1314b1611],
72	is	VBZ	O	be	ccomp	70	SENT_267	[p16l1341t1545r1392b1611],
73	to	TO	O	to	aux	75	SENT_267	[p16l1422t1564r1493b1611],
74	be	VB	O	be	auxpass	75	SENT_267	[p16l1525t1540r1608b1612],
75	evaluated	VBN	O	evaluate	xcomp	72	SENT_267	[p16l1637t1540r2004b1612],
76	.	.	O	.	_	0	SENT_267	[p16l1637t1540r2004b1612],

1	In	IN	O	in	_	0	SENT_268	[p16l109t1661r188b1726],
2	conﬁrmation	NN	O	conﬁrmation	prep_in	11	SENT_268	[p16l233t1656r720b1727],
3	of	IN	O	of	_	0	SENT_268	[p16l766t1656r850b1727],
4	our	PRP$	O	we	poss	6	SENT_268	[p16l884t1685r1010b1728],
5	previous	JJ	O	previous	amod	6	SENT_268	[p16l1054t1661r1367b1751],
6	report	NN	O	report	prep_of	2	SENT_268	[p16l1414t1641r1736b1751],
7	,28	CD	NUMBER	,28	nsubj	11	SENT_268	[p16l1414t1641r1736b1751],
8	the	DT	O	the	det	10	SENT_268	[p16l1784t1656r1897b1727],
9	triple	JJ	O	triple	amod	10	SENT_268	[p16l1944t1656r2139b1751],
10	therapy	NN	O	therapy	dep	7	SENT_268	[p16l11t1770r293b1865],
11	achieved	VBD	O	achieve	_	0	SENT_268	[p16l327t1770r646b1843],
12	SVR	NNP	ORGANIZATION	SVR	dobj	11	SENT_268	[p16l683t1774r859b1842],
13	more	RBR	O	more	advmod	14	SENT_268	[p16l892t1799r1083b1842],
14	frequently	RB	O	frequently	advmod	11	SENT_268	[p16l1121t1770r1505b1865],
15	in	IN	O	in	_	0	SENT_268	[p16l1539t1775r1610b1841],
16	patients	NNS	O	patient	prep_in	11	SENT_268	[p16l1646t1775r1936b1865],
17	with	IN	O	with	_	0	SENT_268	[p16l1972t1770r2140b1842],
18	CC	NN	O	cc	prep_with	16	SENT_268	[p16l12t1888r142b1956],
19	than	IN	O	than	_	0	SENT_268	[p16l201t1884r366b1956],
20	CT/TT	NN	O	ct/tt	nn	21	SENT_268	[p16l426t1886r714b1956],
21	genotypes	NNS	O	genotype	prep_than	11	SENT_268	[p16l771t1909r1139b1980],
22	of	IN	O	of	_	0	SENT_268	[p16l1199t1884r1283b1956],
23	[	CD	NUMBER	[	num	24	SENT_268	[p16l1326t1889r1512b1956],
24	L28	NN	O	l28	prep_of	21	SENT_268	[p16l1326t1889r1512b1956],
25	at	IN	O	at	_	0	SENT_268	[p16l1567t1909r1633b1956],
26	rs12979860	NN	O	rs12979860	prep_at	24	SENT_268	[p16l1689t1886r2137b1961],
27	(	CD	PERCENT	(	number	28	SENT_268	[p16l15t1999r215b2083],
28	96	CD	PERCENT	96	num	29	SENT_268	[p16l15t1999r215b2083],
29	%	NN	PERCENT	%	dep	24	SENT_268	[p16l15t1999r215b2083],
30	vs.	CC	O	vs.	prep	29	SENT_268	[p16l255t2028r346b2069],
31	41	CD	PERCENT	41	num	32	SENT_268	[p16l390t1999r587b2079],
32	%	NN	PERCENT	%	dep	30	SENT_268	[p16l390t1999r587b2079],
33	,	,	O	,	_	0	SENT_268	[p16l390t1999r587b2079],
34	P	NN	O	p	dep	35	SENT_268	[p16l629t2003r688b2068],
35	<	JJR	O	<	appos	24	SENT_268	[p16l726t2015r785b2071],
36	0.001	CD	NUMBER	0.001	num	37	SENT_268	[p16l832t1999r1097b2083],
37	)	NN	O	)	dep	35	SENT_268	[p16l832t1999r1097b2083],
38	.	.	O	.	_	0	SENT_268	[p16l832t1999r1097b2083],

1	About	IN	O	about	_	0	SENT_269	[p16l1136t1998r1375b2070],
2	two	CD	NUMBER	two	prep_about	8	SENT_269	[p16l1414t1998r1799b2070],
3	—	CD	NUMBER	—	num	4	SENT_269	[p16l1414t1998r1799b2070],
4	thirds	NNS	O	third	nsubj	8	SENT_269	[p16l1414t1998r1799b2070],
5	of	IN	O	of	_	0	SENT_269	[p16l1840t1998r1925b2069],
6	studied	VBN	O	study	amod	7	SENT_269	[p16l1951t1998r2137b2070, p16l11t2112r121b2185],
7	patients	NNS	O	patient	prep_of	4	SENT_269	[p16l173t2117r463b2207],
8	accomplished	VBD	O	accomplish	_	0	SENT_269	[p16l519t2112r1027b2207],
9	SVR	NN	ORGANIZATION	svr	dobj	8	SENT_269	[p16l1082t2116r1258b2184],
10	with	IN	O	with	_	0	SENT_269	[p16l1303t2112r1472b2184],
11	the	DT	O	the	det	13	SENT_269	[p16l1525t2112r1639b2184],
12	triple	JJ	O	triple	amod	13	SENT_269	[p16l1692t2112r1889b2207],
13	treatment	NN	O	treatment	prep_with	8	SENT_269	[p16l1943t2136r2138b2184, p16l11t2250r223b2308],
14	,	,	O	,	_	0	SENT_269	[p16l1943t2136r2138b2184, p16l11t2250r223b2308],
15	although	IN	O	although	mark	24	SENT_269	[p16l273t2226r603b2322],
16	one	CD	NUMBER	one	number	17	SENT_269	[p16l647t2226r1050b2298],
17	—	CD	NUMBER	—	nsubj	24	SENT_269	[p16l647t2226r1050b2298],
18	fourth	JJ	ORDINAL	fourth	quantmod	17	SENT_269	[p16l647t2226r1050b2298],
19	of	IN	O	of	_	0	SENT_269	[p16l1095t2226r1179b2298],
20	them	PRP	O	they	prep_of	17	SENT_269	[p16l1212t2226r1402b2298],
21	were	VBD	O	be	cop	24	SENT_269	[p16l1443t2255r1616b2298],
22	nonrespond	JJ	O	nonrespond	amod	23	SENT_269	[p16l1662t2226r2137b2321],
23	—	NN	O	—	nn	24	SENT_269	[p16l1662t2226r2137b2321],
24	ers	NNPS	O	ers	advcl	8	SENT_269	[p16l11t2369r108b2412],
25	to	TO	O	to	_	0	SENT_269	[p16l153t2364r224b2412],
26	previous	JJ	O	previous	amod	28	SENT_269	[p16l270t2345r583b2435],
27	IFN	NN	O	ifn	nn	28	SENT_269	[p16l629t2340r1027b2413],
28	—	NN	O	—	prep_to	24	SENT_269	[p16l629t2340r1027b2413],
29	based	VBN	O	base	partmod	28	SENT_269	[p16l629t2340r1027b2413],
30	treatments	NNS	O	treatment	dobj	29	SENT_269	[p16l1070t2364r1484b2422],
31	;	:	O	;	_	0	SENT_269	[p16l1070t2364r1484b2422],
32	they	PRP	O	they	nsubjpass	34	SENT_269	[p16l1533t2340r1693b2434],
33	are	VBP	O	be	auxpass	34	SENT_269	[p16l1734t2369r1840b2412],
34	known	VBN	O	know	parataxis	8	SENT_269	[p16l1883t2340r2139b2412],
35	to	TO	O	to	aux	36	SENT_269	[p16l11t2479r82b2527],
36	respond	VB	O	respond	xcomp	34	SENT_269	[p16l129t2455r426b2551],
37	poorly	RB	O	poorly	advmod	36	SENT_269	[p16l470t2455r715b2550],
38	to	TO	O	to	_	0	SENT_269	[p16l757t2480r827b2527],
39	repeated	VBN	O	repeat	amod	40	SENT_269	[p16l875t2455r1188b2550],
40	treatments	NNS	O	treatment	prep_to	36	SENT_269	[p16l1233t2479r1645b2527],
41	.	.	O	.	_	0	SENT_269	[p16l1233t2479r1645b2527],

1	This	DT	O	this	nsubj	3	SENT_270	[p16l1694t2455r1862b2527],
2	would	MD	O	would	aux	3	SENT_270	[p16l1904t2455r2140b2528],
3	lend	VB	O	lend	_	0	SENT_270	[p16l10t2611r171b2684],
4	further	JJ	O	further	amod	5	SENT_270	[p16l222t2611r481b2684],
5	support	NN	O	support	dobj	3	SENT_270	[p16l532t2636r820b2707],
6	to	TO	O	to	_	0	SENT_270	[p16l872t2636r942b2683],
7	the	DT	O	the	det	8	SENT_270	[p16l997t2612r1110b2683],
8	efficacy	NN	O	efficacy	prep_to	3	SENT_270	[p16l1163t2611r1440b2706],
9	of	IN	O	of	_	0	SENT_270	[p16l1489t2611r1573b2683],
10	triple	JJ	O	triple	amod	11	SENT_270	[p16l1613t2611r1809b2707],
11	therapy	NN	O	therapy	prep_of	8	SENT_270	[p16l1862t2611r2144b2707],
12	being	VBG	O	be	cop	13	SENT_270	[p16l11t2725r216b2821],
13	higher	JJR	O	higher	xcomp	3	SENT_270	[p16l264t2725r502b2821],
14	than	IN	O	than	_	0	SENT_270	[p16l551t2725r716b2797],
15	treatment	NN	O	treatment	prep_than	13	SENT_270	[p16l767t2749r1130b2797],
16	with	IN	O	with	prep	13	SENT_270	[p16l1176t2725r1345b2797],
17	pegylated	VBN	O	pegylate	dep	16	SENT_270	[p16l1393t2725r1748b2821],
18	IFN	NN	O	ifn	dobj	17	SENT_270	[p16l1798t2730r1954b2797],
19	and	CC	O	and	advmod	17	SENT_270	[p16l2004t2725r2140b2797],

1	RBV	NN	O	rbv	_	0	SENT_271	[p16l11t2867r202b2933],
2	.	.	O	.	_	0	SENT_271	[p16l11t2867r202b2933],

1	There	EX	O	there	expl	2	SENT_272	[p16l106t2976r323b3048],
2	are	VBP	O	be	_	0	SENT_272	[p16l356t3005r460b3048],
3	strong	JJ	O	strong	amod	4	SENT_272	[p16l492t3001r719b3073],
4	points	NNS	O	point	nsubj	2	SENT_272	[p16l749t2981r973b3072],
5	in	IN	O	in	_	0	SENT_272	[p16l1007t2981r1077b3047],
6	this	DT	O	this	det	7	SENT_272	[p16l1110t2977r1236b3048],
7	study	NN	O	study	prep_in	4	SENT_272	[p16l1270t2976r1474b3071],
8	.	.	O	.	_	0	SENT_272	[p16l1270t2976r1474b3071],

1	First	RB	ORDINAL	first	advmod	8	SENT_273	[p16l1512t2981r1690b3058],
2	,	,	O	,	_	0	SENT_273	[p16l1512t2981r1690b3058],
3	ITP/1	NN	O	itp/1	nn	4	SENT_273	[p16l1724t2979r1922b3047],
4	polymorphisms	NNS	O	polymorphism	nsubj	8	SENT_273	[p16l1952t2977r2138b3072, p16l11t3090r418b3185],
5	inﬂuence	NN	O	inﬂuence	nn	7	SENT_273	[p16l463t3090r792b3162],
6	RBV	NN	O	rbv	nn	7	SENT_273	[p16l837t3090r1336b3163],
7	—	NN	O	—	dep	4	SENT_273	[p16l837t3090r1336b3163],
8	induced	VBD	O	induce	_	0	SENT_273	[p16l837t3090r1336b3163],
9	anemia	NN	O	anemia	dobj	8	SENT_273	[p16l1378t3095r1641b3162],
10	in	IN	O	in	_	0	SENT_273	[p16l1682t3095r1752b3161],
11	the	DT	O	the	det	13	SENT_273	[p16l1796t3090r1907b3162],
12	triple	JJ	O	triple	amod	13	SENT_273	[p16l1950t3090r2139b3185],
13	therapy	NN	O	therapy	prep_in	8	SENT_273	[p16l11t3204r292b3299],
14	.	.	O	.	_	0	SENT_273	[p16l11t3204r292b3299],

1	Second	RB	ORDINAL	second	advmod	14	SENT_274	[p16l343t3204r623b3286],
2	,	,	O	,	_	0	SENT_274	[p16l343t3204r623b3286],
3	polymorphisms	NNS	O	polymorphism	nsubj	14	SENT_274	[p16l672t3204r1239b3299],
4	at	IN	O	at	_	0	SENT_274	[p16l1286t3229r1351b3276],
5	rs1127350	NN	O	rs1127350	prep_at	3	SENT_274	[p16l1396t3210r1806b3286],
6	,	,	O	,	_	0	SENT_274	[p16l1396t3210r1806b3286],
7	without	IN	O	without	_	0	SENT_274	[p16l1852t3204r2140b3277],
8	involvement	NN	O	involvement	prep_without	3	SENT_274	[p16l11t3318r462b3390],
9	of	IN	O	of	_	0	SENT_274	[p16l494t3318r579b3390],
10	those	DT	O	those	prep_of	8	SENT_274	[p16l598t3319r786b3390],
11	at	IN	O	at	_	0	SENT_274	[p16l820t3343r885b3390],
12	rs7270107	CD	NUMBER	rs7270107	prep_at	10	SENT_274	[p16l917t3325r1327b3400],
13	,	,	O	,	_	0	SENT_274	[p16l917t3325r1327b3400],
14	protect	VBP	O	protect	_	0	SENT_274	[p16l1364t3343r1621b3414],
15	against	IN	O	against	_	0	SENT_274	[p16l1653t3323r1902b3415],
16	REVinduced	JJ	O	revinduced	amod	17	SENT_274	[p16l1935t3323r2138b3390, p16l11t3434r303b3506],
17	anemia	NN	O	anemia	prep_against	14	SENT_274	[p16l337t3439r615b3505],
18	.	.	O	.	_	0	SENT_274	[p16l337t3439r615b3505],

1	Third	NNP	ORDINAL	Third	nsubjpass	8	SENT_275	[p16l653t3434r885b3515],
2	,	,	O	,	_	0	SENT_275	[p16l653t3434r885b3515],
3	the	DT	O	the	det	5	SENT_275	[p16l925t3434r1035b3505],
4	triple	JJ	O	triple	amod	5	SENT_275	[p16l1070t3434r1260b3529],
5	therapy	NN	O	therapy	appos	1	SENT_275	[p16l1295t3434r1569b3529],
6	can	MD	O	can	aux	8	SENT_275	[p16l1600t3462r1721b3505],
7	be	VB	O	be	auxpass	8	SENT_275	[p16l1756t3434r1838b3505],
8	applied	VBN	O	apply	_	0	SENT_275	[p16l1874t3434r2141b3529],
9	With	IN	O	with	_	0	SENT_275	[p16l7t3547r172b3619],
10	high	JJ	O	high	amod	11	SENT_275	[p16l212t3547r374b3643],
11	efﬁcacy	NN	O	efﬁcacy	prep_with	8	SENT_275	[p16l415t3547r685b3642],
12	by	IN	O	by	_	0	SENT_275	[p16l723t3547r812b3642],
13	careful	JJ	O	careful	amod	14	SENT_275	[p16l850t3547r1089b3620],
14	monitoring	NN	O	monitoring	agent	8	SENT_275	[p16l1131t3552r1548b3643],
15	of	IN	O	of	_	0	SENT_275	[p16l1589t3547r1671b3619],
16	hemoglobin	NN	O	hemoglobin	nn	17	SENT_275	[p16l1700t3547r2140b3643],
17	HEPATOLOGY	NN	O	hepatology	prep_of	14	SENT_275	[p16l1235t3670r1704b3728],
18	,	,	O	,	_	0	SENT_275	[p16l1235t3670r1704b3728],
19	February	NNP	DATE	February	agent	8	SENT_275	[p16l1735t3669r1977b3737],
20	2011	CD	DATE	2011	num	19	SENT_275	[p16l2001t3674r2133b3721],

1	and	CC	O	and	dep	3	SENT_276	[p17l11t118r145b191],
2	prompt	JJ	O	prompt	amod	3	SENT_276	[p17l184t142r462b213],
3	modiﬁcation	NN	O	modiﬁcation	_	0	SENT_276	[p17l501t118r966b191],
4	of	IN	O	of	_	0	SENT_276	[p17l1007t118r1091b190],
5	RBV	NN	O	rbv	nn	6	SENT_276	[p17l1118t123r1302b190],
6	dose	NN	O	dose	prep_of	3	SENT_276	[p17l1338t118r1515b191],
7	.	.	O	.	_	0	SENT_276	[p17l1338t118r1515b191],

1	There	EX	O	there	expl	2	SENT_277	[p17l1558t118r1774b190],
2	are	VBP	O	be	_	0	SENT_277	[p17l1815t147r1918b190],
3	weak	JJ	O	weak	amod	4	SENT_277	[p17l1955t118r2143b190],
4	points	NNS	O	point	nsubj	2	SENT_277	[p17l10t239r233b329],
5	in	IN	O	in	_	0	SENT_277	[p17l278t239r348b304],
6	this	DT	O	this	det	7	SENT_277	[p17l392t234r518b305],
7	study	NN	O	study	prep_in	4	SENT_277	[p17l562t234r760b328],
8	as	RB	O	as	advmod	9	SENT_277	[p17l799t264r863b305],
9	well	RB	O	well	advmod	2	SENT_277	[p17l905t234r1069b306],
10	.	.	O	.	_	0	SENT_277	[p17l905t234r1069b306],

1	First	RB	ORDINAL	first	advmod	8	SENT_278	[p17l1118t239r1296b315],
2	,	,	O	,	_	0	SENT_278	[p17l1118t239r1296b315],
3	it	PRP	O	it	nsubj	8	SENT_278	[p17l1343t239r1393b305],
4	was	VBD	O	be	cop	8	SENT_278	[p17l1431t264r1562b306],
5	a	DT	O	a	det	8	SENT_278	[p17l1606t264r1643b305],
6	retrospective	JJ	O	retrospective	amod	8	SENT_278	[p17l1685t239r2141b329],
7	cohort	NN	O	cohort	nn	8	SENT_278	[p17l11t348r248b419],
8	study	NN	O	study	_	0	SENT_278	[p17l285t348r483b442],
9	conducted	VBN	O	conduct	dep	8	SENT_278	[p17l517t348r898b420],
10	in	IN	O	in	_	0	SENT_278	[p17l935t353r1005b418],
11	a	DT	O	a	det	13	SENT_278	[p17l1044t378r1081b419],
12	small	JJ	O	small	amod	13	SENT_278	[p17l1117t348r1305b419],
13	size	NN	O	size	prep_in	9	SENT_278	[p17l1343t353r1467b419],
14	of	IN	O	of	_	0	SENT_278	[p17l1507t348r1590b419],
15	patients	NNS	O	patient	prep_of	13	SENT_278	[p17l1615t353r1917b443],
16	,	,	O	,	_	0	SENT_278	[p17l1615t353r1917b443],
17	especially	RB	O	especially	advmod	15	SENT_278	[p17l1959t376r2138b443, p17l11t462r199b556],
18	those	DT	O	those	dep	15	SENT_278	[p17l246t462r433b534],
19	with	IN	O	with	_	0	SENT_278	[p17l480t462r644b534],
20	CA/AA	NN	O	ca/aa	nn	21	SENT_278	[p17l696t465r971b534],
21	genotypes	NNS	O	genotype	prep_with	9	SENT_278	[p17l1017t486r1375b558],
22	at	IN	O	at	_	0	SENT_278	[p17l1427t486r1492b533],
23	rs1127350	NN	O	rs1127350	prep_at	9	SENT_278	[p17l1542t468r1952b544],
24	,	,	O	,	_	0	SENT_278	[p17l1542t468r1952b544],
25	and	CC	O	and	_	0	SENT_278	[p17l2007t462r2140b534],
26	included	VBD	O	include	conj_and	9	SENT_278	[p17l11t576r327b649],
27	null	JJ	O	null	amod	29	SENT_278	[p17l354t576r915b671],
28	—	NN	O	—	nn	29	SENT_278	[p17l354t576r915b671],
29	responders	NNS	O	responder	dobj	26	SENT_278	[p17l354t576r915b671],
30	to	TO	O	to	_	0	SENT_278	[p17l945t601r1015b648],
31	previous	JJ	O	previous	amod	33	SENT_278	[p17l1045t581r1349b671],
32	IFN	NN	O	ifn	nn	33	SENT_278	[p17l1380t576r1767b649],
33	—	NN	O	—	prep_to	26	SENT_278	[p17l1380t576r1767b649],
34	based	VBN	O	base	partmod	33	SENT_278	[p17l1380t576r1767b649],
35	therapies	NNS	O	therapy	dobj	34	SENT_278	[p17l1796t576r2135b671],
36	;	:	O	;	_	0	SENT_278	[p17l1796t576r2135b671],
37	the	DT	O	the	det	39	SENT_278	[p17l11t690r122b762],
38	real	JJ	O	real	amod	39	SENT_278	[p17l153t690r279b762],
39	impact	NN	O	impact	dep	8	SENT_278	[p17l311t695r562b785],
40	of	IN	O	of	_	0	SENT_278	[p17l591t690r676b762],
41	I	PRP	O	I	prep_of	39	SENT_278	[p17l691t695r734b761],
42	TPA	NN	O	tpa	nn	43	SENT_278	[p17l736t693r888b761],
43	polymorphisms	NNS	O	polymorphism	nsubjpass	50	SENT_278	[p17l916t690r1484b785],
44	on	IN	O	on	_	0	SENT_278	[p17l1516t719r1610b762],
45	RBV-induced	JJ	O	rbv-induced	amod	46	SENT_278	[p17l1641t690r2142b763],
46	anemia	NN	O	anemia	prep_on	43	SENT_278	[p17l11t809r274b876],
47	may	MD	O	may	aux	50	SENT_278	[p17l312t833r468b899],
48	have	VB	O	have	aux	50	SENT_278	[p17l503t804r666b876],
49	been	VBN	O	be	auxpass	50	SENT_278	[p17l706t804r874b876],
50	obscured	VBN	O	obscure	rcmod	39	SENT_278	[p17l915t804r1257b877],
51	.	.	O	.	_	0	SENT_278	[p17l915t804r1257b877],

1	Second	RB	ORDINAL	second	advmod	6	SENT_279	[p17l1303t804r1583b886],
2	,	,	O	,	_	0	SENT_279	[p17l1303t804r1583b886],
3	the	DT	O	the	det	4	SENT_279	[p17l1627t804r1738b876],
4	study	NN	O	study	nsubjpass	6	SENT_279	[p17l1778t804r1976b899],
5	was	VBD	O	be	auxpass	6	SENT_279	[p17l2008t834r2139b876],
6	conducted	VBN	O	conduct	_	0	SENT_279	[p17l11t919r391b992],
7	in	IN	O	in	_	0	SENT_279	[p17l437t924r507b990],
8	Japanese	JJ	MISC	japanese	amod	9	SENT_279	[p17l547t924r860b1014],
9	patients	NNS	O	patient	prep_in	6	SENT_279	[p17l905t924r1207b1014],
10	,	,	O	,	_	0	SENT_279	[p17l905t924r1207b1014],
11	and	CC	O	and	_	0	SENT_279	[p17l1257t919r1391b992],
12	the	DT	O	the	det	13	SENT_279	[p17l1436t919r1547b991],
13	results	NNS	O	result	nsubjpass	19	SENT_279	[p17l1594t919r1818b992],
14	may	MD	O	may	aux	19	SENT_279	[p17l1866t948r2022b1014],
15	or	CC	O	or	cc	19	SENT_279	[p17l2065t948r2141b991],
16	may	MD	O	may	aux	19	SENT_279	[p17l11t1062r167b1127],
17	not	RB	O	not	neg	19	SENT_279	[p17l208t1057r330b1105],
18	be	VB	O	be	auxpass	19	SENT_279	[p17l373t1033r455b1105],
19	extended	VBN	O	extend	conj_and	6	SENT_279	[p17l499t1033r824b1106],
20	to	TO	O	to	_	0	SENT_279	[p17l867t1057r936b1105],
21	patients	NNS	O	patient	prep_to	19	SENT_279	[p17l981t1038r1262b1128],
22	of	IN	O	of	_	0	SENT_279	[p17l1308t1033r1391b1105],
23	different	JJ	O	different	amod	24	SENT_279	[p17l1422t1033r1731b1105],
24	ethnicities	NNS	O	ethnicity	prep_of	21	SENT_279	[p17l1774t1033r2138b1105],
25	With	IN	O	with	_	0	SENT_279	[p17l7t1147r172b1219],
26	distinct	JJ	O	distinct	amod	28	SENT_279	[p17l212t1147r480b1220],
27	genetic	JJ	O	genetic	amod	28	SENT_279	[p17l519t1152r774b1243],
28	backgrounds	NNS	O	background	prep_with	6	SENT_279	[p17l812t1147r1294b1243],
29	.	.	O	.	_	0	SENT_279	[p17l812t1147r1294b1243],

1	Hopefully	RB	O	hopefully	advmod	8	SENT_280	[p17l1339t1147r1719b1242],
2	,	,	O	,	_	0	SENT_280	[p17l1339t1147r1719b1242],
3	the	DT	O	the	det	4	SENT_280	[p17l1764t1147r1874b1219],
4	results	NNS	O	result	nsubj	8	SENT_280	[p17l1914t1147r2138b1220],
5	presented	VBN	O	present	partmod	4	SENT_280	[p17l10t1261r358b1357],
6	herein	RB	O	herein	advmod	5	SENT_280	[p17l387t1261r614b1333],
7	will	MD	O	will	aux	8	SENT_280	[p17l642t1261r775b1333],
8	promote	VB	O	promote	_	0	SENT_280	[p17l806t1286r1119b1357],
9	future	JJ	DATE	future	amod	10	SENT_280	[p17l1150t1261r1369b1334],
10	studies	NNS	O	study	dobj	8	SENT_280	[p17l1400t1261r1644b1334],
11	in	IN	O	in	_	0	SENT_280	[p17l1677t1266r1747b1332],
12	which	WDT	O	which	rel	23	SENT_280	[p17l1775t1262r1998b1333],
13	the	DT	O	the	det	14	SENT_280	[p17l2029t1261r2140b1333],
14	inﬂuence	NN	O	inﬂuence	nsubj	23	SENT_280	[p17l11t1375r341b1448],
15	of	IN	O	of	_	0	SENT_280	[p17l390t1375r473b1447],
16	the	DT	O	the	det	19	SENT_280	[p17l510t1375r620b1447],
17	I	PRP	O	I	nn	19	SENT_280	[p17l667t1380r711b1446],
18	TPA	NN	O	tpa	nn	19	SENT_280	[p17l713t1378r864b1446],
19	polymorphism	NN	O	polymorphism	prep_of	14	SENT_280	[p17l910t1375r1449b1470],
20	on	IN	O	on	_	0	SENT_280	[p17l1499t1404r1591b1447],
21	RBV	NN	O	rbv	nn	22	SENT_280	[p17l1641t1375r2142b1448],
22	—	NN	O	—	prep_on	14	SENT_280	[p17l1641t1375r2142b1448],
23	induced	VBD	O	induce	rcmod	10	SENT_280	[p17l1641t1375r2142b1448],
24	anemia	NN	O	anemia	nsubjpass	27	SENT_280	[p17l11t1495r274b1562],
25	will	MD	O	will	aux	27	SENT_280	[p17l303t1490r437b1562],
26	be	VB	O	be	auxpass	27	SENT_280	[p17l472t1490r554b1562],
27	pursued	VBN	O	pursue	ccomp	23	SENT_280	[p17l588t1490r880b1585],
28	in	IN	O	in	_	0	SENT_280	[p17l915t1495r985b1561],
29	larger	JJR	O	larger	amod	30	SENT_280	[p17l1019t1490r1222b1586],
30	scale	NN	O	scale	prep_in	27	SENT_280	[p17l1256t1490r1420b1562],
31	and	CC	O	and	_	0	SENT_280	[p17l1455t1490r1589b1563],
32	on	IN	O	on	_	0	SENT_280	[p17l1624t1519r1718b1562],
33	patients	NNS	O	patient	prep_on	27	SENT_280	[p17l1751t1495r2033b1585],
34	of	IN	O	of	_	0	SENT_280	[p17l2070t1490r2152b1562],
35	Various	JJ	O	various	amod	36	SENT_280	[p17l8t1609r266b1677],
36	ethnicities	NNS	O	ethnicity	prep_of	33	SENT_280	[p17l296t1604r661b1676],
37	around	IN	O	around	_	0	SENT_280	[p17l690t1604r950b1677],
38	the	DT	O	the	det	39	SENT_280	[p17l977t1604r1088b1676],
39	world	NN	O	world	prep_around	27	SENT_280	[p17l1111t1604r1342b1677],
40	.	.	O	.	_	0	SENT_280	[p17l1111t1604r1342b1677],

1	References	NNS	O	reference	_	0	SENT_281	[p17l15t1837r541b1924],

1	1	LS	NUMBER	1	_	0	SENT_282	[p17l52t2010r92b2057],
2	.	.	O	.	_	0	SENT_282	[p17l52t2010r92b2057],

1	Shepard	NNP	ORGANIZATION	Shepard	nn	2	SENT_283	[p17l128t2005r347b2074],
2	CW	NNP	ORGANIZATION	CW	nsubj	8	SENT_283	[p17l380t2008r500b2064],
3	,	,	O	,	_	0	SENT_283	[p17l380t2008r500b2064],
4	Finelli	NNP	PERSON	Finelli	nn	5	SENT_283	[p17l537t2005r706b2057],
5	L	NNP	O	L	appos	2	SENT_283	[p17l740t2009r790b2064],
6	,	,	O	,	_	0	SENT_283	[p17l740t2009r790b2064],
7	Alter	NNP	O	Alter	appos	5	SENT_283	[p17l822t2005r960b2057],
8	q	VBD	O	q	_	0	SENT_283	[p17l990t2009r1092b2070],
9	{	CD	NUMBER	{	dobj	8	SENT_283	[p17l990t2009r1092b2070],
10	+	CC	O	+	_	0	SENT_283	[p17l990t2009r1092b2070],
11	Global	JJ	O	global	amod	12	SENT_283	[p17l1129t2005r1313b2057],
12	epidemiology	NN	O	epidemiology	conj_+	9	SENT_283	[p17l1346t2005r1717b2075],
13	of	IN	O	of	_	0	SENT_283	[p17l1747t2005r1809b2057],
14	hepatitis	NN	O	hepatitis	nn	15	SENT_283	[p17l1831t2005r2060b2074],
15	C	NN	O	c	prep_of	12	SENT_283	[p17l2094t2008r2139b2057],

1	Virus	NN	O	virus	_	0	SENT_284	[p17l125t2093r255b2142],
2	infection	NN	O	infection	dep	1	SENT_284	[p17l282t2089r537b2141],
3	.	.	O	.	_	0	SENT_284	[p17l282t2089r537b2141],

1	Lancet	NNP	O	Lancet	nn	3	SENT_285	[p17l567t2093r748b2141],
2	Infect	NNP	O	Infect	nn	3	SENT_285	[p17l774t2089r929b2141],
3	Dis	NNP	O	Dis	_	0	SENT_285	[p17l956t2093r1047b2141],
4	2005	CD	DATE	2005	num	3	SENT_285	[p17l1074t2091r1534b2149],
5	;	:	O	;	_	0	SENT_285	[p17l1074t2091r1534b2149],
6	5:558	CD	NUMBER	5:558	num	7	SENT_285	[p17l1074t2091r1534b2149],
7	—	NN	O	—	dep	3	SENT_285	[p17l1074t2091r1534b2149],
8	567	CD	NUMBER	567	dep	7	SENT_285	[p17l1074t2091r1534b2149],
9	.	.	O	.	_	0	SENT_285	[p17l1074t2091r1534b2149],

1	2	LS	NUMBER	2	_	0	SENT_286	[p17l45t2177r92b2223],
2	.	.	O	.	_	0	SENT_286	[p17l45t2177r92b2223],

1	Hoofnagle	NNP	PERSON	Hoofnagle	nn	3	SENT_287	[p17l128t2172r414b2241],
2	̌	CD	NUMBER	̌	num	3	SENT_287	[p17l438t2175r535b2237],
3	{	NN	O	{	_	0	SENT_287	[p17l438t2175r535b2237],
4	+	CC	O	+	_	0	SENT_287	[p17l438t2175r535b2237],
5	Course	NNP	O	Course	dep	3	SENT_287	[p17l569t2174r760b2224],
6	and	CC	O	and	_	0	SENT_287	[p17l789t2172r888b2224],
7	outcome	NN	O	outcome	dep	3	SENT_287	[p17l918t2189r1154b2224],
8	of	IN	O	of	_	0	SENT_287	[p17l1183t2172r1244b2223],
9	hepatitis	NNP	O	hepatitis	nn	11	SENT_287	[p17l1263t2172r1493b2241],
10	C.	NNP	O	C.	nn	11	SENT_287	[p17l1523t2174r1583b2224],
11	HEPATOLOGY	NNP	O	HEPATOLOGY	prep_of	3	SENT_287	[p17l1616t2175r1957b2223],
12	2002	CD	DATE	2002	num	11	SENT_287	[p17l1983t2177r2138b2231],
13	;	:	O	;	_	0	SENT_287	[p17l1983t2177r2138b2231],

1	36	CD	NUMBER	36	_	0	SENT_288	[p17l128t2262r426b2314],
2	:	:	O	:	_	0	SENT_288	[p17l128t2262r426b2314],
3	S21	CD	NUMBER	s21	number	4	SENT_288	[p17l128t2262r426b2314],
4	—	CD	NUMBER	—	dep	1	SENT_288	[p17l128t2262r426b2314],
5	29	CD	NUMBER	29	dep	4	SENT_288	[p17l128t2262r426b2314],
6	.	.	O	.	_	0	SENT_288	[p17l128t2262r426b2314],

1	3	LS	NUMBER	3	_	0	SENT_289	[p17l46t2348r92b2398],
2	.	.	O	.	_	0	SENT_289	[p17l46t2348r92b2398],

1	Seeff	NNP	PERSON	Seeff	nn	2	SENT_290	[p17l128t2343r265b2395],
2	LB	NNP	O	LB	_	0	SENT_290	[p17l285t2347r377b2395],
3	.	.	O	.	_	0	SENT_290	[p17l285t2347r377b2395],

1	Natural	JJ	O	natural	amod	2	SENT_291	[p17l410t2343r618b2395],
2	history	NN	O	history	_	0	SENT_291	[p17l647t2343r836b2411],
3	of	IN	O	of	_	0	SENT_291	[p17l863t2343r924b2395],
4	chronic	JJ	O	chronic	amod	7	SENT_291	[p17l944t2343r1148b2395],
5	hepatitis	NN	O	hepatitis	nn	7	SENT_291	[p17l1175t2343r1404b2412],
6	C.	NNP	O	C.	nn	7	SENT_291	[p17l1435t2346r1494b2395],
7	HEPATOLOGY	NNP	O	HEPATOLOGY	prep_of	2	SENT_291	[p17l1528t2347r1869b2395],
8	2002	CD	DATE	2002	num	10	SENT_291	[p17l1895t2345r2137b2403],
9	;	:	O	;	_	0	SENT_291	[p17l1895t2345r2137b2403],
10	36	CD	NUMBER	36	dep	2	SENT_291	[p17l1895t2345r2137b2403],
11	:	:	O	:	_	0	SENT_291	[p17l1895t2345r2137b2403],

1	S35	NN	O	s35	_	0	SENT_292	[p17l128t2432r338b2487],
2	—	CD	NUMBER	—	number	3	SENT_292	[p17l128t2432r338b2487],
3	46	CD	NUMBER	46	num	1	SENT_292	[p17l128t2432r338b2487],
4	.	.	O	.	_	0	SENT_292	[p17l128t2432r338b2487],

1	4	LS	NUMBER	4	_	0	SENT_293	[p17l45t2515r92b2567],
2	.	.	O	.	_	0	SENT_293	[p17l45t2515r92b2567],

1	Fried	NNP	O	Fried	nn	2	SENT_294	[p17l128t2515r267b2567],
2	MW	NNP	O	MW	_	0	SENT_294	[p17l298t2518r435b2574],
3	,	,	O	,	_	0	SENT_294	[p17l298t2518r435b2574],
4	Shiffman	NNP	PERSON	Shiffman	nn	5	SENT_294	[p17l470t2515r718b2567],
5	ML	NNP	O	ML	appos	2	SENT_294	[p17l749t2518r866b2574],
6	,	,	O	,	_	0	SENT_294	[p17l749t2518r866b2574],
7	Reddy	NNP	PERSON	Reddy	nn	8	SENT_294	[p17l901t2515r1076b2583],
8	KR	NNP	O	KR	appos	5	SENT_294	[p17l1106t2518r1211b2574],
9	,	,	O	,	_	0	SENT_294	[p17l1106t2518r1211b2574],
10	Smith	NNP	PERSON	Smith	nn	11	SENT_294	[p17l1246t2515r1409b2567],
11	C	NNP	O	C	appos	5	SENT_294	[p17l1440t2517r1501b2574],
12	,	,	O	,	_	0	SENT_294	[p17l1440t2517r1501b2574],
13	Marinos	NNP	ORGANIZATION	Marinos	nn	14	SENT_294	[p17l1535t2518r1761b2567],
14	G	NNP	O	G	appos	5	SENT_294	[p17l1794t2517r1859b2574],
15	,	,	O	,	_	0	SENT_294	[p17l1794t2517r1859b2574],
16	Goncales	NNP	O	Goncales	nn	18	SENT_294	[p17l1894t2515r2140b2567],
17	FL	NN	O	fl	nn	18	SENT_294	[p17l128t2601r203b2649],
18	Jr	NNP	O	Jr	appos	5	SENT_294	[p17l227t2601r288b2663],
19	,	,	O	,	_	0	SENT_294	[p17l227t2601r288b2663],
20	et	FW	O	et	nn	21	SENT_294	[p17l321t2616r368b2650],
21	al.	FW	O	al.	appos	5	SENT_294	[p17l397t2598r455b2650],
22	.	.	O	.	_	0	SENT_294	[p17l397t2598r455b2650],

1	Peginterferon	NNP	MISC	Peginterferon	nsubj	3	SENT_295	[p17l490t2598r854b2668],
2	alfa	FW	O	alfa	nn	3	SENT_295	[p17l884t2598r1066b2650],
3	—	FW	O	—	_	0	SENT_295	[p17l884t2598r1066b2650],
4	2a	FW	O	2a	dobj	3	SENT_295	[p17l884t2598r1066b2650],
5	plus	CC	O	plus	prep	4	SENT_295	[p17l1094t2598r1204b2667],
6	ribavirin	NNP	O	ribavirin	dep	5	SENT_295	[p17l1235t2598r1466b2650],
7	for	IN	O	for	_	0	SENT_295	[p17l1496t2598r1573b2650],
8	chronic	JJ	O	chronic	amod	12	SENT_295	[p17l1602t2598r1806b2650],
9	hepatitis	NN	O	hepatitis	nn	12	SENT_295	[p17l1834t2598r2063b2667],
10	C	NN	O	c	nn	12	SENT_295	[p17l2094t2600r2139b2650],
11	Virus	NN	O	virus	nn	12	SENT_295	[p17l125t2684r255b2733],
12	infection	NN	O	infection	prep_for	3	SENT_295	[p17l282t2681r537b2732],
13	.	.	O	.	_	0	SENT_295	[p17l282t2681r537b2732],

1	N	NN	O	n	nn	3	SENT_296	[p17l567t2684r619b2732],
2	Engl	NNP	O	Engl	nn	3	SENT_296	[p17l646t2681r771b2750],
3	J	NNP	O	J	nsubj	4	SENT_296	[p17l793t2684r817b2746],
4	Med	VBD	O	med	_	0	SENT_296	[p17l845t2681r971b2733],
5	2002	CD	DATE	2002	dobj	4	SENT_296	[p17l997t2681r1528b2740],
6	;	:	O	;	_	0	SENT_296	[p17l997t2681r1528b2740],
7	347:975	CD	NUMBER	347:975	num	8	SENT_296	[p17l997t2681r1528b2740],
8	-982	CD	NUMBER	-982	dep	5	SENT_296	[p17l997t2681r1528b2740],
9	.	.	O	.	_	0	SENT_296	[p17l997t2681r1528b2740],

1	5	CD	NUMBER	5	_	0	SENT_297	[p17l48t2768r92b2819],
2	.	.	O	.	_	0	SENT_297	[p17l48t2768r92b2819],

1	Manns	NNP	O	Manns	nn	2	SENT_298	[p17l127t2767r313b2815],
2	MP	NNP	O	MP	_	0	SENT_298	[p17l349t2767r453b2823],
3	,	,	O	,	_	0	SENT_298	[p17l349t2767r453b2823],
4	McHutchison	NNP	O	McHutchison	nn	5	SENT_298	[p17l491t2764r871b2816],
5	JG	NNP	O	JG	appos	2	SENT_298	[p17l902t2766r996b2829],
6	,	,	O	,	_	0	SENT_298	[p17l902t2766r996b2829],
7	Gordon	NNP	PERSON	Gordon	nn	8	SENT_298	[p17l1035t2764r1250b2816],
8	SC	NNP	PERSON	SC	appos	5	SENT_298	[p17l1287t2766r1382b2823],
9	,	,	O	,	_	0	SENT_298	[p17l1287t2766r1382b2823],
10	Rustgi	NNP	PERSON	Rustgi	nn	11	SENT_298	[p17l1421t2767r1593b2833],
11	VK	NNP	O	VK	appos	5	SENT_298	[p17l1627t2767r1737b2823],
12	,	,	O	,	_	0	SENT_298	[p17l1627t2767r1737b2823],
13	Shiffman	NNP	PERSON	Shiffman	nn	14	SENT_298	[p17l1777t2764r2025b2815],
14	M	NN	O	m	appos	5	SENT_298	[p17l2060t2767r2138b2823],
15	,	,	O	,	_	0	SENT_298	[p17l2060t2767r2138b2823],
16	Reindollar	NN	O	reindollar	nn	17	SENT_298	[p17l128t2847r413b2900],
17	R	NN	O	r	appos	5	SENT_298	[p17l443t2851r500b2906],
18	,	,	O	,	_	0	SENT_298	[p17l443t2851r500b2906],
19	et	FW	O	et	nn	20	SENT_298	[p17l534t2865r581b2899],
20	al.	FW	O	al.	appos	5	SENT_298	[p17l612t2847r669b2899],
21	.	.	O	.	_	0	SENT_298	[p17l612t2847r669b2899],

1	Peginterferon	NNP	MISC	Peginterferon	_	0	SENT_299	[p17l705t2847r1069b2917],
2	alfa	FW	O	alfa	nn	4	SENT_299	[p17l1100t2847r1286b2899],
3	—	FW	O	—	nn	4	SENT_299	[p17l1100t2847r1286b2899],
4	2b	NN	O	2b	dep	1	SENT_299	[p17l1100t2847r1286b2899],
5	plus	CC	O	plus	_	0	SENT_299	[p17l1317t2847r1427b2916],
6	ribavirin	NNP	O	ribavirin	conj_plus	1	SENT_299	[p17l1459t2847r1690b2899],
7	compared	VBN	O	compare	_	0	SENT_299	[p17l1721t2847r1991b2916],
8	with	IN	O	with	prepc_compared_with	6	SENT_299	[p17l2018t2847r2141b2899],
9	interferon	NN	O	interferon	nn	10	SENT_299	[p17l127t2930r397b2982],
10	alfa	NN	O	alfa	pobj	6	SENT_299	[p17l423t2930r608b2982],
11	—	CD	NUMBER	—	num	12	SENT_299	[p17l423t2930r608b2982],
12	2b	NN	O	2b	dep	1	SENT_299	[p17l423t2930r608b2982],
13	plus	CC	O	plus	prep	12	SENT_299	[p17l635t2931r745b2999],
14	ribavirin	NNP	O	ribavirin	dep	13	SENT_299	[p17l772t2931r1003b2982],
15	for	IN	O	for	_	0	SENT_299	[p17l1029t2930r1106b2982],
16	initial	JJ	O	initial	amod	17	SENT_299	[p17l1131t2931r1288b2982],
17	treatment	NN	O	treatment	prep_for	14	SENT_299	[p17l1315t2948r1579b2982],
18	of	IN	O	of	_	0	SENT_299	[p17l1604t2930r1665b2982],
19	chronic	JJ	O	chronic	amod	21	SENT_299	[p17l1683t2930r1887b2982],
20	hepatitis	NN	O	hepatitis	nn	21	SENT_299	[p17l1911t2931r2140b2999],
21	C	NN	O	c	prep_of	17	SENT_299	[p17l128t3016r188b3066],
22	:	:	O	:	_	0	SENT_299	[p17l128t3016r188b3066],
23	a	DT	O	a	det	25	SENT_299	[p17l218t3035r245b3066],
24	randomised	JJ	O	randomised	amod	25	SENT_299	[p17l271t3014r590b3067],
25	trial	NN	O	trial	dep	14	SENT_299	[p17l616t3014r737b3066],
26	.	.	O	.	_	0	SENT_299	[p17l616t3014r737b3066],

1	Lancet	NNP	O	Lancet	_	0	SENT_300	[p17l767t3017r948b3066],
2	2001	CD	DATE	2001	num	1	SENT_300	[p17l973t3015r1504b3073],
3	;	:	O	;	_	0	SENT_300	[p17l973t3015r1504b3073],
4	358:958	CD	NUMBER	358:958	num	5	SENT_300	[p17l973t3015r1504b3073],
5	—	NN	O	—	dep	1	SENT_300	[p17l973t3015r1504b3073],
6	965	CD	NUMBER	965	dep	5	SENT_300	[p17l973t3015r1504b3073],
7	.	.	O	.	_	0	SENT_300	[p17l973t3015r1504b3073],

1	6	CD	NUMBER	6	_	0	SENT_301	[p17l46t3099r92b3149],
2	.	.	O	.	_	0	SENT_301	[p17l46t3099r92b3149],

1	McHutchison	NN	O	mchutchison	nn	2	SENT_302	[p17l127t3097r506b3150],
2	JG	NN	O	jg	_	0	SENT_302	[p17l546t3100r640b3162],
3	,	,	O	,	_	0	SENT_302	[p17l546t3100r640b3162],
4	Lawitz	NNP	O	Lawitz	nn	5	SENT_302	[p17l687t3101r867b3149],
5	EJ	NNP	O	EJ	appos	2	SENT_302	[p17l910t3101r987b3162],
6	,	,	O	,	_	0	SENT_302	[p17l910t3101r987b3162],
7	Shiffman	NNP	PERSON	Shiffman	nn	8	SENT_302	[p17l1035t3097r1284b3149],
8	ML	NNP	O	ML	appos	5	SENT_302	[p17l1327t3101r1444b3157],
9	,	,	O	,	_	0	SENT_302	[p17l1327t3101r1444b3157],
10	Muir	NNP	PERSON	Muir	nn	11	SENT_302	[p17l1491t3101r1631b3150],
11	AJ	NNP	PERSON	AJ	appos	5	SENT_302	[p17l1670t3100r1754b3162],
12	,	,	O	,	_	0	SENT_302	[p17l1670t3100r1754b3162],
13	Galler	NNP	PERSON	Galler	nn	14	SENT_302	[p17l1803t3097r1969b3149],
14	GW	NNP	O	GW	appos	5	SENT_302	[p17l2013t3100r2137b3157],
15	,	,	O	,	_	0	SENT_302	[p17l2013t3100r2137b3157],
16	McCone	NNP	PERSON	McCone	nn	17	SENT_302	[p17l127t3183r365b3232],
17	J	NNP	PERSON	J	appos	5	SENT_302	[p17l402t3184r442b3246],
18	,	,	O	,	_	0	SENT_302	[p17l402t3184r442b3246],
19	et	FW	O	et	nn	20	SENT_302	[p17l487t3198r534b3232],
20	al.	FW	O	al.	appos	5	SENT_302	[p17l575t3181r632b3232],
21	.	.	O	.	_	0	SENT_302	[p17l575t3181r632b3232],

1	Peginterferon	NNP	MISC	Peginterferon	nsubj	4	SENT_303	[p17l678t3180r1043b3250],
2	alfa	FW	O	alfa	nn	4	SENT_303	[p17l1084t3180r1270b3232],
3	—	FW	O	—	nn	4	SENT_303	[p17l1084t3180r1270b3232],
4	2b	FW	O	2b	_	0	SENT_303	[p17l1084t3180r1270b3232],
5	or	CC	O	or	cc	6	SENT_303	[p17l1312t3201r1368b3232],
6	alfa	FW	O	alfa	dobj	4	SENT_303	[p17l1409t3180r1591b3232],
7	—	FW	O	—	nn	8	SENT_303	[p17l1409t3180r1591b3232],
8	2a	FW	O	2a	amod	6	SENT_303	[p17l1409t3180r1591b3232],
9	with	IN	O	with	_	0	SENT_303	[p17l1628t3181r1751b3232],
10	ribavirin	NNP	O	ribavirin	prep_with	4	SENT_303	[p17l1792t3181r2023b3232],
11	for	IN	O	for	_	0	SENT_303	[p17l2064t3180r2141b3232],
12	treatment	NN	O	treatment	prep_for	10	SENT_303	[p17l128t3281r391b3315],
13	of	IN	O	of	_	0	SENT_303	[p17l417t3263r478b3315],
14	hepatitis	NN	O	hepatitis	nn	16	SENT_303	[p17l495t3263r724b3332],
15	C	NN	O	c	nn	16	SENT_303	[p17l752t3266r797b3315],
16	infection	NN	O	infection	prep_of	12	SENT_303	[p17l824t3263r1079b3315],
17	.	.	O	.	_	0	SENT_303	[p17l824t3263r1079b3315],

1	N	NN	O	n	nn	3	SENT_304	[p17l1109t3267r1161b3315],
2	Engl	NNP	O	Engl	nn	3	SENT_304	[p17l1189t3263r1313b3333],
3	J	NNP	O	J	nsubj	4	SENT_304	[p17l1335t3267r1360b3328],
4	Med	VBD	O	med	_	0	SENT_304	[p17l1388t3263r1513b3315],
5	2009	CD	DATE	2009	dobj	4	SENT_304	[p17l1539t3265r2070b3322],
6	;	:	O	;	_	0	SENT_304	[p17l1539t3265r2070b3322],
7	361:580	CD	NUMBER	361:580	num	8	SENT_304	[p17l1539t3265r2070b3322],
8	—	NN	O	—	dep	5	SENT_304	[p17l1539t3265r2070b3322],
9	593	CD	NUMBER	593	dep	8	SENT_304	[p17l1539t3265r2070b3322],
10	.	.	O	.	_	0	SENT_304	[p17l1539t3265r2070b3322],

1	7	CD	NUMBER	7	_	0	SENT_305	[p17l45t3357r92b3406],
2	.	.	O	.	_	0	SENT_305	[p17l45t3357r92b3406],

1	Fellay	NNP	PERSON	Fellay	nn	2	SENT_306	[p17l128t3351r286b3420],
2	J	NNP	PERSON	J	_	0	SENT_306	[p17l315t3355r356b3416],
3	,	,	O	,	_	0	SENT_306	[p17l315t3355r356b3416],
4	Thompson	NNP	PERSON	Thompson	nn	5	SENT_306	[p17l394t3351r697b3420],
5	AJ	NNP	O	AJ	dep	2	SENT_306	[p17l729t3354r814b3416],
6	,	,	O	,	_	0	SENT_306	[p17l729t3354r814b3416],
7	Ge	NNP	O	Ge	nn	8	SENT_306	[p17l854t3354r931b3403],
8	D	NNP	O	D	appos	5	SENT_306	[p17l968t3355r1035b3410],
9	,	,	O	,	_	0	SENT_306	[p17l968t3355r1035b3410],
10	Gumbs	NNP	PERSON	Gumbs	nn	11	SENT_306	[p17l1075t3351r1273b3403],
11	CE	NNP	O	CE	appos	5	SENT_306	[p17l1312t3354r1414b3410],
12	,	,	O	,	_	0	SENT_306	[p17l1312t3354r1414b3410],
13	Urban	NNP	ORGANIZATION	Urban	nn	14	SENT_306	[p17l1453t3351r1626b3403],
14	TJ	NNP	ORGANIZATION	TJ	appos	5	SENT_306	[p17l1660t3353r1745b3416],
15	,	,	O	,	_	0	SENT_306	[p17l1660t3353r1745b3416],
16	Shianna	NNP	O	Shianna	nn	17	SENT_306	[p17l1785t3351r2003b3403],
17	KV	NN	O	kv	appos	5	SENT_306	[p17l2038t3355r2137b3410],
18	,	,	O	,	_	0	SENT_306	[p17l2038t3355r2137b3410],

1	et	FW	O	et	_	0	SENT_307	[p18l127t45r175b79],
2	al.	FW	O	al.	dep	1	SENT_307	[p18l201t27r259b79],
3	.	.	O	.	_	0	SENT_307	[p18l201t27r259b79],

1	ITPA	NN	O	itpa	nn	3	SENT_308	[p18l291t29r441b78],
2	gene	NN	O	gene	nn	3	SENT_308	[p18l466t48r588b97],
3	Variants	NNS	O	variant	nsubj	4	SENT_308	[p18l613t31r823b79],
4	protect	VBP	O	protect	_	0	SENT_308	[p18l850t45r1043b96],
5	against	IN	O	against	_	0	SENT_308	[p18l1069t31r1256b97],
6	anaemia	NN	O	anaemia	prep_against	4	SENT_308	[p18l1283t31r1508b79],
7	in	IN	O	in	_	0	SENT_308	[p18l1533t31r1586b78],
8	patients	NNS	O	patient	prep_in	6	SENT_308	[p18l1612t31r1824b96],
9	treated	VBN	O	treat	partmod	8	SENT_308	[p18l1852t27r2038b80],
10	for	IN	O	for	_	0	SENT_308	[p18l2064t27r2141b79],
11	chronic	JJ	O	chronic	amod	14	SENT_308	[p18l127t110r332b162],
12	hepatitis	NN	O	hepatitis	nn	14	SENT_308	[p18l356t110r585b179],
13	C.	NNP	O	C.	nn	14	SENT_308	[p18l613t113r673b162],
14	Nature	NNP	O	Nature	prep_for	9	SENT_308	[p18l702t113r892b162],
15	2010	CD	DATE	2010	num	14	SENT_308	[p18l919t111r1449b170],
16	;	:	O	;	_	0	SENT_308	[p18l919t111r1449b170],
17	464:405	CD	NUMBER	464:405	num	18	SENT_308	[p18l919t111r1449b170],
18	~	NN	O	~	dep	6	SENT_308	[p18l919t111r1449b170],
19	408	CD	NUMBER	408	dep	18	SENT_308	[p18l919t111r1449b170],
20	.	.	O	.	_	0	SENT_308	[p18l919t111r1449b170],

1	Arenas	NNS	O	arena	nn	2	SENT_309	[p18l123t196r308b245],
2	M	NN	O	m	nsubj	22	SENT_309	[p18l351t196r429b253],
3	,	,	O	,	_	0	SENT_309	[p18l351t196r429b253],
4	Duley	NNP	PERSON	Duley	nn	5	SENT_309	[p18l475t193r642b261],
5	J	NNP	PERSON	J	appos	2	SENT_309	[p18l677t196r718b258],
6	,	,	O	,	_	0	SENT_309	[p18l677t196r718b258],
7	Sumi	NNP	PERSON	Sumi	nn	8	SENT_309	[p18l765t196r905b245],
8	S	NNP	PERSON	S	appos	2	SENT_309	[p18l950t196r995b252],
9	,	,	O	,	_	0	SENT_309	[p18l950t196r995b252],
10	Sanderson	NNP	PERSON	Sanderson	nn	11	SENT_309	[p18l1042t193r1320b245],
11	J	NNP	PERSON	J	appos	2	SENT_309	[p18l1358t196r1400b258],
12	,	,	O	,	_	0	SENT_309	[p18l1358t196r1400b258],
13	Marinaki	NNP	PERSON	Marinaki	nn	16	SENT_309	[p18l1445t193r1696b245],
14	A.	NNP	O	A.	nn	16	SENT_309	[p18l1735t196r1794b245],
15	The	NNP	O	The	nn	16	SENT_309	[p18l1839t193r1949b245],
16	ITPA	NNP	O	ITPA	appos	2	SENT_309	[p18l1992t195r2143b244],
17	c.	VBD	O	c.	_	0	SENT_309	[p18l127t276r392b330],
18	94C	NN	O	94c	dobj	17	SENT_309	[p18l127t276r392b330],
19	>	JJR	O	>	dep	18	SENT_309	[p18l127t276r392b330],
20	A	DT	O	a	dep	19	SENT_309	[p18l127t276r392b330],
21	and	CC	O	and	_	0	SENT_309	[p18l431t276r530b328],
22	g.	VBN	O	g.	conj_and	17	SENT_309	[p18l570t278r1032b345],
23	IVS2	NN	O	ivs2	dobj	22	SENT_309	[p18l570t278r1032b345],
24	.	.	O	.	_	0	SENT_309	[p18l570t278r1032b345],

1	—	NN	O	—	_	0	SENT_310	[p18l570t278r1032b345],
2	.	.	O	.	_	0	SENT_310	[p18l570t278r1032b345],

1	|	NN	O	|	_	0	SENT_311	[p18l570t278r1032b345],
2	.	.	O	.	_	0	SENT_311	[p18l570t278r1032b345],

1	—	NN	O	—	_	0	SENT_312	[p18l570t278r1032b345],
2	.	.	O	.	_	0	SENT_312	[p18l570t278r1032b345],

1	21A	CD	NUMBER	21a	num	5	SENT_313	[p18l570t278r1032b345],
2	>	JJR	O	>	dep	3	SENT_313	[p18l570t278r1032b345],
3	C	NN	O	c	amod	5	SENT_313	[p18l570t278r1032b345],
4	sequence	NN	O	sequence	nn	5	SENT_313	[p18l1073t296r1315b345],
5	variants	NNS	O	variant	nsubj	6	SENT_313	[p18l1354t279r1563b327],
6	contribute	VBP	O	contribute	_	0	SENT_313	[p18l1606t276r1887b328],
7	to	TO	O	to	_	0	SENT_313	[p18l1929t293r1980b327],
8	missplicing	NN	O	missplicing	prep_to	6	SENT_313	[p18l2023t279r2139b327, p18l127t359r337b429],
9	of	IN	O	of	_	0	SENT_313	[p18l361t359r423b411],
10	the	DT	O	the	det	12	SENT_313	[p18l440t359r523b411],
11	ITPA	NN	O	itpa	nn	12	SENT_313	[p18l550t360r701b410],
12	gene	NN	O	gene	prep_of	8	SENT_313	[p18l724t379r860b429],
13	.	.	O	.	_	0	SENT_313	[p18l724t379r860b429],

1	Biochim	NNP	PERSON	Biochim	nn	3	SENT_314	[p18l891t359r1122b411],
2	Biophys	NNP	PERSON	Biophys	nn	3	SENT_314	[p18l1149t359r1366b428],
3	Acta	NNP	PERSON	Acta	_	0	SENT_314	[p18l1389t361r1514b411],
4	2007	CD	DATE	2007	num	3	SENT_314	[p18l1539t360r2070b418],
5	;	:	O	;	_	0	SENT_314	[p18l1539t360r2070b418],
6	1772:96	CD	NUMBER	1772:96	number	7	SENT_314	[p18l1539t360r2070b418],
7	-102	CD	NUMBER	-102	dep	3	SENT_314	[p18l1539t360r2070b418],
8	.	.	O	.	_	0	SENT_314	[p18l1539t360r2070b418],

1	.	.	O	.	_	0	SENT_315	[p18l84t485r92b494],

1	Cao	NNP	O	Cao	nn	2	SENT_316	[p18l128t445r236b494],
2	H	NNP	O	H	_	0	SENT_316	[p18l270t445r339b501],
3	,	,	O	,	_	0	SENT_316	[p18l270t445r339b501],
4	Hegele	NNP	PERSON	Hegele	nn	5	SENT_316	[p18l375t442r561b512],
5	RA	NN	O	ra	appos	2	SENT_316	[p18l594t445r695b494],
6	.	.	O	.	_	0	SENT_316	[p18l594t445r695b494],

1	DNA	NN	O	dna	nn	2	SENT_317	[p18l732t445r886b494],
2	polymorphisms	NNS	O	polymorphism	_	0	SENT_317	[p18l915t442r1339b511],
3	in	IN	O	in	_	0	SENT_317	[p18l1373t446r1425b493],
4	ITPA	NN	O	itpa	prep_in	2	SENT_317	[p18l1458t444r1608b493],
5	including	VBG	O	include	_	0	SENT_317	[p18l1639t442r1899b512],
6	basis	NN	O	basis	prep_including	4	SENT_317	[p18l1929t442r2054b494],
7	of	IN	O	of	_	0	SENT_317	[p18l2088t442r2150b494],
8	inosine	NN	O	inosine	nn	10	SENT_317	[p18l127t528r321b576],
9	triphosphatase	NN	O	triphosphatase	nn	10	SENT_317	[p18l347t525r740b594],
10	deﬁciency	NN	O	deﬁciency	prep_of	6	SENT_317	[p18l767t525r1044b593],
11	.	.	O	.	_	0	SENT_317	[p18l767t525r1044b593],

1	J	NNP	O	J	nn	3	SENT_318	[p18l1069t528r1093b590],
2	Hum	NNP	O	Hum	nn	3	SENT_318	[p18l1123t528r1267b577],
3	Genet	NNP	O	Genet	_	0	SENT_318	[p18l1294t527r1459b577],
4	2002	CD	DATE	2002	num	3	SENT_318	[p18l1484t525r1979b584],
5	;	:	O	;	_	0	SENT_318	[p18l1484t525r1979b584],
6	47:620	CD	NUMBER	47:620	number	7	SENT_318	[p18l1484t525r1979b584],
7	-622	CD	NUMBER	-622	dep	3	SENT_318	[p18l1484t525r1979b584],
8	.	.	O	.	_	0	SENT_318	[p18l1484t525r1979b584],

1	Stepchenkova	FW	O	stepchenkova	nn	2	SENT_319	[p18l128t608r502b677],
2	EI	FW	O	ei	dep	5	SENT_319	[p18l543t611r620b667],
3	,	,	O	,	_	0	SENT_319	[p18l543t611r620b667],
4	Tarakhovskaya	NNP	O	Tarakhovskaya	nn	5	SENT_319	[p18l665t608r1066b676],
5	ER	NN	O	er	_	0	SENT_319	[p18l1107t611r1207b667],
6	,	,	O	,	_	0	SENT_319	[p18l1107t611r1207b667],
7	Spitler	NNP	PERSON	Spitler	nn	8	SENT_319	[p18l1254t608r1430b677],
8	K	NNP	PERSON	K	appos	5	SENT_319	[p18l1473t611r1533b667],
9	,	,	O	,	_	0	SENT_319	[p18l1473t611r1533b667],
10	Frahm	NNP	PERSON	Frahm	nn	11	SENT_319	[p18l1580t608r1757b660],
11	C	NNP	O	C	appos	5	SENT_319	[p18l1802t610r1863b667],
12	,	,	O	,	_	0	SENT_319	[p18l1802t610r1863b667],
13	Menezes	NNP	PERSON	Menezes	nn	14	SENT_319	[p18l1909t611r2139b660],
14	MR	NN	PERSON	mr	appos	5	SENT_319	[p18l126t695r250b751],
15	,	,	O	,	_	0	SENT_319	[p18l126t695r250b751],
16	Simone	NNP	PERSON	Simone	nn	17	SENT_319	[p18l290t694r495b743],
17	PD	NN	O	pd	appos	5	SENT_319	[p18l533t695r639b751],
18	,	,	O	,	_	0	SENT_319	[p18l533t695r639b751],
19	et	FW	O	et	nn	20	SENT_319	[p18l679t709r726b743],
20	al.	FW	O	al.	appos	5	SENT_319	[p18l762t692r820b743],
21	.	.	O	.	_	0	SENT_319	[p18l762t692r820b743],

1	Functional	JJ	O	functional	amod	2	SENT_320	[p18l861t692r1154b744],
2	study	NN	O	study	_	0	SENT_320	[p18l1190t692r1338b760],
3	of	IN	O	of	_	0	SENT_320	[p18l1373t691r1434b743],
4	the	DT	O	the	det	6	SENT_320	[p18l1462t691r1544b743],
5	P32T	NN	O	p32t	nn	6	SENT_320	[p18l1582t693r1736b746],
6	ITPA	NN	O	itpa	prep_of	2	SENT_320	[p18l1773t693r1923b743],
7	Variant	JJ	O	variant	amod	6	SENT_320	[p18l1953t695r2142b743],
8	associated	VBN	O	associate	partmod	6	SENT_320	[p18l127t774r395b826],
9	with	IN	O	with	_	0	SENT_320	[p18l439t774r562b826],
10	drug	NN	O	drug	nn	11	SENT_320	[p18l609t774r735b843],
11	sensitivity	NN	O	sensitivity	prep_with	8	SENT_320	[p18l780t777r1051b842],
12	in	IN	O	in	_	0	SENT_320	[p18l1095t777r1147b825],
13	humans	NNS	O	human	prep_in	11	SENT_320	[p18l1194t774r1423b826],
14	.	.	O	.	_	0	SENT_320	[p18l1194t774r1423b826],

1	J	NNP	O	J	nn	3	SENT_321	[p18l1469t777r1494b839],
2	Mol	NNP	O	Mol	nn	3	SENT_321	[p18l1542t774r1655b825],
3	Biol	NNP	O	Biol	_	0	SENT_321	[p18l1703t774r1812b825],
4	2009	CD	DATE	2009	num	3	SENT_321	[p18l1859t779r2136b833],
5	;	:	O	;	_	0	SENT_321	[p18l1859t779r2136b833],
6	392	CD	NUMBER	392	num	8	SENT_321	[p18l1859t779r2136b833],
7	:	:	O	:	_	0	SENT_321	[p18l1859t779r2136b833],
8	602-613	CD	NUMBER	602-613	dep	3	SENT_321	[p18l128t863r374b916],
9	.	.	O	.	_	0	SENT_321	[p18l128t863r374b916],

1	Sumi	NNP	PERSON	Sumi	nn	2	SENT_322	[p18l128t949r268b999],
2	S	NNP	PERSON	S	_	0	SENT_322	[p18l304t949r350b1006],
3	,	,	O	,	_	0	SENT_322	[p18l304t949r350b1006],
4	Marinaki	NNP	ORGANIZATION	Marinaki	nn	5	SENT_322	[p18l388t946r639b999],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_322	[p18l670t949r796b1006],
6	,	,	O	,	_	0	SENT_322	[p18l670t949r796b1006],
7	Arenas	NNP	O	Arenas	nn	8	SENT_322	[p18l830t949r1015b999],
8	M	NNP	O	M	appos	5	SENT_322	[p18l1051t950r1128b1006],
9	,	,	O	,	_	0	SENT_322	[p18l1051t950r1128b1006],
10	Fairbanks	NNP	ORGANIZATION	Fairbanks	nn	11	SENT_322	[p18l1167t946r1428b999],
11	L	NNP	ORGANIZATION	L	appos	5	SENT_322	[p18l1464t950r1515b1006],
12	,	,	O	,	_	0	SENT_322	[p18l1464t950r1515b1006],
13	Shobowale-Bakre	NNP	O	Shobowale-Bakre	nn	14	SENT_322	[p18l1554t946r2025b999],
14	M	NNP	O	M	appos	5	SENT_322	[p18l2060t950r2137b1006],
15	,	,	O	,	_	0	SENT_322	[p18l2060t950r2137b1006],
16	Rees	NNP	ORGANIZATION	Rees	nn	17	SENT_322	[p18l128t1033r247b1081],
17	DC	NNP	ORGANIZATION	DC	appos	5	SENT_322	[p18l281t1032r398b1089],
18	,	,	O	,	_	0	SENT_322	[p18l281t1032r398b1089],
19	et	FW	O	et	nn	20	SENT_322	[p18l433t1047r480b1081],
20	al.	FW	O	al.	appos	5	SENT_322	[p18l511t1030r569b1081],
21	.	.	O	.	_	0	SENT_322	[p18l511t1030r569b1081],

1	Genetic	JJ	O	genetic	amod	2	SENT_323	[p18l606t1032r818b1081],
2	basis	NN	O	basis	_	0	SENT_323	[p18l848t1029r973b1081],
3	of	IN	O	of	_	0	SENT_323	[p18l1007t1029r1068b1081],
4	inosine	NN	O	inosine	nn	7	SENT_323	[p18l1091t1033r1285b1081],
5	triphosphate	NN	O	triphosphate	nn	7	SENT_323	[p18l1317t1029r1658b1098],
6	pyrophosphohydrolase	NN	O	pyrophosphohydrolase	nn	7	SENT_323	[p18l1690t1029r2139b1098, p18l127t1112r316b1164],
7	deﬁciency	NN	O	deﬁciency	prep_of	2	SENT_323	[p18l343t1112r619b1180],
8	.	.	O	.	_	0	SENT_323	[p18l343t1112r619b1180],

1	Hum	NNP	O	Hum	nn	2	SENT_324	[p18l650t1115r794b1164],
2	Genet	NNP	O	Genet	_	0	SENT_324	[p18l822t1114r987b1164],
3	2002	CD	DATE	2002	num	2	SENT_324	[p18l1012t1113r1543b1171],
4	;	:	O	;	_	0	SENT_324	[p18l1012t1113r1543b1171],
5	111:360	CD	NUMBER	111:360	num	6	SENT_324	[p18l1012t1113r1543b1171],
6	—	NN	O	—	dep	2	SENT_324	[p18l1012t1113r1543b1171],
7	367	CD	NUMBER	367	dep	6	SENT_324	[p18l1012t1113r1543b1171],
8	.	.	O	.	_	0	SENT_324	[p18l1012t1113r1543b1171],

1	Thompson	NNP	PERSON	Thompson	nn	2	SENT_325	[p18l125t1195r428b1264],
2	AJ	NNP	PERSON	AJ	_	0	SENT_325	[p18l454t1198r538b1260],
3	,	,	O	,	_	0	SENT_325	[p18l454t1198r538b1260],
4	Fellay	NNP	PERSON	Fellay	nn	5	SENT_325	[p18l571t1195r730b1264],
5	J	NNP	PERSON	J	appos	2	SENT_325	[p18l751t1199r792b1260],
6	,	,	O	,	_	0	SENT_325	[p18l751t1199r792b1260],
7	Patel	NNP	PERSON	Patel	nn	8	SENT_325	[p18l825t1195r953b1247],
8	K	NNP	PERSON	K	appos	5	SENT_325	[p18l984t1199r1043b1255],
9	,	,	O	,	_	0	SENT_325	[p18l984t1199r1043b1255],
10	Tillmann	NNP	PERSON	Tillmann	nn	11	SENT_325	[p18l1073t1195r1330b1247],
11	HL	NNS	O	hl	appos	5	SENT_325	[p18l1359t1199r1466b1255],
12	,	,	O	,	_	0	SENT_325	[p18l1359t1199r1466b1255],
13	Naggie	NN	O	naggie	nn	14	SENT_325	[p18l1498t1199r1688b1265],
14	S	NN	O	s	appos	5	SENT_325	[p18l1718t1198r1764b1255],
15	,	,	O	,	_	0	SENT_325	[p18l1718t1198r1764b1255],
16	Ge	NN	O	ge	nn	17	SENT_325	[p18l1797t1198r1875b1247],
17	D	NN	O	d	appos	5	SENT_325	[p18l1904t1199r1971b1255],
18	,	,	O	,	_	0	SENT_325	[p18l1904t1199r1971b1255],
19	et	FW	O	et	nn	20	SENT_325	[p18l2004t1213r2051b1247],
20	al.	FW	O	al.	appos	5	SENT_325	[p18l2079t1195r2137b1247],
21	.	.	O	.	_	0	SENT_325	[p18l2079t1195r2137b1247],

1	Variants	NNS	O	variant	nsubj	12	SENT_326	[p18l125t1282r346b1330],
2	in	IN	O	in	_	0	SENT_326	[p18l381t1282r433b1330],
3	the	DT	O	the	det	5	SENT_326	[p18l467t1279r549b1330],
4	ITPA	NN	O	itpa	nn	5	SENT_326	[p18l583t1280r734b1330],
5	gene	NN	O	gene	prep_in	1	SENT_326	[p18l764t1299r886b1348],
6	protect	VBP	O	protect	_	0	SENT_326	[p18l920t1296r1112b1348],
7	against	IN	O	against	_	0	SENT_326	[p18l1144t1282r1332b1348],
8	ribavirin-induced	JJ	O	ribavirin-induced	amod	10	SENT_326	[p18l1364t1278r1839b1331],
9	hemolytic	JJ	O	hemolytic	amod	10	SENT_326	[p18l1870t1278r2142b1347],
10	anemia	NN	O	anemia	prep_against	6	SENT_326	[p18l127t1365r324b1413],
11	and	CC	O	and	_	0	SENT_326	[p18l349t1361r448b1413],
12	decrease	VB	O	decrease	conj_and	6	SENT_326	[p18l475t1361r695b1413],
13	the	DT	O	the	det	14	SENT_326	[p18l722t1361r805b1413],
14	need	NN	O	need	dobj	12	SENT_326	[p18l832t1361r959b1413],
15	for	IN	O	for	_	0	SENT_326	[p18l985t1361r1062b1413],
16	ribavirin	NNP	O	ribavirin	nn	18	SENT_326	[p18l1088t1361r1320b1413],
17	dose	NN	O	dose	nn	18	SENT_326	[p18l1346t1361r1465b1413],
18	reduction	NN	O	reduction	prep_for	14	SENT_326	[p18l1493t1361r1767b1413],
19	.	.	O	.	_	0	SENT_326	[p18l1493t1361r1767b1413],

1	Gastroenterology	NNP	O	Gastroenterology	_	0	SENT_327	[p18l1799t1364r2139b1413, p18l127t1444r277b1514],
2	2010	CD	DATE	2010	num	1	SENT_327	[p18l300t1449r902b1503],
3	;	:	O	;	_	0	SENT_327	[p18l300t1449r902b1503],
4	139:1181	CD	DURATION	139:1181	number	5	SENT_327	[p18l300t1449r902b1503],
5	-1189	CD	DURATION	-1189	dep	1	SENT_327	[p18l300t1449r902b1503],
6	.	.	O	.	_	0	SENT_327	[p18l300t1449r902b1503],

1	Ochi	NNP	PERSON	Ochi	nn	2	SENT_328	[p18l128t1527r263b1579],
2	H	NNP	PERSON	H	_	0	SENT_328	[p18l292t1531r360b1587],
3	,	,	O	,	_	0	SENT_328	[p18l292t1531r360b1587],
4	Mackawa	NNP	ORGANIZATION	Mackawa	nn	5	SENT_328	[p18l391t1527r650b1579],
5	T	NN	ORGANIZATION	t	appos	2	SENT_328	[p18l675t1529r727b1587],
6	,	,	O	,	_	0	SENT_328	[p18l675t1529r727b1587],
7	Abe	NN	PERSON	abe	nn	8	SENT_328	[p18l755t1527r864b1579],
8	H	NN	PERSON	h	appos	5	SENT_328	[p18l892t1531r961b1587],
9	,	,	O	,	_	0	SENT_328	[p18l892t1531r961b1587],
10	Hayashida	NNP	PERSON	Hayashida	nn	11	SENT_328	[p18l993t1527r1279b1596],
11	Y	NN	PERSON	y	appos	5	SENT_328	[p18l1303t1531r1353b1587],
12	,	,	O	,	_	0	SENT_328	[p18l1303t1531r1353b1587],
13	Nakano	NNP	PERSON	Nakano	nn	14	SENT_328	[p18l1384t1527r1597b1579],
14	R	NNP	PERSON	R	appos	5	SENT_328	[p18l1628t1531r1685b1587],
15	,	,	O	,	_	0	SENT_328	[p18l1628t1531r1685b1587],
16	Kubo	NNP	PERSON	Kubo	nn	17	SENT_328	[p18l1717t1527r1865b1580],
17	M	NNP	O	M	appos	5	SENT_328	[p18l1895t1531r1972b1587],
18	,	,	O	,	_	0	SENT_328	[p18l1895t1531r1972b1587],
19	et	FW	O	et	nn	20	SENT_328	[p18l2004t1545r2052b1579],
20	al.	FW	O	al.	appos	5	SENT_328	[p18l2079t1527r2137b1579],
21	.	.	O	.	_	0	SENT_328	[p18l2079t1527r2137b1579],

1	ITPA	NN	ORGANIZATION	itpa	nn	2	SENT_329	[p18l128t1611r278b1661],
2	polymorphism	NN	O	polymorphism	nsubj	3	SENT_329	[p18l309t1610r710b1679],
3	affects	VBZ	O	affect	_	0	SENT_329	[p18l745t1610r912b1662],
4	ribavirin-induced	JJ	O	ribavirin-induced	amod	5	SENT_329	[p18l947t1610r1421b1662],
5	anemia	NN	O	anemia	nsubj	13	SENT_329	[p18l1455t1613r1651b1662],
6	and	CC	O	and	_	0	SENT_329	[p18l1684t1610r1784b1662],
7	outcome	NN	O	outcome	nsubj	13	SENT_329	[p18l1817t1627r2054b1662],
8	of	IN	O	of	_	0	SENT_329	[p18l2088t1610r2150b1662],
9	therapy	NN	O	therapy	prep_of	5	SENT_329	[p18l127t1698r333b1767],
10	—	CD	NUMBER	—	num	9	SENT_329	[p18l358t1732r429b1736],
11	a	DT	O	a	det	13	SENT_329	[p18l459t1720r486b1750],
12	genome-Wide	JJ	MISC	genome-wide	amod	13	SENT_329	[p18l515t1698r880b1768],
13	study	NN	O	study	xcomp	3	SENT_329	[p18l910t1698r1058b1766],
14	of	IN	O	of	_	0	SENT_329	[p18l1086t1698r1147b1750],
15	Japanese	JJ	MISC	japanese	amod	17	SENT_329	[p18l1164t1701r1399b1767],
16	HCV	NN	O	hcv	nn	17	SENT_329	[p18l1430t1701r1584b1750],
17	patients	NNS	O	patient	prep_of	13	SENT_329	[p18l1611t1702r1837b1767],
18	.	.	O	.	_	0	SENT_329	[p18l1611t1702r1837b1767],

1	Gastroenterology	NNP	O	Gastroenterology	_	0	SENT_330	[p18l1872t1701r2140b1750, p18l127t1787r350b1856],
2	2010	CD	DATE	2010	num	1	SENT_330	[p18l373t1792r975b1846],
3	;	:	O	;	_	0	SENT_330	[p18l373t1792r975b1846],
4	139:1190	CD	DURATION	139:1190	number	5	SENT_330	[p18l373t1792r975b1846],
5	-1197	CD	DURATION	-1197	dep	1	SENT_330	[p18l373t1792r975b1846],
6	.	.	O	.	_	0	SENT_330	[p18l373t1792r975b1846],

1	Hezode	NN	O	hezode	nn	2	SENT_331	[p18l128t1871r334b1924],
2	C	NN	O	c	_	0	SENT_331	[p18l364t1873r425b1931],
3	,	,	O	,	_	0	SENT_331	[p18l364t1873r425b1931],
4	Forestier	NNP	PERSON	Forestier	nn	5	SENT_331	[p18l458t1874r693b1923],
5	N	NNP	O	N	appos	2	SENT_331	[p18l720t1874r789b1931],
6	,	,	O	,	_	0	SENT_331	[p18l720t1874r789b1931],
7	Dusheiko	NNP	O	Dusheiko	nn	8	SENT_331	[p18l823t1871r1082b1924],
8	G	NNP	O	G	appos	5	SENT_331	[p18l1114t1873r1178b1931],
9	,	,	O	,	_	0	SENT_331	[p18l1114t1873r1178b1931],
10	Ferenci	NNP	PERSON	Ferenci	nn	11	SENT_331	[p18l1212t1874r1407b1923],
11	P	NN	PERSON	p	appos	5	SENT_331	[p18l1438t1874r1476b1931],
12	,	,	O	,	_	0	SENT_331	[p18l1438t1874r1476b1931],
13	Pol	NN	O	pol	nn	14	SENT_331	[p18l1509t1871r1593b1923],
14	S	NN	O	s	appos	5	SENT_331	[p18l1624t1873r1669b1931],
15	,	,	O	,	_	0	SENT_331	[p18l1624t1873r1669b1931],
16	Goeser	NNP	PERSON	Goeser	nn	17	SENT_331	[p18l1704t1873r1891b1923],
17	T	NN	O	t	appos	5	SENT_331	[p18l1918t1872r1970b1931],
18	,	,	O	,	_	0	SENT_331	[p18l1918t1872r1970b1931],
19	et	FW	O	et	nn	20	SENT_331	[p18l2003t1888r2051b1923],
20	al.	FW	O	al.	appos	5	SENT_331	[p18l2079t1871r2137b1923],
21	.	.	O	.	_	0	SENT_331	[p18l2079t1871r2137b1923],

1	Telaprevir	NNP	O	Telaprevir	_	0	SENT_332	[p18l125t1954r399b2023],
2	and	CC	O	and	_	0	SENT_332	[p18l445t1954r545b2006],
3	peginterferon	NN	O	peginterferon	conj_or	3	SENT_332	[p18l591t1954r957b2024],
4	with	IN	O	with	_	0	SENT_332	[p18l1002t1954r1125b2006],
5	or	CC	O	or	_	0	SENT_332	[p18l1172t1975r1228b2006],
6	without	IN	O	without	_	0	SENT_332	[p18l1273t1954r1489b2006],
7	ribavirin	NNP	O	ribavirin	prep_with	3	SENT_332	[p18l1535t1954r1766b2006],
8	for	IN	O	for	_	0	SENT_332	[p18l1813t1954r1891b2006],
9	chronic	JJ	O	chronic	amod	11	SENT_332	[p18l1938t1954r2142b2006],
10	HCV	NN	O	hcv	nn	11	SENT_332	[p18l128t2039r282b2089],
11	infection	NN	O	infection	prep_for	7	SENT_332	[p18l305t2037r560b2088],
12	.	.	O	.	_	0	SENT_332	[p18l305t2037r560b2088],

1	N	NN	O	n	nn	3	SENT_333	[p18l590t2040r642b2088],
2	Engl	NNP	O	Engl	nn	3	SENT_333	[p18l669t2037r793b2106],
3	J	NNP	O	J	nsubj	4	SENT_333	[p18l816t2040r840b2102],
4	Med	VBD	O	med	_	0	SENT_333	[p18l868t2037r994b2089],
5	2009	CD	DATE	2009	dobj	4	SENT_333	[p18l1020t2038r1621b2096],
6	;	:	O	;	_	0	SENT_333	[p18l1020t2038r1621b2096],
7	360:1839	CD	DURATION	360:1839	num	8	SENT_333	[p18l1020t2038r1621b2096],
8	-1850	CD	DURATION	-1850	dep	5	SENT_333	[p18l1020t2038r1621b2096],
9	.	.	O	.	_	0	SENT_333	[p18l1020t2038r1621b2096],

1	McHutchison	NNP	O	McHutchison	nn	2	SENT_334	[p18l127t2120r493b2172],
2	JG	NNP	O	JG	_	0	SENT_334	[p18l518t2122r610b2185],
3	,	,	O	,	_	0	SENT_334	[p18l518t2122r610b2185],
4	Everson	NNP	PERSON	Everson	nn	5	SENT_334	[p18l643t2123r848b2172],
5	GT	NN	O	gt	appos	2	SENT_334	[p18l878t2121r978b2179],
6	,	,	O	,	_	0	SENT_334	[p18l878t2121r978b2179],
7	Gordon	NNP	PERSON	Gordon	nn	8	SENT_334	[p18l1012t2120r1220b2172],
8	SC	NNP	PERSON	SC	appos	5	SENT_334	[p18l1250t2122r1343b2180],
9	,	,	O	,	_	0	SENT_334	[p18l1250t2122r1343b2180],
10	Jacobson	NNP	PERSON	Jacobson	nn	11	SENT_334	[p18l1371t2120r1608b2185],
11	IM	NNP	O	IM	appos	5	SENT_334	[p18l1638t2123r1736b2179],
12	,	,	O	,	_	0	SENT_334	[p18l1638t2123r1736b2179],
13	Sulkowski	NNP	PERSON	Sulkowski	nn	14	SENT_334	[p18l1769t2120r2032b2172],
14	M	NNP	O	M	appos	5	SENT_334	[p18l2061t2123r2137b2179],
15	,	,	O	,	_	0	SENT_334	[p18l2061t2123r2137b2179],
16	Kauffman	NNP	PERSON	Kauffman	nn	17	SENT_334	[p18l128t2203r391b2256],
17	R	NNP	PERSON	R	appos	5	SENT_334	[p18l419t2207r474b2263],
18	,	,	O	,	_	0	SENT_334	[p18l419t2207r474b2263],
19	et	FW	O	et	nn	20	SENT_334	[p18l506t2221r552b2255],
20	al.	FW	O	al.	appos	5	SENT_334	[p18l579t2203r633b2255],
21	.	.	O	.	_	0	SENT_334	[p18l579t2203r633b2255],

1	Telaprevir	NN	O	telaprevir	_	0	SENT_335	[p18l663t2204r923b2272],
2	with	IN	O	with	_	0	SENT_335	[p18l949t2204r1067b2255],
3	peginterferon	NN	O	peginterferon	prep_with	1	SENT_335	[p18l1094t2203r1444b2273],
4	and	CC	O	and	_	0	SENT_335	[p18l1472t2204r1569b2256],
5	ribavirin	NNP	O	ribavirin	prep_with	1	SENT_335	[p18l1596t2204r1816b2255],
6	for	IN	O	for	_	0	SENT_335	[p18l1844t2203r1918b2255],
7	chronic	JJ	O	chronic	amod	11	SENT_335	[p18l1945t2203r2141b2255],
8	HCV	NN	O	hcv	nn	11	SENT_335	[p18l128t2288r279b2338],
9	genotype	NN	O	genotype	nn	11	SENT_335	[p18l295t2303r532b2355],
10	1	CD	NUMBER	1	num	11	SENT_335	[p18l557t2291r577b2337],
11	infection	NN	O	infection	prep_for	1	SENT_335	[p18l603t2286r845b2337],
12	.	.	O	.	_	0	SENT_335	[p18l603t2286r845b2337],

1	N	NN	O	n	nn	2	SENT_336	[p18l868t2289r920b2337],
2	EnglJ	NN	O	englj	nsubj	3	SENT_336	[p18l940t2286r1101b2355],
3	Med	VBD	O	med	_	0	SENT_336	[p18l1121t2286r1244b2338],
4	2009	CD	DATE	2009	dobj	3	SENT_336	[p18l1263t2287r1840b2345],
5	;	:	O	;	_	0	SENT_336	[p18l1263t2287r1840b2345],
6	360:1827	CD	DURATION	360:1827	num	7	SENT_336	[p18l1263t2287r1840b2345],
7	-1838	CD	DURATION	-1838	dep	4	SENT_336	[p18l1263t2287r1840b2345],
8	.	.	O	.	_	0	SENT_336	[p18l1263t2287r1840b2345],

1	HEPATOLOGY	NNP	O	HEPATOLOGY	_	0	SENT_337	[p18l7t2391r480b2450],
2	,	,	O	,	_	0	SENT_337	[p18l7t2391r480b2450],
3	Vol	NNP	O	Vol	appos	1	SENT_337	[p18l507t2390r615b2443],
4	.	.	O	.	_	0	SENT_337	[p18l507t2390r615b2443],

1	53	CD	NUMBER	53	_	0	SENT_338	[p18l649t2394r730b2450],
2	,	,	O	,	_	0	SENT_338	[p18l649t2394r730b2450],
3	No.	NN	O	no.	appos	1	SENT_338	[p18l758t2393r859b2442],
4	2	CD	NUMBER	2	num	3	SENT_338	[p18l889t2395r937b2450],
5	,	,	O	,	_	0	SENT_338	[p18l889t2395r937b2450],
6	2011	CD	DATE	2011	appos	1	SENT_338	[p18l966t2395r1099b2442],

1	Mederacke	NNP	MISC	Mederacke	nn	2	SENT_339	[p18l124t2611r423b2664],
2	I	NNP	O	I	_	0	SENT_339	[p18l462t2614r497b2671],
3	,	,	O	,	_	0	SENT_339	[p18l462t2614r497b2671],
4	Wedemeyer	NNP	PERSON	Wedemeyer	nn	5	SENT_339	[p18l536t2611r861b2680],
5	H	NNP	O	H	appos	2	SENT_339	[p18l900t2614r969b2671],
6	,	,	O	,	_	0	SENT_339	[p18l900t2614r969b2671],
7	Manns	NNP	O	Manns	nn	8	SENT_339	[p18l1010t2614r1198b2664],
8	MP	NNP	O	MP	appos	5	SENT_339	[p18l1237t2614r1341b2664],
9	.	.	O	.	_	0	SENT_339	[p18l1237t2614r1341b2664],

1	Boceprevir	NNP	PERSON	Boceprevir	_	0	SENT_340	[p18l1384t2614r1688b2681],
2	,	,	O	,	_	0	SENT_340	[p18l1384t2614r1688b2681],
3	an	DT	O	a	det	7	SENT_340	[p18l1730t2632r1793b2663],
4	NS3	NN	O	ns3	nn	7	SENT_340	[p18l1831t2613r1953b2666],
5	serine	NN	O	serine	nn	7	SENT_340	[p18l1995t2614r2151b2664],
6	protease	NN	O	protease	nn	7	SENT_340	[p18l124t2712r347b2764],
7	inhibitor	NN	O	inhibitor	appos	1	SENT_340	[p18l374t2695r618b2747],
8	of	IN	O	of	_	0	SENT_340	[p18l644t2694r706b2747],
9	hepatitis	NN	O	hepatitis	nn	11	SENT_340	[p18l723t2694r954b2764],
10	C	NN	O	c	nn	11	SENT_340	[p18l983t2697r1028b2747],
11	virus	NN	O	virus	prep_of	7	SENT_340	[p18l1054t2698r1201b2755],
12	,	,	O	,	_	0	SENT_340	[p18l1054t2698r1201b2755],
13	for	IN	O	for	_	0	SENT_340	[p18l1231t2694r1308b2747],
14	the	DT	O	the	det	15	SENT_340	[p18l1335t2694r1418b2747],
15	treatment	NN	O	treatment	prep_for	1	SENT_340	[p18l1446t2712r1712b2747],
16	of	IN	O	of	_	0	SENT_340	[p18l1738t2694r1800b2747],
17	HCV	NN	O	hcv	nn	18	SENT_340	[p18l1818t2697r1974b2747],
18	infection	NN	O	infection	prep_of	15	SENT_340	[p18l1998t2694r2150b2747, p18l125t2780r249b2829],
19	.	.	O	.	_	0	SENT_340	[p18l1998t2694r2150b2747, p18l125t2780r249b2829],

1	Curr	NNP	O	Curr	nn	4	SENT_341	[p18l279t2779r409b2830],
2	Opin	NNP	O	Opin	nn	4	SENT_341	[p18l436t2779r581b2847],
3	Investig	NNP	O	Investig	nn	4	SENT_341	[p18l608t2780r821b2847],
4	Drugs	NNPS	O	Drugs	_	0	SENT_341	[p18l846t2780r1012b2847],
5	2009	CD	DATE	2009	dep	4	SENT_341	[p18l1040t2782r1538b2837],
6	;	:	O	;	_	0	SENT_341	[p18l1040t2782r1538b2837],
7	10:181	CD	NUMBER	10:181	num	8	SENT_341	[p18l1040t2782r1538b2837],
8	-189	CD	NUMBER	-189	dep	4	SENT_341	[p18l1040t2782r1538b2837],
9	.	.	O	.	_	0	SENT_341	[p18l1040t2782r1538b2837],

1	Ohnishi	NNP	PERSON	Ohnishi	nn	2	SENT_342	[p18l126t2861r347b2913],
2	Y	NN	PERSON	y	dep	22	SENT_342	[p18l376t2864r426b2921],
3	,	,	O	,	_	0	SENT_342	[p18l376t2864r426b2921],
4	Tanaka	NNP	PERSON	Tanaka	nn	5	SENT_342	[p18l458t2861r656b2913],
5	T	NN	PERSON	t	appos	2	SENT_342	[p18l683t2862r736b2921],
6	,	,	O	,	_	0	SENT_342	[p18l683t2862r736b2921],
7	Ozaki	NNP	PERSON	Ozaki	nn	8	SENT_342	[p18l770t2861r931b2913],
8	K	NNP	PERSON	K	appos	2	SENT_342	[p18l963t2864r1023b2921],
9	,	,	O	,	_	0	SENT_342	[p18l963t2864r1023b2921],
10	Yamada	NNP	PERSON	Yamada	nn	11	SENT_342	[p18l1053t2861r1272b2914],
11	R	NNP	PERSON	R	appos	2	SENT_342	[p18l1301t2864r1358b2921],
12	,	,	O	,	_	0	SENT_342	[p18l1301t2864r1358b2921],
13	Suzuki	NNP	PERSON	Suzuki	nn	14	SENT_342	[p18l1393t2861r1574b2914],
14	H	NNP	PERSON	H	appos	2	SENT_342	[p18l1606t2864r1674b2921],
15	,	,	O	,	_	0	SENT_342	[p18l1606t2864r1674b2921],
16	Nakamura	NNP	PERSON	Nakamura	nn	18	SENT_342	[p18l1707t2861r1999b2914],
17	Y.	NNP	O	Y.	nn	18	SENT_342	[p18l2025t2864r2075b2913],
18	A	NNP	O	A	appos	2	SENT_342	[p18l2105t2864r2153b2913],
19	high-throughput	JJ	O	high-throughput	amod	22	SENT_342	[p18l124t2951r585b3021],
20	SNP	NN	ORGANIZATION	snp	nn	22	SENT_342	[p18l614t2953r740b3003],
21	typing	NN	O	typing	nn	22	SENT_342	[p18l770t2954r946b3021],
22	system	NN	O	system	_	0	SENT_342	[p18l973t2968r1154b3020],
23	for	IN	O	for	_	0	SENT_342	[p18l1185t2950r1262b3003],
24	genome-wide	JJ	O	genome-wide	amod	26	SENT_342	[p18l1291t2950r1658b3021],
25	association	NN	O	association	nn	26	SENT_342	[p18l1689t2954r1983b3003],
26	studies	NNS	O	study	prep_for	22	SENT_342	[p18l2013t2951r2150b3004, p18l125t3037r206b3085],
27	.	.	O	.	_	0	SENT_342	[p18l2013t2951r2150b3004, p18l125t3037r206b3085],

1	J	NNP	O	J	nn	3	SENT_343	[p18l231t3037r256b3099],
2	Hum	NNP	O	Hum	nn	3	SENT_343	[p18l285t3037r430b3086],
3	Genet	NNP	O	Genet	_	0	SENT_343	[p18l458t3036r624b3085],
4	2001	CD	DATE	2001	num	3	SENT_343	[p18l649t3034r1147b3093],
5	;	:	O	;	_	0	SENT_343	[p18l649t3034r1147b3093],
6	46:471	CD	NUMBER	46:471	number	7	SENT_343	[p18l649t3034r1147b3093],
7	-477	CD	NUMBER	-477	dep	3	SENT_343	[p18l649t3034r1147b3093],
8	.	.	O	.	_	0	SENT_343	[p18l649t3034r1147b3093],

1	Suzuki	NNP	PERSON	Suzuki	nn	2	SENT_344	[p18l125t3115r308b3168],
2	A	NNP	O	A	_	0	SENT_344	[p18l344t3117r404b3175],
3	,	,	O	,	_	0	SENT_344	[p18l344t3117r404b3175],
4	Yamada	NNP	PERSON	Yamada	nn	5	SENT_344	[p18l445t3115r663b3168],
5	R	NNP	PERSON	R	appos	2	SENT_344	[p18l702t3118r760b3175],
6	,	,	O	,	_	0	SENT_344	[p18l702t3118r760b3175],
7	Chang	NNP	PERSON	Chang	nn	8	SENT_344	[p18l804t3115r986b3185],
8	X	NNP	O	X	appos	5	SENT_344	[p18l1022t3118r1083b3175],
9	,	,	O	,	_	0	SENT_344	[p18l1022t3118r1083b3175],
10	Tokuhiro	NNP	LOCATION	Tokuhiro	nn	11	SENT_344	[p18l1124t3115r1380b3168],
11	S	NNP	LOCATION	S	appos	5	SENT_344	[p18l1422t3117r1468b3174],
12	,	,	O	,	_	0	SENT_344	[p18l1422t3117r1468b3174],
13	Sawada	NNP	PERSON	Sawada	nn	14	SENT_344	[p18l1512t3115r1714b3168],
14	T	NN	O	t	appos	5	SENT_344	[p18l1752t3116r1804b3175],
15	,	,	O	,	_	0	SENT_344	[p18l1752t3116r1804b3175],
16	Suzuki	NNP	PERSON	Suzuki	nn	17	SENT_344	[p18l1848t3115r2030b3168],
17	M	NNP	O	M	appos	5	SENT_344	[p18l2070t3118r2148b3175],
18	,	,	O	,	_	0	SENT_344	[p18l2070t3118r2148b3175],
19	et	FW	O	et	nn	20	SENT_344	[p18l125t3216r173b3251],
20	al.	FW	O	al.	appos	5	SENT_344	[p18l203t3198r262b3251],
21	.	.	O	.	_	0	SENT_344	[p18l203t3198r262b3251],

1	Functional	JJ	O	functional	amod	2	SENT_345	[p18l298t3198r592b3252],
2	haplotypes	NNS	O	haplotype	nsubjpass	14	SENT_345	[p18l624t3198r915b3268],
3	of	IN	O	of	_	0	SENT_345	[p18l948t3198r1010b3251],
4	PADI4	NN	O	padi4	prep_of	2	SENT_345	[p18l1034t3199r1243b3258],
5	,	,	O	,	_	0	SENT_345	[p18l1034t3199r1243b3258],
6	encoding	VBG	O	encode	partmod	14	SENT_345	[p18l1277t3198r1528b3269],
7	citrullinating	JJ	O	citrullinating	amod	10	SENT_345	[p18l1559t3198r1915b3269],
8	enzyme	NN	O	enzyme	nn	10	SENT_345	[p18l1946t3219r2151b3268],
9	peptidylarginine	NN	O	peptidylarginine	nn	10	SENT_345	[p18l124t3287r573b3358],
10	deiminase	NN	O	deiminase	dobj	6	SENT_345	[p18l607t3287r880b3341],
11	4	CD	NUMBER	4	num	10	SENT_345	[p18l913t3288r961b3347],
12	,	,	O	,	_	0	SENT_345	[p18l913t3288r961b3347],
13	are	VBP	O	be	auxpass	14	SENT_345	[p18l998t3309r1076b3340],
14	associated	VBN	O	associate	_	0	SENT_345	[p18l1110t3288r1380b3341],
15	with	IN	O	with	_	0	SENT_345	[p18l1410t3288r1534b3340],
16	rheumatoid	JJ	O	rheumatoid	amod	17	SENT_345	[p18l1568t3288r1886b3341],
17	arthritis	NN	O	arthritis	prep_with	14	SENT_345	[p18l1920t3287r2148b3340],
18	.	.	O	.	_	0	SENT_345	[p18l1920t3287r2148b3340],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_346	[p18l124t3380r228b3430],
2	Genet	NNP	PERSON	Genet	_	0	SENT_346	[p18l254t3380r420b3430],
3	2003	CD	DATE	2003	num	2	SENT_346	[p18l446t3378r944b3437],
4	;	:	O	;	_	0	SENT_346	[p18l446t3378r944b3437],
5	34:395	CD	NUMBER	34:395	number	6	SENT_346	[p18l446t3378r944b3437],
6	-402	CD	NUMBER	-402	dep	2	SENT_346	[p18l446t3378r944b3437],
7	.	.	O	.	_	0	SENT_346	[p18l446t3378r944b3437],

1	19	CD	NUMBER	19	_	0	SENT_347	[p19l13t23r89b74],
2	.	.	O	.	_	0	SENT_347	[p19l13t23r89b74],

1	De	NNP	PERSON	De	nn	3	SENT_348	[p19l126t22r206b71],
2	Franceschi	NNP	PERSON	Franceschi	nn	3	SENT_348	[p19l237t18r521b71],
3	L	NNP	PERSON	L	_	0	SENT_348	[p19l553t22r604b78],
4	,	,	O	,	_	0	SENT_348	[p19l553t22r604b78],
5	Fattovich	NNP	O	Fattovich	nn	6	SENT_348	[p19l639t18r891b71],
6	G	NNP	O	G	appos	3	SENT_348	[p19l922t21r987b78],
7	,	,	O	,	_	0	SENT_348	[p19l922t21r987b78],
8	Turrini	NNP	PERSON	Turrini	nn	9	SENT_348	[p19l1018t20r1213b71],
9	F	NN	O	f	appos	6	SENT_348	[p19l1245t22r1285b78],
10	,	,	O	,	_	0	SENT_348	[p19l1245t22r1285b78],
11	Ayi	NNP	PERSON	Ayi	nn	12	SENT_348	[p19l1315t21r1410b88],
12	K	NNP	O	K	appos	6	SENT_348	[p19l1441t22r1501b78],
13	,	,	O	,	_	0	SENT_348	[p19l1441t22r1501b78],
14	Brugnara	NNP	PERSON	Brugnara	nn	15	SENT_348	[p19l1535t22r1786b89],
15	C	NNP	O	C	appos	6	SENT_348	[p19l1816t21r1877b78],
16	,	,	O	,	_	0	SENT_348	[p19l1816t21r1877b78],
17	Manzato	NNP	O	Manzato	nn	18	SENT_348	[p19l1910t22r2150b71],
18	F	NN	O	f	appos	6	SENT_348	[p19l125t105r166b161],
19	,	,	O	,	_	0	SENT_348	[p19l125t105r166b161],
20	et	FW	O	et	nn	21	SENT_348	[p19l209t119r257b154],
21	al.	FW	O	al.	appos	6	SENT_348	[p19l296t102r354b154],
22	.	.	O	.	_	0	SENT_348	[p19l296t102r354b154],

1	Hemolytic	JJ	O	hemolytic	amod	2	SENT_349	[p19l399t102r690b171],
2	anemia	NN	O	anemia	_	0	SENT_349	[p19l729t105r926b154],
3	induced	VBN	O	induce	partmod	2	SENT_349	[p19l965t101r1184b155],
4	by	IN	O	by	_	0	SENT_349	[p19l1224t102r1291b171],
5	ribavirin	NNP	O	ribavirin	nn	6	SENT_349	[p19l1329t101r1562b154],
6	therapy	NN	O	therapy	agent	3	SENT_349	[p19l1601t101r1808b171],
7	in	IN	O	in	_	0	SENT_349	[p19l1846t105r1898b153],
8	patients	NNS	O	patient	prep_in	3	SENT_349	[p19l1937t105r2151b171],
9	with	IN	O	with	_	0	SENT_349	[p19l122t184r246b237],
10	chronic	JJ	O	chronic	amod	14	SENT_349	[p19l283t184r489b237],
11	hepatitis	NN	O	hepatitis	nn	14	SENT_349	[p19l525t184r755b254],
12	C	NN	O	c	nn	14	SENT_349	[p19l795t187r841b237],
13	Virus	NN	O	virus	nn	14	SENT_349	[p19l877t188r1008b237],
14	infection	NN	O	infection	prep_with	8	SENT_349	[p19l1047t184r1303b237],
15	:	:	O	:	_	0	SENT_349	[p19l1047t184r1303b237],
16	role	NN	O	role	dep	2	SENT_349	[p19l1345t184r1447b237],
17	of	IN	O	of	_	0	SENT_349	[p19l1485t184r1547b237],
18	membrane	NN	O	membrane	nn	20	SENT_349	[p19l1575t184r1868b237],
19	oxidative	JJ	O	oxidative	amod	20	SENT_349	[p19l1906t184r2151b237],
20	damage	NN	O	damage	prep_of	16	SENT_349	[p19l125t267r347b338],
21	.	.	O	.	_	0	SENT_349	[p19l125t267r347b338],

1	HEPATOLOGY	NNP	O	HEPATOLOGY	_	0	SENT_350	[p19l378t270r721b320],
2	2000	CD	DATE	2000	num	1	SENT_350	[p19l745t268r1279b327],
3	;	:	O	;	_	0	SENT_350	[p19l745t268r1279b327],
4	31:997	CD	NUMBER	31:997	number	5	SENT_350	[p19l745t268r1279b327],
5	-1004	CD	NUMBER	-1004	dep	1	SENT_350	[p19l745t268r1279b327],
6	.	.	O	.	_	0	SENT_350	[p19l745t268r1279b327],

1	20	CD	NUMBER	20	_	0	SENT_351	[p19l7t355r89b402],
2	.	.	O	.	_	0	SENT_351	[p19l7t355r89b402],

1	Russmann	NNP	PERSON	Russmann	nn	2	SENT_352	[p19l125t353r410b403],
2	S	NNP	PERSON	S	nsubj	17	SENT_352	[p19l443t352r489b410],
3	,	,	O	,	_	0	SENT_352	[p19l443t352r489b410],
4	Grattagliano	NNP	O	Grattagliano	nn	5	SENT_352	[p19l526t350r868b421],
5	I	NNP	O	I	appos	2	SENT_352	[p19l902t353r938b410],
6	,	,	O	,	_	0	SENT_352	[p19l902t353r938b410],
7	Portincasa	NNP	O	Portincasa	nn	8	SENT_352	[p19l974t353r1253b403],
8	P	NN	O	p	appos	2	SENT_352	[p19l1285t353r1323b410],
9	,	,	O	,	_	0	SENT_352	[p19l1285t353r1323b410],
10	Palmieri	NNP	PERSON	Palmieri	nn	11	SENT_352	[p19l1359t350r1584b402],
11	VO	NNP	O	VO	appos	2	SENT_352	[p19l1615t352r1733b410],
12	,	,	O	,	_	0	SENT_352	[p19l1615t352r1733b410],
13	Palasciano	NNP	O	Palasciano	nn	16	SENT_352	[p19l1770t350r2048b403],
14	G.	NNP	O	G.	nn	16	SENT_352	[p19l2083t352r2147b403],
15	RibaVirin	NNP	O	RibaVirin	nn	16	SENT_352	[p19l125t433r625b486],
16	—	NN	O	—	appos	2	SENT_352	[p19l125t433r625b486],
17	induced	VBD	O	induce	_	0	SENT_352	[p19l125t433r625b486],
18	anemia	NN	O	anemia	dobj	17	SENT_352	[p19l657t436r867b485],
19	:	:	O	:	_	0	SENT_352	[p19l657t436r867b485],
20	mechanisms	NNS	O	mechanism	dep	18	SENT_352	[p19l903t433r1251b493],
21	,	,	O	,	_	0	SENT_352	[p19l903t433r1251b493],
22	risk	NN	O	risk	nn	23	SENT_352	[p19l1288t433r1387b486],
23	factors	NNS	O	factor	dep	18	SENT_352	[p19l1416t433r1594b486],
24	and	CC	O	and	_	0	SENT_352	[p19l1628t433r1728b486],
25	related	JJ	O	related	amod	26	SENT_352	[p19l1760t433r1943b486],
26	targets	NNS	O	target	dep	18	SENT_352	[p19l1975t451r2150b504],
27	for	IN	O	for	_	0	SENT_352	[p19l125t517r202b569],
28	future	JJ	DATE	future	amod	29	SENT_352	[p19l228t517r392b570],
29	research	NN	O	research	prep_for	17	SENT_352	[p19l419t517r651b570],
30	.	.	O	.	_	0	SENT_352	[p19l419t517r651b570],

1	Curr	NNP	ORGANIZATION	Curr	nn	3	SENT_353	[p19l682t520r813b570],
2	Med	NNP	ORGANIZATION	Med	nn	3	SENT_353	[p19l838t517r965b570],
3	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_353	[p19l991t517r1158b570],
4	2006	CD	DATE	2006	num	3	SENT_353	[p19l1185t519r1755b577],
5	;	:	O	;	_	0	SENT_353	[p19l1185t519r1755b577],
6	13:3351	CD	DURATION	13:3351	number	7	SENT_353	[p19l1185t519r1755b577],
7	-3357	CD	DURATION	-3357	dep	3	SENT_353	[p19l1185t519r1755b577],
8	.	.	O	.	_	0	SENT_353	[p19l1185t519r1755b577],

1	21	CD	NUMBER	21	_	0	SENT_354	[p19l7t604r89b651],
2	.	.	O	.	_	0	SENT_354	[p19l7t604r89b651],

1	Karlsen	NNP	PERSON	Karlsen	_	0	SENT_355	[p19l125t599r329b651],
2	TH	NN	O	th	dep	1	SENT_355	[p19l358t600r476b658],
3	,	,	O	,	_	0	SENT_355	[p19l358t600r476b658],
4	Melum	NN	O	melum	nn	5	SENT_355	[p19l508t599r708b652],
5	E	NN	O	e	appos	2	SENT_355	[p19l739t602r793b659],
6	,	,	O	,	_	0	SENT_355	[p19l739t602r793b659],
7	Franke	NNP	PERSON	Franke	nn	10	SENT_355	[p19l826t599r1012b651],
8	A.	NNP	O	A.	nn	10	SENT_355	[p19l1038t601r1098b651],
9	The	NNP	O	The	nn	10	SENT_355	[p19l1131t599r1241b651],
10	utility	NN	O	utility	appos	2	SENT_355	[p19l1272t599r1437b668],
11	of	IN	O	of	_	0	SENT_355	[p19l1465t599r1526b651],
12	genome	NN	O	genome	prep_of	10	SENT_355	[p19l1547t599r1914b669],
13	—	CD	NUMBER	—	num	15	SENT_355	[p19l1547t599r1914b669],
14	wide	JJ	O	wide	amod	15	SENT_355	[p19l1547t599r1914b669],
15	association	NN	O	association	dep	1	SENT_355	[p19l1945t602r2150b651, p19l125t685r234b734],

1	studies	NNS	O	study	_	0	SENT_356	[p19l260t682r444b735],
2	in	IN	O	in	_	0	SENT_356	[p19l472t685r525b734],
3	hepatology	NN	O	hepatology	prep_in	1	SENT_356	[p19l551t682r859b753],
4	.	.	O	.	_	0	SENT_356	[p19l551t682r859b753],

1	HEPATOLOGY	NNP	O	HEPATOLOGY	_	0	SENT_357	[p19l890t685r1233b734],
2	2010	CD	DATE	2010	num	1	SENT_357	[p19l1257t682r1827b742],
3	;	:	O	;	_	0	SENT_357	[p19l1257t682r1827b742],
4	51:1833	CD	DURATION	51:1833	number	5	SENT_357	[p19l1257t682r1827b742],
5	-1842	CD	DURATION	-1842	dep	1	SENT_357	[p19l1257t682r1827b742],
6	.	.	O	.	_	0	SENT_357	[p19l1257t682r1827b742],

1	22	CD	NUMBER	22	_	0	SENT_358	[p19l7t771r89b818],
2	.	.	O	.	_	0	SENT_358	[p19l7t771r89b818],

1	Ge	NN	O	ge	nn	2	SENT_359	[p19l126t768r204b818],
2	D	NN	O	d	_	0	SENT_359	[p19l231t769r298b826],
3	,	,	O	,	_	0	SENT_359	[p19l231t769r298b826],
4	Fellay	NNP	PERSON	Fellay	nn	5	SENT_359	[p19l328t765r488b835],
5	J	NNP	PERSON	J	appos	2	SENT_359	[p19l507t769r549b832],
6	,	,	O	,	_	0	SENT_359	[p19l507t769r549b832],
7	Thompson	NNP	PERSON	Thompson	nn	9	SENT_359	[p19l577t765r882b835],
8	A	NNP	O	A	nn	9	SENT_359	[p19l904t768r989b832],
9	]	NN	O	]	appos	5	SENT_359	[p19l904t768r989b832],
10	,	,	O	,	_	0	SENT_359	[p19l904t768r989b832],
11	Simon	NNP	PERSON	Simon	nn	13	SENT_359	[p19l1020t768r1198b818],
12	]	CD	NUMBER	]	num	13	SENT_359	[p19l1220t768r1296b832],
13	S	NN	O	s	appos	5	SENT_359	[p19l1220t768r1296b832],
14	,	,	O	,	_	0	SENT_359	[p19l1220t768r1296b832],
15	Shianna	NNP	ORGANIZATION	Shianna	nn	16	SENT_359	[p19l1326t766r1546b818],
16	KV	NN	ORGANIZATION	kv	appos	5	SENT_359	[p19l1572t769r1671b825],
17	,	,	O	,	_	0	SENT_359	[p19l1572t769r1671b825],
18	Urban	NNP	MISC	Urban	nn	20	SENT_359	[p19l1702t766r1876b818],
19	T	NN	O	t	nn	20	SENT_359	[p19l1901t767r1986b832],
20	]	NN	O	]	appos	5	SENT_359	[p19l1901t767r1986b832],
21	,	,	O	,	_	0	SENT_359	[p19l1901t767r1986b832],
22	et	FW	O	et	nn	23	SENT_359	[p19l2016t783r2064b818],
23	al.	FW	O	al.	appos	5	SENT_359	[p19l2089t766r2147b818],
24	.	.	O	.	_	0	SENT_359	[p19l2089t766r2147b818],

1	Genetic	JJ	O	genetic	amod	2	SENT_360	[p19l126t850r339b900],
2	variation	NN	O	variation	nsubj	5	SENT_360	[p19l363t851r606b900],
3	in	IN	O	in	_	0	SENT_360	[p19l635t851r688b900],
4	IL28B	NN	O	il28b	prep_in	2	SENT_360	[p19l717t851r889b900],
5	predicts	VBZ	O	predict	_	0	SENT_360	[p19l919t848r1132b918],
6	hepatitis	NN	O	hepatitis	dobj	5	SENT_360	[p19l1161t848r1391b918],
7	C	NN	O	c	prep	6	SENT_360	[p19l1422t850r1467b900],
8	treatment-induced	JJ	O	treatment-induced	amod	10	SENT_360	[p19l1497t848r2006b901],
9	viral	JJ	O	viral	amod	10	SENT_360	[p19l2032t848r2151b900],
10	clearance	NN	O	clearance	dep	7	SENT_360	[p19l125t932r385b984],
11	.	.	O	.	_	0	SENT_360	[p19l125t932r385b984],

1	Nature	NNP	O	Nature	_	0	SENT_361	[p19l415t935r606b985],
2	2009	CD	DATE	2009	num	1	SENT_361	[p19l633t932r1167b991],
3	;	:	O	;	_	0	SENT_361	[p19l633t932r1167b991],
4	461:399	CD	NUMBER	461:399	number	5	SENT_361	[p19l633t932r1167b991],
5	-401	CD	NUMBER	-401	dep	1	SENT_361	[p19l633t932r1167b991],
6	.	.	O	.	_	0	SENT_361	[p19l633t932r1167b991],

1	SUZUKI	NNP	O	SUZUKI	nn	3	SENT_362	[p19l1447t1036r1702b1087],
2	ET	NNP	O	ET	nn	3	SENT_362	[p19l1730t1035r1816b1086],
3	AL.	NNP	O	AL.	_	0	SENT_362	[p19l1833t1036r1933b1087],
4	421	CD	NUMBER	421	dep	3	SENT_362	[p19l2046t1034r2144b1086],

1	23	CD	NUMBER	23	_	0	SENT_363	[p19l7t1253r89b1303],
2	.	.	O	.	_	0	SENT_363	[p19l7t1253r89b1303],

1	Suppiah	NNP	O	Suppiah	nn	2	SENT_364	[p19l125t1248r349b1318],
2	V	NNP	O	V	_	0	SENT_364	[p19l384t1251r439b1308],
3	,	,	O	,	_	0	SENT_364	[p19l384t1251r439b1308],
4	Moldovan	NNP	MISC	Moldovan	nn	5	SENT_364	[p19l479t1248r761b1301],
5	M	NNP	O	M	appos	2	SENT_364	[p19l799t1251r877b1308],
6	,	,	O	,	_	0	SENT_364	[p19l799t1251r877b1308],
7	Ahlenstiel	NNP	PERSON	Ahlenstiel	nn	8	SENT_364	[p19l914t1248r1189b1301],
8	G	NNP	PERSON	G	appos	5	SENT_364	[p19l1228t1250r1292b1308],
9	,	,	O	,	_	0	SENT_364	[p19l1228t1250r1292b1308],
10	Berg	NNP	PERSON	Berg	nn	11	SENT_364	[p19l1334t1251r1459b1319],
11	T	NN	O	t	appos	5	SENT_364	[p19l1495t1249r1547b1308],
12	,	,	O	,	_	0	SENT_364	[p19l1495t1249r1547b1308],
13	Weltman	NNP	PERSON	Weltman	nn	14	SENT_364	[p19l1585t1248r1839b1301],
14	M	NNP	O	M	appos	5	SENT_364	[p19l1876t1251r1954b1308],
15	,	,	O	,	_	0	SENT_364	[p19l1876t1251r1954b1308],
16	Abate	NNP	ORGANIZATION	Abate	nn	17	SENT_364	[p19l1991t1248r2151b1301],
17	ML	NNP	ORGANIZATION	ML	appos	5	SENT_364	[p19l124t1336r242b1392],
18	,	,	O	,	_	0	SENT_364	[p19l124t1336r242b1392],
19	et	FW	O	et	nn	20	SENT_364	[p19l283t1350r331b1385],
20	al.	FW	O	al.	appos	5	SENT_364	[p19l370t1333r427b1385],
21	.	.	O	.	_	0	SENT_364	[p19l370t1333r427b1385],

1	IL28B	NN	O	il28b	nsubjpass	3	SENT_365	[p19l470t1336r643b1385],
2	is	VBZ	O	be	auxpass	3	SENT_365	[p19l683t1336r720b1385],
3	associated	VBN	O	associate	_	0	SENT_365	[p19l761t1333r1030b1386],
4	with	IN	O	with	_	0	SENT_365	[p19l1066t1333r1190b1385],
5	response	NN	O	response	prep_with	3	SENT_365	[p19l1228t1353r1460b1402],
6	to	TO	O	to	_	0	SENT_365	[p19l1499t1350r1551b1385],
7	chronic	JJ	O	chronic	amod	12	SENT_365	[p19l1591t1332r1797b1385],
8	hepatitis	NN	O	hepatitis	nn	12	SENT_365	[p19l1834t1332r2064b1402],
9	C	NN	O	c	nn	12	SENT_365	[p19l2105t1335r2150b1385],
10	interferon	NN	O	interferon	nn	12	SENT_365	[p19l125t1416r569b1486],
11	—	NN	O	—	nn	12	SENT_365	[p19l125t1416r569b1486],
12	alpha	NN	O	alpha	prep_to	3	SENT_365	[p19l125t1416r569b1486],
13	and	CC	O	and	_	0	SENT_365	[p19l595t1416r695b1469],
14	ribavirin	NNP	O	ribavirin	nn	15	SENT_365	[p19l721t1416r954b1468],
15	therapy	NN	O	therapy	prep_to	3	SENT_365	[p19l980t1416r1192b1486],
16	.	.	O	.	_	0	SENT_365	[p19l980t1416r1192b1486],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_366	[p19l1222t1419r1325b1468],
2	Genet	NNP	PERSON	Genet	_	0	SENT_366	[p19l1352t1418r1518b1468],
3	2009	CD	DATE	2009	num	2	SENT_366	[p19l1543t1416r2113b1476],
4	;	:	O	;	_	0	SENT_366	[p19l1543t1416r2113b1476],
5	41:1100	CD	NUMBER	41:1100	number	6	SENT_366	[p19l1543t1416r2113b1476],
6	—	CD	NUMBER	—	dep	2	SENT_366	[p19l1543t1416r2113b1476],
7	1104	CD	DATE	1104	dep	6	SENT_366	[p19l1543t1416r2113b1476],
8	.	.	O	.	_	0	SENT_366	[p19l1543t1416r2113b1476],

1	24	CD	NUMBER	24	_	0	SENT_367	[p19l7t1500r89b1552],
2	.	.	O	.	_	0	SENT_367	[p19l7t1500r89b1552],

1	Tanaka	NNP	PERSON	Tanaka	nn	2	SENT_368	[p19l123t1500r321b1553],
2	Y	NN	PERSON	y	_	0	SENT_368	[p19l353t1503r403b1560],
3	,	,	O	,	_	0	SENT_368	[p19l353t1503r403b1560],
4	Nishida	NNP	PERSON	Nishida	nn	5	SENT_368	[p19l441t1500r657b1553],
5	N	NNP	O	N	appos	2	SENT_368	[p19l690t1503r759b1560],
6	,	,	O	,	_	0	SENT_368	[p19l690t1503r759b1560],
7	Sugiyama	NNP	PERSON	Sugiyama	nn	8	SENT_368	[p19l798t1502r1062b1571],
8	M	NNP	O	M	appos	5	SENT_368	[p19l1096t1503r1174b1560],
9	,	,	O	,	_	0	SENT_368	[p19l1096t1503r1174b1560],
10	Kurosaki	NNP	PERSON	Kurosaki	nn	11	SENT_368	[p19l1213t1500r1456b1553],
11	M	NNP	O	M	appos	5	SENT_368	[p19l1492t1503r1570b1560],
12	,	,	O	,	_	0	SENT_368	[p19l1492t1503r1570b1560],
13	Matsuura	NNP	PERSON	Matsuura	nn	14	SENT_368	[p19l1608t1503r1871b1553],
14	K	NNP	PERSON	K	appos	5	SENT_368	[p19l1906t1503r1965b1560],
15	,	,	O	,	_	0	SENT_368	[p19l1906t1503r1965b1560],
16	Sakamoto	NNP	PERSON	Sakamoto	nn	17	SENT_368	[p19l2005t1500r2150b1553, p19l125t1602r268b1637],
17	N	NNP	O	N	appos	5	SENT_368	[p19l307t1588r376b1645],
18	,	,	O	,	_	0	SENT_368	[p19l307t1588r376b1645],
19	et	FW	O	et	nn	20	SENT_368	[p19l417t1602r465b1637],
20	al.	FW	O	al.	appos	5	SENT_368	[p19l503t1585r561b1637],
21	.	.	O	.	_	0	SENT_368	[p19l503t1585r561b1637],

1	Genome	NNP	O	Genome	dep	3	SENT_369	[p19l604t1584r991b1638],
2	—	CD	NUMBER	—	num	1	SENT_369	[p19l604t1584r991b1638],
3	wide	JJ	O	wide	amod	4	SENT_369	[p19l604t1584r991b1638],
4	association	NN	O	association	_	0	SENT_369	[p19l1030t1588r1325b1637],
5	of	IN	O	of	_	0	SENT_369	[p19l1364t1584r1425b1637],
6	IL28B	NN	O	il28b	prep_of	4	SENT_369	[p19l1455t1588r1628b1637],
7	with	IN	O	with	_	0	SENT_369	[p19l1665t1585r1789b1637],
8	response	NN	O	response	prep_with	6	SENT_369	[p19l1827t1605r2059b1654],
9	to	TO	O	to	aux	10	SENT_369	[p19l2097t1602r2149b1637],
10	pegylated	VBN	O	pegylate	infmod	6	SENT_369	[p19l124t1674r383b1744],
11	interferon	NN	O	interferon	nn	12	SENT_369	[p19l422t1673r866b1743],
12	—	NN	O	—	nsubj	13	SENT_369	[p19l422t1673r866b1743],
13	alpha	NN	O	alpha	xcomp	10	SENT_369	[p19l422t1673r866b1743],
14	and	CC	O	and	_	0	SENT_369	[p19l905t1674r1005b1727],
15	ribavirin	NNP	O	ribavirin	nn	16	SENT_369	[p19l1045t1674r1277b1726],
16	therapy	NN	O	therapy	conj_and	6	SENT_369	[p19l1317t1673r1523b1743],
17	for	IN	O	for	_	0	SENT_369	[p19l1560t1673r1638b1726],
18	chronic	JJ	O	chronic	amod	22	SENT_369	[p19l1676t1673r1882b1726],
19	hepatitis	NN	O	hepatitis	nn	22	SENT_369	[p19l1919t1674r2150b1743],
20	C.	NNP	PERSON	C.	nn	22	SENT_369	[p19l126t1760r186b1810],
21	Nat	NNP	PERSON	Nat	nn	22	SENT_369	[p19l215t1761r319b1810],
22	Genet	NNP	PERSON	Genet	prep_for	16	SENT_369	[p19l346t1760r512b1810],
23	2009	CD	DATE	2009	num	22	SENT_369	[p19l537t1758r1107b1817],
24	;	:	O	;	_	0	SENT_369	[p19l537t1758r1107b1817],
25	41:1105	CD	DURATION	41:1105	dep	4	SENT_369	[p19l537t1758r1107b1817],
26	-1109	CD	DURATION	-1109	dep	25	SENT_369	[p19l537t1758r1107b1817],
27	.	.	O	.	_	0	SENT_369	[p19l537t1758r1107b1817],

1	25	CD	NUMBER	25	_	0	SENT_370	[p19l7t1846r89b1898],
2	.	.	O	.	_	0	SENT_370	[p19l7t1846r89b1898],

1	Maeda	NNP	PERSON	Maeda	nn	2	SENT_371	[p19l124t1842r311b1895],
2	T	NN	O	t	_	0	SENT_371	[p19l347t1844r399b1902],
3	,	,	O	,	_	0	SENT_371	[p19l347t1844r399b1902],
4	Sumi	NNP	PERSON	Sumi	nn	5	SENT_371	[p19l442t1845r583b1895],
5	S	NNP	PERSON	S	appos	2	SENT_371	[p19l623t1845r669b1902],
6	,	,	O	,	_	0	SENT_371	[p19l623t1845r669b1902],
7	Ueta	NNP	ORGANIZATION	Ueta	nn	8	SENT_371	[p19l712t1846r843b1895],
8	A	NNP	O	A	appos	5	SENT_371	[p19l877t1845r937b1902],
9	,	,	O	,	_	0	SENT_371	[p19l877t1845r937b1902],
10	Ohkubo	NNP	PERSON	Ohkubo	nn	11	SENT_371	[p19l980t1842r1208b1895],
11	Y	NN	PERSON	y	appos	5	SENT_371	[p19l1247t1846r1296b1902],
12	,	,	O	,	_	0	SENT_371	[p19l1247t1846r1296b1902],
13	Ito	NN	PERSON	ito	nn	14	SENT_371	[p19l1339t1846r1413b1895],
14	T	NN	O	t	appos	5	SENT_371	[p19l1452t1844r1505b1902],
15	,	,	O	,	_	0	SENT_371	[p19l1452t1844r1505b1902],
16	Marinaki	NNP	ORGANIZATION	Marinaki	nn	17	SENT_371	[p19l1547t1842r1799b1895],
17	AM	NNP	ORGANIZATION	AM	appos	5	SENT_371	[p19l1835t1845r1961b1902],
18	,	,	O	,	_	0	SENT_371	[p19l1835t1845r1961b1902],
19	et	FW	O	et	nn	20	SENT_371	[p19l2003t1860r2051b1895],
20	al.	FW	O	al.	appos	5	SENT_371	[p19l2089t1842r2147b1895],
21	.	.	O	.	_	0	SENT_371	[p19l2089t1842r2147b1895],

1	Genetic	JJ	O	genetic	amod	2	SENT_372	[p19l126t1934r339b1984],
2	basis	NN	O	basis	_	0	SENT_372	[p19l371t1932r497b1984],
3	of	IN	O	of	_	0	SENT_372	[p19l531t1931r593b1984],
4	inosine	NN	O	inosine	nn	7	SENT_372	[p19l618t1935r813b1984],
5	triphosphate	NN	O	triphosphate	nn	7	SENT_372	[p19l847t1932r1189b2001],
6	pyrophosphohydrolase	NN	O	pyrophosphohydrolase	nn	7	SENT_372	[p19l1223t1931r1846b2001],
7	deﬁciency	NN	O	deﬁciency	prep_of	2	SENT_372	[p19l1880t1931r2154b2001],
8	in	IN	O	in	_	0	SENT_372	[p19l125t2019r178b2067],
9	the	DT	O	the	det	11	SENT_372	[p19l204t2015r287b2068],
10	Japanese	JJ	MISC	japanese	amod	11	SENT_372	[p19l309t2019r546b2085],
11	population	NN	O	population	prep_in	2	SENT_372	[p19l572t2015r887b2085],
12	.	.	O	.	_	0	SENT_372	[p19l572t2015r887b2085],

1	Mol	NNP	ORGANIZATION	Mol	nn	3	SENT_373	[p19l917t2015r1030b2068],
2	Genet	NNP	O	Genet	nn	3	SENT_373	[p19l1058t2018r1225b2068],
3	Metab	NNP	O	Metab	_	0	SENT_373	[p19l1250t2015r1424b2068],
4	2005	CD	DATE	2005	num	3	SENT_373	[p19l1452t2019r1950b2075],
5	;	:	O	;	_	0	SENT_373	[p19l1452t2019r1950b2075],
6	85:271	CD	NUMBER	85:271	number	7	SENT_373	[p19l1452t2019r1950b2075],
7	-279	CD	NUMBER	-279	dep	3	SENT_373	[p19l1452t2019r1950b2075],
8	.	.	O	.	_	0	SENT_373	[p19l1452t2019r1950b2075],

1	26	CD	NUMBER	26	_	0	SENT_374	[p19l7t2101r89b2152],
2	.	.	O	.	_	0	SENT_374	[p19l7t2101r89b2152],

1	Sezaki	NN	O	sezakus	nn	2	SENT_375	[p19l125t2099r292b2152],
2	H	NN	O	h	_	0	SENT_375	[p19l321t2103r390b2159],
3	,	,	O	,	_	0	SENT_375	[p19l321t2103r390b2159],
4	Suzuki	NNP	PERSON	Suzuki	nn	5	SENT_375	[p19l421t2099r603b2153],
5	F	NN	O	f	appos	2	SENT_375	[p19l632t2103r672b2159],
6	,	,	O	,	_	0	SENT_375	[p19l632t2103r672b2159],
7	Kawamura	NNP	PERSON	Kawamura	nn	8	SENT_375	[p19l704t2103r1000b2153],
8	Y	NN	PERSON	y	appos	5	SENT_375	[p19l1024t2103r1074b2159],
9	,	,	O	,	_	0	SENT_375	[p19l1024t2103r1074b2159],
10	Yatsuji	NN	PERSON	yatsujus	nn	11	SENT_375	[p19l1102t2103r1284b2170],
11	H	NN	PERSON	h	appos	5	SENT_375	[p19l1313t2103r1382b2159],
12	,	,	O	,	_	0	SENT_375	[p19l1313t2103r1382b2159],
13	Hosaka	NNP	ORGANIZATION	Hosaka	nn	14	SENT_375	[p19l1413t2099r1618b2152],
14	T	NN	ORGANIZATION	t	appos	5	SENT_375	[p19l1642t2101r1695b2159],
15	,	,	O	,	_	0	SENT_375	[p19l1642t2101r1695b2159],
16	Akuta	NN	ORGANIZATION	akuta	nn	17	SENT_375	[p19l1721t2099r1890b2153],
17	N	NN	ORGANIZATION	n	appos	5	SENT_375	[p19l1915t2103r1984b2159],
18	,	,	O	,	_	0	SENT_375	[p19l1915t2103r1984b2159],
19	et	FW	O	et	nn	20	SENT_375	[p19l2015t2117r2062b2152],
20	al.	FW	O	al.	appos	5	SENT_375	[p19l2089t2099r2147b2152],
21	.	.	O	.	_	0	SENT_375	[p19l2089t2099r2147b2152],

1	Poor	NNP	O	Poor	nn	2	SENT_376	[p19l125t2192r252b2241],
2	response	NN	O	response	nsubj	11	SENT_376	[p19l292t2209r524b2258],
3	to	TO	O	to	aux	4	SENT_376	[p19l563t2206r615b2241],
4	pegylated	VBN	O	pegylate	infmod	2	SENT_376	[p19l655t2188r915b2259],
5	interferon	NN	O	interferon	dobj	4	SENT_376	[p19l955t2188r1226b2241],
6	and	CC	O	and	_	0	SENT_376	[p19l1266t2189r1366b2242],
7	ribavirin	NNP	O	ribavirin	conj_and	2	SENT_376	[p19l1406t2188r1639b2241],
8	in	IN	O	in	_	0	SENT_376	[p19l1678t2192r1731b2240],
9	older	JJR	O	older	amod	10	SENT_376	[p19l1771t2188r1910b2242],
10	Women	NNS	O	woman	prep_in	7	SENT_376	[p19l1948t2209r2151b2241],
11	infected	VBN	O	infect	_	0	SENT_376	[p19l125t2272r342b2325],
12	with	IN	O	with	_	0	SENT_376	[p19l369t2272r492b2325],
13	hepatitis	NN	O	hepatitis	nn	15	SENT_376	[p19l522t2272r752b2342],
14	C	NN	O	c	nn	15	SENT_376	[p19l784t2275r830b2325],
15	virus	NN	O	virus	prep_with	11	SENT_376	[p19l858t2276r989b2325],
16	of	IN	O	of	_	0	SENT_376	[p19l1021t2272r1083b2325],
17	genotype	NN	O	genotype	nn	18	SENT_376	[p19l1103t2290r1351b2343],
18	1b	NN	O	1b	prep_of	15	SENT_376	[p19l1387t2272r1448b2325],
19	in	IN	O	in	_	0	SENT_376	[p19l1480t2276r1533b2324],
20	high	JJ	O	high	amod	22	SENT_376	[p19l1562t2272r1684b2343],
21	Viral	JJ	O	viral	amod	22	SENT_376	[p19l1712t2272r1831b2325],
22	loads	NNS	O	load	prep_in	18	SENT_376	[p19l1861t2272r2014b2325],
23	.	.	O	.	_	0	SENT_376	[p19l1861t2272r2014b2325],

1	Dig	VB	O	dig	_	0	SENT_377	[p19l2049t2276r2153b2343],
2	Dis	NNP	O	Dis	nn	3	SENT_377	[p19l126t2361r218b2410],
3	Sci	NNP	O	Sci	dobj	1	SENT_377	[p19l246t2360r323b2410],
4	2009	CD	DATE	2009	dep	3	SENT_377	[p19l350t2358r921b2417],
5	;	:	O	;	_	0	SENT_377	[p19l350t2358r921b2417],
6	54:1317	CD	NUMBER	54:1317	number	7	SENT_377	[p19l350t2358r921b2417],
7	~	CD	NUMBER	~	dep	3	SENT_377	[p19l350t2358r921b2417],
8	1324	CD	DATE	1324	dep	7	SENT_377	[p19l350t2358r921b2417],
9	.	.	O	.	_	0	SENT_377	[p19l350t2358r921b2417],

1	27	CD	NUMBER	27	_	0	SENT_378	[p19l7t2445r89b2496],
2	.	.	O	.	_	0	SENT_378	[p19l7t2445r89b2496],

1	Atanasova	NNP	PERSON	Atanasova	nn	2	SENT_379	[p19l121t2443r401b2493],
2	S	NNP	O	S	_	0	SENT_379	[p19l428t2442r474b2500],
3	,	,	O	,	_	0	SENT_379	[p19l428t2442r474b2500],
4	Shipkova	NNP	O	Shipkova	nn	5	SENT_379	[p19l505t2440r758b2510],
5	M	NNP	O	M	appos	2	SENT_379	[p19l782t2443r860b2500],
6	,	,	O	,	_	0	SENT_379	[p19l782t2443r860b2500],
7	Svinarov	NNP	PERSON	Svinarov	nn	8	SENT_379	[p19l891t2442r1128b2493],
8	D	NNP	PERSON	D	appos	5	SENT_379	[p19l1153t2443r1220b2500],
9	,	,	O	,	_	0	SENT_379	[p19l1153t2443r1220b2500],
10	Mladenova	NNP	O	Mladenova	nn	11	SENT_379	[p19l1250t2440r1557b2493],
11	A	NNP	O	A	appos	5	SENT_379	[p19l1580t2443r1640b2500],
12	,	,	O	,	_	0	SENT_379	[p19l1580t2443r1640b2500],
13	Genova	NNP	ORGANIZATION	Genova	nn	14	SENT_379	[p19l1671t2442r1881b2493],
14	M	NNP	ORGANIZATION	M	appos	5	SENT_379	[p19l1907t2443r1985b2500],
15	,	,	O	,	_	0	SENT_379	[p19l1907t2443r1985b2500],
16	Wieland	NNP	PERSON	Wieland	nn	17	SENT_379	[p19l2013t2443r2150b2493, p19l124t2524r243b2577],
17	E	NNP	O	E	appos	5	SENT_379	[p19l275t2527r329b2584],
18	,	,	O	,	_	0	SENT_379	[p19l275t2527r329b2584],
19	et	FW	O	et	nn	20	SENT_379	[p19l364t2542r412b2576],
20	al.	FW	O	al.	appos	5	SENT_379	[p19l445t2524r502b2576],
21	.	.	O	.	_	0	SENT_379	[p19l445t2524r502b2576],

1	Analysis	NN	O	analysis	nsubj	10	SENT_380	[p19l535t2524r760b2593],
2	of	IN	O	of	_	0	SENT_380	[p19l794t2524r855b2576],
3	ITPA	NN	O	itpa	nn	5	SENT_380	[p19l880t2525r1031b2576],
4	phenotype-genotype	NN	O	phenotype-genotype	nn	5	SENT_380	[p19l1060t2524r1621b2595],
5	correlation	NN	O	correlation	prep_of	1	SENT_380	[p19l1654t2524r1949b2577],
6	in	IN	O	in	_	0	SENT_380	[p19l1982t2527r2035b2576],
7	the	DT	O	the	det	9	SENT_380	[p19l2068t2524r2151b2577],
8	Bulgarian	JJ	MISC	bulgarian	amod	9	SENT_380	[p19l126t2608r388b2679],
9	population	NN	O	population	prep_in	5	SENT_380	[p19l427t2608r728b2678],
10	revealed	VBD	O	reveal	_	0	SENT_380	[p19l768t2608r988b2661],
11	a	DT	O	a	det	13	SENT_380	[p19l1027t2630r1055b2661],
12	novel	JJ	O	novel	amod	13	SENT_380	[p19l1093t2608r1238b2661],
13	gene	NN	O	gene	dobj	10	SENT_380	[p19l1278t2629r1401b2679],
14	Variant	JJ	O	variant	amod	13	SENT_380	[p19l1439t2612r1629b2661],
15	in	IN	O	in	_	0	SENT_380	[p19l1668t2612r1720b2660],
16	exon	NN	O	exon	prep_in	10	SENT_380	[p19l1760t2629r1888b2661],
17	6	CD	NUMBER	6	num	16	SENT_380	[p19l1928t2610r1975b2661],
18	.	.	O	.	_	0	SENT_380	[p19l1928t2610r1975b2661],

1	Ther	NNP	O	Ther	nn	3	SENT_381	[p19l2017t2608r2152b2661],
2	Drug	NNP	O	Drug	nn	3	SENT_381	[p19l126t2695r270b2762],
3	Monit	NNP	O	Monit	_	0	SENT_381	[p19l295t2695r470b2744],
4	2007	CD	DATE	2007	num	3	SENT_381	[p19l495t2693r886b2752],
5	;	:	O	;	_	0	SENT_381	[p19l495t2693r886b2752],
6	29:6	CD	NUMBER	29:6	number	7	SENT_381	[p19l495t2693r886b2752],
7	—	CD	NUMBER	—	dep	3	SENT_381	[p19l495t2693r886b2752],
8	10	CD	NUMBER	10	dep	7	SENT_381	[p19l495t2693r886b2752],
9	.	.	O	.	_	0	SENT_381	[p19l495t2693r886b2752],

1	28	CD	NUMBER	28	_	0	SENT_382	[p19l7t2781r89b2829],
2	.	.	O	.	_	0	SENT_382	[p19l7t2781r89b2829],

1	Akuta	NN	O	akuta	nn	2	SENT_383	[p19l121t2776r284b2829],
2	N	NN	O	n	_	0	SENT_383	[p19l306t2779r374b2836],
3	,	,	O	,	_	0	SENT_383	[p19l306t2779r374b2836],
4	Suzuki	NNP	PERSON	Suzuki	nn	5	SENT_383	[p19l403t2776r578b2829],
5	F	NN	O	f	appos	2	SENT_383	[p19l605t2779r644b2836],
6	,	,	O	,	_	0	SENT_383	[p19l605t2779r644b2836],
7	Hirakawa	NNP	PERSON	Hirakawa	nn	8	SENT_383	[p19l673t2776r927b2829],
8	M	NNP	O	M	appos	5	SENT_383	[p19l951t2779r1028b2836],
9	,	,	O	,	_	0	SENT_383	[p19l951t2779r1028b2836],
10	Kawamura	NNP	PERSON	Kawamura	nn	11	SENT_383	[p19l1057t2779r1344b2829],
11	Y	NN	PERSON	y	appos	5	SENT_383	[p19l1366t2779r1415b2836],
12	,	,	O	,	_	0	SENT_383	[p19l1366t2779r1415b2836],
13	Yatsuji	NN	PERSON	yatsujus	nn	14	SENT_383	[p19l1440t2779r1614b2846],
14	H	NN	PERSON	h	appos	5	SENT_383	[p19l1642t2779r1709b2836],
15	,	,	O	,	_	0	SENT_383	[p19l1642t2779r1709b2836],
16	Sezaki	NN	PERSON	sezakus	nn	17	SENT_383	[p19l1738t2776r1898b2829],
17	H	NN	PERSON	h	appos	5	SENT_383	[p19l1925t2779r1992b2836],
18	,	,	O	,	_	0	SENT_383	[p19l1925t2779r1992b2836],
19	et	FW	O	et	nn	20	SENT_383	[p19l2021t2794r2067b2829],
20	al.	FW	O	al.	appos	5	SENT_383	[p19l2092t2776r2147b2829],
21	.	.	O	.	_	0	SENT_383	[p19l2092t2776r2147b2829],

1	Amino	NN	O	amino	nn	3	SENT_384	[p19l121t2868r307b2918],
2	acid	NN	O	acid	nn	3	SENT_384	[p19l335t2866r440b2919],
3	substitution	NN	O	substitution	nsubj	18	SENT_384	[p19l466t2865r776b2919],
4	in	IN	O	in	_	0	SENT_384	[p19l802t2869r854b2917],
5	hepatitis	NN	O	hepatitis	nn	9	SENT_384	[p19l879t2866r1099b2935],
6	C	NN	O	c	nn	9	SENT_384	[p19l1126t2868r1172b2918],
7	virus	NN	O	virus	nn	9	SENT_384	[p19l1196t2869r1321b2919],
8	core	NN	O	core	nn	9	SENT_384	[p19l1349t2886r1456b2918],
9	region	NN	O	region	prep_in	3	SENT_384	[p19l1483t2869r1648b2936],
10	and	CC	O	and	_	0	SENT_384	[p19l1674t2866r1772b2919],
11	genetic	JJ	O	genetic	amod	12	SENT_384	[p19l1796t2869r1981b2936],
12	Variation	NN	O	variation	prep_in	3	SENT_384	[p19l2004t2869r2149b2918, p19l125t2952r230b3001],
13	near	IN	O	near	_	0	SENT_384	[p19l257t2969r368b3001],
14	the	DT	O	the	det	17	SENT_384	[p19l394t2949r475b3001],
15	interleukin	NN	O	interleukin	nn	17	SENT_384	[p19l501t2949r785b3002],
16	28B	NN	O	28b	nn	17	SENT_384	[p19l811t2952r919b3001],
17	gene	NN	O	gene	prep_near	9	SENT_384	[p19l947t2969r1066b3019],
18	predict	VBP	O	predict	_	0	SENT_384	[p19l1091t2949r1275b3019],
19	Viral	JJ	O	viral	amod	20	SENT_384	[p19l1297t2949r1410b3001],
20	response	NN	O	response	dobj	18	SENT_384	[p19l1438t2969r1659b3019],
21	to	TO	O	to	_	0	SENT_384	[p19l1686t2967r1737b3001],
22	telaprevir	NN	O	telaprevir	prep_to	18	SENT_384	[p19l1764t2949r2008b3019],
23	with	IN	O	with	_	0	SENT_384	[p19l2031t2949r2151b3001],
24	peginterferon	NN	O	peginterferon	prep_with	22	SENT_384	[p19l124t3033r477b3104],
25	and	CC	O	and	_	0	SENT_384	[p19l496t3033r594b3086],
26	ribavirin	NNP	O	ribavirin	prep_with	22	SENT_384	[p19l613t3033r847b3086],
27	.	.	O	.	_	0	SENT_384	[p19l613t3033r847b3086],

1	HEPATOLOGY	NNP	O	HEPATOLOGY	_	0	SENT_385	[p19l871t3036r1202b3085],
2	2010	CD	DATE	2010	num	1	SENT_385	[p19l1219t3033r1697b3093],
3	;	:	O	;	_	0	SENT_385	[p19l1219t3033r1697b3093],
4	52:421	CD	NUMBER	52:421	number	5	SENT_385	[p19l1219t3033r1697b3093],
5	-429	CD	NUMBER	-429	dep	1	SENT_385	[p19l1219t3033r1697b3093],
6	.	.	O	.	_	0	SENT_385	[p19l1219t3033r1697b3093],

